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The world’s growing population is causing an ever increasing demand for clean safe drinking 
water. In some countries suitable sources of drinking water are becoming scarce and will not 
be able to satisfy future demand. Consequently, there is a need to find alternative sources of 
water that can be used for potable supply or to augment current sources. Advanced water 
treatment methods are now being examined to investigate whether treated domestic sewage 
effluent can be treated to drinking water standards and discharged upstream of a drinking 
water abstraction point; a process known as Indirect Potable Reuse (IPR). The aim of this 
project was to investigate biological activity associated with developmental exposure to IPR 
water at the various stages of treatment using zebrafish embryos. Embryos reared in water 
at different stages of the treatment process were observed for developmental abnormalities, 
and differences in gene expression (compared to an aquarium water control) were used to 
establish both the nature and persistence of these effects along the treatment process. In 
addition to the embryo assays, passive sampling devices, Pharmaceutical Polar Organic 
Integrative Sampler (Pharm-POCIS) were deployed over eight, four week periods to collect 
composite concentrated samples of some of the contaminants present in the effluent. These 
concentrated extracts were then used in an in vitro assay; an Enzyme Immunoassay (EIA) to 
measure the inhibition of prostaglandins (an indirect measure of inhibitors of cyclooxygenase 
activity). We compared our results of the bioassays with the large body of chemical analysis 
data recorded over a number of years from each of the treatments. The developmental 
exposures highlighted a low frequency of consistent abnormalities to the heart and spine, 
and also a lack of pigmentation. Gene expression analysis demonstrates the developmental 
stage of the embryo to have the greatest influence on global gene expression as opposed to 
the treatment. Single genes of interest included the two cytochrome P450s (cyp1a and 
cyp1b1) and somatolactin beta. Some of the pathways disrupted included steroid synthesis, 
retinol metabolism, tryptophan metabolism and melanogenesis. The latter was consistent 
with observations of some embryos devoid of pigment. Along the treatment process reverse 
osmosis seemed to cause the largest change to the gene expression. The extracts from less 
treated effluent inhibited prostaglandin production, however following reverse osmosis 
prostaglandin inhibition was greatly reduced. The chemical contaminantion is rgreatly 
reduced as the effluent progresses along the IPR treatment process, this is evident from 
both the chemical data and the biological assays. Reverse osmosis seems to have the 
greatest influence on the gene expression. The results have highlighted the importance of an 
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1.2 Research question 
1.2.1 Main aim 
The main aim of this project is to assess whether there is a reduction of biological activity in 
the product water from a recycled water plant, specifically from the indirect potable reuse 
(IPR) pilot plant that was being trialled at Deephams waste water treatment works, London 
UK 
1.3 Importance and relevance 
In 2010, the United Nations Resolution 64/292 recognised access to safe drinking water and 
sanitation as being essential human rights (United Nations, 2014). However, the world’s 
population is growing and increased incidences of extreme climate related events for 
example drought, flood, fire and storms, changes in nutrient loading and decreased water 
quality (Brookes et al., 2014) are placing vast amounts of pressure on the available potable 
water sources. Water scarcity is an increasing problem, including in the UK. Consequently, 
there is a need to find alternative sources of water that can be used for potable supply or to 
augment current sources. 
The water industries have for a long time relied upon surface and ground water sources, 
however increasing demand could cause these to be less sufficient for the growing needs of 
the population (Brookes et al., 2014). 
1.4 Environmental contaminants 
There are two main groups of environmental contaminants. Firstly, there are the ones known 
as legacy pollutants which include polycyclic aromatic hydrocarbons, polychlorinated 
biphenyls, dioxins and furans and chlorinated pesticides, for example DDT. These pollutants 
have been present in the environment for many years, their risks are understood, and 
legislation is in place to prevent and stop their release. However, due to the persistent nature 
of these compounds they are still widely detected. The other group of pollutants are known 
as emerging chemicals of concern, these include compounds such as endocrine disrupting 
chemicals, pharmaceuticals, personal care products, antibiotics and flame retardant 
(Burgess et al., 2013). New sources of water present new risks related to water quality and 
recycled water is reported to increase the risk of disinfection by-products, pathogens, 
antibiotic resistant bacteria, potentially endocrine disrupting compounds and cyanobacterial 
toxins (Brookes et al., 2014). 
There has been increased focus on the effect of chemicals present as a mixtures. For years 




effects of single chemicals, and from these studies safe levels have been suggested and 
used by regulators to protect both human and environmental health. Evidence has arisen 
that  effects can be observed from a mixture of chemicals whereby they are individually 
present at concentrations below that has been deemed safe, known as mixture effects 
(Kortenkamp, 2014). Consequently, the potential risks of mixture effects should be taken into 
account when considering media such as waste water effluents, especially if the end use of 










2.1 Water scarcity 
It is reported that, of the total volume of water on the planet, 97.5% of it is saline; 99.99% of 
which makes up the oceans, and the remaining volume is found in salt water lakes (Gray, 
2010). This leaves only 2.5% of the world’s water as non-saline, of which 75% forms the ice 
caps and glaciers, 24% resides as groundwater, with the remaining 1% being present in 
lakes, rivers and soil (Gray, 2010). Consequently, a relatively small amount of freshwater is 
available to supply all human needs and demands. 
With the world’s increasing population and the growing concentration of humans in urban 
areas, there is pressure on the availability of suitable potable water. The world’s population 
is increasing by approximately 80 million people per year, and by 2050, the world’s 
population is predicted to be 9.1 billion (United Nations, 2015). Of this global population, 
50% of people live in cities, with this proportion expected to increase over the next 30 years 
(United Nations, 2015). Moreover, between 1960 and 2012, global gross domestic product 
(GDP – a measure of economic growth) rose by an average of 3.5% per year, putting 
increasing burdens on social and environmental health. With this increasing population and 
rising consumption, demand for fresh water will inevitably increase to meet society’s needs 
for drinking water, adequate sanitation, industry, agriculture, and power generation. It is 
estimated that global water demand will increase by 55% by 2050 (United Nations, 2015) 
and that by 2050, agriculture will need to increase production by 60% and by 100% in 
developing countries. Additionally,  manufacturing industry is estimated to have increased 
production by 400% (United Nations, 2015). However, water scarcity is not a future threat; 






Figure 2.1. Total renewable water resource per capita in m
3
 in 2013 (United Nations, 2015). 
With global water demand predicted to increase, it is estimated that by 2030, worldwide, 
there will be a 40% water deficit if no action is taken (United Nations, 2015). 
In addition to growing population, climate change is predicted to exacerbate the situation in 
certain regions and seasons, due to more frequent extreme weather events (e.g. drought) 
that will impact the availability of the water supply whilst also driving up water demand. 
Changes in rainfall patterns will alter local water cycles, meaning surface and ground water 
sources, usually relied upon as the main source of potable water, may not be recharged 
sufficiently. Increased temperatures will greatly affect already stressed ecological systems, 
and there would be increased need for the use of pesticides. Nutrient loading will also be 
altered, causing eutrophication and an increased burden on the water companies to combat 
these issues before treated waste water is released back into the environment (Brookes et 
al., 2014; United Nations, 2015). 
The UK is certainly no exception; according to a report published by the English and Welsh 
Environment Agency in 2007, the southeast of England was classified as experiencing 
‘serious’ levels of water stress (Environment Agency, 2007). This report was updated in 
2013, and examined the current status of water stress in water company areas in England 
and Wales at present, and under four future scenarios. The report used three classifications 
of water stress; low, moderate and serious stress. The classification was based on 
abstraction, discharge and management and storage of water, and is a measure of stress on 




‘moderate’ or ‘low’ water stress now, future changes to population and/or climate could 
change this stress level to ‘serious, and therefore, the water users and water companies 
should not become complacent (Environment Agency and Natural Resources Wales, 2013). 
Out of the twenty four water company areas in England and Wales, nine of them (three 
areas of Affinity Water (formerly Veolia Water Central), East and South East, Anglian Water, 
Essex & Suffolk Water; South East Water; Southern Water; Sutton & East Surrey Water; and 
Thames Water) were classified by the report as currently experiencing “serious” water 
stress. Also, following the four future scenarios, all of these areas remain classified as 
experiencing “serious” water stress (Environment Agency and Natural Resources Wales, 
2013). One other area (Portsmouth Water) changed classification from “moderate” water 
stress to “serious” water stress in two out of the four scenarios. Fourteen areas are classified 
by the report as currently experiencing “moderate” water stress (Bristol Water, Cambridge 
Water, Cholderton & District Water, Dee Valley Water, Dwr Cymru Welsh Water, 
Northumbrian Water, Portsmouth Water, Severn Trent Water, South Staffordshire Water, 
South West Water, United Utilities, Veolia Water Projects, Wessex Water and Yorkshire 
Water). Only one area out of the twenty four water company areas in England and Wales 
has been classified as currently experiencing “low” water stress (Sembcorp Bournemouth 
Water) (Environment Agency and Natural Resources Wales, 2013). 
In a regional context, the UK is one of nine European countries that is considered to be 
suffering from water scarcity. The other countries include Cyprus, Bulgaria, Belgium, Spain, 
Malta, FYR Macedonia, Italy and Germany (European Environment Agency, 2008). 
2.2 Chemical Contamination 
There has been a global rise in chronic non-infectious diseases, including obesity, 
heightened blood pressure, diabetes, metabolic syndrome, and certain cancers 
(WHO/UNEP, 2013). Increases in human diseases have been coupled with observations 
made in wildlife that are associated with exposure to specific chemicals. For example, DNA 
methylation in the brain stem of polar bears in Greenland has been associated with 
exposure to mercury, and mercury exposure has been associated with observed 
neurological deficits in Inuit children (WHO/UNEP, 2013). Additionally, reproductive and 
developmental effects have been reported in male fish and amphibians in urban and 
agricultural areas, respectively. These diverse effects include genital deformities, decreases 
in semen quality and changes to sex hormones, and their occurrence is mirrored by similar 
increases in abnormalities in the human population (WHO/UNEP, 2013). Therefore, there 
has been increased attention focussed on the risk of chemical exposure and diseases in 




Since 1970, the quality of Europe’s surface waters has greatly improved as a result of a 
number of directives set by the European Union (Bueno et al., 2012). One of these was the 
Urban Waste Water Treatment Directive (91/271/EEC) which was adopted in May 1991. 
This directive had the objective of protecting the aquatic environment for biota, recreation, 
and its use for drinking water, sanitation, industry and commerce (DEFRA, 2012). Urban 
waste water, as referred to in this directive, is defined as the mixture of domestic waste 
water (household waste from kitchens, bathrooms and toilets), industrial waste water 
discharged to sewers, and rainwater run-off draining to sewers (DEFRA, 2012). In October 
2000, another European directive was adopted, the Water Framework Directive (WFD) 
2000/60/EC, and under this directive, chemical contamination is specifically dealt with under 
Decision 2455/2001/EC (Bueno et al., 2012; DEFRA, 2012). The WFD protects surface 
waters by considering all sources of pollution (point and diffuse sources) using a catchment 
based approach (DEFRA, 2012). In 2008, under Decision 2455/2001/EC, 33 substances 
were identified as priority substances, after which a further 8 other pollutants were added 
(Table 2.1 and Table 2.2, respectively). These all had Environmental Quality Standards 
(EQSs) applied to them to protect surfaces waters (rivers, lakes, transitional and coastal 
waters) (European Commission, n.d.-b). These 33 substances were decided upon based on 
their toxicity, persistence in the environment, bioaccumulation, and use, and consequently 
increased risk of them entering surface waters (Bueno et al., 2012). This list of priority 
substances is being continuously reviewed and amended, especially in light of new 
emerging chemicals of concern. In 2012, 15 additional priority substances were added, 6 of 
which were designated as priority hazardous substances, and previous EQSs were reviewed 
and revised. Additionally biota standards were set for several substances where it was 
deemed that due to a substance’s bioaccumulation, a biota standard was more appropriate 
and protective than a standard for water, as the chemical would be present in the biota 
rather than the water column (European Commission, n.d.-b). The fifteen newly proposed 
substances were as follows; six plant protection substances - Aclonifen, Bifenox, 
Cypermethrin, Dicofol, Heptachlor and Quinoxyfen; three substances used as biocidal 
products - Cybutryne, Dichlorvos and Terbutryn; two industrial chemicals - Perfluorooctane 
sulfonic acid (PFOS) and Hexabromocyclodidecane (HBCDD); combustion by-products - 
dioxin and Dioxin-Like polychlorinated byphenyls (PCBs), and three pharmaceuticals - 17 
alpha-ethinylestradiol (EE2), 17 beta-estradiol (E2) and Diclofenac (European Commission, 
2015). The inclusion of the pharmaceuticals was not intended to cast doubt on their 
therapeutic value, but rather to acknowledge the potential adverse effects they have on the 





Table 2.1 The 33 priority substances as identified in Annex II of Directive 2008/105/EC (European 
Commission, n.d.-a) 
Number Chemical name CAS RN EC number 




3 Atrazine 1912-24-9 217-617-8 




Pentabromodiphenylether (congener numbers 28, 47, 99, 100, 
153 and 154) 
32534-81-9 N/A 










10 1,2-Dichloroethane 107-06-2 203-458-1 
11 Dichloromethane 75-09-2 200-838-9 
12 Di(2-ethylhexyl)phthalate (DEHP) 117-81-7 204-211-0 
















19 Isoproturon 34123-59-6 251-835-4 
20 Lead and its compounds 7439-92-1 231-100-4 
21 Mercury and its compounds
a 
7439-97-6 231-106-7 
22 Naphthalene 91-20-3 202-049-5 







25 Octylphenols 1806-26-4 217-302-5 
































31 Trichlorobenzenes 12002-48-1 234-413-4 
32 Trichloromethane (chloroform) 67-66-3 200-663-8 
33 Trifluralin 1582-09-8 216-428-8 









Table 2.2 The list of 8 additional other pollutants amended by Directive 88/347/EEC and 90/415/EEC 
(European Commission, n.d.-a) 





























a: This substance is not a priority substance, but one of the other pollutants for which the EQS are identical to 
those laid down in the legislation that applied prior to 13 January 2009 
b: DDT total comprises the sum of the isomers listed in the reference European Commission, n.d. 
In 2001, an international treaty known as the Stockholm Convention, calling for the 
elimination and restriction of Persistent Organic Pollutants (POPs), was signed and brought 
into force in 2004. Initially, there were 12 chemicals nominated (nicknamed the “dirty 
dozen”), but more recently this has risen to a total of 23 chemicals (Table 2.3) classified as 
priority POPs that are either intentionally or unintentionally produced (European Union, 
2015). 
The United Nations Environment Programme (UNEP) defined POPs as “chemical 
substances that remain in the environment, are transported over large distances, 
bioaccumulate through the food web, and pose a risk, causing effects to the environment 









Table 2.3 The 23 priority Persistent Organic Pollutants (POPs) as nominated under the Stockholm 
Convention which states their production and use must be restricted or eliminated (Stockholm 
Convention, n.d.) 
Compound Use Annex 
Aldrin Pesticide A 
Chlordane Pesticide A 
Chlordecone Pesticide A 
Dichlorodiphenyltrichlorethane (DDT) Pesticide B 
Dieldrin Pesticide A 
Endrin Pesticide A 
Heptachlor Pesticide A 
Hexabromobiphenyl Industrial chemical A 
Hexabromocyclododecane (HBCD) Industrial chemical A 
Hexabromodiphenyl ether and 
Heptabromodiphenyl ether 
Industrial chemicals A 
Hexachlorobenzene (HCB) Pesticide, Industrial chemical 
and Unintentional production 
C 
Alpha-Hexachlorocyclohexane Pesticide A 
Beta-Hexachlorocyclohexane Pesticide A 
Lindane Pesticide A 
Mirex Pesticide A 
Pentachlorobenzene Pesticide, Industrial chemical 
and Unintentional production 
C 
Perfluorooctane sulfonic acid and its salts and 
Perfluorooctane sulfonyl fluoride 
Industrial chemicals B 
Polychlorinated dibenzo-p-dioxins (PCDD) Unintentional production C 
Polychlorinated dibenzofurans (PCDF) Unintentional production C 
Polychlorobiphenyls (PCBs) Industrial chemical and 
Unintentional production 
C 
Technical endosulfan and its related isomers Pesticide A 
Tetrabromodiphenyl ether and 
pentabromodiphenyl ether 
Industrial chemical A 
Toxaphene Pesticide A 
Annex A: Elimination of the chemical’s use and production 
Annex B: Restriction of the production and use of the chemical 
Annex C: Unintentional production, therefore parties need to reduce the release of the chemical and where 




There are a vast number of chemicals in production and in use worldwide, and the exact 
figure is not known. However, in Europe there are estimated to be more than 140 000 
chemicals on the market (UNEP, 2013). It is predicted that under European legislation 
REACH (REACH-Registration, Evaluation, Authorisation & restriction of CHemicals) the 
registered number of chemical substances produced in a volume greater than one tonne will 
exceed 30 000 substances before 2018 (UNEP, 2013). This number of chemicals is 
increasing every year. To further illustrate this point, the US Environmental Protection 
Agency (USEPA) adds, on average, 700 new chemicals every year to its Toxic Substances 
Control Act (TSCA) inventory (UNEP, 2013). 
Despite the increasing demand for chemicals, there is a lack of toxicity and ecotoxicity data 
for approximately 95% of the chemical substances on the worldwide market (Lammer et al., 
2009). Knowledge regarding the nature or extent of the effects of the majority of chemicals 
that are present in the environment is, therefore, limited or non-existent. 
In recent years there has been increasing research on anthropogenic organic contaminants 
known as emerging contaminants, and there is growing fear that these substances could 
pose a threat to the environment, including the aquatic system, and consequently, human 
health. Emerging contaminants include the alkylphenols, flame retardants, hormones, 
pharmaceuticals and personal care products (PPCPs), steroids and pesticides. These 
contaminants can enter the environment via the domestic wastewater system via bathing, 
cleaning, laundry, use of toilets and improper disposal of unused pharmaceuticals (US 
Environmental Protection Agency, 2010).  
2.2.1 Chemical contaminants in the environment 
Trace amounts of various chemical contaminants and their biotransformation products 
remain in waste water effluent following treatment and are discharged into the aquatic 
environment.  These can include inorganic compounds, metals, persistent organic pollutants 
(including chemicals that exhibit endocrine disrupting properties), pharmaceuticals and their 
metabolites, disinfection by-product (DBPs) and others (Fatta-Kassinos et al., 2011). 
Whether they pose a threat to aquatic systems will depend on many factors, including their 
concentration in water, their ability to bioaccumulate in aquatic organisms, their biological 
potency and their mode of action. The main classes of chemical contaminants present in the 





Pharmaceuticals Personal Care Products (PPCPs) and their metabolites 
PPCPs include prescription and over-the counter therapeutic drugs, veterinary drugs, illicit 
drugs, diagnostic agents, cosmetics, fragrances, sun-screen products, drug metabolites and 
transformation products (Fatta-Kassinos et al., 2011).  
Due to incomplete removal during standard waste water treatment processes, PPCPs enter 
the environment via waste water treatment effluent. However, they can also get into the 
environment from the disposal of waste water treatment sludge to landfill, and direct 
application of veterinary medicines in aquaculture and agriculture, which would be added 
directly to the aquatic environment or enter via runoff (Brooks et al., 2010). Even if the input 
of PPCPs is relatively low, and even if they do not persist, the fact that they are being 
continuously used by the population (and therefore continuously discharged into the 
environment) makes them ‘pseudo persistent’ (Fatta-Kassinos et al., 2011). The 
pharmaceuticals which have been commonly detected in treated waste water effluents and 
also drinking water, include antibiotics, lipid regulators, anti-inflammatories, beta-blockers, 
cancer therapeutics and contraceptives (Fatta-Kassinos et al., 2011). Examples of some of 
these PPCPs are discussed below. 
Antibiotics are widely used in both human and veterinary medicine.  The main classes of 
antibiotics include: Aminoglycosides (e.g. Lincomycin); β-Lactams (e.g. Amoxicillin); 
2,4-Diaminopyrimidines (e.g. Trimethoprim); Macrolides (e.g. Erythromycin); Pleuromutilins 
(e.g. Tiamulin); Quinolones (e.g. Ciprofloxacin); Sulfonamides (e.g. Sulfamethoxazole); and 
Tetracyclines (e.g. Oxytetracycline) (Brooks et al., 2010). Antimicrobials include chemicals 
such as triclosan and triclocarbon, that are used in personal care products such as 
antibacterial hand gels, soaps and toothpastes.  
The fate and behaviour of antibiotics varies depending on their class. Quinolones are 
reported to be highly soluble in water and unlikely to adsorb to soil, sediment and suspended 
solids, whereas fluoroquinolones and macrolides are strongly adsorbed to soil, sediment and 
suspended sediment, and are therefore unlikely to be present in surface and groundwaters, 
unless directly discharged. Once bound to soil and sediment, it is reported that antibiotics 
persist.  For example, in chicken manure and soil, chlortetracycline had a half-life of more 
than 30 days, and in marine sediment oxytetracyline’s half-life was 150 days. 
Fluoroquinolones, sulfadiazine, sulfamethoxazole and sulfadimethoxine in sediment had 
half-lives greater than 30 days. Photodegradation is considered to be the main degradation 
pathway for several classes of antibiotics, with half-lives of only a few hours reported for 




sediment it is likely that photodegradation will be less important as a means of removal, 
meaning in turbid waters there could be increased half-lives (Brooks et al., 2010). 
One of the concerns surrounding antibiotic and antimicrobial substances entering the 
environment is that they target beneficial microorganisms. That is, upon entering the 
environment, they will adversely affect non-target microorganisms responsible for 
decomposition and nutrient cycling (Brooks et al., 2010) and may contribute to antibiotic 
resistance. The build-up of antibiotic resistant bacteria in the environment can occur due to 
direct release of antibiotics into the waste water system from patients prescribed antibiotics, 
and can also be gained from horizontal gene transfer, whereby resistant determinants are 
taken up through conjugation (whereby bacteria exchange DNA (plasmids) between 
individuals), transduction (virus introducing DNA) and transformation (genetic material is 
taken up from an external source for example from a lysed cell) (Fatta-Kassinos et al., 
2011). 
The presence of illicit drugs, or more notably, their metabolites, has been used to estimate a 
community’s drug usage. An example of this was an investigation that analysed waste water 
from treatment plants in cities in Italy, Switzerland and United Kingdom (UK). Residues of 
cocaine, opiates, cannabis and amphetamines were measured, and the results enabled the 
researchers to gain a better understanding of the different communities’ drug use. For 
example, the use of cocaine in Milan, Italy, was observed to markedly increase at weekends 
(Zuccato et al., 2008). 
The metabolites and biotransformation products of pharmaceuticals are also found to be 
present in both the influent and effluent of waste water treatment processes, and some of 
these are still biologically active. Following administration of a drug product either orally, 
parenterally and/or topically, it undergoes absorption, distribution, metabolism, and excretion 
(ADME). During the metabolism stage, to allow excretion, the compound can be made 
reactive. The degree of metabolism is also very much dependent on the compound itself; for 
example the antiepileptic drug carbamazepine, and the anti-anxiety drug diazepam, both 
undergo complete metabolisation, whereas iopromide and diatrizoate both leave the body 
unchanged, having undergone no metabolisation (Fatta-Kassinos et al., 2011). Metabolism 
occurs via two stages, phase 1 and 2: phase 1 metabolism involves the addition of a 
functional group, causing it to be more reactive. Phase 1 reactions include oxidation, 
hydroxylation, epoxidation, reduction and hydrolysis. The products from the phase 1 
reactions can then undergo metabolisation via phase 2 processes, including sulphation, 




processes produce highly polar conjugates that can be excreted in the urine or bile, and 
subsequently enter the waste water system (Fatta-Kassinos et al., 2011; Timbrell, 2001). 
 Endocrine Disrupting Chemicals (EDCs) 
It is now known that trace organic chemical contaminants found in waste water effluent have 
endocrine disrupting properties. These include natural and synthetic steroidal hormones 
which have been reported to elicit effects on organisms at extremely low concentrations, 
including concentrations that have been detected in the environment. A number of these 
effects have been observed in wildlife. Endocrine disrupting chemicals (EDCs) are described 
as being exogenous chemicals, which have a secondary, unintentional effect whereby 
following absorption to an organism they either mimic or block hormones and disrupt the 
normal functioning of the organism (Diamanti-Kandarakis et al., 2009; Schug et al., 2011). 
The disruption to hormones is a consequence of the EDCs altering normal hormone levels, 
inhibiting or stimulating the production of hormones or changing the process by which the 
hormones are transported around the body (Schug et al., 2011). Initially it was understood  
that EDCs only acted upon nuclear hormone receptors which include estrogen receptors, 
androgen receptors, progesterone receptors, thyroid receptors, retinoid receptors and others 
(Diamanti-Kandarakis et al., 2009; Schug et al., 2011). More recently it has been discovered 
that the mode of action of EDCs is much wider. In addition to interfering with nuclear 
receptor signalling, EDCs can act via nonsteroidal hormone receptors, nonsteroidal 
receptors, orphan receptors, transcriptional coactivators, enzymatic pathways involved in 
steroid biosynthesis and/or metabolism, and many other mechanisms that converge upon 
endocrine and reproductive systems (Diamanti-Kandarakis et al., 2009; Schug et al., 2011). 
Other mechanisms that EDCs act upon include direct action on the genes and epigenetic 
effects (Schug et al., 2011). The group of molecules which have been identified as having 
endocrine disrupting properties are varied in nature. They include chemicals used as 
industrial solvent/lubricants and their by-products (polychlorinated biphenyls (PCBs), 
polybrominated biphenyls (PBBs), dioxins), plastics (BPA), plasticisers (phthalates), 
pesticides (methoxychlor, chlorpyrifos, dichlorodiphenyltrichloroethane (DDT)), fungicides 
(vinclozolin) and pharmaceuticals agents (diethylstilbestrol (DES)). There are also a number 
of natural chemicals found in both human and animal food, these include phytoestrogens, 
including genistein and coumestrol, that also act as endocrine disruptors (Diamanti-
Kandarakis et al., 2009). 
  Oestrogenic substances are regularly detected in waste water effluents and the effects of 
these oestrogenic substances on non-target species, such as the wild fish population, are 
well documented. Effects include the induction of the egg yolk protein, vitellogenin (VTG) 




for oestrogenic effects of chemicals (Waller & Allen, 2010). It is reported that natural and 
synthetic oestrogens present in the waste water effluent are mainly responsible for the 
effluent’s oestrogenicity (Servos et al., 2005). Natural oestrogens include 17β-estradiol (E2) 
and estrone (E1) and the synthetic oestrogen, 17α-ethynylestradiol (EE2). EE2 is used in 
birth control pills and other oestrogen therapies.  This use as a pharmaceutical constitutes its 
main route into waste water (Waller & Allen, 2010). In a survey of 18 municipal waste water 
treatment effluents in Canada, E2 and E1 were reportedly detected at concentrations of 
2.4 to 26.0 ng/l (mean 15.6 ng/l) and 19 to 96 ng/l (mean 49 ng/l), respectively, in the 
influent. In the effluent, in the same survey, the concentrations of E2 and E1 were reported 
to range from 0.2 to 14.7 ng/l (mean 1.8 ng/l) and 1 to 96 ng/l (mean 17 ng/l), respectively. 
This monitoring study was conducted at treatment sites with varying treatment regimes 
(Servos et al., 2005). Another survey taking effluent samples from a number of UK waste 
water treatment plants, again with a variety of levels of treatment, but mostly receiving 
domestic waste water, were found to have E1 and E2 concentrations ranging from 1 to 
80 ng/l and 1 to 50 ng/l, respectively. In the effluent, EE2 was detected at between 0.2 and 
7.0 ng/l (Desbrow et al., 1998). Concentrations of these compounds that induce VTG 
production in male fish were tested. In the tests, Rainbow trout (Oncorhynchus mykiss) were 
observed to have increased VTG levels at E2 threshold concentration of between 1 and 
10 ng/l and for E1 the threshold concentration was between 25 and 50 ng/l (Routledge et al., 
1998). In other studies reported by Routledge et al., (1998), EE2 at 10 ng/l was reported to 
produce effects in trout and concentrations as low as 0.1 ng EE2/l were observed to 
increase VTG production in male trout. Thus, the environmentally relevant concentrations 
are within the range that have been found to induce VTG production in male fish. 
There are other chemicals that exhibit similar effects on the endocrine system, but often at 
higher concentrations, including plasticisers, pesticides and detergent degradation products 
(Fatta-Kassinos et al., 2011). Alkylphenols, used as precursor for detergents and as an 
additive for a number of compounds, are reported to be oestrogenic (Routledge & Sumpter, 
1997). Male Rainbow trout (O. mykiss) were exposed to an alkylphenol, 4-tert-octylphenol, at 
concentrations of 10 and 100 µg/l, and was observed to significantly increase the production 
of VTG and the threshold concentration for this compound was reported to be between 
1 and 10 µg/l in the trout and between 10 and 100 µg/l in roach (Rutilus rutilus) (Routledge 
et al., 1998). Bisphenol-A has been classified as a non-steroidal estrogenic compound. It is 
widely used particularly in the plastic industry for the production of polycarbonate, epoxy 
resins, unsaturated polyester-styrene resin and flame retardants (Al-Rifai et al., 2007; 
Fromme et al., 2002) and in consumer products such as coatings of cans, powder paints, 




is commonly found in waste water influent and effluent (Al-Rifai et al., 2007). A sampling 
survey conducted in 1997 in Germany, measured bisphenol-A and three phthalates in 
surface waters (lakes, rivers and channels), sediment (from the lakes, rivers and channels), 
sewage effluent and sewage sludge. Bisphenol-A was measured at concentrations ranging 
from 0.0005 to 0.41 µg/l, 0.018 to 0.702 µg/l, 0.01 to 0.19 mg/kg and 0.004 to 
1.363 mg/kg dry weight (dw) in surface water, sewage effluents, sediments, and sewage 
sludge, respectively (Fromme et al., 2002). Phthalates are another group of compounds 
which have been found to exhibit endocrine disrupting properties, with estrogenic and/or 
anti-androgenic activity (Oehlmann et al., 2008). They are widely used in the manufacture of 
polyvinyl chloride (PVC) and other resins and plasticisers. Many of the phthalates, along with 
bisphenol A, are classed as high production plasticisers, due to the large quantities being 
produced and wide-scale use; their release into the environment is continuous and they are 
regularly detected in environmental sampling. Phthalates are listed by the EU as priority 
pollutants; they are not specifically persistent, but because of their continuous release, they 
are always present (Oehlmann et al., 2008). They have a higher affinity to suspended solids 
and sediment as a consequence of their low water solubility (Fromme et al., 2002). Three of 
these phthalates, namely di(2-ethylhexyl)phthalate (DEHP), dibutyl phthalate and 
butylbenzyl phthalate (BBP), were surveyed, along with bisphenol A, in the 1997 German 
survey discussed above. DEHP was the most abundant of the three phthalates, with 
concentrations ranging from 0.33 to 97.8 µg/l, 1.74 to 182 µg/l, 27.9 to 154 mg/kg dw and 
0.21 to 8.44 mg/kg in surface water, sewage effluent, sewage sludge and sediment, 
respectively. dibutyl phthalate was detected at much lower concentrations compared to 
DEHP, and BBP was only detected in a few samples at very low concentrations (Fromme et 
al., 2002). Briefly, predicted no effect concentrations (PNECs) of 10 µg/l in water and 
3.1 mg/kg dw sediment have been derived for dibutyl phthalate. It is reported that endocrine 
disruption has been reported in embryos of Japanese medaka (Oryzias latipes) at DEHP 
concentration as low as 0.01 µg/l (Chikae et al., 2004). These values are low and, therefore, 
effects could have been elicited at some of the sites from the German study.  
Persistent Organic Pollutants (POPs) 
Combustion by-products, PCBs, dioxin and dioxin-like compounds, are amongst the 
15 newly proposed priority chemicals (European Commission, 2015) and are listed as 
priority POPs by the Stockholm Convention (European Union, 2015; Stockholm Convention, 
n.d.). Dioxins are made up of two groups; polychlorinated dibenzon-p-dioxins (PCDDs) and 
polychlorinated dibenzofurans (PCDFs). There are 75 structurally different chemicals in the 
PCDDs (dioxins) group, and 135 PCDFs (furans) (O’Neill, 1998; Wenning & Martello, 2010), 




are formed when chlorinated compounds are combusted at temperatures less than 1000⁰C 
(O’Neill, 1998). Together, the two different groups of dioxins are known as dioxin congeners. 
The number of chlorine atoms and the position of them on the phenyl rings determines the 
individual compound’s behaviour in the environment and its toxicity (O’Neill, 1998; Wenning 
& Martello, 2010). The most toxic of the congeners is 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(2,3,7,8-TCDD). Coplanar PCBs share common structural similarities to PCDDs and PCDFs, 
have associated mechanisms of toxicities, therefore are sometimes called dioxin-like PCBs 
(Wenning & Martello, 2010). 
PCDDs and PCDFs are detected widely in the environment; they are present both naturally 
and as a combustion by-product, and although they are not intentionally produced, have no 
known uses. PCBs are not natural, but PCDF is found as a large contaminate (WHO, 
2010b). The manufacture of PCBs is banned worldwide, but their release to the environment 
is still occurring via the disposal of large scale electrical equipment and waste. Due to 
dioxins’ persistence and bioaccumulation, the main human exposure route is via 
contaminated food (WHO, 2010b). Concentrations of dioxins in drinking and surface waters 
are generally reported to be low, as they are poorly water soluble, and therefore, are more 
likely to be found in soils and sediments, which can lead to contamination of food and biota, 
with a typical half-life in fatty tissues in humans of greater than 7 years (WHO, 2010b). 
Dioxins and dioxin-like substances have been reported to be associated with a large range 
of endpoints, including immunotoxicity, developmental and neurodevelopmental effects, and 
alteration to the thyroid and steroid hormones and reproductive function. Consequently, 
developing infants and children are particularly at risk to the adverse effects of these 
compounds (WHO, 2010b). In mammalian studies they have also been found to be 
carcinogenic (O’Neill, 1998). Epidemiological studies have found evidence of carcinogenicity 
in humans, and the International Agency for Research on Cancer (IARC) has classified 
TCDD as within Group 1, meaning it is carcinogenic to humans. PCBs as a group have been 
classified by IARC as within Group 2A, meaning that they are probably carcinogenic to 
humans (WHO, 2010b). 
 
 Metals 
Human health concerns associated with exposure to metals, including lead, cadmium, 
mercury and arsenic, are widely known (Järup, 2003). Lead, cadmium and mercury are all 
listed by the EU as priority pollutants (Table 2.1). Cadmium compounds are used in 




in the household waste, leading to release from landfill leachates (Järup, 2003). It is also 
used as an anti-corrosive (electroplated onto steel), as pigments in plastics and electronic 
components and nuclear reactors (WHO, 2011a). In the environment it is more likely to be 
associated with suspended particles and sediment; in environmental water it is found at 
levels <1 µg/l. In humans, cadmium is particularly toxic to the kidneys and has been linked to 
osteoporosis (Järup, 2003; WHO, 2011a). In laboratory mammalian studies, oral exposure 
has caused fertility effects, testicular changes, tumours of the prostrate, testes and 
haematopoietic system (WHO, 2011a). Increased risk of cancer has also been observed 
from epidemiological studies (WHO, 2011a). 
Lead is the most abundant heavy element on the planet. It is used for lead acid batteries, 
solder, alloys, cable sheathing, pigment, rust inhibitors, ammunition, glazes and plastic 
stabilisers. The use of lead compounds in petrol has been phased out in North America and 
Western Europe. Lead is also used in plumbing fittings and solder in water distribution 
systems. Lead pipes are still common in older properties in the UK. With the phase-out of 
leaded petrol, atmospheric levels have declined, and subsequently, so have inputs into 
surface waters. However, it is often detected in drinking water, due to its use in plumbing. 
Lead solder on drinking water pipes can lead to levels of between 210-390 µg/l, which is 
sufficient to cause intoxication in children (WHO, 2011b). Children are especially susceptible 
to lead exposure as they absorb up to 4-5 times as much as adults, who absorb 10% of what 
is present in food. Lead is also transferred to the foetus via the placenta in humans from 
12 weeks of gestation. Lead in young primates resulted in significant behavioural and 
cognitive deficits, including impaired activity, attention, adaptability, learning ability and 
memory as well as increased distractibility. In humans, the threat posed by chronic lead 
exposure is highest in infants, children up to 6 years of age and the unborn child. 
Epidemiological studies have found that lead exposure is associated with kidney disease, 
gonadal dysfunction (decreased sperm counts and effects in females), increased risk of 
preterm delivery and minor developmental malformations. Other endpoints associated with 
lead exposure include evidence to indicate that it is mutagenic, with proven neurological 
effects on infants and children (WHO, 2011b).  
Mercury is used as a cathode in the electrolytic production of chlorine and caustic soda, in 
electrical appliances, in industrial and control instruments, laboratory apparatus and as a raw 
material in fungicides, antiseptics, preservatives, pharmaceuticals, electrodes and reagents. 
However, over recent years, its industrial use has been reduced due to increasing 
environmental concerns. It is reported that in rainfall, levels of mercury range from 5 to 
100 ng/l (mean 1 ng/l). Mercury is naturally present in groundwater and surface waters at 




deposits. In the US and Japan, levels in wells have been recorded as high as 2 µg/l and 5.5 
µg/l, respectively. However, food is reported to be the main source of human exposure via 
fish and fish products. As with cadmium and lead, exposure to mercury can cause adverse 
effects to the kidney, but more importantly, it causes neurological disturbances (WHO, 
2005). 
Considering ecological concern, in the UK, copper has been ranked as being of greatest 
concern (Donnachie et al., 2014). Copper is reported to be detected in UK rivers at 
concentrations between 0.02 and 133 µg/l with the median of 4.7 µg/l, this is with lowest 
adverse effects in freshwater organisms being reported at 2.5 µg/l and 2.8 µg/l in periphyton 
(algae) and rainbow trout (O. mykiss), respectively (Donnachie et al., 2014). 
 Disinfection by-products 
There are reported to be over 500 disinfection by-products (DBPs). These DBPs are formed 
following reaction between the disinfectants routinely used during waste water and drinking 
water treatment (i.e. chlorine, chloramine, ozone, ultra violet radiation and chlorine dioxide), 
and naturally occurring organic matters (NOMs), inorganic matter (bromide and iodide) and 
chemical contaminants (Richardson et al., 2007). Consequently, the higher the concentration 
of NOMs in the water prior to disinfection, the greater the level of DBPs formed. Therefore, 
with increasing pressure on the already stressed water sources, there will be an increased 
tendency to use water with higher natural levels of NOMs, bromide and/or iodide which, 
under less stressed circumstances, would not be used as a potable source. In the UK, the 
Drinking Water Inspectorate (DWI) state that water treatment companies must take 
measures to minimise the production of DBPs, by removing DBP pre-cursors and taking 
steps not to create conditions that are specifically favourable for their formation (DWI, 2012). 
However, in the UK there are only drinking water regulations for a handful of DBPs. 
Trihalomethanes (THMs) as a group have a guideline level of 100 µg/l (this includes 
chloroform, bromoform, dibromochloromethane and bromodichloromethane) and 10 µg/l for 
bromate (DWI, 2012). Other DBPs include the group known as haloacetic acids (HAAs), 
formaldehyde, acetaldehyde, 3-chloro-4-(dichloromethyl)-5-hydroxy-2-(5H)-furanone (MX) 
and N-nitrosodimethylamine (NDMA). 
THMs in drinking water have been associated with increased occurrence of bladder cancer. 
Risk of cancer, mutagenicity and genotoxicity are the main focus surrounding the 
toxicological research in DBPs. There is evidence that emerging DBPs are more genotoxic 
than some of the regulated ones (Richardson et al., 2007). A review carried out in the US 




DBPs and iodinated DBPs were found to have the greatest genotoxic potency (Richardson 
et al., 2007), however there were still many data gaps. 
Pesticides 
Pesticides are designed to kill targeted pests (weeds, insects, fungi etc.) and they are 
released into environment in large volumes. They are heavily regulated and their occurrence 
in the environment is usually carefully monitored. However, research on the environmental 
risks posed by chemicals including pesticides is on-going, and as has been discussed 
previously, bans and restrictions on use can be put in place if new information comes to light 
to indicate that they pose an undue risk to human health and/or the environment. One such 
pesticide is atrazine, which is widely used globally to control annual broadleaf and grassy 
weeds. Atrazine belongs to the class of herbicides known as chlorotriazines and is a 
selective systemic herbicide (WHO, 2010a). It is now listed as an EC priority substance 
(Table 2.1) and since 2004 has been banned in the UK and the rest of Europe. However, 
due to its unusually high persistence, it is still being detected in UK and European waters. It 
is reported to cause intersex in frog and immunosuppression in amphibians and fish 
(WHO/UNEP, 2013). Atrazine altered the hypothalamic control of pituitary-ovarian function, 
which included the decrease of levels of prolactin and luteinising hormone (Birnbaum & 
Fenton, 2003).  
Another pesticide of interest is metaldehyde, which is the active ingredient in slug pellets. 
These are widely used both in agriculture and by amateur gardeners and are then washed 
into rivers and waste water treatment system. It has recently gained interest because it is 
often detected in UK drinking water at a concentration above the standard of 0.1 µg/l for 
pesticides and it is not removed by conventional treatment processes. The European Food 
Safety Authority (EFSA) reported that following repeat exposure in dogs, metaldehyde 
targeted the testes and prostate, and the liver in rats and mice. Some neurological effects 
were observed following acute exposure in rats, dogs and rabbits. However, it has not been 
found to be genotoxic or carcinogenic and mammalian tests have shown it to have no 
foetotoxicity or teratogenic effects (EFSA, 2010). Its high usage and poor removal from 
water treatment processes does raise its level of concern.  
Glyphosate is a broad spectrum herbicide, and is reported to have the highest production 
volume out of all herbicides currently on the market. It is detected in the air during spraying, 
surface waters and in food (Guyton et al., 2015). Glyphosate is most commonly used as a 
formulation known as Roundup, which contains glyphosate in the form of isoproylamine salt, 
along with various adjuvants to enhance glyphosate’s herbicidal properties, including 




are both extensively used in agriculture and as domestic and urban-area weed killers (Uren 
Webster et al., 2014). The use of genetically modified crops which are engineered to be 
resistant to glyphosate has increased its global usage (Al-Rajab & Hakami, 2014). 
Glyphosate is highly water soluble (10500 mg/l) with a half-life of 6 to 10 weeks in water and 
1 to 9 weeks in soil (Al-Rajab & Hakami, 2014). The International Agency for Research on 
Cancer (IARC) has classified glyphosate as a group 2A, meaning it is probably carcinogenic 
to humans. This classification is based on evidence in humans that it increased the risk of 
non-Hodgkin lymphomas, increases the incidence of renal tubule carcinoma in CD-1 male 
mice, increased incidence of haemangiosarcoma in male mice, increased incidence of 
pancreatic islet-cell adenoma in male rats and promoted skin tumours in an initiation-
promotion study in mice (Guyton et al., 2015). Glyphosate has also been reported to induce 
DNA and chromosomal damage in mammals in vivo and in human and animal cell in vitro 
assays, and it causes oxidative stress in studies in rodents and in vitro studies (Guyton et 
al., 2015). In the environment, glyphosate is degraded to aminomethylphosphoric acid 
(AMPA), both of these are detected in blood and urine samples taken from agricultural 
workers, as well as in the wider environment (Guyton et al., 2015). Worldwide concentrations 
of glyphosate in rivers have been reported up to  approximately 10-15 µg/l, with much higher 
concentrations being reported following direct application to the water body (Uren Webster et 
al., 2014). In laboratory studies, adverse effects in fish including DNA damage have been 
reported at environmentally relevant concentrations (Uren Webster et al., 2014). 
Chlorpyrifos is another pesticide which is widely used worldwide and in the UK. It is a 
broad-spectrum chlorinated organophosphate insecticide, nematicide and acaricide used for 
the control of pests on numerous crops as well as lawns and ornamental plants (John & 
Shaike, 2015). It is reported to be toxic, but it is not persistent, which has allowed its 
continued use and registration. However, even though it is reported not to persist its 
persistence in soil varies from a few days to  four years, this variability is dependent upon 
the climate and soil microorganisms (John & Shaike, 2015). Following application 
chlorpyrifos rapidly binds to soil and plants (Eaton et al., 2008). Due to this high affinity to 
soils, it has a low tendency to leach, but can reach surface waters when bound to 
suspended solids and particulates, and once in the water it will bind to sediments, with 
unbound residues undergoing volatilisation (Eaton et al., 2008; John & Shaike, 2015). 
Chlorpyrifos is reported to be still to be present in water following eight weeks and in 
sediments under anaerobic conditions the half-life is between 100 to 200 days (John & 
Shaike, 2015). The main target of chlorpyrifos is the central and peripheral nervous system, 
due to it being aacetylchlolinesterase (AChE) inhibitor (Eaton et al., 2008). It is reported that 




than the nervous system (Eaton et al., 2008). However, there are mammalian studies that 
have indicated that chlorpyrifos caused adverse effects on brain development, is 
reproductive toxicant, feototoxic, developmental neurotoxin and endocrine disruptor (John & 
Shaike, 2015). Chlorpyrifos is toxic to fish, it is reported to cause developmental, 
behavioural, neurological, oxidative, histopathological and endocrine effects in aquatic life. 
The lowest LC50 is reported to be 1.8 µg/l in bluegill sunfish (Lepomis macrochiru) (John & 
Shaike, 2015). 
 
2.3 Mixture/combination effects 
The health risk of all the above chemicals, chemical groups and classifications cannot be 
fully determined on the basis of their concentrations in the environment alone. Data are now 
available reporting that mixtures of chemicals (each individually present at concentrations 
below their predicted no effect concentration (PNEC) and therefore deemed to be safe), can 
cause adverse effects when in combination. It is considered, and has been found, that 
chemicals together in a mixture can have synergistic or antagonist effects. There are a 
number of approaches to test and predict these effects. The approaches include; 
concentration addition, toxicity equivalency factor, independent action, and effect 
summation. The theory behind concentration addition assumes that the components of a 
mixture behave in a similar way, and that if one of the components is removed, it can be 
replaced with another at a concentration that has the equivalent effectiveness of the one 
removed, and the overall effect of the mixture will remain unchanged. This means that every 
component in the mixture contributes a proportion of the overall effect. Therefore, when 
dealing with a mixture of components of similar effects, the concentration addition approach 
can be applied (Silva et al., 2002). Independent action is stated to be more applicable to 
mixtures where the components have differing mode of actions. Effect summation assumes 
that the mixture effect is caused by the arithmetic sum of the effects of the individual 
components of the mixture (Silva et al., 2002). However, as reviewed by Silva et al. (2002), 
there are doubts as to the reliability of this method. Tests that combined a number of 
xenoestrogens (including hydroxylated PCBs, benzophenones, parabens, bisphenol A and 
genistein) at concentrations below their individual NOECs or EC10s were carried out using 
the Yeast Estrogen Screen (YES). It was reported that concentration addition and toxicity 
equivalency factor were the most relevant approaches to calculate the additive mixture 
effects of these chemicals. From this it was concluded that the estrogenic agents tested at 
the concentration below the derived NOECs or EC10s were capable of acting together to 




In addition to mixtures of chemicals, in the environment, organisms can be exposed to 
chemicals as well as alterations conditions such as temperature, dissolved oxygen etc. This 
was investigated by Fitzgerald et al. (2016), whereby zebrafish embryos were exposed to 
low oxygen conditions and copper. It was observed that the during early development low 
oxygen levels reduced the effect of copper toxicity, however after hatching, at low oxygen 
concentrations, copper toxicity was increased due to increased up-take of the copper 
(Fitzgerald et al., 2016).  
2.4 Technical Solutions/Water treatment 
Waste water treatment plants are not specifically designed to remove the emerging 
contaminants discussed earlier, although many contaminants are removed or partly removed 
by waste water treatment systems, greatly reducing the environmental burden of chemical 
contaminants. Nevertheless, many chemical contaminants and chemicals of emerging 
concern are being increasingly detected in drinking water supplies. As with waste water 
treatment, drinking water treatment is not specifically designed to remove chemicals of 
emerging concern. Standard drinking water treatment systems typically consist of 
coagulation/flocculation and granular filtration which are designed to remove colloidal and 
suspended solids. Following this the water is then disinfected to inactivate and/or remove 
pathogens (US Environmental Protection Agency, 2010).  
The discharge of untreated waste water into the aquatic environment can cause 
environmental harm and adverse effects on the human population using the waterways. 
These effects include oxygen depletion, eutrophication, water-borne pathogens, sewage 
litter and sewage solids (DEFRA, 2012). Therefore, effective treatment processes have to be 
utilised. In the UK the sewer network consists of over 624 200 km of pipeline, which 
manages over 11 billion litres of waste water from domestic and industrial sources each day 
(DEFRA, 2012). Waste water treatment consists of five stages; preliminary treatment, 
primary (sedimentation) treatment, secondary (biological) treatment, tertiary treatment, and 
sludge treatment (DEFRA, 2012; Gray, 2010). The level of treatment given is dependent on 
a number of factors, including the size of the community the treatment plant serves, or more 
accurately, the population equivalent. This factor is a measure of the oxygen demand of the 
organic load, therefore it is specific to loading, rather than just a measure of the population in 
the catchment area (DEFRA, 2012). The level of treatment is also dependent on the 
discharge point, whether that is inland, estuarine or coastal waters, and if the place of 
discharge has been classified as sensitive (eutrophic or at risk of becoming eutrophic or 
used as an abstraction source, and if there is further protection on the area, such as bathing 




2.4.1 Preliminary treatment 
Preliminary treatment entails the removal of large solids and grit, separation of storm water 
and, when present in large amounts, the removal of oil and grease (Gray, 2010). Discharge 
of effluent into freshwater or estuarine systems with a population equivalent of <2000  (or 
coastal discharge when the population equivalent <10 000) is permitted under the Urban 
Waste Water Directive following only preliminary treatment (DEFRA, 2012). This level of 
treatment would remove very few, if any, chemical contaminants and pathogens. 
2.4.2 Primary (sedimentation) treatment 
The purpose of primary treatment is to remove settleable solids; the waste water enters the 
sedimentation tank at a speed that allows the fine solids to settle-out via gravity. This stage 
of the process produces a sludge (containing the settled solids) known as primary sludge 
(Gray, 2010). As well as gravity causing the suspended solids to settle out, floatation allows 
suspended solids which are less dense than water (e.g. oil and grease) to rise  to the 
surface, where they can be skimmed off using blades (Gray, 2010). Primary treatment 
reportedly removes between 30 and 40% of the biological oxygen demand (BOD), 40 to 70% 
of suspended solids, and up to 50% of faecal coliforms (Gray, 2010). The removal of 
suspended solids removes some chemical contaminants, in particular the ones adsorbed to 
the surfaces of the particles. Under the Urban Waste Water Directive, waste water with a 
population equivalent of between 2000 and 1000 and >10 000 can be discharged to 
estuarine and coastal water, respectively, if the receiving water has been classified as a 
“less sensitive area”. In the UK this was practiced up until the 1990’s, when the impact of this 
practice was realised. Consequently, from the late 1990s and early 2000s these “less 
sensitive area” designations were phased out and withdrawn completely. This means that 
secondary treatment is now the minimum requirement for all these cases (DEFRA, 2012). 
2.4.3 Secondary (biological) treatment 
Following primary treatment, the settled wastewater undergoes secondary treatment. This is 
a biological treatment whereby dissolved and colloidal organic matter is oxidised by 
microorganisms (Gray, 2010). It acts by treating the BOD and total suspended solids (TSS) 
(US Environmental Protection Agency, 2010). The microorganisms act under both aerobic 
and anaerobic conditions, and following treatment the wastewater has to be separated from 
the microbial biomass. This is achieved by secondary sedimentation, and produces an 
effluent known as clarified effluent (Gray, 2010). There are a number of different biological 
treatment methods, but the main ones used in the UK are the activated sludge process and 
filter trickling (DEFRA, 2012). Activated sludge treatment is designed to remove organic 




an aerated reactor, where a mixed microbial population utilises the biological load, removing 
the organic material, thus resulting in a reduced BOD load. The second stage consists of a 
settling tank, or clarifier, whereby the solids (activated sludge) are removed from the 
wastewater process. Some of this activated sludge is discarded, but a portion of it is 
recycled back into the first stage of the process (US Environmental Protection Agency, 
2010). Alternatively, the waste water is trickled over filter beds consisting of media with a 
large surface area, for example gravel. The large surface area of the media and the feed of 
organic matter from the waste water together with the addition of aeration, provides ideal 
conditions for the growth of biofilms on the surface of the media. The chemical nutrients in 
the water are consequently broken down by the microbial community in the biofilm, resulting 
in microorganism growth. Following the treatment, as with the activated sludge process, 
there is the production of sludge waste. Contaminants can therefore be removed during this 
process via biodegradation and/or adsorption on to solids. However, adsorption of chemicals 
to the sludge can become a concern when disposing of the activated sludge. Trickling filter 
systems have been found to be less effective at removing natural oestrogens (E1 and E2) 
compared to the activated sludge processes. However, plants which utilised a tertiary 
treatment process had much improved removal rates compared to that of secondary 
treatment process alone (Servos et al., 2005).  
A requirement of the Urban Waste Water Directive was that catchments with a population 
equivalent greater than 15000 had to be carrying out secondary treatment. In the UK, by the 
end of the year 2000 there was 90% compliance with this requirement. At the end of 2007, 
the UK was 99.9% compliant, there was just one catchment with a population equivalent of 
>15 000 without secondary treatment in Brighton and Hove (DEFRA, 2012). 
2.4.4 Tertiary/advanced treatment 
Due to the secondary treatment process only reducing the biological loading of waste water 
and reducing contaminants, in specific circumstances (such as when the discharge is into a 
sensitive area), a tertiary process can be required. There is an increasing demand for 
improved water quality, and this treatment step is designed to further treat the biologically 
treated effluent, to remove more of the BOD, suspended solids, bacteria, known chemical 
contaminants or nutrients (Gray, 2010). Tertiary treatments include prolonged settlement in 
lagoons, irrigation on to grassland or via percolation areas, straining through a fine mesh, 
sand or gravel filtration, membrane filtration, and disinfection using chlorination, ultraviolet 
and ozone treatments (Gray, 2010). In the UK, tertiary treatment is rarely used to treat waste 
water effluent, only in specific areas during summer months to protect bathing waters.  




A tertiary treatment used for waste water treatment and drinking water treatment is Granular 
activated carbon (GAC). Contaminants in the water being treated are adsorbed on to the 
GAC, and held on to the surface by chemical and physical bonding (US Environmental 
Protection Agency, 2010). GAC used for waste water treatment is produced in granular or 
powdered forms. Granular form is used as a fixed-bed column and the water being treated is 
passed through the bed (US Environmental Protection Agency, 2010). GAC treatment is 
effectively a final ‘polishing treatment’ step which will remove organic chemicals present at 
low concentrations. GAC is used as an advanced treatment step in wastewater treatment 
and in drinking water treatment (US Environmental Protection Agency, 2010). Powdered 
activated carbon (PAC) can be added at various stages of the treatment process and 
intermittently, making it a flexible treatment method. PAC is added directly into the treated 
water as a slurry and is  removed from the treated water in the sludge so cannot be reused 
like a GAC bed (Gray, 2010). The efficiency of GAC at removing a number of 
pharmaceuticals was tested in lab scale and pilot plant drinking water treatment processes, 
and was found to be highly effective at removing carbamazepine and diclofenac. GAC was 
used in this study as a final treatment step following ozonation, and it was found to  remove 
all the pharmaceuticals tested (e.g. carbamazepine, diclofenac, bezafibrate and primidone), 
including clofibric acid, which had proved resistant to ozonation (Ternes et al., 2002). 
 Disinfection 
Disinfection of treated water, whether treated effluent from a waste water treatment process, 
or abstracted water entering a drinking water treatment process, does not result in sterile 
water. However, it reduces the risk of infection by reducing the number of bacteria and 
viruses to an acceptable level (Gray, 2010).  
 Chlorination 
In the US, disinfection using chlorination is used as both an advanced waste water treatment 
step and in drinking water treatment, in the UK chlorination is used only in drinking water 
treatment. Its purpose is the same in both waste water and drinking water treatments; to 
inactivate and/or remove pathogens from the water (US Environmental Protection Agency, 
2010). Worldwide, chlorination is the most commonly used disinfection treatment for drinking 
water systems, but only widely used for effluent treatment in the USA; ultraviolet and ozone 
are more commonly used treatments as a tertiary process in Europe (Gray, 2010). Chlorine 
reacts with water to form hypochlorous acid and hydrochloric acid (Gray, 2010). The chlorine 
is used as either a gas or as concentrated hypochlorite liquid (US Environmental Protection 
Agency, 2010). However, when used as an advanced treatment step for waste water 
treatment, the water has to be dechlorinated before being discharged to the environment. 




removing chemical contaminants via oxidation and chlorination. However, this reaction is 
known in certain instances to form potentially harmful disinfection by-products (DBPs), such 
as chloroform (US Environmental Protection Agency, 2010). 
 Ultraviolet radiation  
Ultraviolet (UV) radiation can also be used as a disinfectant to inactivate pathogens in 
drinking water, and as an advanced treatment for waste water. UV light breaks the bonds in 
organic molecules (particularly benzene rings) and it reacts with water molecules to produce 
highly reactive hydroxyl radicals which then react with the organic molecules (US 
Environmental Protection Agency, 2010). These reactions may inactivate pathogens and 
transform contaminants. The reaction efficiency can be increased by adding hydrogen 
peroxide, thus increasing the concentration of hydroxyl radicals (US Environmental 
Protection Agency, 2010). Unlike chlorine, UV radiation has no residual action, therefore if it 
is being used to disinfect drinking water, it is usually only used in smaller treatment plants, 
where the consumers are in very close vicinity to the treatment process so as to avoid re-
contamination of the water (Gray, 2010). 
 Ozone 
Ozone is a strong oxidant and disinfectant, which inactivates pathogens and reacts with 
contaminants. Ozone is reported to directly oxidise contaminants and, like the UV treatment, 
reacts with water molecules to produce hydroxyl radicals that, in turn, react with the 
contaminants (US Environmental Protection Agency, 2010). Like UV treatment, ozonation 
can be improved by adding hydrogen peroxide, or coupling with UV radiation (US 
Environmental Protection Agency, 2010). Ozone is a strong oxidiser, but has  no residual 
treatment to protect the water in the distribution network (Gray, 2010). The efficiency of 
ozone at removing a number of pharmaceuticals was tested in lab scale and pilot plant 
drinking water treatment processes. Ozone at 0.5 mg/l removed diclofenac and 
carbamazepine by >90%, ozone at 1.0 and 1.5 mg/l removed 50% of primidone and 
bezafibrate, respectively. At 3.0 mg ozone/l, 10% and 20% of primidone and bezafibrate, 
respectively, remained. Although, even at the highest concentration of ozone treatment, 
namely 3 mg ozone/l, clofibric acid was only removed by <40% (Ternes et al., 2002).  
 Membrane filtration 
Membrane filtration is used in water treatment and other sectors that require separation; for 
example the food industry. It includes microfiltration, ultrafiltration, nanofiltration and reverse 





Figure 2.2 Illustration of the different membrane filtration processes, detailing the increasing pressure, 
decreasing pore size and increased removed efficiency of the different processes from microfiltration 
down to reverse osmosis (modified from Environmental Technology Centre, 2016). 
 Microfiltration 
Microfiltration removes suspended or colloidal particles by a sieving technique, which is 
dependent on the size of the pores in membranes relative to that of the size of the particles 
in the particulate matter (US Environmental Protection Agency, 2010). Microfiltration 
removes particles between 0.1 and 5 µm in size (Figure 2.2). Membranes can be either 
tubular, capillary, hollow fibre, or spirally wound sheets.  
 Ultrafiltration 
Similar to microfiltration, ultrafiltration (UF) removes suspended or colloidal particles using 
the same sieving technique explained above. However, the pores are much smaller, 
requiring the pressure to be much greater, up to 3000 kPa. The treated water is forced 
through the membrane and the concentrated particles are pumped to a waste tank. The size 
of the particles removed by UF, 0.1 to 0.01 µm (Figure 2.2), means that UF can remove 
bacteria, viruses and cellular fragments (pyrogens) (Gray, 2010).  
 Nanofiltration 
Nanofiltration (NF) is driven by pressure and utilises membranes that both allow diffusion 




water compared to that of reverse osmosis (RO, described below), but RO produces a 
higher quality of treatment. The particles size range that NF removes is between 0.01 and 
0.001 µm (Figure 2.2), and is used to remove colour, total organic carbon (TOC), humic acid 
and organic molecules (Gray, 2010). A study investigating the removal of a number of 
pharmaceuticals from a groundwater source using both NF and RO processes found that the 
removal efficiencies of the two processes were similar, and highly effective at greatly 
reducing the concentrations of the majority of the pharmaceuticals tested. The 
pharmaceuticals hydrochlorothiazide, propyhenazone, carbamazepine and gilbendamide 
were removed by >90%; ketoprofen sulfamethoxazole and metoprolol were removed by 
>80%; acetaminophen was removed by >70%; gemfibrozil by >40% and mefenaminc acid 
by >30%. Dicolfenac and sotalol were not detectable following treatment with NF 
(Radjenović et al., 2008). 
 Reverse osmosis 
Similar to the other membrane processes, reverse osmosis (RO) is operated under pressure 
and utilises a semi-permeable membrane (Gray, 2010; US Environmental Protection 
Agency, 2010). The movement of the water arises from different pressures (see Figure 2.3) 
and the movement will keep occurring until the pressure has equalised; this process is 
known as osmotic pressure (Gray, 2010). It has been designed to remove contaminants 
from water. The water is forced through the membrane, leaving the concentrate waste on the 
membrane, which then has to be treated and disposed of separately (US Environmental 
Protection Agency, 2010). Unlike MF and UF, the membranes on RO and nanofiltration 
remove contaminants that are dissolved (US Environmental Protection Agency, 2010). 
Reverse osmosis operates via diffusion-controlled transport, and allows water to pass 
through the membrane of an RO system, it leaves the concentrated salts on the untreated 
side of the membrane (Gray, 2010). The particles size range that RO removes is between 
0.001 and 0.0001 µm (Figure 2.2), and removes both organic and inorganic compounds. It is 
reported to remove metals such as aluminium, copper, nickel, zinc and lead at an average 
removal rate of between 94% and 98% of the total dissolved solids. The organic compounds 
it has been reported to remove include trihalomethanes (THMs), polychlorinated biphenyl 
(PCBs), pesticides, benzene, as well as others, with removal rates of between 85 and 90% 
(Gray, 2010). In the same study described in the NF section, RO had similar removal 
efficiencies for the following pharmaceuticals hydrochlorothiazide, propyhenazone, 
carbamazepine and gilbendamide were removed by >90%; ketoprofen was removed by 
>80%; metoprolol and sotalol were removed by >70%; acetaminophen was removed by 
>50%; gemfibrozil by >40% and mefenaminc acid by >30%. Dicolfenac and 





Figure 2.3 Schematic detailing the difference between osmosis and reverse osmosis (Aqua Technology 
Water Stores, 2015). 
2.4.5 Sludge treatment 
Sludge treatment simply consists of removing the water, then the stabilising and disposal of 
the sludge (Gray, 2010). Following primary treatment, the sludge consists of 95-96% water 
and, depending on the process, secondary sludge from an activate sludge process can 
consists of up to 98.5% water (Gray, 2010). Removal of water from the sludge can be 
achieved by addition of chemicals. The sludge needs to be stabilised to control the 
anaerobic degradation which takes place during storage. Stabilisation is reached via 
anaerobic digestion, aerobic digestion or lime addition (pH>11). Previously sludge was 
disposed of to surface waters or at sea, however at the end of 1998 this practice was ceased 
by the Urban Waste Water Directive (DEFRA, 2012). Now, the treated sludge is disposed of 
to land or incinerated (DEFRA, 2012; Gray, 2010). The sludge can also disposed of via 
anaerobic digestion; this process produces biogas which can be used as a renewable 
energy source (DEFRA, 2012). 




Worldwide, the total volume of water remains unchanged, but fluctuations occur in terms of 
its quality, physical state and availability, due to the hydrological cycle and rate of use in 
society. Due to this continuous movement of water, potable water, having been used in 
domestic and industrial processes, is carried by the sewers to waste water treatment works 
for treatment, and then recycled back into the drinking water system. 
It has been estimated that, globally, 20% of groundwater supplies are currently over-
exploited (United Nations, 2015). Consequently, there is a need to find alternative sources of 
water that can be used for potable supply, or to augment current sources. Water recycling 
(or water reuse) is one of those alternatives. There are two main types of water potable 
reuse, known as direct and indirect reuse. These are detailed below and Figure 2.4 
illustrates their general process. 
 
 
Figure 2.4 Schematic illustrating potable water reuse, including both direct (DPR) and indirect potable 
reuse (IPR) systems 
 
2.5.1 Direct Potable Reuse (DPR) 
Direct potable reuse describes the method that introduces waste water that has undergone 
waste water treatment, followed by a form of advanced treatment, directly into a drinking 
water distribution system. Direct reuse eliminates the intermediary ecological steps that 
would usually act upon the treated sewage or storm water in a standard treated waste water 




This method is only used in one place, Windhoek in Namibia (Dominguez-Chicas & 
Scrimshaw, 2010; Khan & Roser, 2007). The city of Windhoek relies on three reservoirs for 
70% of its water supply (du Pisani, 2006). In 1969, the potable water treatment plant that 
supplied potable water to the city of Windhoek was converted to be able to treat water from 
the reservoirs and the final effluent from the city’s wastewater treatment plant (du Pisani, 
2006). The treatment plant has undergone many upgrades, but following independence in 
1990, a new water recycling plant has been built, which now provides the city with 35% of its 
water requirements (du Pisani, 2006). The recycling project in Windhoek uses a multiple 
barrier system that includes: pre-ozonation, coagulation/flocculation, dissolved air flotation, 
dual media filtration, main ozonation, activated carbon filtration, ultrafiltration and finally 
chlorination (Lahnsteiner & Lempert, 2007, cited in Verstraete & Vlaeminck, 2011). 
2.5.2  Indirect Potable Reuse (IPR) 
There are two types of indirect potable reuse (IPR); unplanned (or incidental) and planned. 
This normal recycling process, known as unplanned or incidental IPR, occurs after the 
treated effluent is discharged upstream from a drinking water treatment abstraction point. 
This receiving water body acts as an ecological buffer over time (this can be weeks to years, 
but in UK rivers this would be only a few days), and works by natural degradation processes 
(biodegradation, photodegradation, adsorption etc.) and dilution (NRMMC et al., 2008). 
Planned IPR describes the reuse method where waste water that has undergone waste 
water treatment followed by advanced treatment is discharged to a water course. The 
treated water is then mixed with the receiving water and natural environmental processes 
occur, leading to further degradation of any contaminants and dilution. The mixture of 
recycled water and ambient water is then abstracted and added to the local drinking water 
treatment system (NRC, 1998). 
Planned IPR differs from what is often the case in unplanned processes in that it is the 
deliberate augmentation of potable water supplies with highly treated recycled water from 
conventional sewage treated processes (Khan & Roser, 2007). The potable water sources 
that are augmented with recycled water can be both surface waters (e.g. rivers and 
reservoirs) as well as groundwater sources (Khan & Roser, 2007). When an aquifer is 
recharged using recycled water it can be indirect, by infiltration, or direct, via injection into 
the subsurface (Drewes et al., 2003). Since 1962, indirect potable reuse via ground water 
recharge has been used in Los Angeles, USA (NRC, 1998). 
Singapore has been running a reuse scheme since 2003. Secondary treated effluent 
undergoes further treatment via micro- and ultra-filtration, reverse osmosis and ultraviolet 




collectively produce 30% of the country’s water requirements. However, the majority of this 
water is destined for non-potable uses (i.e. for industry), but 7.5% of this recycled water is 
now being used as planned indirect potable reuse through its addition to a reservoir and 
then going for further drinking water treatment, it now constitutes up to 2.5% of the city’s 
potable water needs (Verstraete & Vlaeminck, 2011). 
Australia boasts the largest water recycling facility in the Southern Hemisphere and the third 
largest in the world (Freeman et al., 2008; Lawrence et al., 2008; both cited by Hawker, 
Cumming, Neale, Bartkow, & Escher, 2011). This project uses treated wastewater from six 
existing wastewater treatment plants in the South East Queensland area (Hawker et al., 
2011). The existing wastewater treatment plants that feed the water-recycling project in 
Queensland undertake biological nutrient removal, producing treated water of secondary 
standard (Hawker et al., 2011). This water then undergoes advanced water treatment, which 
includes a dual membrane approach, utilising microfiltration and reverse osmosis, followed 
by advance oxidation (hydrogen peroxide /Ultra Violet (UV)). The water is then stabilised and 
finally disinfected with chlorine (Hawker et al., 2011). 
In this example from Queensland, it is reported that,  at present, the recycled treated water 
from the Advanced Water Treatment Plants (AWTPs) is being used only by coal-fired power 
stations (Queensland Water Commission, 2008; cited in Hawker et al., 2011). The current 
government policy states that the recycled water can only be used to recharge the reservoir, 
Lake Wivenhoe, when the combined dam levels in South East Queensland fall below 40% 
(Rodriguez et al., 2009; cited in Hawker et al., 2011). Due to large amounts of rainfall since 
the recycling project has been in operation, this 40% threshold has not yet been reached. 
Drewes et al. (2003) reported that in the USA indirect potable water reuse projects that have 
been established, or that have been proposed, used conventional secondary wastewater 
treatment, followed by tertiary filtration before soil-aquifer treatment (SAT). Before recycled 
water is injected into an aquifer or for surface water recycling projects in the USA, the water 
has to be treated using membrane technologies such as pre-treatment using microfiltration 
followed by nanofiltration or reverse osmosis (Drewes et al., 2003). In the project in 
California the recycling plant uses a treatment process that includes microfiltration, reverse 
osmosis, ultraviolet and hydrogen peroxide treatment. This highly treated water is used to 
recharge an aquifer, which also prevents saltwater intrusion (Verstraete & Vlaeminck, 2011). 
2.5.3 Issues surrounding water reuse 




The Water Reuse Foundation conducted a survey in both the US and UK, and one of the 
criteria was public perception and public acceptance of water reuse. It was reported that 
almost all the respondents found the use of recycled water for non-potable applications such 
as irrigation and industrial use generally acceptable. However, when asked whether recycled 
should be used in indirect potable reuse situations the responses were negative in nature 
(Miller, 2006). It is considered that there are two beliefs held that prevent the full acceptance 
of water reuse, “naturalness” and “contagion”. In the case of “naturalness”, the general 
public consider natural to be best, and the belief held is that waste water is not natural, 
whereas river water can be considered to be natural, even if it contains waste water from an 
earlier discharge point (unplanned IPR). The theory of “contagion” is that once the water is 
contaminated then it will always be contaminated (Miller, 2006). However, unplanned reuse 
is a well operated system in many parts of the world, including the UK.  
 Lack of uniform regulations 
Internationally, there are  reported to be vast differences between the standards and 
guidelines set for recycled water in each country (Miller, 2006). There is also a lack of limits 
and standards for new and emerging contaminants (Fatta-Kassinos et al., 2011).  The lack 
of consensus internationally is likely to hinder wider acceptance of what constitutes safe 
practice for recycled water within society. 
 Pricing of recycled water 
Recycling water is energy intensive, and the costs of supply are generally higher.  This will 
not be accepted publicly, thus it will be unprofitable for the water companies to invest in 
these technologies. Reuse systems are often more expensive than traditional potable 
systems, but water from reuse systems is often under-priced (subsidised) to encourage use 
and acceptance. However, this price discrepancy can be off-set later when the pressures on 
water sources increase. This in turn increases the value and positivity towards the reuse 
system (Miller, 2006). 
 Technologies 
There are a large number of different technologies for water reuse available and being used 
and trialled around the world. However if these are technologies are not paired with the 
end-use of the water, or potential future use, then these schemes will be unsuccessful 
(Miller, 2006). 
 Economics  
In the 1970s Perth, Australia, suffered with a reduction in rainfall of between 15 and 20%, 
which caused a 40% decrease in the levels of reservoirs, which was coupled with a rapid 




desalination plants to meet the city’s demands including the period of severe drought in 2010 
(Brookes et al., 2014). The authorities in Sydney and Adelaide also invested in desalination 
plants following droughts. However, unlike the Perth example, once the plants were finished, 
rainfall levels increased, and additional water supply from the new desalination plants was 
not required. Another example in Australia saw the authorities in Brisbane investing in a 
water reuse system to implement an indirect reuse system, following long persistent 
droughts. Similarly to the Sydney and Adelaide examples, rainfall increased, and the 
decision has been made to reduce the reliance on water reuse (Brookes et al., 2014).  
 Environmental impact 
The main purpose of water reuse is to provide an alternate water source or to augment 
existing sources. However, removing a treated waste water discharge from a river can have 
adverse environmental impact. It could cause low flows in rivers, especially during periods of 
reduced rainfall. This will impact the aquatic organisms and could, in turn, impact the 
recreational use of the water course, for example fishing.  
 Chemical and microbiological safety 
The quality of recycled water is normally based on standard determinants such as BOD, 
chemical oxygen demand (COD), pH, total suspended solids, metals and microbiological 
load, which includes viruses, bacteria and protozoa (Fatta-Kassinos et al., 2011). However, 
as already discussed, standard wastewater treatment often leaves trace chemical 
contaminants and microorganisms still present in the effluent. 
2.5.4 Trace chemical contaminants in recycled water 
It is reported that the two main issues related to potable water reuse are pathogens and 
residual organic constituents that are not completely removed by the conventional and 
advanced wastewater treatment processes (Drewes et al., 2003). The residual organic 
constituents of recycled water arise from three main sources: anthropogenic organic 
compounds added by consumers, natural organic matter (NOM) already found in drinking 
water, and soluble microbial products (SMPs) produced during wastewater treatment from 
the decomposition of organic material (Drewes et al., 2003).  
The number of potential contaminants in effluent is vast, and it is impractical, if not 
impossible, to screen for all known potential chemicals. Therefore, Total Organic Carbon 
(TOC) is often used as means of assessing the water quality. Drewes et al. (2003) reported 
that the State of California Department of Health Services proposed the use of TOC as 




Department of Health Services proposed a TOC concentration <0.5 mg/l for recycled water 
in groundwater abstracted for drinking water. 
In the large water-recycling project in Queensland, Australia, the water entering and leaving 
the Advanced Water Treatment Plants (AWTPs) has undergone chemical analysis. Between 
May and November 2008 the recycled water from the AWPTs underwent analysis for a total 
of 113 organic chemicals; these included DBPs, hormones, PPCPs, pesticides and other 
organic micro-pollutants as well as inorganic microbial analytes that had been detected in 
source wastewaters (Queensland Water Commission 2009; cited in Hawker et al., 2011). Of 
the 113 chemicals analysed, 15 were detected and quantified at least once (described below 
in terms of the maximum concentration detected in treated recycled water). The DBPs 
detected and quantified included: bromodichloromethane (8 µg/l), dibromochloromethane 
(2 µg/l), chloroform (16 µg/l), dichloroacetic acid (0.9 µg/l) and N-nitrosodimethylamine 
(NDMA) (0.01 µg/l); the contaminants considered to be good indicators of industrial waste 
detected and quantified included: 4-t-octylphenol (0.04 µg/l), bisphenol A (0.022 µg/l) and 
4-nonylphenol (0.069 µg/l for total nonylphenols); the PPCPs detected and quantified 
included: paracetamol (0.01 µg/l), salicylic acid (a breakdown product of aspirin) (0.01 µg/l) 
and N,N-diethyl-m-toluamide (DEET) (used in insect repellent) (0.01 µg/l); the pesticides 
detected and quantified included dalapon (0.02 µg/l) and triclopyr (0.03 µg/l); and the other 
contaminants detected and quantified included caffeine (consumer product) (0.03 µg/l) and 
cholesterol (natural product excreted  by mammals including humans) (0.011 µg/l) (Hawker 
et al., 2011). 
In this Queensland example, the planned destination for the recycled treated water was the 
reservoir, Lake Wivenhoe. Contaminants not removed by the advance treatment would 
undergo dilution upon entering the reservoir and also further attenuation will occur via 
volatilisation, sorption to suspended particles and sediment, hydrolysis, photolysis and 
biodegradation. 
When used in ecotoxicity testing, effluents from some advanced treatments have been 
observed to still cause adverse effects, including advanced treatments such as ozonation. It 
is considered that is potentially because transformation products are formed during the 
treatment, which are more toxic than the parent compounds (Lundström et al., 2010). For 
example, a life cycle test using harpacticoid copepod, Nitocra spinipes, was conducted to 
investigate juvenile development and survival when the animals were exposed to differently 
treated effluents. Effluent having undergone conventional treatment was observed to cause 
adverse effects. No effects on early development were found, but there was increase in time 




conventional treatment with the addition of ozonation (the lowest dose) resulted in the least 
degree of negative effects overall, and decreased the amount of time it took the copepods to 
reach sexual maturity. The effluent that had undergone conventional treatment with the 
addition of a moving bed biofilm reactor treatment combined with ozone, did not improve the 
quality of the treatment compared with ozone alone. The effluent that had undergone 
conventional treatment with the addition of active carbon treatment was observed to have 
more negative effects than the effluent that had the addition of ozone treatment. The authors 
suggested that this was due to activated carbon removing essential metal ions from the 
water. The time taken to reach sexual maturity was increased, and survival was decreased. 
The effluent that had undergone further treatment with UV and hydrogen peroxide caused 
few developmental and survival effects on the copepods over time, but there was still a 
negative effect at the population level (Lundström, Björlenius, et al., 2010). 
The effects of disinfection processes on the adverse effects effluents have on the immune 
system of juvenile rainbow trout (Oncorhynchus mykiss) were studied. Fish were exposed 
for 28 days to the effluent that had undergone primary treatment and then before and after 
one of the following treatments, UV, ozonation and peracetic acid. Fish exposed to the 
effluent from the primary treatment and all three disinfectant processes were observed to 
have significantly decreased in their mass:length ratios. Exposure to primary treated effluent 
resulted in significant increase in macrophage-related phagocytosis, the disinfection step 
removed this effect. However, ozonation resulted in a decrease in unstimulated and 
nitrogen-stimulated T lymphocyte proliferation compared to fish exposed to primary-treated 
or to aquarium water. T lymphocytes proliferation were stimulated in the fish exposed to 
peracetic acid (Hébert et al., 2008). 
Zebrafish embryos were exposed to a number of different effluents: embryos that were 
exposed to effluent that had undergone conventional treatment were observed to have 
significantly prolonged hatching times (in the 75% and 100% concentrations) compared to 
the control. In effluent that had undergone sand filtration, the hatching was prolonged in 
12.5%, 75% and 100% effluent concentration groups. The advanced treatments removed 
this effect. Interestingly the embryos in the reference toxicant mixture group (50 µg/l musk 
ketone and 7.6 mg/l phenylthiourea in DMSO) were observed to have complete lack of 
pigment, which was considered to be due to the phenylthiourea. Heart rates of the fish 
embryo were decreased compared to the control in the conventional treated effluent. The 
sand filtration did not remove the concentration of pharmaceuticals or triclosan, although it 




In another study, Rainbow trout were exposed to differently-treated effluents, and the 
metabolic profiles of the fish investigated. The metabolic profiles in the plasma from the fish 
exposed to the reference effluent were similar to those fish that had been exposed to tap 
water and the reference effluent that had been further treated with activated carbon. The 
authors suggested that this is an indication that the plasma profile of fish exposed to effluent 
treated in more advanced treatments such as in this case (the moving bed biofilm reactor 
(MBBR) technology and high dose ozone) was very different to “normal” water (Samuelsson 
et al., 2011). 
In a different study, MBBR was found to be efficient at removing oestrogens. However, 
expression of oestrogen-responsive genes suggested that some estrogenic substances 
were still present in the effluent. Membrane bioreactor removed most of the measured 
oestrogens, and reduced the induction of oestrogen-responsive genes. However, fish 
exposed to this effluent had significantly enlarged livers (Gunnarsson et al., 2009). 
Embryo larval development of Japanese medaka (Oryzias latipes) was examined following 
exposures to a number of differently-treated effluents and various dilutions; the LC50s were 
33.7%, 62.9%, 60% and 64.4% from exposures to raw effluent, secondary treated effluent, 
with the addition of ultrafiltration and with the addition of microfiltration, respectively. No 
acute toxicity was observed in the exposure to effluent that had undergone further treatment 
with activated carbon or reverse osmosis. The sex ratio was altered in the raw effluent from 
25%, secondary treated, ultrafiltration and microfiltration all at 50%, but no alteration was 
observed in the larvae exposed to the effluent that had undergone further treatment with 
activated carbon or reverse osmosis (Zha & Wang, 2005). 
2.6  Effects monitoring 
Monitoring the health of the environment, and the effects of chemicals on wildlife and human 
health, is a complex task, and new knowledge is continually being gained. Environmental 
risk of chemicals can be determined in a number of ways, and ultimately, requires a 
multidisciplinary approach. Sometimes an effect is observed, either in wildlife or in the 
laboratory, resulting in the requirement for further research to determine the chemical or 
chemical group responsible, or a chemical is detected in the environment, and research is 
undertaken to ensure that that chemical does not pose an undue risk to the environment as 
a whole. Examples of the former include the well documented case of bird populations seen 
to be declining because of decreased survival of chicks due to eggshell thinning. The 
ultimate cause of this was the insecticide DDT, and its breakdown product, DDE (Hickey & 
Anderson, 1968; Henry & Kaiser, 2009 and Blus 2003 cited by WHO/UNEP, 2013). In 1970, 




be a consequence of tributyltin (TBT) use as an antifoulant (Gibbs & Bryan, 1986 cited by 
WHO/UNEP, 2013). More recently, in 2003, the pharmaceutical, diclofenac was found to be 
the cause of the dramatic decline in vulture population which had been occurring since the 
1990s (Oaks et al., 2004). As discussed earlier in Section 2.2.1, chemicals are assessed 
with regards to their toxicity, and fate and behaviour. These assessments require both 
chemical analysis and biological assessment.  
2.6.1  Analytical chemistry 
Current analytical methods available to determine the chemical contaminants present in 
environmental water samples usually include a pre-concentration step, which consists of 
solid-phase extraction (SPE), solid-phase microextraction (SPME), stir bar sorptive 
extraction (SBSE), or liquid-liquid extraction (LLE) (Bueno et al., 2012). This is then followed 
by a separation and determination step which can include liquid (LC) or gas chromatography 
(GC), coupled with mass spectrometry (MS), therefore, LC-MS or GC-MS. These tandem 
mass spectrometry methods offer higher performance than that of single-quadrupole 
instruments. Triple-quadrupole ion trap or hybrid triple quadrupole-ion trap systems are most 
commonly used techniques to analyse organic compounds in complex matrices, with 
LC-MS/MS being utilised to analyse polar and semi-polar organic compounds, and GC-MS 
being used for non-polar analytes, which are relatively volatile and thermally stable (Bueno 
et al., 2012). 
2.6.2 Environmental sampling 
Chemical pollutants often exist in the environment at low concentration, which means 
measuring them can pose difficulties, hence large volumes of water are often necessary to 
enable the sample to be concentrated and to allow detection of a larger number of 
chemicals. These samples can either be taken as spot or composite samples. Spot sampling 
will take a sample from a specific time point, and, as a consequence, might not capture the 
entire range of chemicals present in the environment. Composite sampling can be taken 
using autosamplers, which continuously sample the water over a specific time period, for 
example for 24 hours. Also, passive samplers can be deployed in a body of water (and also 
used for air sampling) for days or weeks, and collect a composite concentrated sample of 
the chemicals in the water. However, once the sample is collected, a choice is made as to 
what specific chemicals to measure. This is because the analytical methods required vary, 
depending on the physicochemical properties of specific chemicals. Therefore, the chemistry 
is targeted to specific chemicals, potentially leading to chemicals of known or unknown 




of an environmental sample, but this is very often also targeted; for example, VTG 
expression in male fish.  
2.6.3 Toxicity testing 
Regulatory toxicity testing requirements for substances include; acute freshwater fish test 
(96 hour LC50), acute toxicity to daphnids (48 hour EC50), and the growth inhibition test in 
freshwater algae (growth rate and/or biomass 72 hour EC50). For the standard OECD 203 
fish acute toxicity test, approximately 120 adult fish are required per chemical test (Schulte & 
Nagel, 1994). With increasing knowledge of the adverse effects that chemicals cause on the 
environment and human health, regulations and legislations concerning the testing of 
chemicals are becoming stricter. Consequently, the numbers of animals used in the process 
of registering chemicals is likely to increase, if the same standard testing scheme remains in 
place. There has, therefore, been pressure to develop alternative methods of testing new 
and existing chemicals. For fish, these alternatives include in vitro fish cell assays and 
Quantitative Structure-Activity Relationships (QSARs). Another alternative to the adult fish 
test is to use the early developmental stages of fish embryos.  
Braunbeck & Lammer, (2006) report that in a 1997 review, following an evaluation of 
approximately 150 toxicological studies on different life-stages of fish, it was found that, in at 
least 80% of studies, chronic toxicity could be reliably estimated using the results from early 
life-stage studies. Braunbeck & Lammer (2006) also stated that this conclusion has been 
further confirmed by other reviews of the data. 
2.6.4 Genomic approaches 
Genomics or ‘omics’ approaches are explained in detailed in subsequent chapters, but 
briefly there are three strands to this approach: transcriptomics, proteomics and 
metabolomics. The process of main relevance to this project is transcriptomics, which 
measures the fluctuations in gene expression (Poynton et al., 2008). This approach has 
been used extensively as a tool for investigating human disease, but more recently has been 
utilised for ecotoxicology, whereby the gene expression between exposed and unexposed 
cells, tissues or whole organisms can be compared. This allows any differences in gene 
expression (RNA) between the two groups to be highlighted, and acts as an indication or 
confirmation of a specific biological response (Figure 2.5). Gene expression can be 
measured for individual genes, or as in the case with microarrays, groups of genes, or the 
test organism’s entire transcriptome are measured. When the entire transcriptome is 




overlooked in standard targeted approaches. This is especially useful when investigating the 
toxicological risk of environmental samples consisting of a complex mixture of contaminants. 
 
Figure 2.5 Gene expression (modified from Dale et al., 2012) 
2.6.5 Whole effluent testing 
Single substances are tested to determine their persistency, bioaccumulation and toxicity 
(PBT) on a routine basis. This is often a requirement under discharge consents, and for 
European legislation such as REACH. However, in the wider environment, organisms are 
rarely exposed to a single substance,  bearing in mind the existence of an estimated 140 
000 chemicals on the market worldwide (UNEP, 2013). In the real world, a single organism 
is likely to be exposed to a whole array of chemicals during its life. In the assessment of the 
PBT properties of an effluent from an industrial process, assumptions as to the composition 
of the effluent can be made from knowledge of the chemicals used in that specific industrial 
process. However, a study of the potential risks of this effluent to the environment will only 
consider the effects of individual chemicals in isolation rather than to the combination of all 
chemicals used/produced. This method of risk assessment has the potential to overlook the 
presence of other potentially harmful substances that are undetected, synthesised as 
by-products or as breakdown products, and may also miss the consequences of the mixture 
effects of multiple chemicals acting upon different points in a biological pathway. Domestic 
and industrial water treatment works receive wastewater from homes, industries, and 
businesses, making any assessment of the hazard of the plant’s influent difficult.  
Additionally, using the standard single substance testing and assessment approach, the 
effects that substances may have when mixed together i.e. potential additive and/or 
synergistic effects, may be missed. Consequently, there has been increasing interest in the 
development of a PBT-test that can used to assess entire environmental samples, such as 
effluent, surface water or sediments (OSPAR Commission, 2007). It has been reported that 
this ‘whole sample’ approach has been used in a number of studies and, following analytical 
chemical analysis, only a small proportion of the adverse effects observed could be 
explained by the substances identified (OSPAR Commission, 2007). Therefore, it could be 




unidentified substances, and/or by mixture effects caused by exposure to a combination of 
substances (OSPAR Commission, 2007). 
Testing every single conceivable combination of chemicals at varying concentrations is 
unrealistic, which is one of the reasons that the ‘whole sample’ approach is becoming 
increasingly recognised as a sensible approach to risk assessment. Whole Effluent 
Assessment (WEA) which is also referred to as Whole Effluent Testing (WET), and Direct 
Toxicity Assessment (DTA), is an assessment for ‘whole sample’ approach, but specifically 
for effluent (OSPAR Commission, 2007). In some countries including USA, Canada, 
Germany Ireland, Spain and Sweden, WEA is already used in national legislation and 
permitting (OSPAR Commission, 2007).  
2.7 Model Organisms 
A model organism is defined as “an organism suitable for studying a specific trait, disease, 
or phenomenon, due to its short generation time characterised genome, or similarity to 
humans; examples are a fly, fish, rodent or pig, whose biology is well known and accessible 
for laboratory studies” (Nature, 2014). Therefore, an appropriate model organism should 
provide both technical and practical advantages for studying the biological process, 
mechanism, endpoint etc., and the traits need to be generalised so that they are 
representative for a wider group of organisms (Segner, 2009). Zebrafish, as will be 
described below are both easy and cost-effective to use in studies, and they can provide 
theoretical data that can be used to answer specific questions surrounding vertebrate 
biology, genetics, toxicology and disease (Segner, 2009). 
2.7.1 Zebrafish and zebrafish embryos 
The chosen organism for the in vivo assays for this project was the zebrafish (Danio rerio) 
embryo. Adult zebrafish are a common laboratory fish, originally from India and Burma (they 
are thus tropical fish). They are a popular fish in laboratories because (i) they are a relatively 
small with an adult growing to approximately 5 cm, (ii) they can be housed at a relatively 
high stocking density, (iii) they are easy to care for and maintain, (iv) they have a life-span of 
approximately 3 years but with a short generation time of 3 months and are reproductively 
capable for approximately 1.5 years, (v) one female zebrafish can produce between 100 to 
200 eggs on a weekly basis and these eggs are externally fertilised, (vi) their eggs are 
transparent, making the development easy to observe, and (vii) they rapidly develop and are 
free-swimming larvae at 5 days post fertilisation (Scholz et al., 2008). Due to the zebrafish’s 
popularity as laboratory fish (not only for ecotoxicological assessments, but also for human 




development has been extensively documented and staged, and their genome is sequenced 
and fully annotated with microarrays available. Due to the development and genome 
sequence of the zebrafish being well understood, any abnormalities can easily be identified, 
making them the ideal test organism for this project. 
As zebrafish are vertebrate organisms, they share many similarities with mammals, based 
on organs and cell types present. Zebrafish have been described as the “canonical 
vertebrate”, because of the similarities they share with mammalian biology. In combination 
with the similarities they share in mammalian biology, and because of the advantages listed 
above, zebrafish have become an important test organism and zebrafish models are used to 
study human diseases with a known genetic cause, induced by chemical exposure and 
bacterial pathogenesis (Rubinstein, 2003).  
There is significant demand from the public to reduce (or stop all together) the use of animal 
testing. There is also a demand from industry to replace animal experimentation with a less 
costly, and less time consuming method of testing the environmental and health effects of 
substances (Scholz et al., 2008). There are a number of alternative testing methods to 
animal testing; these include predictive modelling, using structural activity relationships, 
toxicity testing using cell based systems, and fish embryos (Scholz et al., 2008). One of the 
most popular fish embryo models currently used in developmental toxicity, drug discovery, 
human disease research, genetics and ecotoxicological studies, is that of the zebrafish, 
Danio rerio (Scholz et al., 2008). Other relevant fish species which have also been 
suggested as relevant are medaka (Oryzias latipes), and the fathead minnow (Pimephales 
promelas) (Braunbeck & Lammer, 2005). 
2.8 Sensitive window of exposure 
Testing chemicals on zebrafish embryos results in exposure during development. 
Developmental exposure is known as a sensitive window of exposure; for example, 
hormones act during all stages of life, but the timing of action is important because it affects 
the potency. Once the hormone is removed, the action is halted, consequently during 
embryonic, foetal, and neonatal development, alterations to ‘normal’ hormone levels can 
cause permanent alternation to development. Additionally, once the action has occurred 
during this sensitive window, the changes will last a lifetime (WHO/UNEP, 2013). For 
example, thyroid hormone is essential for brain development during foetal and neonatal 
period of human development; insufficient supply of thyroid hormones causes mental 





2.9 Testing Unknowns 
When determining the environmental risk posed by a chemical or a contaminated 
environmental sample (e.g. effluent entering receiving water), targeted testing has the 
potential of missing significant adverse and unknown biological effects, and can miss the 
compounds responsible. Two methods available to assess environmental risk are toxicity 
identification evaluation (TIE), and effects-directed analysis (EDA). TIEs are used to identify 
chemicals causing a toxic effect in effluents, receiving waters, interstitial waters, 
groundwater, and sediments. They use whole organism testing, resulting in ecological 
relevance. There are three stages of a TIE: characterisation, followed by identification and 
finally confirmation. Initially, the environmental sample is demonstrated to cause toxicity, with 
no assumption made about the cause of the toxicity. This is followed by assessment of 
classes of chemicals that could be responsible for the toxicity. Specific toxicants are 
identified and then finally the chemical responsible is confirmed by further whole organism 
tests using spiked environmental samples of the suspect chemical at a known concentration 
(Burgess et al., 2013). EDAs use mostly in vitro endpoints, with the focus on organic 
contaminants that have a known adverse effect.  As with TIEs, EDA are used to test 
samples such as effluents, receiving waters, interstitial waters, groundwaters, sediments, 
but, unlike TIEs, EDAs can include tissues and biological fluids. In EDAs, chemical analysis 
is non-targeted, and they use biological effects as the method to identify the toxicant from 
the vast number of possible toxicants; this then enables the chemical analysis to be targeted 
on chemicals that have a significant contribution to the measured toxic effects. The steps 
involved in an EDA are: separation of organic chemicals from the sample matrix (this 
includes sample clean-up, preconcentration, and fractionation), followed by biological 
testing, then chemical analysis, and finally as with TIE, there is a confirmation step. The 
main steps of EDA are fractionation and toxicity testing, and as a consequence of there often 
being many fractions to test, high throughput in vitro assays are favoured. The fractions are 
created based on physicochemical properties of the components of the sample, for example 
hydrophobicity and polarity (Burgess et al., 2013). 
2.10 Testing strategy 
Based on the sum of this information, a multi-disciplinary approach was used for this project. 
Initially, toxicity testing was carried out on zebrafish embryos, using a method based on the 
OECD testing methods. This was following by microarrays to determine any genetic markers 
of concern, and further confirmation was carried out using in vitro testing. Available chemical 










3.1 Deephams Indirect Potable reuse pilot plant 
The reuse pilot project that was the subject of this study was trailed by Thames Water 
Utilities Ltd. The 600 m3 d-1 IPR pilot plant was designed to generate data for any future 
plans to operate a full scale project (M. Raffin et al., 2011). The pilot IPR plant was fed final 
effluent from a conventional activated sludge plant (M Raffin et al., 2012).  
The final effluent from the waste water treatment plant enters the IPR plant and undergoes a 
500 µm pre-filtration step (M. Raffin et al., 2011). Once the effluent has been pre-filtered it is 
filtered by a submerged continuous membrane filtration process providing finer filtration, 
known as microfiltration (MF) (M Raffin et al., 2012). Following MF, one stream of product 
water is treated with anti-scalant and sulphuric acid to control scaling after which it is passed 
through a reverse osmosis (RO) process (Marie Raffin et al., 2012). The resulting water from 
the RO process is then treated by an Advanced Oxidation Process (AOP) consisting of 
ultraviolet disinfection and hydrogen peroxide dosing (M. Raffin et al., 2011). The final stage 
of the treatment process consists of the water being pH corrected and fed through a 
degassing tower (M Raffin et al., 2012). 
A second stream of product water from the MF process is directed straight into a separate 
AOP system, where it does not undergo treatment via reverse osmosis or anti-scalant. The 
product from this AOP system will be referred to as AOP1, and the product water which has 
undergone both MF and RO treatment followed by AOP will be referred to as AOP2. There 
are three points along the IPR treatment process where chloramine can be dosed, at pre-
filter, pre-MF and pre-RO (Figure 3.1); the chloramine is used to minimise biofouling in the 
pipework and equipment (M. Raffin et al., 2011; M Raffin et al., 2012). 
Figure 3.1 Figure 3.1 illustrates the IPR treatment plant processes that were in operation. 
The IPR plant was fully automated, with an advanced water sampling instrumentation that 
monitors and controls the process, and an on-site supervisory control and data acquisition 
(SCADA) system to record trends and collect data on quality at various stages of the 






Figure 3.1 The IPR treatment process that was in operation at the Deephams waste water treatment plant. 
MF: Microfiltration; RO: Reverse Osmosis; AOP: Advanced Oxidation Process; and FP: Final Product. 
As previously stated, the main aim of this project is to identify any potential risks to health 
from exposure to recycled water and, more specifically, from the pilot IPR plant that was 
being trailed at Deephams waste water treatment works. The effluent/product water from 
each treatment process within the IPR plant was examined for potential biological activities. 
This was accomplished using a number of steps: collation and interpretation of the chemical 
analysis data provided by Thames Water, in vivo bioassays in zebrafish and their embryos, 
deployment of passive samplers, gene expression analysis using microarray technology, 
and in vitro mammalian cell confirmatory tests. 
3.2 Analytical Chemistry (Historical Thames Water data) 
Between 2008 to 2012, Thames Water Ltd analysed the water at the different treatment 
stages of the IPR plant to determine the presence or absence and concentration of over 400 
compounds.  Given the extent of the analytical chemistry data, and as a way to initially 
assess the chemical make-up of the different product waters, the chemicals detected in the 
water at each stage of the treatment process were analysed, categorised and some basic 
physicochemical, fate and behaviour, aquatic toxicological and mammalian toxicological data 
were gathered. Once these data were gathered, the known effects of chemicals that 
occurred above the limit of detection (>LoD) were noted.  
The information collected for each contaminant present above the LoD was as follows: 
 Identification and use: chemical name and CAS registration number; and the use.  
 Physical chemical properties and fate and behaviour: the compound’s molecular 




pressure); solubility in water; octanol water coefficient (Log Kow); Bioconcentration 
Factor (BCF); and biodegradation within 28 days (%) and half-life (days). 
 Ecotoxicology: aquatic ecotoxicology (lowest acute and chronic L(E)C50/NOEC). 
 Potential target organs and/or toxicological endpoint from mammalian data: skin and 
eye irritation and skin sensitisation; effects to sensory organs; effects on the 
gastrointestinal tract and/or liver; effects on the brain and/or the central nervous 
system (CNS); effects on the immune system; effects on the kidney; effects to the 
cardiovascular system and/or blood; contaminant reported to be carcinogenic; 
contaminant reported to be genotoxic; contaminant reported to cause developmental 
toxicity; contaminant reported to be a reproductive toxicant; and toxicant reported to 
be endocrine disrupting. 
 Other: this section includes compound approvals. For example, if it is a pesticide, has 
it been approved for use as a pesticide in the UK, also any health standards set by 
authoritative bodies such as the World Health Organization (WHO), the European 
Food Safety Authority (EFSA) etc. and any other pieces of information which may be 
useful in the risk assessment of the specific contaminant. 
The literature search for each compound was restricted to a specific number of sources. 
These sources being used were considered to be authoritative and reliable, the sources are 
listed in Table 3.1. A wider search was conducted on the compounds for which had no or 




Table 3.1 The table below details all the sources used to search for relevant toxicity, ecotoxicity, physical chemical properties, fate and behaviour data. The 
majority of the searching was carried out in the years 2011 and 2012 
Sources Address 
 Classification 
PAN http://www.pesticideinfo.org/Search_Chemicals.jsp  
ChemID http://chem.sis.nlm.nih.gov/chemidplus/  
EC Priority Pollutants http://ec.europa.eu/environment/water/water-framework/priority_substances.htm  
NORMAN http://www.norman-network.net/index_php.php?module=public/about_us/emerging&menu2=public/about_us/about_us  
Physical properties/Fate & Behaviour/Uses 
 
ChemID http://chem.sis.nlm.nih.gov/chemidplus/  
SRC PhyProp http://www.syrres.com/what-we-do/databaseforms.aspx?id=386  
SRC Biodeg http://www.syrres.com/what-we-do/databaseforms.aspx?id=382 
HSDB http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB 
IUCLID http://esis.jrc.ec.europa.eu/index.php?PGM=dat  
WHO EHC http://www.who.int/ipcs/publications/ehc/ehc_alphabetical/en/index.html  
Human Health/Toxicity 
 
IUCLID http://esis.jrc.ec.europa.eu/index.php?PGM=dat  
IPCS InCHEM http://www.inchem.org/ 
ATSDR http://www.atsdr.cdc.gov/substances/indexAZ.asp#A  
IARC http://monographs.iarc.fr/ENG/Classification/index.php  
US EPA IRIS http://cfpub.epa.gov/ncea/iris/index.cfm?fuseaction=iris.showSubstanceList  
TOXNET http://toxnet.nlm.nih.gov/ 
NTP http://ntp.niehs.nih.gov/  
WHO Background documents http://www.who.int/water_sanitation_health/dwq/chemicals/en/index.html#E  
ITER http://www.tera.org/iter/ 
HPA Compendium of Chemical Hazards http://www.hpa.org.uk/Topics/ChemicalsAndPoisons/CompendiumOfChemicalHazards/  








US EPA ECOTOX http://cfpub.epa.gov/ecotox/  
HSDB http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB 
IUCLID http://esis.jrc.ec.europa.eu/index.php?PGM=dat  
OECD SIDS http://www.chem.unep.ch/irptc/sids/OECDSIDS/sidspub.html 




Australian PUBCRIS http://services.apvma.gov.au/PubcrisWebClient/welcome.do  
US EPA RUP http://www.epa.gov/opprd001/rup/rup6mols.htm  
WHO Classification http://www.who.int/ipcs/publications/pesticides_hazard/en/  





BNF http://www.bnf.org/bnf/index.htm  
Australian TGA http://www.tga.gov.au/index.htm  
EMA http://www.ema.europa.eu/ema/  
Cosmetics and personal care products 
 
CTFA http://www.ctfa.org.nz/ 















ATSDR: Agency for Toxic Substances and Disease Registry 
BNF: British National Formulary 
CTFA: Cosmetic Toiletry and Fragrance Association Inc. 
EC: European Commission 
EFSA: European Food Safety Authority 
EHC: Environmental Health Criteria 
EMA: European Medicines Agency 
EU: European Union 
FDA: Food and Drug Administration 
FSA: Food Standards Agency 
HERA: Human and Environmental Risk Assessment on ingredients of household cleaning products 
HPA: Health Protection Agency 
HSDB: Hazardous Substances Data Bank 
HSE: Health and Safety Executive 
IARC: International Agency for Research on Cancer 
IPCS: International Programmes on Chemical Safety 
IRIS: Integrated Risk Information Systems 
ITER: Internal Toxicity Estimated for Risk Assessment 
IUCLID: International Uniform Chemical Information Database 
JECFA: Joint Expert Committee on Food Additives 
NORMAN: Network of reference laboratories for monitoring of emerging environmental pollutants 
NTP: National Toxicology Program 
OECD: Organisation for Economic Co-operation and Development 
PAN: Pesticide Action Network 
PUBCRIS: Public Chemical Registration Systems 
RUP: Restricted Use Pesticides 
SCCS: Scientific Committees on Consumer Safety 
SIDS: Screening Information Data Set 
TGA: Therapeutic Goods Administration 
WHO: World Health Organization 





3.3 In vivo studies 
3.3.1 Fish Husbandry 
A group of 30 adult male and 30 female zebrafish (Danio rerio) (Tübingen strain) of breeding 
age were sourced from University College London (UCL) in July 2011. Upon arrival at Brunel 
University the fish were kept in quarantine, in static renewal tanks for a two weeks period 
prior to being sexed and placed into flow-through tanks. The fish were separated based on 
sex and placed into 10 litre tanks. The physical difference between the male and female 
zebrafish is illustrated in Figure 3.2. Throughout the quarantine period and the following 
breeding period, the fish were fed 3 times a day; twice with flake food (King British Tropical 
flake food, Lillicos, Surrey) and once with adult brine shrimp (Tropical Marine Centre, 
Gamma irradiated). They were kept at a temperature of 26-28°C and with a photoperiod of 
14 hours of light and 10 hours of dark, which are considered to be optimal husbandry 
conditions (Westerfield, 2007). The water was dechlorinated carbon-filtered (5 and 10 µm) 
tap water from header tanks at a flow rate of 20 litres/hour. All tubing (flow-line, air-lines, 
siphon and attached to the grids) was made of medical grade silicon (VWR, UK). 
 
Figure 3.2 Male and female zebrafish. The female (bottom of the picture) has a larger abdomen whereas 
the male (top of the picture) has a sleeker body shape and has a darker yellow pigmentation.  Differences 
in behaviour can also be observed, with males chasing the females. The photo is from “Zebrafish Change 






3.4 Fish Breeding and Embryo Collection 
In the wild, zebrafish breed in the morning shortly after the sun rises. In laboratory conditions 
this is soon after the artificial light is switched on (Westerfield, 2007). 
Male and female zebrafish were kept separately until the day before embryos were needed. 
In the afternoon, 4 females to 2 males were grouped together in narrow breeding tanks with 
a volume of 9.5 litres (15 cm wide and 40 cm deep with a height of 25 cm) (Figure 3.3). Each 
tank was fitted with a metal grid, allowing the eggs to fall to the bottom of the tank and 
preventing them from being eaten by the adults (Figure 3.3). Egg collection took place the 
following day approximately 1 hour after dawn (the lights were switched on at 7.30 am, and 
collection of embryos commenced at 9 am).  
 
Figure 3.3 The photograph on the left illustrates the narrow breeding tank containing the breeding fish 
(four females and two males) metal grid, flow-line and air-line. The photograph on the right illustrates five 
breeding tanks and three holding tanks (one for males and two for females), to enable the breeding 
females to be rotated to ensure adequate rest days between breeding events. 
Once it had been confirmed visually that the breeding groups had produced eggs, the adult 
fish were returned to their relevant holding tanks and the grids were then removed. Once the 
eggs had settled to the bottom of the tanks a glass siphon was used to collect the eggs into 
a fine mesh net and placed into 300 ml glass crystallising dishes containing fresh water from 
the header tank. From these dishes a plastic 3 ml Pasteur pipette was used to move some 
batches of the embryos into a glass petri dish containing fresh water from the header tank. A 
Leica MZ FL III fluorescence stereomicroscope with a maximum magnification of 800x was 
then used to sort the embryos, removing debris, dead and unfertilised eggs. The pre-cent 




a clean crystallising dish containing water from the header tank. The collected, sorted and 
unsorted embryos were kept in the SANYO incubator to monitor them at the desired 
temperature. 
 
3.4.1 Effluent collection 
 
 
Figure 3.4 Schematic of the IPR plant with the positions (1-6) of the where the composite samples or 
point samples were taken 
Twenty-four hour composite effluent samples were collected from Deephams IPR the day before an 
before an effluent exposure was due to start if possible. Composite samplers were held at the IPR plant (





Figure 3.4), and the staff at the site would program them to start sampling the day before 
water samples were due to be collected (Figure 3.5). The treatment water was collected in 
acid washed and silanised 2.5 litre brown glass Winchester bottles. The collection chamber 
of the sampler was chilled to 4°C, and they were transported back to Brunel University in 
cool-boxes containing ice blocks. On return to Brunel they were immediately transferred to 
the fridge or cold storage room to be kept at 4°C. 
 
Figure 3.5 Some of the composite samplers positioned along the IPR treatment process They had to 
placed close to an outlet for the specific treatment process, but must not impede access to the 
containers; therefore, some had to be placed outside the container (as is seen in the far right picture) 
whereas there was sufficient space for others to be left inside (the left and middle pictures). The middle 
picture illustrates the collection of the effluent within a glass Winchester. 
3.4.2 Zebrafish development exposures (48 hours) 
For each of the 48 hour zebrafish developmental exposures, embryos were collected as described above 
described above and, if possible, composite samples were collected from IPR plant the day before the 
before the exposure was due to start. If composite samples were not available, a grab sample was 
sample was collected instead. Each sample bottle containing treatment water was vigorously shaken 
shaken after which 2 ml (or the relevant control; aquarium header tank water or tap water) was pipetted 
was pipetted into a well of a 24 well plate. The plates were then labelled and placed in the incubator. The 
incubator. The configuration of the plates is detailed in Figure 3.6 
Figure 3.7. While the plates were equilibrated to the correct temperature within the incubator, 
the embryos were collected and sorted as detailed above. Once the healthy looking and 
fertilised embryos had been isolated and were free of other debris, one embryo was gently 
placed into each well (containing 2 ml of the exposure water) of the 24 well plates, which 
were then returned to the incubator. The embryos were collected shortly after fertilisation; 
they were placed in the exposure between the 2-cell and 64-cell stages (0.75 hours to 2 




included dissolved oxygen (HACH oxygen and temperature probe), pH, general hardness, 
carbonate, nitrate and nitrite (API 5 in 1 test strips), and ammonia (API ammonia test strips) 
(Table 3.2). The temperature within the incubator was recorded with a thermometer to check 
on-the-spot and continuous readings were also taken using the two Tiny Tag data loggers 





Table 3.2 The range of general physio-chemical properties of the control and exposure waters 
Treatment Range of physico-chemical properties 












7.5 0-20 0-0.5 0 180 240 
Tap water 8 0 0 0 180 240 
Final product 6.5 0-20 0 0-1.0 0-30 0 
AOP2 6.0 0-20 0-0.5 0-3 0 0 
Reverse 
osmosis 
6-7 0 0 0-1.0 0-30 0-40 
AOP1 7.5-8.5 40 0-1 0-3 180 180-240 
Microfiltration 7.5-8 40-80 0-3 0-3 180 240 
Final effluent 7.5-8 40-80 0-3 0-3 180 240 
 
 
Figure 3.6 The temperature within the incubator was measured using TingTags, showing the temperature 








1 2 3 4 5 6 
 
A CONTROL CONTROL CONTROL AOP2 AOP2 AOP2 
 
B TAP TAP TAP RO RO RO 
 
C MF MF MF AOP1 AOP1 AOP1 
 
D FE FE FE FP FP FP 
  1 2 3 4 5 6 
Plate 2 A AOP2 AOP2 AOP2 CONTROL CONTROL CONTROL 
 
B RO RO RO TAP TAP TAP 
 
C AOP1 AOP1 AOP1 MF MF MF 
 
D FP FP FP FE FE FE 
  
1 2 3 4 5 6 
Plate 3 A FE FE FE FP FP FP 
 
B CONTROL CONTROL CONTROL AOP2 AOP2 AOP2 
 
C TAP TAP TAP RO RO RO 
 
D MF MF MF AOP1 AOP1 AOP1 
  
1 2 3 4 5 6 
Plate 4 A FP FP FP FE FE FE 
 
B AOP2 AOP2 AOP2 CONTROL CONTROL CONTROL 
 
C RO RO RO TAP TAP TAP 
 
D AOP1 AOP1 AOP1 MF MF MF 
  
1 2 3 4 5 6 
Plate 5 A MF MF MF AOP1 AOP1 AOP1 
 
B FE FE FE FP FP FP 
 
C CONTROL CONTROL CONTROL AOP2 AOP2 AOP2 
 
D TAP TAP TAP RO RO RO 
  
1 2 3 4 5 6 
Plate 6 A AOP1 AOP1 AOP1 MF MF MF 
 
B FP FP FP FE FE FE 
 
C AOP2 AOP2 AOP2 CONTROL CONTROL CONTROL 
 
D RO RO RO TAP TAP TAP 
  
1 2 3 4 5 6 
Plate 7 A TAP TAP TAP RO RO RO 
 
B MF MF MF AOP1 AOP1 AOP1 
 
C FE FE FE FP FP FP 
 
D CONTROL CONTROL CONTROL AOP2 AOP2 AOP2 
  
1 2 3 4 5 6 
Plate 8 A RO RO RO TAP TAP TAP 
 
B AOP1 AOP1 AOP1 MF MF MF 
 
C FP FP FP FE FE FE 
 
D AOP2 AOP2 AOP2 CONTROL CONTROL CONTROL 
 
Figure 3.7 Distribution of the treatments across the well plates used for both the 48 hour observation 
(Experiments 3 and 4). CONTROL: water from the header tank; TAP: water from Brunel University 




following reverse osmosis treatment; RO: water from the reverse osmosis treatment process; AOP1: 
water from the advanced oxidation process following microfiltration treatment; MF: water following the 
microfiltration treatment stage; and FE: water following secondary sewage treatment and a pre filtration 
step. 
Above both shelves of the incubator, aquarium lights were attached and a timer was set to 
ensure the embryos had a photoperiod of 14 hours of light and 10 hours of dark. 
Observations using the Leica MZ FL III fluorescence stereomicroscope and the Leica DC 
300F digital image recording system were taken at 4, 8, 12, 16, 24, 36 and 48 hours post 
fertilisation and specific endpoints/developmental endpoints were noted to have occurred or 
not. The well plates had lids, so limited evaporation would have taken place. Due to the 
volumes used in the study (2 ml per well/per embryo) it was not possible to conduct chemical 
analysis on exposure water, however, chemical analysis had been undertaken on the 
product waters from the IPR site and chemical analysis data was recorded for the tap and 
control water (Appendix). 
Table 3.3 shows the toxicity endpoints/developmental endpoints, which were examined in 
each embryo at each time point. The endpoints displayed in Table 3.3 are sourced from a 
number of references, including the OECD background document for the fish embryo toxicity 





Table 3.3 Toxicological and developmental endpoints visible in zebrafish embryos at specified time 
points 
Development stage 
Hours post fertilisation 
4 8 12 16 24 36 48 
Coagulated egg* + + + + + + + 
Termination of blastula formation +       
Start of epiboly  +      
Termination of epiboly   +     
Formation of somites*    + + + + 
Eye development    + + + + 
Tail detachment*     + + + 
Spontaneous body movement     + + + 
Malformation of head     + + + 
Malformation of sacculi/otoliths     + + + 
Malformation of tail     + + + 
Malformation of heart     + + + 
Modified chorda structure     + + + 
Scoliosis     + + + 
Yolk deformation     + + + 
General growth retardation     + + + 
Presence of heart-beat/blood circulation*      + + 
Heart-beat frequency       + 
Formation of edemata       + 
Pigmentation       + 
*Endpoints used by the German DIN in their whole effluent testing regime. 
+This developmental should be visible at this time-point or the specified malformation could be visible at this 
time-point. 
 
At 48 hours heart rates were recorded by counting the number of beats over a period of 30 
seconds. The embryos were then transferred into RNAlater® stabilisation solution (Life 
Technologies, UK), kept at 4°C for 24 hours to allow the RNAlater® stabilisation solution to 
penetrate the tissue, and then stored at -80°C. 




The zebrafish breeding, embryo collection, and sorting and effluent collection for this set of 
exposures were the same as for the 48 hour observation described above. However, instead 
of using 24 well plates, 300 ml crystallising dishes were used to begin with, containing 
200 ml IPR product water, header tank water or tap water. IPR product water was pre-
warmed in a water bath before being put into the crystallising dishes. Approximately 50 
sorted embryos were placed in to each crystallising dish. There were 3 replicates, and the 
IPR product water, control or tap water was partially renewed, by replacing a third of the 
treatment water every other day, until feeding began on 5 days post-fertilisation, after which 
it was renewed on a daily basis to prevent the build–up of uneaten food. On day 9-10 
post-fertilisation the zebrafish larvae were moved to larger (1 litre capacity) glass beakers. 
As these were too large to sit in the incubator, the beakers were placed in fish tanks and 
water flowed from the header tanks and acted as large water baths; this is illustrated in 
Figure 3.8.  
 
Figure 3.8 Photograph of the exposure beakers in the tanks which acted like large water baths to keep 
the water within the beakers at a constant temperature, optimum for zebrafish development. The air-lines 
can also be seen, the air-lines as in previous studies were medical grade silicone tubing and on the end 
of each air-line there was a glass Pasteur pipette which allowed a gentle air flow to be bubbled through. 
Air-lines were also added, with a very gentle air flow so as not to damage the delicate larvae, 





Table 3.4 Average dissolved oxygen levels in an extended exposure study over a 24 hour period prior to 
adding airlines  
Treatment Dissolved oxygen (mg/l) at 0 
hours 
Dissolved oxygen (mg/l) at 24 
hours 
Control 9.20 7.74 
Tap 8.71 7.78 
Final product 9.52 7.84 
AOP2 8.50 7.63 
Reverse osmosis 9.80 8.04 
AOP1 9.60 7.61 
Microfiltration 8.93 7.67 
Final effluent 5.03 5.51 
 
The zebrafish (now free swimming larvae) were observed on a daily basis, so that any 
abnormalities could be noted and photographed, and dead ones removed. Once in the 
beakers, the larvae were fed twice daily; once with ZM-0 flake food and once with live 
artemia. This exposure was terminated on day 15. 
3.4.4 Zebrafish embryo exposures for gene expression (48 hours) 
For each 48-hour zebrafish embryo exposures for gene expression, the same breeding 
regime was followed as is detailed in Section 3.4 and composite samples (when available) 
were collected from the IPR plant the day before the exposure was due to start. 
Once the IPR product waters arrived back from the pilot plant, they were emptied out into 
labelled acid washed 300 ml glass crystallising dishes; 200 ml was placed into each dish. A 
glass petri dish was then used as a lid, and they were placed in large fish tanks which 
received a flow of heated water from the header tank to keep them at the optimum 
temperature of 28°C. They were left overnight to allow them to reach the desired 
temperature. There were two replicates (i.e. two crystallising dishes) for each of the 
exposure water, i.e. the six product waters collected from the IPR plant, the tap water and 
control water from the header tank. There were also two replicates (two crystalising dishes) 
for each time-point (six in total). Therefore there were 96 dishes in each experiment. At the 
start of the exposure, the day after effluent collection, the embryos were sorted as previously 





Figure 3.9 The photographs illustrate the 96 dishes in the large tanks acting as water baths. There were 
four large tanks in total and the dishes were randomly placed within the tanks. Within the large tanks 
there were a number of smaller up-turned tanks to prevent header tank water intrusion.  
Observations and sampling were carried out at the six time-points, 8, 12, 16, 24, 36 and 48 
hour post fertilisation. At each time-point the relevant dishes were removed i.e. a group of 
50 embryos that had been exposed to either header tank water, tap water or one of the six 
IPR product waters along with the corresponding replicate. Consequently, at each 
sampling/time-point, 16 dishes were removed from the tanks. At each sampling point photos 
were taken of one individual from each dish, dead ones were counted and removed, and any 
abnormal embryos were removed and preserved separately. The ‘normal’ looking embryos 
remaining were pooled (due to the survival rate there was always >20 embryos in each pool) 
and preserved together in RNAlater®. These exposures were repeated 3 times over a period 
of approximately a month. 
3.5 Genomics 
The embryos from the 48 hour exposures for gene expression (detailed in Section 3.4.4) 
were transported to Liverpool University on dry ice where the RNA was extracted and 
microarrays were conducted. 
3.5.1 RNA Extraction 
RNA from the preserved embryos (stored in RNAlater® at -80°C transported on dry ice) was 
extracted using RNeasy Mini Kit provided by Qiagen (Qiagen, 2012). The kit enables 100 µg 
of RNA longer than 200 bases to bind to the silica membrane provided in the kit. Broadly, the 
embryos were lysed and homogenised in a buffer which inactivates the RNases to ensure 
purification of intact RNA. Ethanol is added to precipitate RNA ; the sample is then added to 
a spin column. In the column the RNA binds to the membrane where the contaminants can 




The protocols supplied with the RNeasy Mini Kit are not specific to fish embryos so were 
slightly adapted and are detailed as follows. 
β-Mercaptoethanol was added to the Buffer RLT before use, 10 µl of β-mercaptoethanol was 
added per 1 ml of Buffer RLT, this was then be stored at room temperature (15-25°C) for up 
to 1 month (Qiagen, 2012). Ethanol (100%) was added to the Buffer RPE as indicated on the 
bottle (Qiagen, 2012). 
Lyse and homogenise 
The embryos were removed from the -80°C freezer and defrosted on ice, the RNAlater® 
was removed using a pipette. Then 350 µl Buffer RLT (with the added β-mercaptoethanol) 
was added, then, using a 1 ml syringe, the mix was drawn up to enable homogenisation 
within the syringe. The lysate was passed 10 times (5 times as stated in the Qiagen protocol 
was insufficient and blocked the filter) through a blunt 20-gauge needle (0.9 mm diameter). 
Then 350 µl of 70% ethanol was added to the homogenised lysate and mixed well via 
pipetting and syringe the homogenate (700 µl) into each RNeasy spin column placed in a 
2 ml collection tube. The lid was closed and gently centrifuged for 15 seconds at >8000 x g 
(>10 000 rpm) and then the flow-through was discarded.  
DNase digestion and binding total RNA 
The next series of steps were optional “On-Column DNase Digestion with the RNase –Free 
DNase Set”. The RNase-Free set (cat. No. 79254) is reported to give on-column digestion of 
DNA during RNA purification. The DNase is then removed in the following wash steps. 
For the first time the kit was used, DNase I stock solution was prepared by dissolving the 
lyophilized DNase I (1500 Kunitz units) in 550 µl RNase-free water. Qiagen advise to do this 
via injecting the water into the vial using a syringe, and then gently mixing by inverting, not 
with use of the vortex. The DNase I can be divided into single use aliquots and stored at -
20°C for up to 9 months. 
Once the DNase I solution is prepared, 350 µl Buffer RW1 was added to the RNeasy spin 
column. The lid was closed and centrifuged for 15 seconds at >8000 x g (>10 000 rpm) to 
wash the spin column and membrane and then the flow-through was discarded. The 
collection tube is kept for the last step. 
Then 10 µl DNase I stock solution is added to 70 µl Buffer RDD. This was then gently mixed 




of the tube. DNase I is reported to be very sensitive to physical denaturation, this is why 
gentle inversion should be used to mix rather than a vortex. 
The DNase I mix (80 µl) was then added to the RNeasy spin column membrane and placed 
on the benchtop (20-30°C) to incubate for 15 minutes. It was ensured that the DNase I mix 
was added directly to the membrane as, if left to stick to the walls of the tube or O-ring of the 
column, the removal of DNA will be incomplete. 
In this final stage of this optional DNase digestion step 350 µl of Buffer RW1 was added to 
the RNeasy spin column. The lid was closed and it was centrifuged for 15 seconds at >8000 
x g (>10 000 rpm) and then the flow-through was discarded.  
Wash 
Then 500 µl Buffer RPE was added to the RNeasy spin column, the lid closed, and it was 
centrifuged for 15 seconds at >8000 x g (>10 000 rpm) to wash the spin column membrane 
and then the flow-through was discarded.  
Another 500 µl Buffer RPE was added to the RNeasy spin column, the lid closed and it was 
centrifuged for 2 minutes at >8000 x g (>10 000 rpm) to wash the spin column membrane. 
This longer time in the centrifuge dries the spin column membrane to ensure there is no 
ethanol left following the RNA elution. Residual ethanol has the potential to affect with 
subsequent reactions.  
The RNeasy spin column is then added to a new 2 ml collection tube and the old collection 
tube with containing the flow-through is discarded. The lid was closed and centrifuge at full 
speed for 1 minute. This step removes the chance of carryover of Buffer RPE or residual 
flow-through remains on the outside of the spin column. 
Elution  
The spin column was then placed in a new 1.5 ml collection tube, and 36 µl RNase-free 
water was directly added to the spin column membrane, the lid was closed and this was 
allowed to soak into the membrane for 1 minute. Then it was centrifuged for 1 minute at 
>8000 x g (>10 000 rpm) to elute the RNA. 
The eluate from the previous step was placed back on to the spin column membrane and left 
for 1 minute before centrifuging again for 1 minute at >8000 x g (>10 000 rpm). 




The Thermo Scientific NanoDrop™ 1000 Spectrophotometer is a full spectrum (220-750 nm) 
spectrophotometer. The sample was pipetted directly onto the end of the fibre optic cable, 
and then the second fibre optic cable was brought into contact with the sample, 
consequently the liquid sample acts as a bridge between the two fibre optic ends. A pulsed 
xenon flash lamp provides the light source (Thermo Scientific, 2008). The manufacturer’s 
instructions were followed, the pedestal was cleaned prior to use, the Nucleic acid reading 
and RNA-40 measurement options chosen, and the instrument was blanked using RNase-
free water with a volume of 1 µl. Following this each sample could be measured taking 1 µl 
from each sample. The quantity of RNA was recorded in ng/µl and the purity of the sample is 
recorded as the ratio of absorbance at 260 and 280 nm, 260/280 ratio. For RNA a ratio of 
2.0 is stated to generally be accepted as “pure” RNA. If the ratio is considerably lower than 
this it can be an indication of the presence of protein, phenol or other contaminants that 
absorb strongly at or near to 280 nm (Thermo Scientific, 2008).  
3.5.3 RNA quality 
The extracted RNA was checked for contamination and quality using gel electrophoresis. 
The technique separates out the molecules dependent on their size. Both DNA and RNA are 
negatively charged, therefore with the gel having a positive charge at one end and a 
negative charge at the other, the molecules of interest in this instance the RNA, will move 
toward the positive charge. The smaller molecules will travel a greater distance than the 
larger molecules. A DNA ladder was used to estimate the size of the molecules. The RNA 
bands were visualised using ethidium bromide which fluoresces under UV illumination. A 
1.5% standard agarose gel was used. 
3.5.4 Microarray 
One-Color Microarray-Based Gene Expression Analysis Low Input Quick Amp Labelling 
supplied by Agilent Technologies was used to conduct the microarray. RNA samples ranging 
between 10 and 200 ng of total RNA can be input in this kit. The kit produces fluorescent 
cRNA and uses T7 RNA polymerase, which amplifies target material and incorporates 
cyanine 3-labeled cytidine triphosphate (CTP) (Agilent Technologies, 2010). It is stated in 
the protocol that the kit produces an amplification of at least a 100-fold from total RNA to 
cRNA with this kit.  
Broadly, the procedure includes the following steps; cDNA synthesis, cRNA synthesis and 
amplification, cRNA purification, preparation of hybridization sample, 17 hour hybridisation 
(65°C), wash, scan and feature extraction (Agilent Technologies, 2010). 




Heating blocks were equilibrated at 37°C, 65°C, 80°C, 40°C and 70°C. 
RNase-free microfuge tubes and tips were used and volumes of at least 2 µl were used in 
the pipette to improve accuracy. 
A dilution series of the One-colour Spike mix was then made and this was dependent on the 
starting amount of mRNA. A concentration of 75 ng total RNA was used.  
The first dilution was prepared by labelling a new sterile 1.5 ml microcentrifuge tube “Spike 
Mix First Dilution”. The One-Colour Spike Mix stock solution was vigorously mixed on the 
vortex mixer and heated at 37°C for 5 minutes, followed by a final mixing on the vortex. Then 
they were briefly spun on the centrifuge to drive the contents to the bottom of the tube. The 
2 µl of the Spike Mix stock was added to the First Dilution tube and 38 µl of Dilution Buffer 
(provided in the Spike-In Kit) to a ratio of 1:20 (Agilent Technologies, 2010). This was then 
thoroughly mixed on the vortex and spun down quickly to collect all the liquid at the bottom 
of the tube. This tube then contained the First Dilution. 
To make the second dilution, a new sterile 1.5 ml microcentrifuge tube was labelled “Spike 
Mix Second Dilution”. Then 2 µl of the First Dilution is added to this tube and then 48 µl of 
Dilution Buffer to make a ratio of 1:25 as stated in protocol provided by Agilent Technologies. 
This is then thoroughly mixed on a vortex mixer and spun down quickly to collect all of the 
liquid at the bottom of the tube. This tube now contained the Second Dilution. 
To make the third dilution, a new sterile 1.5 ml microcentrifuge tube “Spike Mix Third 
Dilution” was used. Then 2 µl of the second Dilution was added and then 38 µl of the Dilution 
Buffer to the ratio of 1:20. This is then thoroughly mixed on a vortex mixer and spun down 
quickly to collect all of the liquid at the bottom of the tube. This tube now contained the Third 
Dilution. 
When this assay was conducted for the this project, batches of 24 and 48 samples were 
prepared, which meant an increased volume was needed as 2 µl of the Spike Dilution was 
needed for each labelling reaction, thus volumes of 48 and 96 µl were needed, rather than 
38 µl. Therefore, final volumes of the Third Dilution of 60 and 120 µl were made. Instead of 
2 µl of the second dilution and 38 µl of the Dilution Buffer (final volume 40 µl), for 
24 samples, a volume of 3 µl of the second dilution and 57 µl of the Dilution Buffer (final 
volume of 60 µl) in the correct ratio of 1:20. For 48 samples a volume of 6 µl of the second 
dilution and 114 µl of the Dilution Buffer (final volume of 120 µl) in the correct ratio of 1:20. 
The fourth dilution, as referred to in the protocol was not made up, because the starting total 




amount of 50 ng was initially tried, but the labelling of cyanine 3 dye was poor; better results 
were gained using the amount of 75 ng. 
The final step was to add 2 µl of the Third Dilution to 75 ng of sample total RNA, and to 
continue with the cyanine 3 labelling. 
Preparation of labelling reaction 
For each assay with the total RNA and diluted RNA spike in control cannot exceed 3.5 µl. 
Each batch of assays included 24 samples so the master mix was made up to 30 µl. The kit 
allows total RNA amount of between 10 to 200 ng. We started at 50 ng but the labelling was 
poor, so we increased the concentration of total RNA to 75 ng. 
Total RNA of 75 ng was added to a 1.5 ml microcentrifuge tube in a final volume of 1.5 µl. 
The RNA samples were diluted with RNase free water. Then 2 µl of the diluted Spike Mix 
was added to each tube, resulting in each tube containing 3.5 µl. 
This was followed by the preparation of the T7 Promoter Primer, the T7 Promoter Primer 
was mixed with water, the volumes of which were determined depending on the number of 
reactions been completed. In this instance 24 reactions were being carried out each time, 
therefore 24 µl T7 Promoter Primer was added to 30 µl of nuclease free water giving a final 
volume of the mixture of 54 µl. From this T7 Promoter Primer, 1.8 µl was added to each tube 
containing the RNA, giving a final volume of 5.3 µl. The primer and template were then 
denatured by incubating at 65°C for 10 minutes. Followed by 5 minute incubation on ice. 
Then the 5X first strand buffer was warmed at 80°C for 3 to 4 minutes to ensure that it was 
fully re-suspended, mixed using a vortex and spun down in the microcentrifuge, this was 
then kept at room temperature until required. 
These steps were followed by the preparation of the cDNA Master Mix, the components of 
the master mix were mixed just prior to use, gently mixed using a pipette and kept at room 
temperature. The volumes used of the components of the master mix were again dependent 
on the number of reaction being performed. As 24 were being carried out as standard the 
volumes of each components added were as follows: 5X First Strand Buffer 60 µl, 0.1M DTT 
30 µl, 10mM dNTP mix 15 µl and AffinityScript RNase Block Mix 36 µl (this is a blend of 
enzymes so had to mixed on ice). Before the addition of the cDNA Master Mix was added to 
the template and primer mix, these were spun down in a microcentrifuge to ensure the 
contents was at the bottom of the tube. Following on from this 4.7 µl of the cDNA Master Mix 




were then incubated at 40°C for 2 hours, followed by 15 minutes at 70°C. The samples were 
then placed on ice for 5 minutes and then spun down in the microcentrifuge. 
The next step is the addition of Transcription Master Mix. As with the cDNA master mix the 
components have to mixed together just prior to being used, and as like previous mixtures, 
the volumes are dependent on the number of reaction being prepared. For making up 24 
reactions the following volumes of each component were mixed together: nuclease-free 
water 22.5 µl, 5x Transcription Buffer 96 µl, 0.1 M DTT 18 µl, NTP mix 30 µl, T7 RNA 
Polymerase blend 6.3 µl (kept on ice and added to the mix just prior to use) and cyanine 
3-CTP 7.2 µl. These components were gently mixed by pipetting at room temperature, then 
6 µl of the Transcription Mix was added to each sample tube, mixed by pipetting, resulting in 
a final volume of 16 µl. The samples were then incubated for 2 hours at 40°C.  
Purification of the labelled/amplified RNA 
The first stage of this step was to add 84 µl of nuclease-free water to the cRNA sample 
which results in a final volume of 100 µl following this 350 µl of the Buffer RLT is added and 
mixed by pipetting, then 250 µl of ethanol was added and mixed again by pipetting. The 
700 µl cRNA sample was then transferred to an RNeasy mini column in 2 ml collection tube. 
This was then centrifuged at 4°C for 30 seconds at 13 000 rpm, the flow-through discarded. 
Then 500 µl of the buffer RPE was added to the column, placed in the centrifuge at 4°C for 
30 seconds at 13 000 prm and the flow-through discarded again. Another 500 µl was then 
added and placed in the centrifuge for 4°C for 1 minute at 13 rpm, and the flow-through 
discarded. The RNeasy column was then transferred to a new 1.5 ml collection tube and 
placed in the centrifuge at 4°C for 30 seconds at 13 000 rpm to remove any trace of the 
buffer. The collection tube was then discarded and a fresh tube was used ready to elute the 
cleaned cRNA sample into. Then 30 µl of RNase-free water was added directly on to the 
RNeasy column’s filter, the tube was left for  minute and then placed into the centrifuge at 
4°C for 30 seconds at 13 000 rpm. The column was then discarded and the 30 µl of purified 
labelled RNA was safely in the 1.5 ml tube.  
Quantification of the cRNA 
The quantification step was carried using the Nanodrop and using the Microarray 
Measurement tab, RNA-40 as the sample type. The standard procedure for using the 
Nanodrop was used and 1 µl of sample was loaded onto the pedestal and the 
measurements recorded, specifically cyanine 3 dye (pmol/µl), RNA absorbance ratio 
(260 nm/280 nm) and the cRNA concentration (ng/µl). These measurements were used to 





Firstly, the concentration of cRNA (ng/µl) was used to determine the cRNA yield (µg): 
 
µ𝑔 𝑜𝑓 𝑐𝑅𝑁𝐴 =




Secondly, the concentration of cRNA (ng/µl) and cyanine 3 (pmol/µl) was used to determine 
the specific activity: 
pmol Cyanine 3 per µg cRNA =




The recommended yields and specific activity are dependent on the microarray format, 1-, 
2-, 4- or 8-pack (Figure 3.10). The microarrays being used in this study were 8-pack format. 
Therefore the recommended yield and specific activity were 0.825 µg and 6 pmol Cy3/cRNA, 
respectively. 
 
Figure 3.10 Illustration of the 1-, 2-, 4- and 8 pack Agilent microarray formats (Agilent Technologies, 
2016). 
 Hybridisation 
Following on from calculating the cRNA yield and the specific activity, the hybridisation step 
was started. 
Preparation of x10 blocking agent 
To prepare the x10 blocking agent, 500 µl of nuclease-free water was added to the vial 
containing lyophilised 10X Blocking Agent which was supplied with the Agilent Gene 
expression Hybridisation kit. This mix using the vortex and then placed in the centrifuge to 




Preparation of hybridisation samples 
For the 8-pack format microarray the following components were mixed together to make the 
fragmentation mix: 600 ng cyanine3-labeled, linearly amplified cRNA, 5 µl 10X Blocking 
Agent, make up to 24 µl with nuclease-free water and then add 1 µl of 25X Fragmentation 
Buffer to get the total volume of 25 µl. The volume needed to achieve 600 ng of 
cyanine3-labeled, linearly amplified cRNA is calculated using data collected in the previous 
step to determine the cRNA yield and specific activity. This mix was then incubated at 60°C 
for 30 minutes to fragment the RNA. It was then immediately placed on ice for 1 minute. 
Then a hybridisation mix is added, this is made up, again volumes of components are 
dependent on the microarray format, for the 8-pack microarray format, the following volumes 
of component were mixed together the 25 µl of cRNA from the Fragmentation mix and 25 µl 
2x GEx Hybridisation Buffer HI-RPM, which will stop the fragmentation reaction. The two 
components should be mixed well using a pipette, but without introducing any bubbles. 
These were then spun in the centrifuge for 1 minute at 13 000 rpm, the sample was then 
kept on ice ready to load to load onto the array.  
 Preparation of the hybridisation assembly 
A clean gasket slide was loaded into the Agilent SureHyb chamber base, then the 40 µl of 
the hybridisation mix was pipetted into one of the wells. Once all eight wells were filled the 
DNA microarray was placed array “active side” down onto the SureHyb gasket slide. Then 
the SureHyb chamber cover was placed onto the sandwiched slides and the chamber 
fastened was clamped on and the clamp tightened (Figure 3.11). Once assembled the slide 
chamber was placed in the chamber rotisserie in a hybridisation oven and was set at 65°C 






Figure 3.11 Schematic of Agilent SureHyb hybridisation chamber (Berger & Bulyk, 2009). 
 Microarray Wash 
Once the hybridisation step is complete than the chambers need disassembling and the 
slides need to be washed. The wash procedure to prevent ozone degradation of the 
cyanine 3 was used. Firstly, the stabilisation and drying solution was warmed in water bath 
at 40°C, following complete dissolution of the precipitate the solution was allowed to stand at 
room temperature to equilibrate to room temperature. Secondly, the washes with 
stabilisation and drying solution was carried out, Table 3.5. 
Table 3.5 Wash conditions as defined in the protocol (Agilent Technologies, 2010) 
 Dish Wash Buffer Temperature  Time 
Disassembly 1 GE Wash Buffer 1 Room temperature  
1
st






 Wash 3 GE Wash Buffer 2 37°C 1 minute 
Acetonitrile wash 4 Acetonitrile Room temperature 10 seconds 
3
rd
 Wash 5 Stabilisation and 
Drying solution 
Room temperature 30 seconds 
GE: Gene Expression 
The wash steps were followed as per the protocol.  
 Scanning and Feature Extraction 
Once the wash steps were completed the slides were scanned immediately as to minimise 
the impact of environmental oxidants on the signal intensities. The slides were place in 
holders which were then placed in the scanner carousel. The relevant settings were selected 
and once read the data were extracted. For each sample there was a QC Report which was 
checked to intensity reading, limited wash residue, that the QC spots are correct, that the 
data are normally distributed and that all the other parameters have been assessed as good 
or excellent. 
The microarray data analysis is explained in detail in Chapter 6. 
3.6 Passive Samplers 
Polar Organic Integrative Sampler (POCIS) devices were deployed at the site. These were 
supplied by National Laboratory Services (NLS) part of the Environment Agency. 
3.6.1 Deployment 
A series of 8 back-to-back deployments were conducted. The first deployment started in 
mid-August 2011, and the last deployment was removed at the end of March 2012. Due to 
restrictions at the IPR pilot plant at Deephams, the passive samplers could only be deployed 
at the three stages of the treatment process: post final effluent (FE), post microfiltration (MF) 
and post reverse osmosis (RO), Figure 3.12 represents where, along the treatment process, 






Figure 3.12 A diagram representing the IPR treatment process, the processes highlighted in red indicate 
where the passive samplers were deployed. 
Ideally, samplers would have been placed after each part of the treatment process. Each 
deployment lasted approximately 4 weeks Table 3.6 indicates the schedule of the 
deployments. 
Table 3.6 Dates, lengths and types of passive sampling deployments 
Deployments Date deployed Date removed 
No. of days 
deployed 




1 17/08/2011 13/09/2011 27 3.9 3 
2 13/09/2011 14/10/2011 31 4.4 3 
3 14/10/2011 14/11/2011 31 4.4 3 
4 14/11/2011 06/12/2011 22 3.1 3 
5 06/12/2011 18/01/2012 43 6.1 3 
6 18/01/2012 15/02/2012 28 4 3 
7 31/01/2012 28/02/2012 28 4 3 





The varying time periods of deployments are due to delivery mix ups and access to the 
Deephams site.  
The samplers were delivered in cool-boxes via courier in the morning of the day of 
deployment, and taken from Brunel University to the IPR treatment site at Deephams 
sewage treatment works in the afternoon. On each day of deployment and collection, 
















1 17/08/2011 21 Bright and sunny, no exhaust fumes or similar 13/09/2011 19.5 Bright and sunny, no exhaust fumes or similar 
2 13/09/2011 19.5 Bright and sunny, no exhaust fumes or similar 14/10/2011 18 Bright and sunny, no exhaust fumes or similar 
3 14/10/2011 18 No engine fumes 14/11/2011 10 Grey and drizzle, no exhaust fumes or similar 
4 14/11/2011 10 Grey and drizzle, no exhaust fumes or similar 06/12/2011 7.5 Clear and sunny, no exhaust fumes or similar 
5 06/12/2011 7.5 Clear and sunny, no exhaust fumes or similar 18/01/2012 11 No exhaust fumes or similar 
6 18/01/2012 11 No exhaust fumes or similar 15/02/2012 10 No exhaust fumes or similar 
7 31/01/2012 2 No exhaust fumes or similar 28/02/2012 15 
Slight odour of exhaust fumes, there was lots of 
work taking place at the STW adjacent to the 
IPR plant. 
8 28/02/2012 15 
Slight odour of exhaust fumes, there was lots of 
work taking place at the STW adjacent to the 
IPR plant. 
28/03/2012 21 Clear and sunny, no exhaust fumes or similar 
Deployment 2: The passive sampler from the post microfiltration ballast tank was removed for 40 hours during its deployment by the Thames Water staff on site, it was placed 





Deployment would always start from “clean to dirty”; therefore, the samplers for reverse 
osmosis would be positioned first, followed by the microfiltration, and finally the final effluent. 
A flat headed screw driver was used to open the metal tins in which the sampler cages were 
stored. Once the samplers were open to the air, the blank disc was also removed from its foil 
and left on the side the entire time the test samplers were open to the air. The cage was tied 
with rope and lowered into the relevant ballast tank. The control disc was then covered with 
foil and placed in the on-site fridge. For each treatment process where there was a POCIS 
deployment, there were three POCIS discs with the addition of the blank. 
The passive samplers were left in the relevant ballast tanks for approximately four weeks 
(Table 3.4). When their deployment was over, they were collected. During collection when 
the samplers were exposed to the air, the corresponding blanks were also exposed and left 
to one side. They were transported back to Brunel in chill ice boxes, the discs removed from 
the cages, and membrane discs were wrapped in ethanol rinsed foil and stored at -20°C and 
extraction has begun.  
3.6.2 POCIS Extraction 
The method for extraction of the Pharm-POCIS discs was modified from both Dr Frances 
Orton’s thesis (Orton, 2008) and the Environment Agency’s method of extracting POCIS 
using the solvent mix for pharmaceutical-POCIS (HLB-oasis sorbent) supplied via personal 
communication. 
All glassware was acid washed before use, and then solvent rinsed before each use. There 
was sufficient glassware for sets of each item to be designated as control, reverse osmosis 
(1 to 3), microfiltration (1 to 3) and final effluent (1 to 3); therefore following their initial acid 
wash, between sets of deployments, a solvent rinse was carried out. The solvent rinse 
consisted of once with methanol and twice with ethanol, and then the glassware was left to 
dry (for at least 2 hours, but usually overnight). This included the glass vials, pipettes, 
burettes and flasks. 
Four POCIS discs at a time were removed from the -20°C freezer and, the plastic bags they 
were stored in were opened to allow them to equilibrate to room temperature. Each disc was 
then removed from the bag, the foil wrapping was loosened, and they were left in the fume 
hood overnight to allow the media fully dry.  
Ethanol rinsed foil was used to make small funnels, one for each disc. The nuts were 
loosened on the plates holding the membrane together, using an ethanol rinsed adjustable 




Taking one disc at a time, the disc was placed on a piece of the ethanol rinsed pre-creased 
tin foil and the membrane of the disc was cut with a scalpel blade (Figure 3.13). The sorbent 
from the POCIS disc was then carefully emptied onto the tin foil. This was then emptied into 
a glass burette, a glass ethanol rinsed Pasteur pipette filled with methanol was then used to 
wash any residual sorbent from the foil into the burette (Figure 3.13). The advice received 
from the Environment Agency was to use a minimum amount of methanol to wash the foil 
and get the sorbent from the sides of the burette (ideally no more than 15 ml); a volume of 
10 ml was used each time. 
The sorbent and methanol mixture was allowed to mix and settle; it settled quickly with 
methanol. A timed period of 2 minutes was allowed for each, then the stopcock was opened 
and the methanol was allowed to drain into a 50 ml flask. The burette was fitted with a glass 
frit which prevented the sorbent from being washed down with the solvent. 
Once the methanol had drained through completely, 10 ml of a solvent mix 
(dichloromethane:isopropanol:trifluoroacetic acid 80%:20%:0.1%  (8 ml (8000 µl) DCM: 2 ml 
(2000 µl) IPA: (0.01ml (10 µl) of TFA)) was added to the sorbent, and allowed to mix and 
settle, (this mixture remains in solution). After 5 minutes, the stopcock was opened and the 
solvent mix was allowed to drain into the 50 ml glass flask.   
 
Figure 3.13 Pictures of the equipment and process used to extract from the POCIS discs. The top left is 
the POCIS disc on the pre-creased solvent rinsed foil just prior to cutting the membrane. The other three 
pictures show the extract being eluted from the sorbent in the burettes.  
The four flasks were then placed in a water bath at 30°C under a nitrogen flow. The solvents 




the 5 ml was transferred into an ethanol rinsed 10 ml glass vial with screw-top lid. The flask 
was then rinsed with 0.5 ml of ethanol to ensure all residue was collected. Then in the vials 
the solvent mixture continued to dry down under nitrogen using the SPE (Solid Phase 
Extraction) manifold. 
Once the solvents had been evaporated (or when ~10 µl left likely to be the TFA), 1 ml 
ethanol was added, capped, wrapped with parafilm, and stored in fridge. 
3.6.3 POCIS Extracts Analysis 
A pooled 1ml sample of the POCIS extracts were sent to Centre for Environment Fisheries 
and Aquaculture Science (CEFAS) laboratories at Lowestoft. Pharmaceutical analysis was 
undertaken by ultra-performance liquid chromatography tandem mass spectrometry 
(UPLC-MS/MS). The method analysed the pharmaceuticals listed below with the limits of 
quantitation in brackets. 
Ibuprofen (1 ng/l) 
Dichlofenac (2 ng/l) 
Paracetamol (2 ng/l) 
Erythromycin (1 ng/l) 
Sulfamethoxaole (2 ng/l) 
Trimethoprim (1 ng/l) 
Propanolol (1 ng/l) 
Clofibric acid (1 ng/l) 
Mefenamic acid (2 ng/l) 
Dextropropoxyphene (2 ng/l) 
Tamoxifen (1 ng/l) 
Acetyl-Sulfamethoxazole (2 ng/l) 






3.7 In vitro assays 
3.7.1 Cell culture 
SC5 juvenile mouse Sertoli cells (Hofmann et al., 1992) which were originally provided by Dr 
Ewa Raipert-de Meyts of the Copenhagen Rigshospitalet, Department of Growth and 
Reproduction, Denmark. The protocol was described by Kristensen et al. (2011) with slight 
modifications. 
Media 
The cell line used for the cell culture part of the project were SC5 (mouse juvenile Sertoli 
cells), as they produce a high quantity of prostaglandin D2. The media used to culture them 
was Dulbecco’s modified Eagle’s medium (DMEM - high glucose: Sigma D5796), with 10% 
heat inactivated foetal calf serum (FCS: place 50 ml aliquot in 60°C for 1 hour), 100 U/ml 
penicillin, 100 µg/ml streptomycin and 1mM L-glutamine. For 500 ml of DMEM the following 
was added; 50 ml heat inactivated FCS, 5 ml penicillin/streptomycin (Sigma P4333) and 5 ml 
L-glutamine (Sigma G7513), this was then referred to as full media. 
Cell resurrecting 
A batch of SC5 cells were removed from the liquid nitrogen store and defrosted in a water 
bath at 37°C. The cells are stored in dimethyl sulfoxide (DMSO), so, once defrosted, they 
have to be handled quickly to prevent degradation of the cells. Once defrosted, 1 ml of the 
cell suspension was transferred to 10 ml of full media, with some of the media being used to 
rinse out the tube the cell suspension was stored. The mixture of cells and media was then 
placed in the centrifuge for 5 minutes at 1000 rpm; while the cells were being spun, 8 ml of 
full media was added to a 75 cm3 cell culture flask. The cells were then removed from the 
centrifuge and then as the cells were contained in a pellet at the bottom of the tube, the 
media now containing the DMSO was discarded, and 5 ml of fresh full media was added to 
the tube. The media was then pipetted up and down to re-suspend the cells; once the cells 
were re-suspended, the entire 5 ml cell suspension was added to flask containing 8 ml of full 
media, giving a final volume of 13 ml of media. The cells were then incubated at 37°C with 
5% CO2. 
After 24 hours the media was changed, to ensure the removal of any residual DMSO. On the 
second day the cells were checked for normal growth and any signs of contamination. Once 
the cells have reached 60-70% confluence they were split/sub-cultured; if they were allowed 
to become >80% confluence they would stressed. Splitting the cells was carried out by 




this was removed 2 ml of trypsin was added and left in incubator for approximately 
2-3 minutes. In the two fresh 150 cm3 cell culture flasks 19 and 18 ml of fresh full media 
were added to each. The trypsinated cells were then examined to ensure they were lifting 
from the surface of the flask and aggregated, then 8 ml of fresh full media was added to the 
flask; this acts by neutralising the trypsin. The cell suspension was then pipetted up and 
down to break up the aggregated cells, and 1 and 2 ml of the cell suspension were added to 
the clean flasks containing 19 and 18 ml of media, respectively, to make a final volume of 
media of 20 ml in each. The remainder of the cell suspension was discarded. The two 
different volumes of cell suspension were used to ensure there was sufficient cell growth, but 
a higher concentration can sometimes grow too rapidly and become fully confluent before 
there is time to split the cells. Splitting the cells is also known as sub-culturing or passaging; 
with this particular cell line they should not allowed to go past passage 29, as the cells start 
producing increased/decreased levels of prostaglandin, therefore the number of passages 
each batch of cells were on were recorded, and a new batch was resurrected when 
29 passages were reached. 
3.7.2 Prostaglandin Inhibition Assay 
The Prostaglandin D2-Methoxime (MOX) Enzyme Immunoassy (EIA) kit manufactured by 
Cayman Chemical Company was used. The protocol from the kit was followed but, briefly, 
the same full media was used as previously described in Section 3.7.1   
Day1: Seeding cells in 24 well plates 
The EIA plate allows 32 samples to be processed at a time. The cells should be checked 
and should be 70% confluent, then the cells were trypsinased as described before and 20 µl 
of the resulting cell suspension was taken for the haemocytometer. While the cells were 
being counted, the suspension was placed in the centrifuge for 5 minutes at 1000 rpm. The 
SC5 cells had to be at a concentration of 1x 105 cells/ml. Cell counts from the four corners of 
the haemocytometer were made, and an average number of cells calculated. The following 
calculation was used to determine the volume of cell suspension required: 
Cells per ml =
 Average number of cells in 4 grids counted
Volume of the grid
 
Total number of cells = Cells per ml × Volume of cell suspesion 
Final Volume (ml) =






The cell suspension was used to seed two 24 well plates with 500 µl of cell suspension 
being placed in each well providing a subsequent 5x 104 cells per well concentration. The 
plates were then placed at 37°C with 5% CO2 overnight to allow the cells to attach to the 
surface of the well plates. 
Day 2: Treatment with chemicals 
It was ensured, prior to starting, that clear plate plans had been created, ensuring wells for 
positive and negative controls, ibuprofen control, and treatment chemicals. Serial dilution of 
the test compounds and vehicle in full media were prepared, and known as treatment media. 
A negative control was prepared consisting of a 3 ml of 1% ethanol media. In addition to the 
negative control, a positive control was also prepared to test for cell toxicity, 3 ml of 2% triton 
(triton causes 100% cell death and the ethanol control would be assumed to cause 0% cell 
death, therefore the treatments would be expected to be somewhere in between these two 
controls) is used to normalise media. Ibuprofen was used as a positive control for the EIA 
itself. The 24 well seeded plates from the previous day were checked for cell growth, 
attachment and any signs of contamination; if satisfactory, the media from the wells was 
rapidly but gently removed, and 200 µl of full media was added to each well to prevent the 
cells from drying out. The 200 µl of treatment media was added to the relevant wells, 
consequently the test chemicals were now 200 times diluted, and each well contained 400 µl 






1 2 3 4 5 6 
A Blanks RO Ibu 1 Ibu 5 RO 1 RO 5 EtOH 
B Blank MF Ibu 2 Ibu 6 RO 2 RO 6 EtOH 
C EtOH Ibu 3 Ibu 7 RO 3 RO 7 Blank Raw 
D Triton Ibu 4 Ibu 8 RO 4 RO 8 Triton 
       
 
1 2 3 4 5 6 
A Blanks RO MF 1 MF 5 FE 1 FE 5 Triton 
B Blank MF MF 2 MF 6 FE 2 FE 6 EtOH 
C EtOH MF 3 MF 7 FE 3 FE 7 Blank Raw 
D EtOH MF 4 MF 8 FE 4 FE 8 Triton 
 
Figure 3.14 An example of the plate plan for the seeded 24 well plates. Ibu 1-8 serially diluted ibuprofen 
acting as the positive EIA control; RO1-8: serially diluted extract from the POCIS sampler position post 
reverse osmosis; MF1-8: serially diluted extract from the POCIS sampler position post microfiltration; FE 
1-6: serially diluted extract from the POCIS sampler position post pre-filtration also known as final 
effluent (FE);  EtOH: ethanol blanks as negative controls; Blanks: the extracts taken from the blank 
POCIS discs at the different sampled point along the IPR plant; and Triton: the positive control for the 
cell toxicity assay. 
 
Day 3: Prostaglandin D2-MOX EIA set up 
The protocol provided by Cayman Chemicals was followed but, briefly, the procedure was as 
follows: initially the heating block and centrifuge were switched on and set at 60°C and 4°C, 
respectively. The MTT solution was removed from the freezer. Two sets of Eppendorf tubes 
were labelled for each sample and negative control. The EIA buffer from the kit was 
prepared by dissolving 10x concentrate EIA buffer in 90 ml ultra-pure water. The 




ethanol:water mix, and adding a small volume of it to the 0.1 g methoxylamine HCL, which 
was then vortexed and transferred to 0.82 g sodium acetate mixed well and added to the 
rest of the 10% ethanol solution. From this 10 ml solution 100 µl was added to one set of 
Eppendorf tubes and place in the fridge. 
The prostaglandin D2 standard was then derivatised by diluting 100 µl standard with 900 µl 
Millipore water. Then, immediately after diluting the standard, a 1:1 solution of diluted 
standard and MOX were prepared and then heated in the block at 60°C for 30 minutes. This 
mixture was then 20 ng/ml standard, and could be stored in the fridge for one month and 
used in subsequent assays. 
While the prostaglandin standard was on the heating block, 200 µl medium from the 
exposed cells was removed without disturbing them. This medium was transferred to the 
pre-chilled Eppendorf tubes and kept on ice. The remaining 200 µl media in the wells was 
left, and the plates returned to the incubator; this was in preparation for the MTT assay. The 
Eppendorf tubes were then pulsed on the centrifuge at 4°C, following the centrifuge, 100 µl 
medium was removed, leaving any debris at the bottom of the tube, and this 100 µl media 
was transferred to the chilled Eppendorf tubes containing the 100 µl MOX solution previously 
added These tubes were then heated at 60°C for 30 minutes. Once the tubes were heated 
for 30 minutes they were removed from the block and stored on ice until ready to use. While 
the samples were on the heating block the standard solution series was prepared, 200 µl of 
the derivatised standard (20 ng/l) was transferred to a new Eppendorf tube and diluted with 
600 µl Millipore water, creating a stock concentration of 5 ng/ml. Then 8 Eppendorf tubes 
were labelled, with the first containing 950 µl full media, and the remaining tubes (2 to 8) 
containing 500 µl full media. The 5 ng/ml stock was then used for the serial dilution by 
adding 50 µl to the first tube, and then transferring 500 µl from the first to second, 500 µl 
being added from second to third and so on, mixing by pipetting up down between each 
dilution. By this point the treatment samples would have been ready and placed on ice. The 
D2-MOX AChE Tracer was then reconstituted; a whole vial of tracer was added to 30 ml of 
EIA buffer, which could then be stored in the fridge for one month to be used in subsequent 
assays. A volume of 6 ml of this tracer was used for each EIA plate, therefore 6 ml of this 
tracer was transferred into a separate tube and 60 µl tracer dye was added; this dye was 
added to the aliquot to be used on the day of the assay, not to the tracer stock. The D2-MOX 
EIA antiserum was also reconstituted in a similar way, the whole vial of antiserum was 
reconstituted in 30 ml of EIA buffer, and then could be stored in the fridge for one month. 
Again 6 ml of this was aliquoted out, and 6 µl of antiserum dye added to the aliquot. At this 




As with the 24 well treatment plates, a clear plate plan was created earlier, and 50 µl full 
media was added to the NSB wells, 50 µl EIA buffer was added to NSB and B0 wells, 50 µl 
of standard and samples were added to the relevant wells as per following the plan, and 50 
µl of the tracer (except for the TA and blank) followed by 50 µl of antiserum (except for TA, 
blank and NSB). The plate was then sealed and placed in the fridge overnight. 
 
Figure 3.15 An example EIA 96 well plate plan. EIA blank: background absorbance caused by Ellman’s 
Reagent; NSB: Non-Specific-Binding, non-immunological binding of the tracer to the well; B0: Maximum 
binding, the maximum amount of the tracer that the antibody can bind in the absence of free analyte; Std 
1-8: the serially diluted prostaglandin D2 standard, Ibu 1-8 serially diluted ibuprofen acting as the 
positive EIA control; RO1-8: serially diluted extract from the POCIS sampler position post reverse 
osmosis; MF1-8: serially diluted extract from the POCIS sampler position post microfiltration; FE (which 
is labelled as RAW in the figure) 1-6: serially diluted extract from the POCIS sampler position post pre-
filtration also known as final effluent (FE); Etoh: ethanol blanks as negative controls; and POCIS blanks: 
the extracts taken from the blank POCIS discs at the different sampled point along the IPR plant. 
At this point the cell toxicity/MTT assay can be carried out, this is described below in section 
3.7.3. 
Day 4: Reading the EIA plate 
Firstly, wash buffer was prepared by dissolving 5 ml concentrated wash buffer in 2 litres of 
purite water, and 1 ml of polysorbate was added. A vial of Ellman’s Reagent was 
reconstituted into 50 ml Millipore water, and then the tube was covered with foil to protect the 
reagent from the light. The automatic plate water was used to empty the wells from the EIA 
plate, and it was rinsed five times with the wash buffer. With the use of a multichannel 
pipette, 200 µl of the reconstituted Ellman’s reagent was added to each well. The plate was 
re-covered with the film lid and wrapped in tin foil to protect the reagent from the light. The 
covered plate was then placed on the plate shaker at speed 5, and left to develop for 
96 minutes. Once the plate had developed, it was read on the spectrophotometer plate 




A.U. (blank subtracted). If the absorbance of the wells exceeds 1.5 the plate would have 
been washed again and fresh Ellman’s reagent added, and left to develop again.  
3.7.3 Assay for cytotoxicity/MTT assay 
This assay was carried out during day 3 of the EIA. Initially the MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) was removed from the freezer, covered in foil, and left 
in the water bath at 37°C. The MTT solution was 5 mg/ml MTT in Phosphate Buffered Saline 
(PBS) or Hank’s Balanced Salt Solution (HBSS), and was stored at -20°C. This MTT solution 
was used to make MTT medium, which was prepared into a 1 in 20 dilution of MTT in growth 
medium; 20 ml of this MTT medium was made each time (1 ml 5 mg/ml MTT solution into 19 
ml of full media).  
The cell culture/treatment media from each of the wells of both 24 well plates was gently 
removed, and 200 µl MTT medium was added. These were then incubated for 45 minutes at 
37°C with 5% CO2. Subsequently the MTT media solution was removed, and the cells in 
each well were washed with 200 µl HBSS. The HBSS was then removed, and the crystals 
that had formed in the bottom of the wells were then dissolved with 200 µl of dimethyl 
sulfoxide (DMSO). The plates were then covered with tin foil to protect them from the light 
and placed on a plate shaker for 20 minutes. The contents of each well were then 
transferred to a 96 well plate and read on the spectrophotometer plate reader at 570 nm and 
620 nm.  
The negative controls were normalised as 100%, and any well that fell below the 2 times 
standard deviation was considered to be toxic. 
3.8 Additional in vivo exposures 
3.8.1 NSAIDs exposures 
Additional zebrafish embryos exposures were conducted using three of the most potent 
NSAIDs analysed on the prostaglandin inhibition EIA. The three NSAIDs tested were 
diclofenac sodium (Sigma-Aldrich, 99.9% Pharmaceutical secondary standard traceable to 
USP, PhEur and BP, certified reference standard), mefenamic acid (Sigma-Aldrich, >98%) 
and naproxen (Sigma-Aldrich, 99.9% Pharmaceutical secondary standard traceable to USP, 
PhEur and BP, certified reference standard). 
 Stocks and exposure concentrations 





Table 3.8 The concentration of the stocks for each of the NSAIDs  
Stocks in ethanol 
NSAIDs 
Diclofenac sodium Mefenamic acid Naproxen 
Master stock (µg/l) 30 000 30 000 50 000 
Working stock 1 (µg/) 3000 300 1250 
Working stock 2 (µg/) 300 30 500 
Working stock 3 (µg/) 30 3 50 
Working stock 4 (µg/) 3 0.3 5 
Working stock 5 (µg/) 0.3 N/A 0.5 
 
The master stock of each of the NSAIDs was used to make up the first working stock, which 
was then serially diluted resulting in 5 or 4 (in the case of mefenamic acid) working stocks.   
Each of these working stocks were used to make the final test concentration, which was 
done by pipetting 1 ml of each into a 100 ml Duran bottle. The 1 ml of working stock was 
then left in the fumehood to evaporate. Following evaporation of the ethanol, 100 ml of 
header tank water was weighed into the bottle, the bottle was then shaken vigorously and 
stirred with a magnetic stirrer.  
Table 3.9 The concentration of the final exposures for each of the NSAIDs  
Final exposure concentrations (ng/l) 
NSAIDs 
Diclofenac sodium Mefenamic acid Naproxen 
Made from Working stock 1  30 000 3000 12500 
Made from Working stock 2 3000 300 5000 
Made from Working stock 3 300 30 500 
Made from Working stock 4 30 3 50 





A solvent control and header tank water were also used; the solvent control consisting of 1 
ml of ethanol and being allowed to evaporate. 
 Zebrafish embryo exposure (72 hour) 
The same zebrafish breeding regime used in previous exposures was followed, with the 
breeding adults being paired the day before the exposure was to start. Twenty four well 
plates were used, and 2 ml of the exposure media was placed into each well the day before 
the start of the exposure, and the plates were left in the incubator overnight. In the morning 
of start of exposure, the exposure media from the previous day was removed, and fresh 
media was added to each well. The plates were returned to the incubator to allow the correct 
temperature to be reached. There was a plate for each concentration, control (header tank 
water) and solvent control, and on each plate there were four control wells with header tank 
water. Basic physical chemical properties of the water were taken at the start of the study. 
These included dissolved oxygen, temperature (HACH probe), pH, general hardness, 
carbonate, nitrate and nitrite (API 5 in 1 test strips) and ammonia (API ammonia test strips). 
The temperature within the incubator was recorded with a thermometer to check on the spot 
and also continuous readings were taken using the two Tiny Tag data loggers.  
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Figure 3.16 Representation of the plate lay out. There was a plate with this lay out for each concentration 
of the NSAID and solvent control, and there was a plate where all 24 wells were control. 
The embryos were sorted and one embryo per well was added. The plates were returned to 
the incubator, with daily observations being carried out on a daily basis until 72 hours post 
fertilisation. At 24 hours post fertilisation, the number of movements within a 20 second 
period were recorded for every surviving embryo. At 48 hours post fertilisation the number of 
heart beats per 30 seconds were recorded for every surviving embryo. At every observation, 




number of hatchings and number of mortalities recorded. At the 72 hour point, final 
observations were made and the embryos were preserved in RNAlater® stabilising solution, 
the normal looking ones being pooled together, and any abnormal looking embryos were 
separately stored. Each exposure for the individual NSAIDs was repeated twice. 
3.8.2 Tyrosinase inhibitor exposures 
Additional zebrafish embryos exposures were conducted using three tyrosinase inhibitors. 
The three tyrosinase inhibitors tested were 4-n-butylresorinol (supplied by TCI, >98%), kojic 
acid (supplied by Sigma Aldrich, >98.5%) and niacinamide (supplied by Sigma Aldrich, 
99.7%). 
 Stocks and exposure concentrations 
Table 3.10 The concentration of the stocks for each of the tyrosinase inhibitors  
Stocks in double 
distilled water 
Tyrosinase inhibitors 
4-n-Butylresorinol Kojic acid Niacinamide 
Master stock (mg/l) 100 500 10000 
Working stock 1 (mg/) N/A 50 N/A 
 
Based on the desired final concentrations, and the fact that none of the tyrosinase inhibitors 
required to be dissolved in solvent, a serial dilution was not needed. The volume of the stock 
was varied in relation to the final concentration, with the final volume being made with water 
from the header tank, and made up to 500 ml in a larger Duran bottle. Again, these were 
then vigorously shaken and placed on the magnetic stirrer. There was also no requirement 
for a solvent control, so one control was used using solely header tank water. As there were 
limited data on the toxic concentrations, and known environmentally relevant concentrations, 





Table 3.11 The concentration of the final exposures for each of the tyrosinase inhibitors  
Final concentration of tyrosinase inhibitors 
4-n-Butylresorinol 
(µg/l) 
Kojic acid (µg/l) 
Niacinamide 
(mg/l) 
10 5 10 
100 50 100 
1000 500 1000 
 
 Zebrafish embryo exposure (72 hour) 
The same zebrafish breeding regime used in previous exposures was followed, with the 
breeding adults being paired the day before the exposure was to start. Crystallising dishes 
were used, with a capacity of 300 ml; 200 ml of the exposure media was placed into each 
dish on the morning exposure was due to start, and left in the incubator to acclimatise. There 
were two dishes for each concentration and control (header tank water). Basic physical 
chemical properties of the water were taken at the start of the study; these included 
dissolved oxygen, temperature (HACH probe), pH, general hardness, carbonate, nitrate and 
nitrite (API 5 in 1 test strips) and ammonia (API ammonia test strips). The temperature within 
the incubator was recorded with a thermometer to check on the spot, and also continuous 
readings were taken using the two Tiny Tag data loggers.  
The embryos were sorted, and 50 embryos were added per dish. The dishes were returned 
to the incubator and observations were carried out on a daily basis until 72 hours post 
fertilisation. At every observation, signs of developmental delay and malformations were 
made, photographs taken, number of hatchings, and number of mortalities recorded. At the 
72 hour point, final observations were made, and then preserved in RNAlater® stabilising 
solution; the normal looking ones being pooled together, and any abnormal looking embryos 






CHAPTER 4: Investigating the Chemicals 







During the running of the pilot IPR plant at Deephams waste water treatment plant, Thames 
Water had been taking twice weekly samples of the water from the various processes and 
sending them for chemical analysis. There are data for over 400 chemicals, which had been 
categorised by Thames Water into classes such as Endocrin Disrupting Chemicals (EDCs) 
and Pharmaceuticals, Pesticides, Organics, Inorganics, Nutrients and Microbiology. 
4.1.1 Daily and seasonal fluctuations 
Thames Water stated that the composition of the effluent from the Deepham’s sewage 
treatment works did not show any alteration due to day of the week or season. However, it 
has been stated that there is an expected alteration in the composition during the day due to 
peaks in water usage, Table 4.1 shows the range of concentrations during the a 24 hour or 
15 hour period for ammonium, Total Organic Carbon (TOC), Biochemical Oxygen Demand 
(BOD) and Chemical Oxygen Demand (COD).  
Table 4.1 Diurnal data supplied by Thames Water 
Measurement December 2009 June 2010 
Minimum (mg/l) Maximum (mg/l) Minimum (mg/l) Maximum (mg/l) 
Ammonium as NH4
a 
0.05 0.6 0.05 0.33 
TOC
b 
8.8 12.7 0.4 13.1 
BOD
b 
1.8 4.1 1 4.9 
COD
b 
27.9 41 25.2 33.8 
a
From 1 am to midnight 
b
From 9 am until midnight 
TOC: Total Organic Carbon 
BOD: Biochemical Oxygen Demand 
COD: Chemical Oxygen Demand 
 
4.1.2 Categorising the contaminants 
For this project the contaminants were further categorised and work examining the reduction 
of the contaminants based on their category was carried out (data not shown), to establish if 
there was a specific category of contaminant that was persisting within the IPR plant 
treatment process. I used very specific categories, for example pharmaceuticals were further 
categorised into their mode of action, for example Pharmaceutical-Beta blocker. Once these 




toxicological endpoints targeted by each contaminant that had been detected above the limit 
of detection (LoD) from at least one point along the treatment process. This was 
accomplished by taking a contaminant in turn and performing a literature search to 
determine if there are specific target organs and/or effects such as carcinogenicity, 
genotoxicity, reproductive and/or developmental effects and if it is endocrine disrupting. In 
addition to these potential human health impacts, certain physicochemical properties were 
noted as well as fate and behaviour and limited ecotoxicological data. Once these had been 
noted, a category was assigned to each endpoint. This was then used to determine if any 
product water from any point along the treatment process would have had the potential to 
exhibit a specific toxicological effect, and subsequently, a hypothesis could be formulated as 
to the likelihood of an effect that might be observed in the development of zebrafish and/or 
gene expression results.  
Whilst completing the literature searching and the categorisation it became evident that 
many of the contaminants often had more than one potential endpoint.  
4.1.3 Toxicological endpoints along the treatment process 
Figure 4.1 below illustrates the frequency of pesticides being detected in the different 
product waters with a specific target organ and/or toxicological endpoint. It is important to 
note that one contaminant can have multiple health effects, and these data do not take into 
consideration potencies or the concentration at which they were detected, just that they are 
present. The figure shows, for example, that in final effluent there have been 34 individual 
pesticides detected above the limit of detection that caused an effect on the gastrointestinal 
tract and/or liver of experimental mammals. However, in the final product there were only 3 
pesticides detected above the limit of detection that exhibit a similar effect. The figure shows 






Figure 4.1 Total number of pesticides detected at concentrations above limits of detection at the various 
points along the treatment process, with reported health outcomes 
4.1.4 Chemical analysis data on the aquarium water 
Analysis was also conducted on the aquarium and tap water used as controls in the 
zebrafish embryo exposures. Samples were taken on three separate occasions in August 
2013. The results of this sampling are displayed in the Appendix. The chemistry was 
organised by Thames Water Ltd. 
4.2 Passive samplers 
Passive samplers vary in design, but simply they are devices that enable continuous 
monitoring of contaminants, both atmospheric and aqueous. In the aqueous environment 
they remove the difficulties associated with sampling living organisms (Zhang et al., 2008) 
























































































to. Contaminants are absorbed onto a membrane/material, allowing them to be extracted, 
which then enables them to be identified and sometimes (dependent on the membrane and 
target contaminants) a relative concentration of the contaminants can be determined or the 
extract can be used in exposure experiments and in vitro bioassays.  
There are two standard passive samplers used in aquatic systems and these are Semi-
Permeable Membrane Device (SPMD) and the Polar Organic Integrative Sampler (POCIS). 
There is also a third, type, but less widely used, the Diffusive Gradients in Thin Films (DGT). 
SPMD and POCIS are commonly used together due to them targeting different contaminants 
and combining the two increases the variety of contaminants sampled.  
4.2.1 SPMD 
SPMDs are designed to function in a similar way to the processes involved bioconcentration 
in an organism, but with the addition of the ability of enabling semi-quantitative to 
quantitative estimates of concentrations of hydrophobic organic chemicals (Huckins et al., 
2006). SPMD is “an envelope of lay-flat low density polyethylene containing triolein, a major 
component of fish lipid” (Environment Agency, n.d.). SPMD will absorb hydrophobic 
compounds present in the water; these have log Kow of >3 but are not bound to sediment, 
such as PAHs, PBCs, organochlorine pesticides and synthetic pyrethroids. Only 
contaminants that are dissolved in the water and are bioavailable will be absorbed by the 
device (Environment Agency, n.d.). It is reported that a standard SPMD will remove the 
contaminants present in the equivalent of approximately 1 to 4 litres of water per day 
(Environment Agency, n.d.). 
4.2.2 POCIS 
POCIS consist of a solid receiving hydrophobic phase (sorbent) with two hydrophilic 
microporous polyethersulfone (PES) membranes either side (Zhang et al., 2008). POCIS are 
reported to absorb a complimentary array of hydrophilic organic chemicals, as SPMD does 
not absorb compounds with a log Kow <3. POCIS absorbs compounds such as 
pharmaceuticals, steroid hormones and veterinary medicines (Environment Agency, n.d.). 
As with the SPMD, the POCIS will only absorb compounds that are dissolved and 
bioavailable, unbound to the sediment (Environment Agency, n.d.). 
The absorption of hydrophobic compounds to the sorbent is prevented by the membrane, 
and only the hydrophilic compounds that are able to pass through the membrane 







The DGT samples ionic species from the water,  and as with the SPMD and POCIS, only 
dissolved and bioavailable compounds will be absorbed (Environment Agency, n.d.). DGT is 
used to sample toxic metals such as nickel, copper, chromium, cadmium and zinc and 
phosphate (Environment Agency, n.d.). 
4.2.4 Deployments 
At the Deephams IPR plant, pharm-POCIS devices were deployed. The extracts could then 






CHAPTER 5: Identifying Apical Endpoints in Developing 
Zebrafish Embryos Exposed to the 
Different Product Waters from the IPR 







As previously stated, due to the complex chemical composition of the different product 
waters from the Indirect Potable Reuse (IPR) plant, and therefore (by interference) the many 
possible biological activities and potential effects, this project was non-hypothesis led at the 
start. Therefore, the main research question to address initially was whether any biological 
effects could be observed following exposure to the various product waters from the IPR 
plant at different treatment stages, and secondly, whether the treatment process itself could 
remove or enhance these effects. Specifically for this stage of the research I was interested 
in finding out if any obvious developmental malformations or other apical endpoints occurred 
following exposure to the different product waters from the IPR plant.  
5.2 Aims and Objectives 
5.2.1 Aim  
To determine if product waters from the different treatment stages of the IPR plant caused 
observable effects on developmental endpoints. 
5.2.2 Objective  
Expose zebrafish embryos to each of the product waters from the IPR plant, including final 
effluent (FE), microfiltration (MF), advanced oxidation following MF but in the absence of 
reverse osmosis (AOP1), reverse osmosis (RO), AOP following MF and RO (AOP2) and 
final product (FP). Observe the embryos during their development at defined developmental 
time-points, recording survival, hatching, heart rates and abnormalities. Compare these 
measured endpoints to zebrafish embryos reared in purified aquarium water (referred to as 
Control) and tap water. 
5.3 Introduction 
5.3.1 Test Organism 
Embryos from the zebrafish, Danio rerio Tübingen strain, were used as the test organism for 
all the studies described in this chapter. A detailed description of the zebrafish as a model 
organism and their use in research is detailed in the General Introduction, section 2.7.1. 
5.3.2 Fish Embryo Toxicity (FET) Test 
As part of environmental risk assessments, there is a regulatory requirement to test 




and initially the fish embryo test was seen as a potential replacement for this test (Scholz et 
al., 2008). In the 96 hour acute fish test (OECD 203), sub-lethal effects are not considered, 
and only the LC50 (Lethal Concentration for 50% of the individuals in the test group) is 
reported. Therefore this test is likely to underestimate the potential adverse long-term 
environmental effects, and short-term mortality is only specifically useful in the case of 
accidental spills (Nagel, 2002). Additionally, the acute fish test uses large numbers of adult 
fish and puts them under a significant degree of pain and suffering as well as being time 
consuming and costly. Consequently, there has been increasing pressure to find relevant 
alternative(s). Also, it is difficult to derive an LC50 for a complex and largely undefined 
mixture of chemicals. 
Lange et al., (1995) compared the suitability of using zebrafish embryos in toxicity testing as 
a replacement for the acute fish test using adults. They also compared cytotoxicity assay in 
the RTG-2 cells (Rainbow Trout Gonad), where the cell viability was tested using Neutral 
Red uptake, and the MTT assay. They found that for the majority of the 10 compounds 
tested, the zebrafish embryo test was more sensitive than the acute fish test using adult 
zebrafish (Lange et al., 1995). In that study it was also noted that the embryo test was more 
sensitive for all 10 compounds tested compared to the RTG-2 cell cytotoxicity assay (Lange 
et al., 1995). In Germany, the fish embryo test has been adopted as a routine test to 
determine the toxicity of wastewater effluents, with results that are comparable to those of 
the acute toxicity fish tests using adult fish (Scholz et al., 2008).  
The Organization for Economic Co-Operation and Development (OECD) has issued a 
number of guidance documents for the fish embryo test (FET). The first draft of the OECD 
guideline of the FET was submitted to the OECD in 2006 and was approved in 2013 
following review (OECD, 2006, 2013). The OECD draft FET test guidelines specify the fish 
species to be the zebrafish (D. rerio), but include the caveat that the method could be 
adapted for fathead minnow (Pimephales promelas), Japanese medaka (Oryzias latipes) 
and other relevant species of interest (OECD, 2006). However, in the finalised revised 
version of the guidelines, only zebrafish are specified (OECD, 2013). 
The zebrafish embryotoxicity test (ZET) is widely used, but there are still reported to be inter-
laboratory differences in its responses, and there is a lack of standardisation in a number of 
key areas. Variations include factors such as the specific developmental endpoint(s) that are 
considered and the developmental stages at which endpoints are measured, whether 
cytotoxicity is considered or not, and  differences in approaches to determine exposure to 
the test compound (i.e. within the embryo or in the water), if carried out at all (Beekhuijzen et 




example variations exist as to when the start of the exposure occurs, from <2, 6-8 or 24 
hours post fertilisation (hpf) (Beekhuijzen et al., 2015; Hermsen et al., 2011; Selderslaghs et 
al., 2012). Beekhuijzen et al. (2015) discussed the use of a standardised starting point, and 
suggested that this should be comparable with that of mammalian developmental toxicity 
studies in rats and rabbits. In these mammalian developmental toxicity studies, maternal 
exposure is started following the completion of implantation of the embryo also referred to as 
the gastrulation period (OECD, 2001). In zebrafish embryos this would correspond to 5¼ hpf 
(Kimmel et al., 1995). Beekhuijzen et al. (2015) argue that this standardised approach will 
enable the results from both zebrafish embryo studies and mammalian developmental 
studies to be compared and more effectively used in predictive models. 
Another variation in experimental design is the temperature at which the embryos are 
reared. The updated OECD guidelines for the FET test, OECD 236, state a temperature of 
26°C (OECD, 2013). However, 28.5°C has also been reported to be the best temperature to 
rear zebrafish embryos in order for accurate developmental staging (Kimmel et al., 1995; 
Westerfield, 2007).  It is also stated that zebrafish embryos can tolerate a temperature range 
of 24 to 33°C (Westerfield, 2007). Beekhuijzen et al. (2015) compared some results of 
toxicity studies at both 26°C and 28°C, and concluded that at 28°C there was increased 
mortality whereas at 26°C there were an increased number of malformations. At the 
temperature of 26°C the rate of development is reduced, and therefore the reduced number 
of malformations at 28°C might be due to a greater developmental rate which effectively 
means that the embryos spend less of their time being exposed to the chemical during 
specific windows of development. Embryos raised at 26°C develop more slowly, which 
increases the duration of exposure at each developmental stage, thereby potentially 
increasing their sensitivity to teratogenic effects (Beekhuijzen et al., 2015). It was also 
highlighted that at a higher temperature evaporation of the exposure media would increase, 
potentially increasing the concentration of non-volatile test compounds in the media 
(Beekhuijzen et al., 2015). Beekhuijzen et al. (2015) concluded that using a temperature of 
26°C would increase the predictability of the zebrafish embryo assay, but that more research 
was required to determine an optimum temperature. Certainly, being aware of these 
experimental differences, combined with the knowledge of how they could potentially affect 
the experimental outcome, leads to a lack of confidence in the reliability of data when 
comparing results derived from exposures adopting slightly different temperatures. For my 
exposures, a temperature range between 27 and 28°C was used, based on information 
reported in a number of credible sources (Kimmel et al., 1995; Westerfield, 2007). 
There is also debate over whether it is better to remove the chorion (egg shell) when 




72 hpf (Kimmel et al., 1995). The chorion is a permeable shell consisting of pore canals 
which are between 500-700 nm in diameter (Gustafson et al., 2012). It is considered that for 
certain compounds, the chorion might act as a barrier and prevent or reduce the embryo 
itself from being exposed to the test compound, especially larger compounds which would 
be unable to pass through the pore canals. Therefore, some researchers remove the chorion 
whereas others do not, as it is time consuming to do so, consequently reducing the 
advantage of the assay being high through-put. More importantly, some researchers have 
found that dechorionated embryos have increased mortality and abnormality rates compared 
to chorionated ones (Beekhuijzen et al., 2015; Selderslaghs et al., 2012). Subsequently, the 
results obtained from the differing procedures are not comparable. During an inter-laboratory 
study for the harmonisation of the zebrafish developmental assay Gustafson et al. (2012), 
determined that the chorion did not prevent the uptake of any of the 20 compounds tested. 
Additionally, silver nanoparticles have been reported to pass through the pore canals of the 
chorion (Gustafson et al., 2012). However, Selderslaghs et al. (2012) reported on two 
studies whereby it was confirmed that the chorion of the zebrafish embryo acted as a barrier 
to a cationic polymer (Luviquat HM 522) and thalidomide, whereby teratogenic effects were 
only observed following removal of the chorions. However, the second treatment process 
used at the IPR plant was microfiltration and microfiltration is reported to remove particles 
between the size of 0.05 and 5 µm (Gray, 2010). Consequently, with post treatment with 
microfiltration and beyond it, chemical contaminants still present in the treatment water 
would be of the size range to pass through the pores of the chorion.  
Different researchers report using different test chambers. For my research, 24 well plates 
and 300 ml glass crystallising dishes were both used, depending on the specific 
experimental outcome being measured. From the literature, 96 and 24 well plates are widely 
used, and the OECD 236 guidelines state that 24 well plates should be used (OECD, 2013). 
It has been reported that within the well of a 96 well plate there is insufficient room for the 
embryo to move and that skeletal malformations in the form of tail kinks have been observed 
at an increased frequency compared the frequency in embryos raised in 24 well plates 
(Selderslaghs et al., 2009). However, the authors of that research also observed a greater 
number of skeletal malformations at the 144 hpf time-point compared with embryos at 55 
and 72 hpf, but still with a greater number in the smaller wells of the 96 well plate 
(Selderslaghs et al., 2009). Also, each 96 well has a reduced volume compared to wells of a 
24 well plate (360 µl and 3000 µl, respectively), potentially causing a reduced dissolved 
oxygen concentration in the smaller well over the length of the exposure and increased 
evaporation over time. As the majority of testing for this project consisted of using treated 




oxygen, especially with the product water from final effluent and microfiltration, and therefore 
the 24 well plates were favoured. The well plates are of particular benefit when observing the 
zebrafish embryos for malformations or delays in development. One embryo was added per 
well, enabling individuals to be monitored throughout the entire period of the exposure. Also, 
should death occur, the decomposing embryo in a well remains isolated from the other 
embryos. Dishes were used when larger numbers of individuals were required to produce a 
pooled sample for the genomic work. Due to the large number of dishes required, they were 
placed into heated water baths as opposed to the incubator. 
Further examination of the variations in experimental design adopted by different research 
groups showed the length of exposure time to be variable also. The OECD 236 now 
specifies a period of 96 hpf (OECD, 2013). The draft version of OECD FET test released in 
2006 stated an exposure time of 48 hours (OECD, 2006). In Germany, zebrafish embryos 
are exposed for 48 hours in their standardised whole effluent testing, which was established 
in 2002, and made mandatory in 2005 (Braunbeck & Lammer, 2005). When Schulte & Nagel 
(1994) developed a test design for the zebrafish embryo assay, they stated a exposure time 
of 48 hours, with the assumption that pain and suffering could be avoided up to that time 
point. According to The Animals (Scientific Procedures) Act 1986, fish in the embryonic form 
are classified as a protected animal from the stage at which it becomes capable of 
independent feeding. For zebrafish this is after 96 hpf, and can be determined by the 
complete resorption of the yolk sac. 
The method of exposure varies among researchers; flow-through is always the preferred 
method for the majority of aquatic toxicity studies, allowing a more stable exposure to the 
target concentration and keeping the dissolved oxygen level at a steady state. However, it is 
not possible to use the standard flow-through methods used for adult fish in large tanks and 
flowmeters, due to the small size of the embryos and the need to examine development 
under a microscope on a daily basis. Consequently, usually a static or semi-static/renewal 
system is applied. The OECD FET test guideline (OECD  236) recommends that the test 
media should be refreshed on a daily basis for compounds that are susceptible to 
degradation over a 96 hour period (OECD, 2013). The static approach is also favourable in 
terms of cost and time, and was therefore used for all the described experiments reported in 
this chapter.  
Variations in the FET test also occur in choice of dose range and use of solvents. For the 
exposures described in this chapter a dose range was not required, as it was decided that 
the embryos should be exposed directly to the different product waters. As no additional 




The use of solvents in the FET assay will be discussed later, when direct chemical 
exposures were carried out.  
Test Validity 
The OECD 236 stipulates the following criteria to classify a FET as valid (OECD, 2013): 
 Overall fertilisation of eggs to be >70%. 
 Water temperature to be maintained at 26±1°C. 
 The overall survival of embryos in the control group to be >90% for the length of the 
96 hour exposure. 
 Use of a positive control (e.g. 3,4-dichloroaniline) and for the embryo survival rate 
within this group to be at a minimum of 30% at the end of the 96 hour exposure. 
 The hatching rate in the negative control should be >80% at the end of the 96 hour 
exposure. 
 Dissolved oxygen in the negative control and highest test concentration should >80% 
saturation at the end of the 96 exposure. 
5.3.3 Exposure during development/Sensitive Window 
The embryonic and foetal stages are particularly sensitive to chemical exposure because the 
stages of embryogenesis are easy to disrupt. Disruption to these early developmental stages 
can cause death, malformation, growth retardation and functional disorders (Timbrell, 2001). 
Disruptions to development can cause organisational and functional effects to the organism 
which will persist throughout life. Two clear mammalian examples of this are illustrated by 
the consequences of developmental exposure to two pharmaceuticals: diethylstilbestrol and 
thalidomide. WHO/UNEP (2013) reviewed the case of diethylstilbestrol (DES). DES is a 
potent synthetic oestrogen that was widely used between the 1940s and 1970s in Europe 
and in the US as a treatment for pregnant women to prevent/reduce the risk of miscarriages. 
Initially it was only prescribed to women deemed to be in a high risk group, but later was 
more widely distributed, and it use was claimed to improve the health of babies. 
Consequently, the numbers exposed were vast (WHO/UNEP, 2013). DES was found to be 
ineffective at preventing miscarriages and significant health effects were observed in the 
children of the exposed mothers, so its use was discontinued. It was associated with a rare 
type of vaginal cancer in a low percentage (<0.1%) of adolescent daughters who were 
exposed to it during in utero development. These adverse effects were only observed in the 
offspring, and not in the mothers themselves, and also the effects were not observed until 
the children had entered adolescence.  This delay in the manifestation and discovery of the 
adverse health effects meant that in utero exposure to DES continued unabated for many 




Following this discovery of a low level of cancer, DES exposure to daughters in utero was 
associated to more frequent (approximately 90-95%) benign reproductive problems including 
reproductive tract malformations and dysfunction, miscarriage, pre-term delivery and low 
birth weight, ectopic pregnancies and premature labour and births. When DES exposure 
occurred in utero it was found to change the normal genetic programming that acts on 
differentiation of the reproductive tract (WHO/UNEP, 2013). Effects were not only observed 
in the daughters but also in the reproductive system of sons, who displayed increased risks 
of developing cancer, namely testicular germ cell cancer (WHO/UNEP, 2013). 
Another example is thalidomide, which was used extensively in the late 1950s as a 
treatment in pregnant women for morning sickness. It was found to cause severe birth 
defects in the offspring in the form of reduced limb size and malformed limbs. Contrary to 
DES, however, the adverse effects were not observed later in the child’s life, for limb 
malformations were observed from birth, but again without causing any maternal toxicity. 
Along with the limb malformations, thalidomide was also linked to congenital heart disease, 
malformation of the inner and outer ear, and ocular abnormalities (J. H. Kim & Scialli, 2011). 
5.3.4 Endpoints 
As previously mentioned, the precise choice of endpoints selected during zebrafish embryo 
assays will be dependent on the main research aim and hypothesis.  
Schulte & Nagel (1994) separated the toxicological endpoints from a 48 hour exposure for 
the zebrafish embryo into two distinct groups, lethal and specific mode of action, which are 





Table 5.1 Classification of identified endpoints in the 48 hour zebrafish embryo toxicity test (Schulte & 
Nagel, 1994). 
Lethal endpoints Endpoints related to specific mode of action 
Coagulation of the embryo Reduced number of somites 
Gastrulation not initiated Absence of circulation 
Non completion of gastrulation Absence of eyes 
Absence of somites Absence of spontaneous movement after 24 hours 
No extension of the tail Significantly reduced heartbeat 
Absence of heartbeat Absence of otolith 
Absence of spontaneous movements after 48 hours Absence of pigmentation 
 
Survival 
The simplest determination of lethality in a zebrafish embryo at any stage of development is 
coagulation. However, Table 5.1 details that at the 48 hpf there are number of other 
observations which, if made, also indicate death of the embryo. Lethality is a simple and 
straightforward endpoint to assess, and can indicate general toxicity as well as adverse 
developmental effects.  
Hatching 
Zebrafish embryos reared at 28.5°C hatch from their chorions between 48 and 72 hpf, but 
this depends on the thickness of the chorion and the muscular activity of the embryo itself 
(Kimmel et al., 1995). Taking this into consideration, it is feasible to assume that if a 
compound reduces the movement of the embryo, then hatching will be delayed and vice 
versa. Release from the chorion can also occur from handling of the embryos, therefore care 
must be taken when handling the embryos as so not to skew hatching data.  
Heart Rate 
Due to the transparent nature of the eggs, the heartbeat of a zebrafish embryo should be 
visible by 48 hours and therefore the heart rate can be measured. Heart rate was reported to 
be an important sub-lethal endpoint (Nagel, 2002).  
Abnormalities 
Abnormalities (determinants of developmental toxicity) can be classified using some of the 




This was the case in a study conducted to determine if a chemical’s physical properties, in 
this instance BCF or Log P, can be used to predict its toxicity and developmental effects. 
This was done by comparing LC50 data of 133 chemicals against the relevant physical 
properties. The researchers found that BCF and LogP were not predictive of a chemical’s 
biological effect; however, developmental effects could be predicted using the abnormalities 
themselves. For example pericardial oedema and yolk sac oedema are more reliable 
predictive endpoints of whether  a compound exhibits developmental toxicity or not 
(Ducharme et al., 2013). 
Whilst developing a zebrafish embryo teratogenicity assay, Brannen and colleagues would 
classify embryos as non-viable if any of the following endpoints were noted at the 5 day post 
fertilisation (120 hpf) stage; no heartbeat, all or part of the body degraded, and/or growth 
retardation/malformation so severe that short-term survival would be highly unlikely 
(Brannen et al., 2010). They then scored the viable larva at the 5 day post fertilisation stage 
based on body length, motility, cardiovascular function, pigmentation and morphology of 
most anatomical structures (Brannen et al., 2010). These were then scored 1 to 5 based on 
severity, in order to generate a quantifiable approach to assessing the abnormalities. In a 
related study, the following morphological endpoints of  5 day old zebrafish larva were 
assessed: upper jaw, lower jaw, anterior lower jaw, pharyngeal arch, forebrain, midbrain, 
hindbrain, eyes, otic capsules, heart, swim bladder, yolk, intestine, notochord, somites, tail 
and fins. These were then scored 0.5 to 5, with 5 being normal in appearance and 0.5 being 
grossly malformed. From these scores they determined a NOAEL and teratogenic index 
(LC25/NOAEL), which was used in a predictive model (Panzica-Kelly et al., 2010). In 
addition, further endpoints (including body length, swim bladder inflation, pigmentation, liver 
and stomach morphology) that were particular to specific developmental stages, or as 
indicators of unusual types of toxicity, were included. These endpoints were not used to 
determine the NOAEL, but were included to determine whether any abnormalities observed 
may be due to a delay in development or were caused by direct effects upon the 
morphology, thereby subsequently impacting endpoints used to determine the NOAEL 
(Panzica-Kelly et al., 2010). The scoring system firstly classified the severity of the 
abnormality, after which it then classified the abnormality according to whether it was due to 




Table 5.2 Endpoints that are observed and the various significant time-points during zebrafish 
development that, if present or absent, can indicate a disruption to normal development and is therefore 
categorised as an abnormality. Some of these endpoints have been determined as lethal, sub-lethal or 
teratogenic. “ * ” indicates that the endpoint will be observable at that specific time-point (modified from 
(Braunbeck & Lammer, 2005; Nagel, 2002; Schulte & Nagel, 1994). 
 
8 hours 24 hours 48 hours 120 hours 
Lethal endpoints 
Coagulation * * * 
 












Sub lethal/developmental endpoints 
Completion of gastrula * 
   




























Endpoints of teratogenicity 




































Length of tail 
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Abnormalities occurring during development of an organism are often caused by teratogens. 
Teratogens are defined as “any agent that physically or chemically alters developmental 
processes and produces structural deformities in an organism” (Conley & Richards, 2010). In 
general, teratogens do not cause toxicity to the mother, but specifically target a certain 
developmental stage of the embryo, causing a deformity (Timbrell, 2001). These deformities 
are commonly referred to as birth defects. In the past only gross anatomical abnormalities 




have been understood to include all morphological abnormalities, including subtle effects 
observed in behaviour, biochemistry and learning (Conley & Richards, 2010). As teratogens 
impact different developmental processes, the timing of exposure is crucially important to the 
overall developmental effect (Timbrell, 2001). Teratogens differ from mutagens because 
teratogenic effects are not heritable, as they disrupt the somatic cells rather than the germ 
cells. Mutagens cause alteration in the germ cells, causing genetic disruptions that are 
passed on to future generations. Additionally, mutagens can cause mutagenicity at any 
stage of life of an organism, conversely teratogens can only exert an effect during the 
developmental stage (Conley & Richards, 2010). 
The severity of an abnormality caused by exposure to a teratogen is directly related to the 
specific point during development at which the organism is exposed, the duration of 
exposure and dosage (Conley & Richards, 2010). Teratogenic effects can lead to 
malformations, functional disorders and growth retardation. If these effects are severe, the 
endpoint that is measured is death, and consequently teratogenic effects can go unreported 
(Conley & Richards, 2010). 
In the environment, teratogens are divided into three categories: mechanical disruptors, 
environmental factors, and chemical contaminants. Mechanical disruptors include 
abnormalities caused by parasites forming cysts on a developing limb, or predators 
removing a limb that then regenerates with a deformity due to external factors such as 
abrasion from sand and gravel. Environmental factors include variables such as ultra violet 
(UV) radiation, oxygen levels, temperature and pH. UV radiation can directly disrupt cells of 
a developing organism, but can also transform certain chemical contaminants via photolysis 
into potent teratogens (Conley & Richards, 2010). A number of chemicals have been 
identified as being teratogens, some of these are classed as xenobiotics (substances which 
have no essential biological function) and others are classed as essential substances, such 
as some metals and nutrients, but at an inappropriate dose (too little or too much) can cause 
a teratogenic effect (Conley & Richards, 2010). 
5.4     Material and methods 
Three sets of developmental exposures were carried out, all using slightly different 
experimental designs depending on their ultimate purpose. The three sets of exposures 
were intended for developmental observations, an extended exposure and exposures 
specifically for gene expression analysis. The methodologies for each type of exposure are 
detailed in Chapter 3; any deviations from that are detailed below.  




Exposures specifically intended for developmental observations were carried out during 
December 2011 and February 2012, and were independently repeated four times. The 
second exposure experiment was, however, stopped after 24 hours due to the high mortality 
rate in all treatments and control. 
For the first developmental exposure it was not possible to collect a composite sample post 
final product, due to unplanned maintenance work at the IPR plant. However 24 hour 
composite samples were prepared from the other five treatment processes, and a spot 
sample was taken of the final product water. In this exposure, one 24-well plate was used 
per treatment, with 4 wells on each plate dedicated to the control (n=20 total for each 
treatment) Tap water was not included as a treatment in this exposure. 
In the second observation there were operational issues at the IPR plant and again it was 
not possible to collect composite samples from all the treatment processes, and therefore 
spot samples were collected instead.  
In the third observation, composite samples were collected from all treatment processes 
except for AOP2, where a spot sample was taken because an insufficient number of 
auto-samplers were present on-site at the time of sample collection. The exposure/plate 
configuration as detailed in Chapter 3, Section 3.4.2 was used.  
In the fourth observation, 24-hour composite samples were collected for all 6 treatment 
processes. The 8 hour post fertilisation (hpf) time point was missed out due to a fault in the 
microscope causing the 4 hpf observation point to take several hours. For both the third and 
fourth observation studies it was not possible to travel to the laboratory to carry out the 
observation at the 36 hour time-point. 
5.4.2 Extended embryo exposures 
These exposures were repeated four times, but in the third and fourth exposures the tap 
water and final product water were omitted because a reduced number of zebrafish embryos 
than expected were obtained.    
5.4.3  Gene expression exposures 
These exposures were repeated three times, although in the second experiment final 
product and AOP2 treatment water samples of the IPR plant were unavailable due to a fault 
at the site. However, there was limited time left for the plant before decommissioning, so it 






None of the treatments significantly affected survival of the embryos over the 0 to 48 hour 
time period compared to the aquarium water control. The OECD 236 guidelines state there 
is a requirement for ≥90% survival in the controls for the test to be a valid OECD test, 
whereas survival in the control group typically ranged from 66.67 to 70.83% with an average 
survival of 68.75% ±2.08 (mean ± SD). However, a number of variations were tried including 
use of an embryo media, but the survival rate within the controls and treatments remained 
variable. This could have been due to temporal variations in the quality of embryos, and/or 
small variations to water quality from one experiment to the next. 
The survival rate was analysed individually for the three types of exposures (48 hour 
developmental observations, 48 hour gene expression and the extended exposure) as they 
were carried out slightly differently and for different endpoints, but they were also combined. 
Figure 5.1 displays the average percent survival from all exposures over 48 hours, as all 
zebrafish embryos, regardless of exposure purpose, were observed for a 48 hour time 
period, with observations being made at regular time-points (4, 8, 12, 16, 24, 36 and 48 
hours post fertilisation).  
The control group survival rate in the first observation after 48 hours was only 67% with no 
other visible signs of abnormal development in any of the embryos. This was also true for 
the third and fourth exposures. In all three exposures, between 36 and 48 hpf very few (if 
any) additional embryo deaths were observed in any of the treatments. The majority of 
deaths occurred between 4 and 12 hpf, irrespective of treatment. 
Figure 5.2 displays the percent survival data at 48 hpf from three of the four developmental 
observations (see Section 5.4.1). Experiment 2 was omitted due to operational issues at the 
plant.  These data at the 48 hour time point were used in statistical analysis to allow 
comparison with survival in the extended and gene expression exposures (Figure 5.3 and 
Figure 5.4). Both Figure 5.1 and Figure 5.2 suggest that there were no obvious differences in 
the survival rates in relation to the treatment water the embryos were exposed to. Univariate 
analysis of variance using SPSS confirmed that there was no significant difference in the 
survival of the embryos at 48 hours based on the treatment water they were exposed to 
(P. value >0.05). Additionally, there was good consistency in the survival measured in all 
three exposures (1, 3 and 4) (P. value >0.05). 
Figure 5.3 displays the mean percent survival of the embryos exposed to the different IPR 




there were three replicates, and the exposures were repeated four times. In the figure it can 
be observed that there was a large difference in survival between the different exposures. 
The second exposure had the largest survival rate, with the third exposure having the lowest 
level of survival out of the four exposures. However, as with the initial developmental 
exposures, the different treatment waters produced quite consistent survival rates across the 
different treatments within each exposure. This was tested using univariate analysis of 
variance in SPSS and it was found that there was no significant difference in the survival of 
the embryos at 48 hours based on the treatment water to which they were exposed (P. value 
>0.05). However, as is evident from Figure 5.3, there was a significant difference between 
the number of surviving embryos between the different exposures (P. value <0.05). 
Figure 5.4 displays the mean per cent survival in the groups of embryos sampled at 48 hours 
in the gene expression exposures. There were two replicate dishes for each treatment, and 
each exposure was repeated independently on three separate occasions. The survival rate 
was lower overall in this type of exposure compared to the other two types of exposures 
(Figure 5.2 and Figure 5.3). Univariate analysis of variance revealed a significant effect on 
the survival of the embryos (P. value 0.041). Using the LSD post-hoc test, these differences 
were present between the following treatments; control and tap (P. value 0.035), control and 
AOP1 (P. value 0.033), tap and final effluent (P. value 0.022), final product and final effluent 
(P. value 0.017), AOP2 and final effluent (P. value 0.041), reverse osmosis and final effluent 
(P. value 0.005) and AOP1 and final effluent (P. value 0.002). This would indicate that the 
survival rate in the final effluent was significantly reduced relative to most of the other 
treatment waters from the IPR plant. However there was no significant difference between 
per cent survival in the final effluent and the control (P. value >0.05). Additionally, the 






































Figure 5.2 Survival (%) observed in the first 48 hours of the developmental exposures. The exposures were repeated four times (Experiment 2 is not included due 




























Figure 5.3 Survival (%) observed in the first 48 hours of the extended exposures. The mean was calculated from the three replicates for each treatment, and the 


































Figure 5.4 Survival (%) observed in 48 hour group from the gene expression exposures. The mean was calculated from the two replicates for each treatment, and 
the exposures were repeated three times. However, in the first exposure, final product and AOP2 treatments were not available from the IPR plant, so these groups 
































The numbers of hatched embryos were recorded at 48hpf in the developmental exposures 
and the extended exposures. It was not possible to record the number of hatched embryos 
at 48hpf in the gene expression exposures as sampling was extremely time dependent, and 
priority was given to recording the numbers and types, if any, of malformed embryos.  
Figure 5.5 shows the mean number of hatched embryos at 48 hours in Experiments 1, 3 and 
4 of the initial developmental exposures. The 95% confidence intervals indicate a large 
variation in the numbers of embryos hatching in all treatments and control waters when 
comparing all three exposures. In Figure 5.6, hatching results for the first exposure were 
removed and data from just the last two exposures were examined. The decision to omit 
Experiment 1 from the analysis was taken on the basis that this was the first embryo 
exposure that I conducted in my research, and the hatching data seemed largely at odds 
with the subsequent experiments.  The confidence intervals for these data are now much 
smaller and the results seem a lot more consistent; embryos reared in the control water do 
seem to have a reduced hatching rate compared to the other exposures, and reverse 
osmosis, final product and microfiltration all had similar numbers of hatched embryos that 
were increased in number compared to the control.  
An initial chi-square test was conducted on frequency of hatched embryos reared in the 
different waters and it was determined that there was an association between treatment and 
the number of hatched embryos at 48 hours in all three experiments (observation 1, 
X2 = 21.31, df = 6, P value = 0.0016 (<0.05); observation 3 X2 = 14.08, df = 7, 






Figure 5.5 Average numbers of hatched embryos at 48 hours in developmental Exposures 1, 3 and 4 with 
95% confidence intervals. 
 
Figure 5.6  Average number of hatched embryos at 48 hours in developmental Exposures 3 and 4 with 
95% confidence intervals 
Further statistical analysis on the hatching data determined that the frequency of hatched 
embryos in the first exposure was very different from the frequencies recorded in the other 
































































analysis. Univariate analysis of variance of data from Exposures 3 and 4 showed a 
significant effect of treatment on the number of hatched embryos (P. value <0.05). However, 
there was no significant difference in hatching rate between Exposure 3 and 4 (P. value 
0.640). A post-hoc test, LSD was conducted on the data, and it indicated that the significant 
differences in numbers of hatched embryos were present between control and all the other 
treatments, including tap water (P. value <0.05). Other significant differences arose between 
the following, all with P. values <0.05; tap and final product (P value = 0.022), tap and 
reverse osmosis (P value = 0.001), tap and microfiltration (P value = 0.022), final product 
and AOP2 (P value = 0.028), final product and AOP1 (P value = 0.047), AOP2 and reverse 
osmosis (P value = 0.01), AOP2 and microfiltration(P value = 0.028), reverse osmosis and 
AOP1 (P value = 0.002), reverse osmosis and final effluent (P value = 0.008) and AOP1 and 
microfiltration (P value = 0.045). There was not a clear increase or decrease in the 
frequency of hatching as treatment process is followed from either end. 
5.5.3 Heart rates 
Heart rates of individual embryos were recorded in the developmental exposures 1, 3 and 4 
at the 48hpf time point (Figure 5.7). The data were not normally distributed, and therefore a 
non-parametric statistical test was conducted. A Kruskal-Wallis test found no significant 
differences in the heart rates recorded in Exposure 3. In contrast, statistically significant 
differences in heart rates of embryos exposed to the different product waters from the IPR 
plant were found in Exposures 1 and 4, P values = 0.0250 and 0.0481, respectively. A 
post-hoc test, Mann-Whitney U was carried out to determine where these differences 
occurred. In Exposure 1, the following heart rates recorded in the treatments were 
determined to be statistically significantly different from one another; final product and 
control (P value = 0.0047), AOP1 and control (P value = 0.0035) and final effluent and 
control (P value = 0.0455). In Exposure 4 the differences occurred among the following 
treatments; microfiltration and tap (P value = 0.0165), microfiltration and final product (P 
value = 0.0185), microfiltration and reverse osmosis (P value = 0.0263), final effluent and tap 
(P value = 0.0193), final effluent and final product (P value = 0.0292), and final effluent and 
reverse osmosis (P value = 0.0286). 

















































































































































































































Figure 5.7  The three graphs show the heart rates (beats per minute (bpm)) measured at 48 hour from the three developmental observation exposures. The points 
represent the mean bpm and the 95% confidence intervals. Graph a shows the heart rates from the Exposure 1, graph b heart rates from Exposure 3 and graph c 






5.5.4  Abnormalities 
In all exposures carried out there were a variety of abnormal looking embryos. Abnormal 
embryos were individuals that were determined to be alive but showed clear malformation in 
structure, movement and/or appearance. These results were recorded at the 48 hour 
time-point. However, there were other embryos that had malformations at earlier time-points 
which then went on to die; these were counted as dead. It was observed that some 
abnormal embryos had more than one abnormality, for example a curved spine and 
enlarged heart. However, the frequencies of abnormalities in all incidences were too low to 
apply any meaningful statistical analysis, but the types of abnormality in the different 
treatment groups were of interest. 
Figure 5.8 shows the total number of abnormalities observed at 48 hours combined from all 
three exposure experiments with the corresponding survival. All embryos were observed in 
every treatment. There was a low incidence of abnormalities in all treatments, including the 
control. A total of eight abnormal embryos were identified in the controls; however, it is 
important to note that seven of these occurred in the fourth exposure of the extended 
exposure and in the same replicate (dish). Survival for this group was also 60% in controls 







Figure 5.8 Total numbers of abnormal embryos observed and the corresponding mean survival (%) for 
each treatment group at 48hpf in all exposure experiments. The survival data include the 95% confidence 
intervals. 
Table 5.2 lists the endpoints that can be observed at each specific time-point of 
development. For this analysis, the frequency of abnormal embryos was analysed from data 
collected at 48 hpf only. However, for the developmental exposures, abnormality data were 
collected at all time-points (4, 8, 12, 16, 24, 36 and 48 hpf). These observations were only 
made on a daily basis for the extended exposure studies. For the gene expression 
exposures, abnormalities were recorded at each sampling time point, but only selected 
embryos were recorded. As embryos were divided into discrete treatments and time-points 
for sampling, the same population was not followed/observed between 8 hours and 48 
hours. Consequently, the 48 hour time-point was examined to allow comparison across the 
exposures. Some abnormal appearing embryos from the developmental observation 
exposures that were recorded as abnormal before 48hpf had died by the time the 48 hour 























































Figure 5.9 shows both the type and frequency of the various abnormalities examined at 
48hpf. Abnormalities occurred in the control embryos as well as in the other treatments; 
however, in the control, the 8 recorded occurrences of abnormalities were categorised into 
just four types abnormality. The abnormalities observed in the embryos exposed to Final 
Product also were categorised into four types of abnormality, followed by AOP1 having five 
types, tap, AOP2 and microfiltration with six, final effluent with nine and reverse osmosis with 
the greatest number of categories of abnormality, with ten. 
In the control group, abnormalities included enlarged heart (cardiomegaly), blood clot in the 
heart, absence of pigmentation and curvature of the spine. According to Table 5.2, absence 
of pigmentation and formation of oedema are both sub-lethal endpoints; however, modified 
chorda and malformed heart are teratogenic endpoints. Conversely, it is unclear if the blood 
clot in the heart would be classified as a malformed heart. Some researchers classify 
pericardial oedema and yolk sac oedema as teratogenic effects (Hermsen et al., 2011), 
whereas others classify these as sub-lethal effects (Braunbeck & Lammer, 2005; Fraysse et 
al., 2006). 
In the Final Product water, abnormalities included absence of a tail, malformed head, 
curvature of the spine, and no movement. The first three types of abnormality are all classed 




The types of abnormalities observed in AOP1 included absence of a tail, enlarged yolk sac, 
enlarged heart, blood clot in the heart and curvature of the spine; all of these are classified 
as being teratogenic endpoints. 
The abnormalities recorded in the embryos reared in tap water included; no eye 
development, no otolith development, tail not detached, blood clot in the heart, head 
malformed, and curvature of the spine. These abnormalities are all classed as teratogenic 
apart from the eye development at 48 hours, which is sub-lethal. 
In the AOP2, the types of abnormality included absence of eye development, enlarged yolk 
sac, enlarged heart, blood clot in the heart, no pigmentation and curvature of the spine. 
Absence of eyes and pigmentation at 48 hours are classified as sub-lethal; however, the 
other four abnormalities are classified as teratogenic. 
The types of abnormalities observed in the embryos reared in water from the microfiltration 
treatment included absence of eye development, absence of a tail, enlarged yolk sac, head 
malformed, no pigmentation and curvature of the spine. No eyes and no pigmentation at 48 
hours are deemed as sub-lethal, whereas the other four abnormalities are classified as 
teratogenic. 
In the groups of embryos which were reared in final effluent there were a total of nine types 
of abnormalities and these included: (i) absence of somites, (ii) absence of eye 
development, (iii) absence of otolith development, (vi) tail not detached, (v) absence of a tail, 
(vi) no movement, (vii) no heartbeat, (viii) absence of pigmentation, and (ix) no circulation. At 
the 48 hour time-point, no eyes, movement, circulation or pigmentation are classed as sub-
lethal, whereas no somites and no heartbeat at 48 hours are considered a lethal endpoint 
and the remaining are classified as being teratogenic endpoints. 
The abnormalities observed in the embryos reared in RO water included absence of eye 
development, absence of a tail, no movement, enlarged yolk sac, enlarged heart, head 
malformed, no heartbeat, no pigmentation, curvature of the spine and no circulation. Lack of 
eyes, movement and pigmentation at 48 hours are considered to be sub-lethal endpoints. No 







Figure 5.9 Total number of the different types of abnormalities observed at the 48 hour time-point in all three exposure types (developmental observations, 
extended and gene expression exposures). Numbers above the bars indicate the number of individuals with at least one abnormality recorded/out of the number of 
surviving embryos at the 48 hpf time point (in the extended exposures, exposures to tap water and final product were not repeated in the two final repaets, hence 
the lower total number of surviving embryos). The value of the bar indicate the number of abnormalities recorded in embryos exposed to each of the product 
waters, it was observed that some abnormal embryos had more than one classifiable abnormality, thus the difference between number of abnormal individuals 
and abnomalities. The proportion of the bar, idientified the different colours, indicate a specific type of abnomality. The red colours indicate abnormalities which 
are classied as lethal, blues indicate sublethal abnormalities and the greens indicate abnormalitites which are classified as being teratogenic (the classification are 






Death of an embryo is an important developmental toxicological endpoint, and can be 
considered an indicator of general toxicity (Brannen et al., 2010). Survival was examined 
over the 48 hour exposure period (exposure from 0 hpf to 48 hpf) in all exposure studies 
(irrespective of their ultimate purpose). For the first two study types (48 hour developmental 
observation and extended exposures), there was no significant difference between the 
survival of the embryos reared in product water from any of the treatments at the IPR plant 
compared to the control and tap waters. The survival of the embryos in control water (water 
from the header tanks at the aquarium facility at Brunel University) was below what would be 
considered valid in an OECD FET test; however it did not vary significantly from the test 
waters. A number of strategies were used to improve the survival of the controls, including 
the use of zebrafish embryo media and rinsing the embryos in distilled water over a fine 
mesh filter, but these methods did not improve the survival. It is therefore possible that the 
embryo survival rate achieved here was largely determined by biological (genetic) factors, 
including the quality of the gametes produced by the zebrafish.  
Indeed, it was observed that if overall survival was decreased in one experiment, it was also 
decreased in all treatments, including the controls, suggesting initial embryo quality and/or 
experimental conditions together were driving overall survival rather than the treatments. 
Efforts were made to ensure that all variables were consistent across treatments, with the 
exception of the physicochemical properties of the product waters themselves. Temperature 
was kept constant in all studies by conducting exposures in an incubator or water bath. Due 
to differences in the level of treatment (and biological loading), it is possible that oxygen 
levels in the Final Effluent and microfiltration (MF) may have been lower than that of the 
controls or treatment water further along the treatment process (AOP1, AOP2 and FP). The 
same would also be true for nitrates and nitrites, and, therefore, if slightly raised levels of 
nitrate and nitrites (and reduce oxygen) in the less treated product waters were affecting the 
survival, the effects would only be observed in those earlier treatment stages. Both the 
product waters from the final effluent and microfiltration stage of the treatment were 
observed to have increased levels of nitrates and nitrites. However, from the possible 
explanations for the overall decreased survival on certain study events, it is likely that the 
quality of the embryos remains an important factor. Embryos were collected and sorted in a 
consistent way prior to each exposure by the same researcher. They were sorted and placed 
into clean aquarium/control water, with debris removed before being placed into the 




Mixed breeding groups were used along with several different groups, to optimise the 
quantity of embryos, so that any groups producing less than optimum embryos could be 
missed. 
In the gene expression exposures significant differences in survival at 48 hpf were observed 
between the different treatment groups, between embryos reared in final effluent (the source 
water into the IPR plant) and the produced waters from the IPR process. Despite this, there 
was no significant difference between survival of the embryos in final effluent compared to 
the controls. It is unclear why for this study design the survival would be similar for the 
control and final effluent, but different in the other treatments. Additionally, there was no 
significant difference in survival between treatments in independent experiments carried out 
on different days. Two explanations can be offered for this when considering differences that 
were recorded in the different experimental events/repeats in the two other study designs. 
Firstly, the gene expression exposures were all conducted within the same month (March 
2012), meaning the conditions at the IPR plant would have been similar as there would have 
little change in the weather, specifically temperature and rainfall. These two factors would 
affect the plants efficiency and dilution. Also, the adult breeding groups were the same and 
there would be little difference in the age of the fish, and the conditions in the laboratory 
changed little over this short time frame. Conversely, the other two study designs were 
started in late 2011, and repeats were conducted into early April 2012, Thus providing larger 
scope for conditions at the IPR plant and laboratory to alter, albeit slightly. Secondly, in the 
first study design, the embryos were exposed in individual wells of a 24 well plate, meaning 
that if one embryo died, its decomposition would not impact on the other embryos in its 
exposure group. In the second study design the embryos were exposed to the product 
waters in groups in crystallising dishes, as they were in the gene expression exposure, but 
they checked every 24 hours and any dead embryos were removed, thereby decreasing 
effects of decomposition on the other embryos. In the gene expression exposure, this was 
not possible, and the 48 hour group were left for the entirety of the 48 hours, with any dead 
embryos remaining with the living ones. The initial developmental observations saw that the 
majority of deaths occurred within this first 12-16 hours; therefore this could have impacted 
survival on this group. It might also offer an explanation as to why the survival was, as a 
whole, less in the gene expression exposure compared to the other study designs. This 
highlights positive aspects of using a well plate for short-term embryo exposures or 







Hatching was recorded in the first study design (48 hour developmental observations), and 
this study was successfully repeated three times. There were obvious differences in the 
hatching rate between first repeat and the last two repeats. It is considered that this could be 
due to the slightly different experimental design used in the first exposure compared to the 
last two. The first exposure was conducted at the very preliminary stages of the research 
project, without any previous experience, and observations, including numbers of hatched, 
were recorded earlier on day two of the exposure (the 48 hour point). With insight from the 
first exposure, a number of modifications to the experimental design were made, including 
staggering the start time of treatments across the plates, and ensuring that hatching was 
recorded as the first observation across all the well plates. As there was a large number of 
embryos to record (including heart rates and individual photographs taken), the observations 
took several hours to complete. Zebrafish begin to hatch around this time, and can emerge 
from the chorion within hours, which is why it was important to record hatching as the first 
observation for all test samples in a staged manner. 
Based on the differences between the repeats of this study and potential explanations for 
these differences, the hatching recorded in the first exposure study was removed from 
further analysis. Examining the hatching data from the last two repeats of this study, 
significant differences in the number of hatched embryos were observed between 
treatments, with fewer embryos being observed to have been hatched in the control 
compared to the other treatments. The rate of hatching may increase if properties of the 
water weaken the chorion, or if the embryo movement increases. The product water from the 
IPR plant did undergo chloramination and tap water is chlorinated; however, the control 
water was also dechlorinated. There was an alteration in water hardness and pH along the 
treatment process. 
In a study testing 133 chemicals, altered hatching rate as an endpoint was recorded to be 
correlated with another twenty endpoints. These other endpoints included abnormalities 
such as curvature, yolk sac size and yolk sac oedema (Ducharme et al., 2013). This 
correlation of the hatching rate and morphological endpoints suggests that hatching rate 
could be used as an indicator of developmental toxicity in zebrafish embryo assays 
(Ducharme et al., 2013). 
5.6.3 Heart rate 
Heart rates were recorded in the first study design, 48 hour developmental observations at 




were not found to significantly differ among the treatments and control in the middle of the 
three experimental repeats. However, heart rates were shown to be significantly different in 
the first and last repeats. In the first repeat, the difference arose only when comparing the 
heart rates in embryos reared in AOP1 product water and control and final effluent product 
water and control. The same differences were not repeated in the last replicate, with 
differences occurring with microfiltration and three other treatments - tap, final product and 
reverse osmosis product waters. Additionally, heart rates were significantly different when 
comparing final effluent and the same three treatments as were different to microfiltration. 
Taken in isolation this indicates that the heart rates in the embryos exposed to product water 
that had undergone the least amount of treatment were significantly different from three 
much more advanced treatments. However, this result was not repeatable in the subsequent 
experimental repeats.  The confidence intervals became smaller in each progressive test, 
and are smallest in the final repeat. Due to the difficulty involved in recording the heart rates 
it is possible that I was able to record this endpoint more accurately with practice, and that 
the data became more reliable at each attempt. 
A group of researchers determining endpoints in zebrafish assay to predict teratogenicity, 
omitted heart rate along with larval length, head-trunk angle, otic vesicle length (the 
estimated distance between the eye and the otic vesicle), somite number, swim bladder 
development, stomach morphology and liver morphology from the final analysis (Brannen et 
al., 2010). This decision was made on the basis that (i) they had a variable background, and 
could only be proven to be affected when other more predictive or reliable endpoints were 
also affected, (ii) they were not easy to accurately assess, and (iii) were observed not to 
change greatly despite the exposure group (Brannen et al., 2010). However, heart rates 
have been reported to be altered by certain chemicals. Nagel (2002) reported that the drugs 
verapamil and propranolol both reduce the heart rate in exposed zebrafish embryos, and 
that theophylline and isoprenalin were both reported to increase the heartbeat. Results of 
exposure to these four drugs were as expected, and demonstrated that the zebrafish embryo 
model reacted in much the same way as humans do to these drugs (Nagel, 2002). It was 
therefore suggested by Nagel (2002) that the zebrafish embryo assay could be used as a 
model to determine suitable compounds that have an effect on cardiovascular system of 
other vertebrates.  
I found heart rate to be a very variable endpoint, and also one that was very time consuming 
to measure. Measuring heart rate could still prove important for hypothesis driven research 
(i.e. when the chemical or chemicals are hypothesised to specifically alter heart rate), but 





Abnormalities were observed in the embryos reared in the control and tap waters as well as 
the product waters from the IPR plant. However, the nature of the abnormalities observed in 
the embryos reared in the IPR product waters were more variable than those observed in the 
embryos reared in control waters. Also, more abnormalities of the embryos reared in the 
treatment waters could be classified as teratogenic. The different abnormalities observed in 
the embryos at 48 hpf have been divided into either lethal, sub-lethal or teratogenic 
endpoints, based on the information detailed in Table 5.2. The lethal endpoints include no 
heartbeat, tail not detached, and no somites. The sub-lethal endpoints include no circulation, 
no pigmentation, no otolith development, no eye development, and no movement. The 
endpoints classified as teratogenic included enlarged yolk sac (however, some researchers 
class yolk sac oedema as sub-lethal), curvature of spine or kinks/twisted spine or tail, head 
malformed, blood clot in the heart, enlarged heart, and no tail. 
As previously stated, if death occurred before 48 hpf then it could not be automatically 
assumed that a developmental toxicant or teratogenic response was responsible. However, 
with a relatively high survival rate and large sample population it is likely that if teratogenic 
endpoints are being exerted, then they would have been observed. As stated earlier, 
teratogens can be divided into three groups; mechanical disruptors, environmental factors 
and chemical contaminants. Mechanical disruption would be unlikely here as the embryos 
were exposed under laboratory conditions. The main focus of this project was to determine if 
any of the chemical contaminants present in the product waters might affect the 
development of the zebrafish embryos. However, environmental factors could also influence 
this process because the different samples of product waters were collected from the 
treatment plant on the different days for each repeat exposure. The nature of effluent is 
variable as it is affected by outside temperatures and flow rates at the time of collection and 
the content of the influent. To mitigate against this possibility, 24 hour composite samples 
were collected, but nevertheless the exposures were carried out over a number of study 
times which spanned a number of months. Temperature during the exposures was 
controlled by conducting the exposures in either the incubator or water baths, and ensuring 
the exposure waters had all equilibrated to the correct temperature prior to the introduction 
of the embryos. Therefore, there could have been subtle differences in the physical 
properties between treatments and days; oxygen concentration was one factor which was of 
particular concern. 
When organisms which are dependent on oxygen for survival, as nearly all vertebrates are, 




generation, leads to the production of reactive oxygen species (ROS) and causes cell 
damage and apoptosis  (Long et al., 2015). Fish that are kept in hypoxic conditions are often 
observed to swim to the surface of the water where there is more oxygen, increase 
ventilation capacity to absorb more oxygen or decrease movement to reduce the rate of 
oxygen consumption (Robertson et al., 2014). Including, these behavioural changes, 
physiological and biochemical changes are initiated, these can include changes to the gill to 
increase the surface area, increasing the heart rate and haemoglobin content, modification 
in the structure or activity of specific ion channels, and activation of anaerobic adenosine 
triphosphate (ATP) production via glycolysis (Robertson et al., 2014). It has also been 
reported and detailed in Long et al. (2015), that hypoxia induces significant alterations to 
gene expression profiles in a number of different species of fish, and hypoxia-inducible 
factor-1 (HIF-1) has been found to be the fundamental step in the regulation for hypoxia-
induced genes (Long et al., 2015). The concentration of dissolved oxygen present in which a 
water body is considered to be hypoxic varies depending on authors, however, hypoxia 
seems to be referred to when the dissolved oxygen is 0 to 2.8 mg/l. Long et al. (2015), states 
that in the aquatic environment hypoxia is reached when dissolved oxygen is <2 mg/l, Wu 
(2002) reported it to be dissolved oxygen is  <2.8 mg/l (Wu, 2002), and Robertson et al. 
(2014) exposed fish to severe hypoxia and total anoxia with a dissolved oxygen 
concentrations of 5 and less than 0.5%, respectively (these are approximately, 0.6 and less 
than 0.06 mg O2/l). In fish, effects of hypoxia include suppression of development, reduction 
in growth, disruption to endocrine system, reproductive effects and great numbers of 
mortalities (Long et al., 2015). Specifically, Long et al. (2015) observed zebrafish larvae that 
had been exposed to dissolved oxygen levels of 5% for a 24 hour time period to have 
smaller intestine lumen, larger yolk sac and smaller body length when compared to control 
fish (Long et al., 2015). However, along with other studies, Long et al (2015) found that 
developing zebrafish exposed to hypoxic conditions during early stages of development had 
greater tolerance to subsequent periods of hypoxia (Long et al., 2015). 
Prior to 14 days post fertilisation zebrafish use their skin as the main respiratory surface 
(Robertson et al., 2014).  
In studies conducted by Shang & Wu (2004), reported that hypoxic conditions can act as a 
teratogen in zebrafish embryos, and anoxic (no oxygen) conditions were found to cause 
100% mortality within 24 hours (Shang & Wu, 2004). The same study reported a dose-
response relationship related to the dissolved oxygen concentration and mortality being 
12.3%, 17%, 28.3% and 89.7% mortality at 5.8, 1.0, 0.8 and 0.5 mg O2/l, respectively, over a 
120 hour exposure period (Shang & Wu, 2004). The same researchers also found 




producing significant increases in embryo heart rates compared to that of the controls (5.8 
mg O2/l) up  to 96 hour time point, after which they were recorded to decrease compared to 
the controls. The number of individuals with malformations also increased in the 0.8 mg O2/l 
group compared to the control (5.8 mg O2/l). These malformations included developmental 
delay, loss of normal synchronization in development (tails were observed to develop faster 
than the heads), spinal deformity (axial curvature) and failure to develop vascular systems; 
the latter led to death after several days (Shang & Wu, 2004). It was reported that after 
168 hours, the number of abnormalities in the hypoxic group was 18.3%, which was 
significantly greater than that recorded in the control group (10.3%). Additionally the body 
length was reported to be significantly reduced in the hypoxic group. As well as the 
malformations, the levels of sex hormones were affected; testosterone levels in the hypoxic 
embryos were increased and the estradiol levels were significantly reduced. Apoptotic cells 
were observed to be significantly reduced in the tail and increased in the head (Shang & Wu, 
2004). Robertson et al 2014) found that the cellular responses exhibited by developing 
zebrafish when exposed to hypoxic conditions differed in relation to the developmental stage 
and degree of oxygen reduction. These researchers examined the effects of hypoxia of 
zebrafish embryos at 18, 24 and 36 hpf. A HIF-1 response was not observed in embryos at 
18 hpf at low oxygen levels, but was initiated at 24 hpf and 36 hpf, indicating the sensitivity 
to low oxygen increased with increasing age of the embryo (Robertson et al., 2014). It was 
also observed by the researchers that embryos exhibited a cellular hypoxia response during 
early development had  increased tolerance to hypoxia as an adult and hypoxia during early 
development caused increased number of males in the population. This latter finding was 
linked to increased testosterone production, which is reportedly due to impaired aromatase 
activity (Robertson et al., 2014).  
It has been observed that the concentration of oxygen affect the toxicity of copper in 
developing zebrafish embryos, and the copper toxicity is altered dependent on the 
developmental stage (Fitzgerald et al., 2016). It is reported that at early stages of 
development hypoxic conditions supress the toxicity of copper, via the alteration of HIF 
signalling pathway,  However, after hatching copper toxicity is increased in hypoxic 
conditions, reported to be due to increased copper uptake under hypoxic conditions 
(Fitzgerald et al., 2016).  
It is reported that zebrafish embryos at 18 hpf, are very tolerant to anoxic conditions. 
However by 24 hpf, when the heart developing and the heart is beating, the tolerance to 
anoxia reduces (Robertson et al., 2014). At 36 hpf, when the cardiovascular system is fairly 




tolerant to anoxia, this is when early hatching may occur as a response to low oxygen levels 
(Robertson et al., 2014). 
In this current study the embryos were exposed to effluent; as a result there was the concern 
that decreased dissolved oxygen levels could influence the findings, especially in the product 
waters from near the start of the treatment plant. It was not possible to measure the 
dissolved oxygen in the 48 hour observations exposures as these were conducted in 24 well 
plates, resulting in the volume of water being too small to measure with a standard oxygen 
probe. However, readings were taken during the extended exposures studies where dishes 
and beakers were used, enabling the oxygen probe to be used to record levels. Examining 
these readings it is considered unlikely that the effects of hypoxia observed by Shang & Wu 
(2004) would have been elicited in these current studies (Table 3.4). The oxygen level did 
decrease over the 24 hour time period (Table 3.4), and this could have decreased further 
following another 24 hours, but in the first 24 hours of exposure the levels were not recorded 
as hypoxic (<2.8 mg O2/l), or near the level tested in the study carried out by Shang & Wu 
(2004) of 0.8 mg O2/l. However, the levels were below the control level used by Shang & Wu 
(2004) of 5.8 mg O2/l in the final effluent, and this treatment did have lower oxygen levels 
than the other treatments. The optimum oxygen level is stated to be between 6 mg O2/l and 
saturation (Westerfield, 2007). If further studies were conducted it would be important to 
develop a reliable technique to easily and safely measure the dissolve oxygen levels in all 
test vessels. 
Both mammals and fish possess the heterodimeric transcription factor hypoxia inducing 
factor 1 (HIF-1α), which is inducible under hypoxic conditions. It is reported to regulate the 
transcription of a number of hypoxia related genes involved in erythropoiesis, angiogenesis 
and glucose transport (Shang & Wu, 2004; Wu, 2002). It was previous highlighted that HIF-1 
is the fundamental step in the regulation of hypoxia-induced genes (Long et al., 2015). Long 
et al. (2015), exposed developing zebrafish (120  hpf) to hypoxic conditions and observed 
there to be 132 significantly up-regulated genes and 41 significantly down-regulated genes 
(Long et al., 2015). The majority of the hypoxia induced genes were reported to be involved 
in biosynthesis of source material of haemoglobin, haemtopoiesis and oxidation-reduction 
processes (Long et al., 2015). However, at 24 hpf, genes involved in haemoglobin were not 
observed to be up-regulated following hypoxia (Long et al., 2015). One of the genes which 
was most greatly inhibited by hypoxic conditions was hela (hatching enzyme 1a), its 
expression was reduced by 51-fold by hypoxic condition (5% dissolved oxygen) (Long et al., 
2015). Zebrafish are reported to have four hif1a genes, these include hif1aa, hif1ab, hif1a1 
and hif1al2, however in the study conducted by Long et al (2015), only hif1a12 was 




encoding for hypoxia inducing factor would only be expressed under severe hypoxic 
conditions, not something that was observed during this current study 
One of the abnormalities observed that could have been caused by chemical contamination 
was the lack of pigmentation. Initially, this abnormality was considered to be a delay in 
development, until it was observed that the embryos seemed to be developing normally in all 
other respects apart from the development of pigmentation. In the extended exposure, 
however, no larvae were observed to be present without pigmentation. Therefore, as the 
lack of pigmentation was occurring at a low incidence, it could be that this abnormality did 
not occur to any observable degree in the extended exposure due to random chance, that 
the embryos were able to compensate and therefore appeared normal, or that unpigmented 
embryos died before they had reached the larval stage. Pigmentation of zebrafish embryos 
should be visible from 24 hours post fertilisation (hpf) (Kimmel et al., 1995), with retina 
pigmentation occurring at 30 hpf and tail pigmentation at 36 hpf (Kimmel et al., 1995). It has 
been reported by a number of authors that the process of pigmentation can be affected 
following exposure to certain chemicals. Zebrafish embryos exposed to anilines and phenols 
were observed to have reduced pigmentation (Schulte, 1997; cited in Nagel, 2002). Another 
study found a dose dependent hypopigmentation effect in fish embryo cells exposed to p-
tert-butylphenol, a substance known to affect pigmentation in humans (Maiwald, 1997 cited 
in Nagel, 2002). The relevance of hypopigmentation to human health has not been fully 
established. Brannen et al. (2010) tested 31 chemicals in the zebrafish embryo assay and 
compared the results to those from in vivo mammalian studies. They found that three 
chemicals affected pigmentation, all-trans-retinoic acid, hydroxyurea and retinol. Along with 
pigmentation, the other adverse effects these chemicals had in common were effects on the 
cardiovascular system and fin development (Brannen et al., 2010). Pigmentation was not 
observed as an endpoint in the corresponding mammalian studies. However, cardiovascular 
system effects were observed in the studies testing those three chemicals (Brannen et al., 
2010). In single chemical exposures, effects on skin pigmentation in zebrafish embryos was 
found to not be associated with oedema (Ducharme et al., 2013). 
Another abnormality observed was oedema of the yolk sac and/or heart and heart 
malformations. In the same study that found hatching rate to be strongly correlated with a 
number of morphological endpoints, it was reported that cardiovascular and gross 
morphology endpoints were well correlated - specifically pericardial oedema. Oedema of or 
around the heart, and yolk sac oedema, were also found to be strongly associated 
endpoints. It has been suggested that this may occur because the mechanism of fluid 
retention is similar in both cases (Ducharme et al., 2013). Oedema is reported to have a 




(Ducharme et al., 2013). However, there was no clear association between hatching rate in 
my studies with the abnormalities reported to be correlated with hatching rate. This was due 
to the hatching rate being different in the controls compared to that of all of the other 
treatments, and the frequency of abnormalities being very low and occurring across all 
treatments. 
Many of the studies that have compared endpoints observed in zebrafish embryos employ 
single chemical exposures. In this project, the embryos were exposed to large complex 
mixture of chemicals, which may explain the relatively large number of different 
abnormalities observed.  
5.7 Conclusions 
It is considered that the observations made in this group of studies indicate that the product 
waters from the different IPR treatments did not appear to affect survival of zebrafish 
embryos.  
Variability in the measurement of various endpoints (e.g. heart rate and hatching) means it is 
difficult to determine if the treatment process is affecting these endpoints. 
The change in the type of abnormalities found in a low number of individuals in the controls 
and along the IPR process warn that development may be impacted by various chemicals in 
the water. 
Pigmentation loss, cardiovascular abnormalities and skeletal deformities appear to be the 
most common effects observed in process waters. 
As there is a large variety of chemical contaminants in effluent, and there were a variety of 
different abnormalities observed in the treatments and controls, lethal, sub-lethal and 
teratogenic abnormalities, it was not possible to single out one chemical or groups of 







CHAPTER 6: Determination of Alterations to Gene 
Expression Profiles of the Developing 
Zebrafish Embryos Exposed to the 
Different Product Waters from the IPR 






In the previous chapter, it was reported that there was a low incidence of abnormalities in 
zebrafish exposed developmentally to the processed water from the IPR plant that were not 
observed in the controls. The aetiology of these abnormalities was unknown. Therefore 
analysis of global gene expression of embryos exposed to the processed water undertaken. 
The rationale for this research was to generate mechanistic insights that could was be used 
to develop specific hypothesis to be tested empirically taking into account the analytical 
chemistry data provided by Thames Water Ltd.   
6.2 Aims and Objectives 
6.2.1 Aims:  
1. To determine if any of the product waters from any of the treatment stages at the IPR 
plant caused significant differences in individual gene expression levels relevant to 
specific biological pathways and functions. 
2. To identify whether changes in gene expression could be associated with the 
observed changes in phenotype. 
3. To determine if ‘culprit chemicals’ measured in the IPR water could be identified that 
might explain the observed changes in gene expression and phenotype based on 
current knowledge. 
6.2.2 Objectives:  
1. To expose zebrafish embryos to each product water from the IPR plant and to an 
aquarium control and tap water control.  
2. To sample zebrafish embryos at different stages of development for gene expression 
analysis by microarray. 
6.2.3 Genomics  
 Genomic Approaches 
DNA encodes genetic information; the entirety of an organism’s DNA is its genome. The 
study of the genome is known as genomics (World Health Organization, 2002). The term 
genomics was first used in 1986 by Thomas H. Roderick (McKusick, 1997). Genomics differs 
from genetics mainly because genetics is concerned with evaluating the properties of an 
individual gene, whereas genomics examines all genes and their relationships with one 
another, to determine how they influence in the organism’s biological functions, including 




transcriptomics, proteomics, and metabolomics, known as ‘omic’ technologies were derived 
from genome sequencing projects; they measure fluctuations in gene expression, proteins 
expression, and the levels of metabolites in a cell, tissue or organism, respectively (Poynton 
et al., 2008).These techniques generate a huge amount of complex data;  as a result, 
analysis and interpretation of these data is a large undertaking and requires bioinformatics 
(Snape et al., 2004). Bioinformatics uses an interdisciplinary approach, involving computer 
science, statistics, and mathematics to develop methods and software applications to 
analyse biomolecular data (Dale et al., 2012). Bioinformatics is of particular importance for 
analysing the large datasets generated from genome sequencing, and in this case, 
experiments using microarrays (Dale et al., 2012). Systems biology combines the omics data 
gathered from an organism to determine the global response within it, from the genotype to 
phenotype (Simmons et al., 2015). 
The omics approach has been used within toxicology, when it is termed toxicogenomics. 
Data generated from toxicogenomics  has enabled a greater understanding of the 
mechanism of action of certain chemicals, and it has been used in drug discovery and 
researching existing drugs (Poynton et al., 2008). In 2004, Snape et al. introduced the term 
ecotoxicogenomics, which describes the incorporation of the omic technologies into 
ecotoxicology (Snape et al., 2004). One of the underpinning reasons why 
ecotoxicogenomics is so important is the need to reduce the number of animals used in 
ecotoxicity testing. Ecotoxicogenomics helps elucidate the underlying molecular 
mechanisms of toxicity, to allow the development of predictive models and Quantitative 
Structure-Activity Relationship-models (QSAR-models) (Snape et al., 2004). As well as 
Snape et al. (2004) highlighting that data generated from omics technologies can be used to 
reduce the numbers of animals used in ecotoxicological testing, both Snape et al. (2004) and 
Van Aggelen et al (2010) stated that it may also be used to inform the researcher on the 
possible Mode of Action (MOA) of chemicals. Previously, ecotoxicological studies solely 
focused on apical biomarkers, which often do not provide information about the mechanisms 
of toxicity, and thus the association with molecular alteration and outcomes in the whole 
organism (Snape et al., 2004; Van Aggelen et al., 2010). The molecular and cellular 
biomarkers identified can be associated with population and ecosystems responses, which 
can be used to inform ecological risk assessments for existing and new chemicals and 
technologies (Snape et al., 2004).  
Genomic responses leading to biological effects can occur either directly or indirectly. The 
severity of the response is determined by the duration of the exposure and potency of the 
chemical. A genomic response could be reversed, have a short-lived effect on survival or 




global gene expression can be of greater interest and provide a much greater wealth of 
knowledge. It is also important to have a large sample size and to examine responses at 
differing time intervals. Additionally, the assessment of the alteration in gene expression 
should not just be concerned with the differences in expression of individual genes, but in 
relation to how the genes respond within given pathways. If the expression of multiple genes 
has been altered, and analysis shows that those genes act together within a genetic 
pathway, initiating a specific biological response, more confidence can be had that that 
specific biological process is likely to be affected by the exposure/conditions tested.   
Snape et al (2004) stated that there is the need to develop and refine new technologies to 
measure gene, protein, and metabolite profiles in populations of wildlife which are exposed 
to “multiple stressors in complex natural environments” (Snape et al., 2004). 
 Microarrays 
Most references to microarrays refer to an array that measures the expression of cDNA. 
There are many types of arrays including single nucleotide polymorphism (SNP) arrays and 
methylation arrays; however, this study used only the cDNA microarray, so only this type of 
array will be discussed. The rationale behind the use of a microarray is if a compound elicits 
an effect on an organism, the effect will be initiated at a molecular level and will be apparent 
as a change in gene expression. Information in DNA is transferred to mRNA, this mRNA is 
translated to form a specific protein. This alteration can be detected when the 
chemical/condition being tested acts directly on the nuclear receptors, thereby altering the 
gene expression. However, some chemicals act directly on proteins and enzymes 
themselves, and in these incidences it it can be less clear whether we would see an effect 
on the genome. Transcriptional changes in gene expression (i.e. gene up- or down-
regulation) can either be measured on different scales, from an individual genes, small 
groups of genes, or an organism’s entire genome. Individual gene expression is usually 
investigated using the Quantitative Polymerase Chain Reaction (QPCR), which measures 
whether there is more, or less, of the gene being expressed, relative to that of the control 
gene (e.g. a house-keeping gene). The groups of genes, or entire genome, can be 
investigated using microarrays, whereby the expression levels of a whole array of genes are 
measured to assess their expression compared to that of a control sample. Any alteration 
measured at a genetic level does not automatically result in an effect on the organism as a 
whole, for alterations in gene expression due to an outside stressor can be alleviated via 
cellular mechanisms. Consequently, very often, toxicogenomic changes are seen as an early 
warning signal of the potential for adverse effects, and an indication as to what those 




Microarrays are tools used in genomics; their use in toxicological studies can lead to the 
discovery of novel biomarkers and adverse effects (Van Aggelen et al., 2010). Microarrays 
are comprised of a glass slide onto which known fragments of DNA are spotted onto the 
surface. They can include a specific array of DNA fragments; for example, if the researcher 
was solely interested in estrogenicity, then the DNA fragments spotted on to the slide may 
only be representative of genes known to be involved in estrogenicity. Or they can consist of 
a wider number of DNA fragments, for example the entire genome of the species or 
organism of interest. The different DNA fragments, known as probes, are placed in 
designated positions on the slide, to enable gene identification at the end of the procedure. 
A RNA sample of interest (known as the ‘target sample’) is purified, amplified and labelled 
using a fluorescent dye. The target sample is then placed onto the slide, where it undergoes 
hybridisation; i.e. is allowed to react with the DNA fragments (probes) attached to the slide to 
create probe-target interaction. This hybridisation is left to occur under optimum conditions, 
including high ionic strength buffers, and at elevated temperatures. Following hybridisation, 
the arrays are washed to remove any cross-hybridisation, where the targets have bound to 
the incorrect probes. As the target sample has been labelled using a fluorescent dye, this 
fluorescence can be measured (Dufva, 2009). By measuring the fluorescence, with further 
analysis, an assessment can be made as to which individual genes have been up-regulated, 
down-regulated or remained unchanged in comparison with a control sample. The 
expression of each differentially expressed gene is then assessed to see if they belong to a 
common pathway, which can inform as to whether there is the potential for a biological 
function to be affected.  
 Different types of microarrays 
There are three main types of commonly used microarray technologies; spotted microarrays, 
Affymetrix GeneChips, and other in situ synthesised assays (Seidel, 2008). Spotted 
microarrays consist of probes which are oligonucleotides, cDNA or small fragments of PCR 
products; these are designed to correspond to the mRNA in the target sample. The probes 
are spotted onto a glass slides, using fine needles which are controlled by a robotic arm. The 
needles pick up DNA from microtiter plates and place it onto the surface of the glass slide 
(Seidel, 2008). After the initial expenditure for the hardware, this is a low cost option, and 
enables researchers to produce their own customised microarrays. However, they are 
unstandardised, and can be labour intensive. 
Affymetrix GeneChips are the most established commercial array. These consist of multiple 
short oligonucleotides (usually 25-mers), synthesised in situ onto the surface of the chip 




oligonucleotides, and uses photolithographic techniques - the same techniques utilised for 
producing computer chips, hence the use of the name GeneChips (Dale et al., 2012).  
Other commercial companies have differing methods of producing microarrays which are 
either based on the spotted array or Affymetrix methods. These companies include Agilent, 
Nimblegen, Oxford Gene Technology, Xeotron, Combimatrix, Febit and Nanogen (Hobman 
et al., 2007). The microarrays used in this project were sourced from Agilent Technologies. 
Agilent use a process which enables the construction of long oligonucleotides (60-mers) 
onto glass slides using ink jet printing (Hobman et al., 2007). The ink jet printing technology 
was developed by Hewlett Packard, and modified to control the liquid precursors of DNA 
synthesis. Agilent Technologies formed out of Hewlett Packard. The printing technology 
means that it is a very flexible technology and the arrays can be easily customised to 
researcher’s requirements (Seidel, 2008). However, it is reported that its flexibility results in 
difficulties in comparing results from different experiments. With the Affymetrix method,  
whereby the chips are mass produced, and all the same, the comparison from intra- and 
inter-laboratories is easier than when comparing the results from studies using customised 
Agilent arrays (Seidel, 2008).  
In addition to the different types and methods of production of microarrays, there are also 
two-colour or one-colour (single channel) arrays. This refers to the number of dyes used to 
measure gene expression. One-colour measures the intensity, so is therefore an absolute 
reading of gene expression, whereas the two-colour measures the ratio of the two colours or 
the relative difference of the gene expression between two samples (Xiao et al., 2006). 
Figure 6.1 illustrates the basic principles of the two methods: for the purposes of this work, a 
one-colour (single channel) system was used. The two-colour approach is the most 
established method and has been used for longer than the one-colour approach.  
With the two-colour approach, the mRNA from a biological sample of interest (e.g. the 
diseased tissue, exposed cells, or tissue from a treated organism) and a control sample are 
isolated and cDNA is amplified.  The target cDNA is labelled with one dye (cyanine 5 dye 
(Cy5), red dye), and the control cDNA sample is amplified and labelled with another dye 
(cyanine 3 dye (Cy3), green dye) (Figure 6.1). Both these labelled cDNA samples are then 
combined and hybridised to one single array. Where the probes on the array are measured 
to be red, then it can be assessed that that corresponding gene is expressed in the sample 
of interest. Where the probes on the array are measured to be green, then it is assessed that 
the corresponding gene is being expressed in the control sample. Where the probes are 
measured to be yellow then it can be determined that these genes are being expressed in 




ratios are generated from direct comparison between two samples, and the experimental 
design would have to incorporate enough individuals, tissue, samples, or cells, to have 
adequate number of comparisons.  
For the one-colour approach, samples are treated the same way as with the two colour 
approach, until they reach the labelling stage (Figure 6.1). Instead of two different dyes 
being used, one dye is used, and with the Agilent system, this is cyanine 3 (Cy3), due to it 
being less vulnerable to environmental degradation including ozone, pH and organic 
solvents compared to cyanine 5 (Cy5) (Xiao et al., 2006). The labelled samples (target and 
control) are then each hybridised to an individual array (Figure 6.1). The intensity of the 
green colour from the probes is then measured, giving an expression level for each gene. 
These readings from each array can then be compared to the others to determine the 
differences in gene expression between samples. It was decided that the one-colour 
approach was preferable than the two-colour approach, because the one-colour are more 
cost effective than the two-colour approach, especially with the number of replications (the 
experiment was repeated three times), time-points (six time-points, 8 hpf to 48 hpf) and 
treatments (six product waters from the IPR plant, plus a tap water and a control). 
 






6.3.1 Gene Expression Exposures 
The aim of this part of the project was to determine if differences in gene expression levels 
occurred between zebrafish embryos reared in product waters from the IPR plant, relative to 
gene expression in embryos reared in control water. As developing embryos were being 
used, and their gene expression levels were being determined, it was considered important 
to identify time-points that had the greatest amount of genomic activity and which also 
encompassed critical developmental windows during embryogenesis. The Zfin website was 
used which hosts the Zebrafish Model Database (University of Oregon, 2015). This website 
contains a wealth of information on zebrafish, including their development and gene 
expression. It contains details of specific genes that are expressed during certain stages of 
development, and at what point in development specific organs and biological systems are 
forming. 
Figure 6.2 below represents the reported number of genes expressed in the developing 
zebrafish embryo associated with growth of biological systems. It is not an exhaustive list 
and the data were collated at the end of 2011. However, this information was used to gain a 
better understanding of the time points that would be most relevant to sample at during 
development, in order to measure gene expression of the embryos. Early development was 
chosen because it is sensitive to chemical interference and disruption, leading to 
organisational and often permanent changes in phenotype (Schug et al., 2011) . However, 
as genes can be “switched-on” and then “switched-off”, it was important to choose time 
points where large number of genes were being expressed. Figure 6.2 indicates that from 
5.25 hpf and 48 hpf, there are a larger number of genes involved in the development of 
biological systems being expressed. This time period fell into the majority of time points used 
for observations in the previous developmental observation exposures. The 4 hour time 
appeared to have fewer expressed genes than the other 6 time points, and 4 hours was 
considered to be a very short exposure time. For this reason 4 hpf was not included as a 
sampling point for the gene expression exposures.  Instead, it was decided that 8, 12, 16, 
24, 36 and 48 hpf would be most relevant, and would provide a good representation of many 





Figure 6.2 The graph represents the number of genes expressed during the development of zebrafish 
embryos at the key stages of embryo growth. The data were gathered from the Zfin website (University of 
Oregon, 2015) and were collated on 11/10/2011. The figure does not represent all genes expressed, only 
genes reported on the website that are associated with developing zebrafish, and is  not an exhaustive 
list of the number of  genes being expressed at each time point. The time points used for observations 
points in the previous zebrafish 48 hour developmental exposure are highlighted in red and by the 
arrows. 
The time points at which various anatomical structures were first evident were also 
examined using data gathered from Zfin website (University of Oregon, 2015)  and available 
at the end of 2011. It was determined that many anatomical structures first became evident 
between 14 and 16 hpf, and it was logical to assume that significant gene expression would 
occur before and during this time, throughout the formation of these structures. Some of the 
structures remain for the duration of the animal’s life, and others develop to form more 
advanced structures. The largest number of structures to become evident for the first time 
occur at 14-16 hours. At this time point parts of the brain, endocrine system, immune 
system, neural tube, olfactory system, pancreas primordium and renal system are evident. 
Prior to this time, at 11.66-14 hours, parts of the cardiovascular system, immature eye, 
muscle cells, muscle pioneer, neural rod, and reproductive system are evident. Therefore, 
before 14 hours, a number of genes will have been expressed that are involved in the 
development, regulation and maintenance of these structures 
From hours 22 to 24 hours additional structures that go on to develop further include mature 




hours more parts of the heart and liver are evident. At 19-22 hours there is a peak in 
structures becoming evident; these include the heart, inner ear, and kidney.  
The stages of development that appeared as though they could be best for microarray 
analysis were 12-14, 19-22, 24 and 48 hpf, with greatest importance being given to 
24 hours, when maximum gene expression associated with developmental and growth 
occurs, and many of the organs and biological systems have formed, or are in the process 
forming. There is an obvious rise in the number of reported genes expressed between 4.5 
hours and 5.25 hours (Figure 6.2). However, it was decided that considering exposure time, 
the embryos at this stage would have only been exposed for a relatively short time. It is 
important to note that the data on the number of genes expressed collated from the Zfin 
website represent only the number of genes with expression data, and do not represent the 
actual total number of genes expressed. 
Based on the available information, it was decided that 8, 12, 16, 24, 36 and 48 hpf would be 
the most relevant time points as they coincided with important developmental stages that 
had been previously documented, and (with the exception of 4 hours, due to the lack of 
exposure time) were consistent with observation time points used previously in the 
developmental exposures. 
The detailed material and methods for the gene expression exposures are detailed in the 
previous General Material and Methods chapter. Any deviations from these methods are 
detailed below. 
All the gene expression exposures were carried out during March 2012. 
 Gene expression exposure No.1 
Composite 24 hour samples were collected from the IPR plant for all treatment processes, 
except for post AOP2 and final product, because these two treatment processes were shut 
down at time of sample collection. It was decided that the product water for the rest of the 
processes should be collected, and that the exposure should go ahead, as the IPR plant was 
going to be decommissioned at the end of March 2012, and it was unclear if these two 
processes would be fixed in time.  
Due to deterioration in health and egg production in the Founder (F0) fish used to generate 
embryos in the 48 hour observation studies, it was decided that the F1 generation should be 
used as breeding adults instead.  




Composite 24 hour effluent samples were collected from all 6 stages of the IPR treatment 
process. 
 Gene expression exposure No. 3 
Composite 24 hour effluent samples were collected from all 6 stages of the IPR treatment 
process. 
6.3.2 Microarray 
In October/November 2012, the embryos (preserved in RNAlater) from these exposures 
were taken to the Institute of Integrative Biology at Liverpool University and the microarrays 
were completed with guidance and instruction from Dr Philipp Antczak. 
6.4 Results and analysis 
The microarrays and the analysis were carried out at the Institute of Integrative Biology at 
Liverpool University by Dr Philipp Antczak and overseen by Professor Francesco Falciani. I 
worked alongside Dr Antczak to complete the practical work and he completed the analysis 
which is detailed below. I worked alongside Dr Richard Evans, Brunel University, to 
complete some of analysis shown on individual gene expression. 
For all the microarrays carried out, Quality Control (QC) files are available and can be 
obtained from the author.  
6.4.1 Normalisation 
The data was initially normalised, so that variation between the arrays could be analysed 
alone, without the variations caused by non-biological sources. Bolstad et al., (2003) 
describe the existence of two types of variations when analysing multiple arrays; these are 
interesting variations, and obscuring variations. The interesting variation would be the 
biological difference between samples arising from differential gene expression in exposed 
and un-exposed organisms. The obscuring variation arises from the processes involved in 
conducting the experiment; for example, manufacture of the arrays and sample preparation 
(labelling, hybridization and scanning) (Bolstad et al., 2003; Potier & Rivals, 2012). Some of 
these can be minimised  using specific experimental designs whereby the same time-point is 
used, and the experiment  conducted by the same person each time; but it is impossible to 
control for every potential variation, which is why normalisation is used to correct for this 
(Potier & Rivals, 2012). When normalising microarray data for two-colour arrays there are 
two steps of normalisation to complete: normalisation between arrays, followed by 
normalisation within arrays. Normalisation between arrays ensures that the intensities have 




within arrays accounts for differences in the signals associated with Cy3 and Cy5 dyes 
known as dye bias (Carzaniga et al., 2007; G. Smyth, n.d.). As one-colour arrays were 
utilised for this study, only normalisation between arrays was required. For one-colour 
arrays, two methods of normalisation between the different arrays used can be applied; 
quantile normalisation and/or cyclic loess normalisation (G. Smyth, n.d.). Both of these 
methods were carried out, and the resulting normalised data used to create Principal 
Component Analysis (PCA) plots to make an initial assessment of the data generated from 
the microarrays.  
Quantile normalisation is the most popular method of normalisation for data generated from 
a one-colour array. It makes the assumption that the distribution of the intensities across the 
arrays are the same, and without experimental error (Carzaniga et al., 2007). Quantile 
normalisation can either be conducted by selecting one chip as a baseline against which all 
other chips are normalised against, or by using a pairwise method (Bolstad, 2001). Quantile 
normalisation was used to begin with, and the PCA shown in Figure 6.2 and Figure 6.3 
clearly illustrates how the developmental stage of the embryos had the strongest influence 
over the gene expression (i.e. separated the groups) compared to any of the other variables 
including experiment/exposure (1, 2 or 3) and exposure to the different IPR product waters.  
If the tap and control waters are treated as chemical exposures, there were some 
differences between the three individual experiments (1, 2 and 3); i.e. the experiments 
themselves influenced the gene expression (Figure 6.4).  
For the second method of normalisation, cyclic loess normalisation was used to create the 
PCA plot shown in Figure 6.5. Cyclic loess normalisation subjects each conceivable pair of 
arrays to loess normalisation (Smyth, n.d.)  which performs locally weighted linear 
regressions on the whole dataset,  and then combines them to produce one smooth curve 
(Stekel, 2003; Wade, 2007). Therefore, each data point within the dataset was normalised 
against the corresponding control group. For example, RO 8 hpf Experiment 1 was 
compared against Control 8 hpf Experiment 1, and MF 36 hpf Experiment 3 was normalised 
against Control 36 hpf Experiment 3. Subsequently a ratio is calculated, and the influences 
of the embryo’s developmental stage and experiment (1, 2 or 3) were removed, making it 
possible to see if there were any differences due to exposure to the different IPR product 
waters. A PCA plot again was used to make initial assessments using this normalisation 





Figure 6.3 Quantile normalised principal component analysis (PCA) plot showing similarities in gene 
expression in the pooled embryos exposed to at the different time points in the different IPR product 
waters, tap and control.  
 
Figure 6.4 PCA plot whereby both the tap and control waters were considered as chemical treatments 
and the different experiments (1, 2 and 3) are highlighted, showing that the experiment has an influence 





Figure 6.5 PCA plot of data normalised against the control group. 
6.4.2 Individual gene expression 
A two group comparison using Limma (an R/Bioconductor software package) was carried 
out on each individual gene expression dataset, against the corresponding control; for 
example, 8 hour control against 8 hour final product. Within Limma the toptable function was 
used; this function summarises the results of the model, conducts hypothesis tests, and 
adjusts the p-values to allow for multiple testing (G. K. Smyth, 2004). The analysis provides 
log fold changes, average expression, moderated t-test, standard error, P-value, and 
adjusted P-value (G. K. Smyth, 2004). The package uses a Bayesian model to moderate the 
standard errors by using all genes, which reduces the error to a common value, resulting in 
P-values with a normal t-statistic, but the moderated t-statistic has increased degrees of 
freedom, increasing the reliability. The adjustment made to the adjusted P value is in 
accordance with Benjamini and Hochberg’s method to control the false discovery rate. 
The B-statistic labelled as ‘B’ in Table 6.1 is the log-odds of an individual gene being 
differentially expressed. 
False discovery rates (FDRs) can be calculated from the p-value using the Benjamini-
Hochberg procedure; this requires that the p-values are uniformly distributed under the null 
hypothesis. The method then sorts the p-values into ascending order, and then divides each 
p-value by its percentile rank to calculate an estimated FDR. Very small p-values near the 




Table 6.1 Individual genes which were identified as being differentially expressed compared to the same genes in the control samples. Log fold change (LogFC)>0 




hpf Probe Name Systematic Name logFC 
 




t P.Value adj.P.Val B 
Tap 48 A_15_P195156 NM_001037674 0.517261 somatolactin beta 2.790518 8.730334 1.39E-07 0.00605 5.831553 
Final 
Product 
16 A_15_P683421 TC381473 0.562369 Unknown 2.336993 9.139347 6.95E-08 0.003034 6.263581 
16 A_15_P661806 NM_001030127 0.360696 zgc:114065 2.509881 7.575909 8.83E-07 0.015055 4.635352 
16 A_15_P132886 NM_205622 0.329937 
luteinizing hormone beta 1; 
luteinizing hormone, beta 
polypeptide 
2.340346 7.484641 1.03E-06 0.015055 4.528206 
16 A_15_P400500 TC376026 0.248182 Unknown 2.382267 7.143164 1.89E-06 0.020599 4.114621 
24 A_15_P679141 NM_001105113 0.499824 
novel protein similar to 
vertebrate phospholipid 
scramblase 1 
2.556971 15.23649 4.61E-11 2.01E-06 10.77498 
24 A_15_P190981 ENSDART00000057296 0.281613 Unknown 2.554738 7.309202 1.57E-06 0.034352 4.585307 
24 A_15_P270651 NP13323810 0.276651 Unknown 2.409246 7.023698 2.60E-06 0.037799 4.210404 
36 A_15_P262686 A_15_P262686 0.421607 Unknown 2.348355 9.18382 6.40E-08 0.002792 6.332795 
48 A_15_P584892 TC395851 0.800674 Unknown 2.547976 11.58461 2.44E-09 0.000106 7.348301 
48 A_15_P195156 NM_001037674 0.500144 somatolactin beta 2.790518 7.550252 9.64E-07 0.021051 4.167615 
AOP2 
8 A_15_P625245 NM_001128380 0.550568 
odorant receptor, family E, 
subfamily 128, member 7; 
odorant receptor, family E, 
subfamily 128, member 6 
2.482616 8.548881 1.62E-07 0.00709 3.857985 
16 A_15_P561292 NM_001127254 0.263603 novel immune-type receptor 2.474206 7.733182 6.74E-07 0.029446 4.816688 
48 A_15_P195156 NM_001037674 0.61238 somatolactin beta 2.790518 9.244572 6.28E-08 0.00274 5.754219 
RO 
48 A_15_P195156 NM_001037674 0.641299 somatolactin beta 2.790518 10.82385 6.61E-09 0.000288 7.583933 
48 A_15_P513717 EH438239 0.371965 Unknown 3.053541 7.174754 1.86E-06 0.020266 4.122775 
48 A_15_P733840 EH438239 0.343911 Unknown 3.103451 6.671604 4.60E-06 0.033488 3.482535 
48 A_15_P101761 NM_001001849 0.206208 
transient receptor potential 
cation channel, subfamily V, 
member 6 
2.636785 7.699042 7.48E-07 0.016322 4.742881 







hpf Probe Name Systematic Name logFC 
 




t P.Value adj.P.Val B 
48 A_15_P631042 NM_181760 -0.14208 annexin A1c 3.921124 -7.23007 1.68E-06 0.020266 4.190432 
AOP1 
12 A_15_P131961 NM_001145708 0.377019 
Cytochrome P450, family 1, 
subfamily B, Polypeptide 
2.531125 7.867428 6.48E-07 0.028271 5.150077 
16 A_15_P164691 NM_001110391 0.172887 cerebellin 4 percursor 2.552454 8.701309 1.37E-07 0.006 6.29359 
24 A_15_P659656 NM_131879 0.40655 
Cytochrome P450, family 1 
subfamily A 
2.972813 7.990429 4.97E-07 0.010857 5.737169 
24 A_15_P100578 NM_131879 0.279395 
Cytochrome P450, family 1 
subfamily A 
3.514583 8.225231 3.39E-07 0.010857 6.02719 
48 A_15_P659656 NM_131879 0.562108 
Cytochrome P450, family 1 
subfamily A 
3.10311 11.16808 4.18E-09 0.000183 7.82275 
48 A_15_P131751 NM_131879 0.510272 
Cytochrome P450, family 1 
subfamily A 
3.109281 9.627507 3.55E-08 0.000516 6.650837 
48 A_15_P100578 NM_131879 0.431093 
Cytochrome P450, family 1 
subfamily A 
3.647145 9.925879 2.30E-08 0.000502 6.899576 
MF 
12 A_15_P171581 NM_001145708 0.70819 
Cytochrome P450, family 1, 
subfamily B, Polypeptide 
2.860979 7.485303 1.23E-06 0.010725 4.692729 
12 A_15_P659656 NM_131879 0.60633 
Cytochrome P450, family 1 
subfamily A 
2.880383 7.812946 7.09E-07 0.007734 5.08635 
12 A_15_P548722 TC414122 0.599259 Unknown 2.405274 8.92135 1.22E-07 0.002444 6.290873 
12 A_15_P100578 NM_131879 0.448848 
Cytochrome P450, family 1 
subfamily A 
3.412419 6.959559 3.06E-06 0.022259 4.022909 
12 A_15_P131751 NM_131879 0.445688 
Cytochrome P450, family 1 
subfamily A 
2.949657 6.695098 4.91E-06 0.030623 3.667686 
12 A_15_P131961 NM_001145708 0.444175 
Cytochrome P450, family 1, 
subfamily B, Polypeptide 
2.531125 9.268807 7.23E-08 0.002444 6.630814 
12 A_15_P339770 ENSDART00000114701 0.435986 Unknown 2.633949 8.712291 1.68E-07 0.002444 6.078005 
24 A_15_P659656 NM_131879 0.511047 
Cytochrome P450, family 1 
subfamily A 
2.972813 10.04424 2.18E-08 0.000475 7.995783 
24 A_15_P100578 NM_131879 0.356946 
Cytochrome P450, family 1 
subfamily A 
3.514583 10.50829 1.14E-08 0.000475 8.426655 
36 A_15_P659656 NM_131879 0.502182 
Cytochrome P450, family 1 
subfamily A 
3.011647 8.222874 2.93E-07 0.007741 5.784139 
36 A_15_P131751 NM_131879 0.461879 
Cytochrome P450, family 1 
subfamily A 
3.023627 8.108303 3.55E-07 0.007741 5.650983 
36 A_15_P100578 NM_131879 0.366185 
Cytochrome P450, family 1 
subfamily A 
3.546661 6.863995 3.09E-06 0.044994 4.06378 







hpf Probe Name Systematic Name logFC 
 




t P.Value adj.P.Val B 
subfamily A 
48 A_15_P131751 NM_131879 0.608141 
Cytochrome P450, family 1 
subfamily A 
3.109281 11.47404 2.81E-09 6.13E-05 8.030865 
48 A_15_P100578 NM_131879 0.431144 
Cytochrome P450, family 1 
subfamily A 
3.647145 9.927049 2.30E-08 0.000334 6.905441 
Final 
effluent 
12 A_15_P171581 NM_001145708 0.722068 
Cytochrome P450, family 1, 
subfamily B, Polypeptide 
2.860979 7.631994 9.59E-07 0.012178 4.871177 
12 A_15_P659656 NM_131879 0.585301 
Cytochrome P450, family 1 
subfamily A 
2.880383 7.541975 1.12E-06 0.012178 4.762099 
12 A_15_P164111 NM_130940 0.568771 
similar to bonnie and clyde; 
bonnie and clyde 
2.769646 12.5328 9.78E-10 4.27E-05 9.116653 
12 A_15_P100578 NM_131879 0.458201 
Cytochrome P450, family 1 
subfamily A 
3.412419 7.10458 2.37E-06 0.020691 4.212463 
12 A_15_P131961 NM_001145708 0.431418 
Cytochrome P450, family 1, 
subfamily B, Polypeptide 
2.531125 9.002601 1.08E-07 0.002352 6.371895 
24 A_15_P659656 NM_131879 0.407037 
Cytochrome P450, family 1 
subfamily A 
2.972813 7.999995 4.90E-07 0.010687 5.749158 
24 A_15_P100578 NM_131879 0.301522 
Cytochrome P450, family 1 
subfamily A 
3.514583 8.876656 1.21E-07 0.005299 6.786937 
24 A_15_P213061 NM_001030106 0.228872 si:busm 1-132m23.3 2.501567 7.368465 1.42E-06 0.020668 4.925478 
24 A_15_P500697 ENSDART00000146728 0.153671 Unknown 2.794794 6.935972 3.04E-06 0.033141 4.322612 
48 A_15_P659656 NM_131879 0.474143 
Cytochrome P450, family 1 
subfamily A 
3.10311 9.420367 4.82E-08 0.001319 6.471406 
48 A_15_P131751 NM_131879 0.449317 
Cytochrome P450, family 1 
subfamily A 
3.109281 8.477439 2.07E-07 0.003012 5.579879 
48 A_15_P100578 NM_131879 0.402595 
Cytochrome P450, family 1 
subfamily A 
3.647145 9.269723 6.04E-08 0.001319 6.337353 





In the tap water exposure, when the gene expression was compared to that of the aquarium 
water controls, only one gene was determined as significantly differentially expressed, and 
that was somatolactin beta, with over expression. 
In final product there were ten individual genes which were determined to be differentially 
expressed compared to the control; all of them exhibited over expression. Six of these genes 
have not been identified; the others were zgc-114065, luteinizing hormone, a novel protein 
similar to vertebrate phospholipid scramblase1, and somatolactin beta. 
In AOP2 product, three individual genes were determined to be differentially expressed 
compared to that of the control, all of them with over expression. These genes were an 
odorant receptor gene, an immune-type receptor gene, and somatolactin beta. 
In reverse osmosis product, there were six individual genes determined to be differentially 
expressed compared to that of the control- all of them with over expression, apart from one 
which was under expressed. The under expressed gene was annexin A1c, the other five 
over expressed genes were two unidentified genes, cation channel gene, si:dkey-24I11.8, 
and somatolactin beta. 
In AOP1 product there were three individual genes that were determined to be differentially 
expressed compared to that of the control - all of them with over expression. These were 
Cytochrome P450, family 1, subfamily B, polypeptide, Cytochrome P450, family 1 subfamily 
A, and cerebellin 4 percursor. 
In microfiltration product there were four individual genes determined to be differentially 
expressed compared to that of the control - all of them with over expression. Two of these 
genes have not been identified and the other two were Cytochrome P450, family 1, 
subfamily B, polypeptide, Cytochrome P450, family 1 subfamily A. 
In final effluent there were five individual genes determined to be differentially expressed 
compared to that of the control - all of them with over expression. One has not been 
identified, a gene similar to bonnie and clyde, sibusm 1-132m23.3, Cytochrome P450, family 
1, subfamily B, polypeptide, Cytochrome P450, family 1 subfamily A. 
It was noted that somatolactin beta was over expressed in the embryos exposed to tap, final 
product, AOP2, and reverse osmosis product waters; all of these waters have undergone 
significant treatment. Additionally, it was observed that the same two cytochrome P450 
genes were over expressed in the first half of the IPR treatment process in embryos exposed 




6.4.3 2-Factor ANOVA Gene Level 
Using the normalised data from the quantile and loess methods, a 2-factor ANOVA for gene 
level was carried out. Examining the influence of the experiment (1, 2 or 3) on gene 
expression, there were 20746 and 21238 genes differentially expressed using the quantile 
and loess normalised data, respectively. This indicates that there was a large number of 
individual genes being differentially expressed in the three different experiments. By 
assessing the influence of developmental stage of the embryos (hours post fertilisation) on 
the number of differentially expressed genes using the two methods, it was found that there 
were 29467 and 27932 differentially expressed genes using the quantile and loess 
normalised data, respectively, thus indicating that the developmental stage had a greater 
influence on the number of genes differentially expressed than the experiment (1, 2 or 3). 
The number of differentially expressed genes based on IPR treatment process (i.e. sample), 
was only 63 and 34 based on the quantile and loess normalised data, respectively. 
6.4.4 2-Factor ANOVA Pathway Level 
Another 2-factor ANOVA was carried out, but at the pathway level rather than just individual 
gene level. Assessing the influence of the experiment (1, 2 or 3) on differentiated expression 
of pathways in the zebrafish embryos determined that there were 329 and 269 pathway 
indices differentially expressed using the quantile and loess normalised data, respectively. 
Examining the influence of the developmental stage of the embryos (hours post fertilisation) 
on the number of pathways indices using the two methods, there were 392 and 289 
differentially expressed pathway indices using the quantile and loess normalised data, 
respectively. The number of pathway indices differentially expressed based on IPR 
treatment process (sample) was only 10 and 5 when using the quantile and loess normalised 
data, respectively. However, from this small number of pathway indices, it was determined 
that these were all pathways broadly involved in hormone synthesis/metabolism and 
detoxification, suggesting that the embryos had upregulated their detoxification mechanism 
when exposed to the different IPR treatment process waters, and these mechanisms may 
also affect hormone synthesis. This is because steroid hormone synthesis is reported to be 
controlled by activity of a number of cytochrome P450 enzymes and some steroid 
dehydrogenases and reductases (Sanderson, 2006). The pathways that are influenced 
(using the quantile normalised data method) by the IPR treatment process (sample) group 
are as follows (number in the brackets indicates number of indices among the three different 
exposures repeated): 
1. Steroid hormone biosynthesis (3/3) 




3. Retinol metabolism (2/3) 
4. Metabolism of xenobiotics by cytochrome P450 (2/3) 
5. Drug metabolism-cytochrome P450 (1/3) 
6. Drug metabolism-other enzymes /(1/3) 
The pathways that are influenced (using the loess normalised data method) by the IPR 
treatment process (sample) group are as follows (number in the brackets indicates number 
of indices): 
1. Steroid hormone biosynthesis (1/3) 
2. Tryptophan metabolism (1/3) 
3. Retinol metabolism (1/3) 
4. Metabolism of xenobiotics by cytochrome P450 (2/3) 
Nonylphenols have been associated with disruptions to the steroid metabolism pathway; this 
is further discussed in section 6.5.3, Table 6.2 details the concentration of nonylphenols 
detected in the product waters along the IPR treatment process. 
Table 6.2 Concentrations of nonylphenol detected in product waters along the IPR treatment plant. 







Final effluent Nonylphenol (NP) 
Nonylphenol monoethoxylate (NP1EO) 
Nonylphenol diethyoxylate (NP2EO) 













Microfiltration Nonylphenol (NP) 
Nonylphenol monoethoxylate (NP1EO) 
Nonylphenol diethyoxylate (NP2EO) 













AOP1 Nonylphenol (NP) 
Nonylphenol monoethoxylate (NP1EO) 
Nonylphenol diethyoxylate (NP2EO) 













Reverse osmosis Nonylphenol (NP) 
Nonylphenol monoethoxylate (NP1EO) 
Nonylphenol diethyoxylate (NP2EO) 













AOP2 Nonylphenol (NP) 
Nonylphenol monoethoxylate (NP1EO) 
Nonylphenol diethyoxylate (NP2EO) 
















*<LoD; data supplied by Thames Water; nonylphenols were not sampled for in the aquarium water 
 
6.4.5 SAM Time-course Analysis 
The Significance Analysis of Microarrays (SAM) determines whether alterations in gene 
expression are statistically significant or not, and works by conducting gene specific t-tests 
(Zheng et al., 2007). A small positive constant is added to the denominator of the 
gene-specific t-test; this ensures that genes with small fold changes are not recorded as 
being significant (Zheng et al., 2007). Additionally, it applies repeated permutations of the 
data to make an estimate of the percentage of genes significantly related to the response, as 
well as the genes identified by chance (false discovery rate, FDR). Both the fold change and 
FDR thresholds can be specified (Chu et al., n.d.; Zheng et al., 2007).  
There are two approaches for the analysis of time-course data using SAM; these are ‘slope 
based’ and ‘signed area’ based. The slope based approach is applicable for analysing genes 
with a monotonous increasing or decreasing expression over time (Chu et al., n.d.). The 
signed area based approach is more appropriate for the dataset being analysed in this study 
as it is better at finding genes that increase and then plateau, or their expression returns to 
baseline levels (Chu et al., n.d.); put simply, the switching-on and -off of genes which would 
be expected to occur during embryonic development.  
For this SAM time-course analysis, the slope and signed area were used for assessing the 
individual gene expression and pathways, by comparing all combinations of time-courses 
with two treatments at a time; for example Control 8hpf-48hpf vs Final effluent 8hpf-48hpf, 
and comparing all treatments as pseudo-one class time-courses. Therefore the individual 
IPR treatment process stages are used to order the analysis as along the time-course i.e. 
Final effluent 8hpf → MF 8hpf → AOP1 8hpf → RO 8hpf → AOP2 → FINAL 8hpf → Tap 
8hpf →Control 8hpf. In this way each specific developmental stage is compared along the 
treatment process.  
6.4.6 Gene level SAM time-course analysis 
This analysis examined the expression of the individual genes. For this analysis, only the 
loess dataset was used because the quantile dataset showed a strong link to time related 
genes. The false discovery rates (FDR) were calculated for each combination for the SAM 
time-course and the smallest FDR was recorded in Table 6.3.  
Traditionally, t-tests are designed to compare two sets of results, however in a microarray 




chance, lots of genes will be determined as being differentially expressed (Carzaniga et al., 
2007). The example given by Carzaniga et al., (2007) states that when random values are 
used, the t-test will consider 5% of the genes as significant. If a dataset consists of 10 000 
genes this will mean 500 genes will be determined to be differentially expressed. 
Consequently, a correction factor is used on the p values to help control for these false 
positives; one method for correction is known as the FDR. FDR works by multiplying each 
p value by the total number of tests, and dividing by the number of (the remaining) larger 
p values. This results in a q value, and is the expected number of false positives (Carzaniga 
et al., 2007). Very often these q values range from 0 to 0.1 (10%), and, the lower the value, 
the fewer false positives there are, and the more confidence there are in the numbers of 
significantly difference reported in the gene expression. The FDRs reported in the Table 6.3 
indicate that the majority of the genes found using the signed area approach are significant, 





Table 6.3 The minimum false discovery rate (FDR) for the loess normalised dataset using the SAM time-
course analysis for gene level.  The smallest FDR is indicative of whether there is anything significant or 
not 
Comparison Minimum FDR signed 
area approach 
Minimum FDR slope 
approach 
MF vs Final 0.08 1.12 
Final effluent  vs Final 0.11 1.09 
Final effluent  vs RO 0.14 0.8 
MF vs RO 0.15 0.39 
RO vs Final 0.28 1.1 
Tap vs MF 0.29 1.23 
MF vs AOP2 0.35 1.15 
Final effluent  vs AOP2 0.59 0.74 
Tap  vs RO 0.62 1.35 
AOP1 vs RO 0.71 1.12 
AOP1 vs Final 0.75 1.15 
AOP1 vs Final effluent   0.78 1.16 
Tap vs Final effluent   0.98  0.66 
MF vs Final effluent   1.06 1.04 
AOP1 vs MF 1.12 1.03 
Tap vs Final 1.13 1.19 
RO vs AOP2 1.13 1.08 
Tap vs AOP2 1.14 1.18 
AOP1 vs AOP2 1.16 0.28 
AOP1 vs Tap 1.21 1.14 






Figure 6.6 Illustration of the IPR treatment plant with the selection of the minimum FDRs for loess 
normalised dataset using SAM time-course analysis at gene level using the signed approach. The lower 
FDRs indicate larger difference in the gene expression. The minimum FDRs are displayed in Table 6.3 
6.4.7 Pathway Level SAM time-course analysis 
This was followed by carrying out the same analysis, but on the pathway level, using both 
loess and quantile normalised datasets. Loess does not contain any of the control values, as 
these were used for normalisation, therefore in the Table 6.4 they are recorded as NA. For 
the pathway level there are very few potentially significant sets. The only potentially 
significant sets are two in the quantile signed area approach, and one in the Loess slope 
methods, the FDRs are marked with a * in Table 6.4 and the specific pathways are detailed 






Table 6.4 The minimum false discovery rate (FDR) for both the quantile and loess normalised datasets 
using the SAM time-course analysis for pathway level 
Minimum FDR Quantile normalised 
dataset using the 
slope approach 
Loess normalised 
dataset using the 
slope approach 
Quantile normalised 




dataset using the 
signed area 
approach 
Control vs AOP1 0.99 NA 1.28 NA 
Control vs Tap 0.96 NA 1.33 NA 
Control vs MF 0.59 NA 1.07 NA 
Control vs FE   0.75 NA 1.06 NA 
Control vs RO 1.03 NA 1.12 NA 
Control vs AOP2 1.04 NA 0.93 NA 
Control vs Final 0.43 NA 0.95 NA 
AOP1 vs Tap 1.2 1.12 0.46 1.26 
AOP1 vs MF 1.2 1 1.04 1.25 
AOP1 vs FE   1.12 1.07 0.85 0.79 
AOP1 vs RO 1.22 1.13 1.18 1.38 
AOP1 vs AOP2 1.18 1.05 0.19* 1.09 
AOP1 vs Final 1.08 1.1 0.37 0.6 
Tap vs MF 1.1 1.26 1 0.6 
Tap vs FE   1.27 1.43 0.99 0.77 
Tap vs RO 1.23 1.49 1.06 1.37 
Tap vs AOP2 1.2 1.38 0.7 1.12 
Tap vs Final 0.63 1.21 0.81 1.3 
MF vs FE   0.77 1.1 0.91 1 
MF vs RO 1.13 1.26 1.06 0.32 
MF vs AOP2 1.11 1.26 0.44 1.3 
MF vs Final  0.27 1.09 0.12* 0.22 
FE vs RO 1.07 1.26 1.02 0.4 
FE  vs AOP2 0.57 1.19 1.11 0.61 
FE  vs Final 0.42 0.17* 0.38 0.82 
RO vs AOP2 1.39 1.27 1.05 1.33 
RO vs Final 1.25 1.18 1.04 0.9 






Figure 6.7 Illustration of the IPR treatment plant with the selection of the minimum FDRs for quantile 
normalised dataset using SAM time-course analysis at pathway level using both the signed and slope 
approach. The FDRs shown on the figure are significantly different. The minimum FDRs are displayed in 
Table 6.4.  
 
Table 6.5 The three (highlighted in Table 6.4 above) significantly up- or down-regulated pathways using 




















Metabolism of xenobiotics 
by cytochrome P450 
Retinol metabolism 
 




Metabolism of xenobiotics 







Final effluent  
vs Final 
0.17 Loess Slope None Fatty acid metabolism 
Valine, leucine and 
isoleucine degradation 
Synthesis and degradation 






6.4.8 Pseudo Time-course 
Instead of comparing one treatment against another along the time series (8 to 48 hpf), a pseudo time-
pseudo time-course was used to analyse the data. This time-course used the different treatment 
treatment processes from the IPR plant, starting at the least processed sample and moving along the 
along the process to the final product, and, finally, the control water,  
Figure 6.8. 
Final effluent (Raw) → MF → AOP1 → RO → AOP2 → Final product → Control 
 
Figure 6.8  Illustration of the order of the pseudo time-course. MF: microfiltration, AOP: advance 
oxidation process  
The datasets that had undergone quantile and loess normalisation, SAM time course 
analysis slope approach, and signed area, were analysed using this pseudo time-course 
method, to determine individual genes (gene level) or entire pathways that had been up or 
down regulated along the treatment process at the different time intervals.  
For both the gene level analysis and pathway analysis, the FDRs were calculated; the 
smallest values indicating the most significant difference in genomic regulation. Table 6.6 
and Table 6.7 show the minimum FDRs for each method of analysis. As previously noted, it 
is considered that the signed area results are the most relevant when compared to the slope 
approach as the gene regulation would not necessarily be a gradual up- or down-regulation 





Table 6.6 The false discovery rates (FDR) for both the quantile and loess normalised datasets using the 
SAM time-course analysis (both slope and signed area approaches) for individual gene expression were 









Loess Time Slope Loess Time 
Signed  
8 hpf 0.94 Inf 0.3 0.48 
12 hpf 0.08 Inf 0.27 0.24 
16 hpf 0.42 Inf 0.51 0.31 
24 hpf 0.11 Inf 0.24 0.2 
36 hpf 1.11 Inf 0.35 0.24 
48 hpf 0.16 Inf 0.48 0.44 
 
Table 6.7 The false discovery rates (FDR) for both the quantile and loess normalised datasets using the 
SAM time-course analysis (both slope and signed area approaches) for pathway level expression were 









Loess Time Slope Loess Time 
Signed  
8 hpf 0.89 0 1.12 0.52 
12 hpf 0.07 0.01 0.07 0.47 
16 hpf 0.25 0 0.24 0.24 
24 hpf 0.22 0 0.08 1.17 
36 hpf 0.33 0.03 0.8 0.15 
48 hpf 0.44 0 0.1 Inf 
 
The differentially regulated pathways listed in Table 6.8 were generated using the pseudo 
time-course from the dataset that underwent quantile normalisation, and signed area SAM 




therefore, here the most significantly altered along the IPR treatment process. For example, 
at 8 hpf, a total of 20 pathways were up-regulated along the treatment process, and the most 





Table 6.8 The up- and down-regulated pathways with the five lowest FDRs using the quantile normalised 

















Top five pathways that were down-
regulated 
8 20 1. Pyrimidine metabolism 
2. Protein export 
3. Tryptophan metabolism  




155 1. 1. Fatty acid metabolism 
2. 2. Valine, leucine and isoleucine 
degradation 
3. 3. beta-Alanine metabolism,  
4. 4. Purine metabolism 
5. 5. Propanoate metabolism 
 
12 2 1. Metabolic pathways 
2. Purine metabolism 
 






16 65 1.Spliceosome 
2.Drug metabolism - other enzymes  
3.Sulfur relay system  
4.Propanoate metabolism  
5.Lysine degradation 
 




5.Arginine and proline metabolism 
 
24 158 1.NOD-like receptor signalling 
pathway 
2.Oxidative phosphorylation 
3.Adherens junction  
4.Cytokine-cytokine receptor 
interaction  
5.TGF-beta signalling pathway 






36 151 1.Hedgehog signalling pathway 
2.Cytokine-cytokine receptor 
interaction 
3.Selenoamino acid metabolism 
4.Basal transcription factors 
5.Regulation of actin cytoskeleton 
21 1.Glycosphingolipid biosynthesis - 
lacto and neolacto series 
2.Phagosome 
3.ErbB signalling pathway 
4.MAPK signalling pathway 
5.Citrate cycle (TCA cycle) 
48 133 1.Circadian rhythm – mammal 
2.Metabolic pathways 
3.Ubiquitin mediated proteolysis 









Once the microarray data had been normalised, it was used to create a PCA plot to gain a 
better understanding of the variables (experiment, treatment, stage of development) 
influencing the gene expression. In Figure 6.3 it can be clearly observed that developmental 
stage has an important effect on separating out the data spatially, indicating it had the 
greatest influence on the gene expression. Figure 6.4 and Figure 6.5 indicated that the three 
different independent repeat exposure experiments also influenced the gene expression. 
This finding could have been because the nature (including chemical composition) of the 
treated sewage effluent changed between sample times, and therefore the exposure media 
were not identical despite being collected from the same place albeit on different days. 
Therefore, the composition and physical properties may vary slightly. There would also be 
predictable slight variation in the control and tap waters that were used to compare the IPR 
treatments against.  Future studies would take greater account of these differences, 
especially the tap water control. Additionally, the pairing of individual zebrafish in each 
breeding group used to obtain embryos was not the same, as they were randomly selected 
each time. Despite these differences, it is interesting to note that the different experiments 
could have such a large influence on the gene expression. The data collected from the 
observational exposures showed some indication that the survival, hatching and 
abnormalities could vary from one experimental day to another. However, survival in the 
exposures for gene expression did not significantly vary between experimental days. 
Nevertheless, it does demonstrate the importance of experimental repeats, and how subtle 
changes in the water chemistry can impact the results. 
In the individual gene analysis it was determined that three genes were significantly over expressed in 
expressed in certain sections of the IPR plant. Somatolactin beta was over expressed in embryos 




appear at the far end of the treatment process (
 
Figure 6.9). There were also two cytochrome P450 genes found to be significantly over expressed in 
embryos exposed to AOP1, microfiltration, and final effluent product waters, the first three stages of the 
IPR treatment process (
 
Figure 6.9). The product water from these three treatments all have in common that they 






Figure 6.9 An illustration of the stages of treatment of the IPR treatment plant. The treatments highlighted 
in green (pre-filtered (final effluent), microfiltration and AOP1) all were observed to cause the zebrafish 
embryos to increase the expression of cytochrome P450 genes and the treatments in orange (reverse 
osmosis, AOP2 and final product), including tap water, were all found to increase the zebrafish embryo’s 
expression of the gene coding for somatolactin beta. 
6.5.1  Somatolactin beta 
Somatolactin is reported to be a glycoprotein hormone, exclusive to fish, that is part of the 
growth hormone/prolactin superfamily (Wan & Chan, 2010). Somatolactin is primarily 
expressed in the pars intermedia of the pituitary gland, separate from the 
proopiomelanocortin (POMC)-producing cells (Kaneko & Hirano, 1993; Wan & Chan, 2010).  
There are two isoforms of somatolactin, known as somatolactin alpha and somatolactin beta 
(Wan & Chan, 2010), and both these isoforms have been identified in zebrafish (Wan & 
Chan, 2010; Y Zhu et al., 2004).  
The primary function of somatolactin is still uncertain, but it is considered to have several 
functions that overlap with other members of the growth hormone and prolactin family (Wan 
& Chan, 2010). These functions include the following: 
1. Steroidogenesis and reproductive maturation (Planas et al., 1992; Rand-Weaver et 
al., 1992). 
2. Acid-base balance (Wan & Chan, 2010). 
3. Background adaptation (Wan & Chan, 2010). 
4. Immune function (Calduch-Giner et al., 1993, cited in Wan and Chan, 2010). 
5. Energy mobilisation and stress (Rand-Weaver et al., 1993). 
6. Lipid metabolism and pigmentation (Fukamachi et al., 2009; Y Zhu & Thomas, 1997). 





The fact that the somatolactin beta gene was differentially expressed became a point of 
interest once its association with pigmentation was realised. In the previous chapter it was 
described that some of the embryos exposed to the product waters, and in one incident in 
the control group, had a lack of pigmentation. Therefore, it was hypothesised that the 
differential expression of somatolactin beta could be having an influence on the development 
of pigmentation in the zebrafish. However, this would be considered more likely if the 
expression of the somatolactin beta gene had been observed to be less than that of the 
control. Also, researchers have found that decreasing, or preventing, the production of 
somatolactin does not result in lack of pigmentation. Based on studies on mutant medaka 
(Oryzias latipes) which did not express the somatolactin gene (colour interfere, ci), it was 
considered likely that somatolactin could act in the proliferation and morphogenesis of 
epidermal chromatophores, regulation of the body colour, or the secretion of cortisol 
(Fukamachi et al., 2009). However, when somatolactin gene was silenced in zebrafish (D. 
rerio) during embryonic development, the only effect observed was a delay in the inflation of 
the swim bladder (Yong Zhu et al., 2007).  
As it is considered that somatolactin has overlapping functions with growth hormones and 
prolactin family functions, it has been stated by Wan and Chan (2010) that the studies 
undertaken to determine the specific functions of somatolactin, whereby somatolactin has 
been knocked down during embryonic development, were potentially compromised by the 
“compensational effects” of the other genes with overlapping functions (Wan & Chan, 2010).  
In the previous chapter, the embryos that lacked pigmentation were found in all three types 
of exposures (developmental observation, extended exposure, and gene expression), and 
occurred in the control as well as the IPR product waters (specifically AOP2, reverse 
osmosis, microfiltration, and final effluent product waters). However, gene expression 
analysis found a increase of expression of somatolactin beta in embryos reared in product 
waters from reverse osmosis, AOP2, final product and tap waters. Therefore, it is unclear 
whether the pigmentation effects were as a result of changes in the expression of the 
somatolactin beta. 
6.5.2  Cytochrome P450 
Cytochrome P450 mono-oxygenase is a collection of isoenzymes, and they are based on 
the haem protein. They are situated in the smooth endoplastic reticulum of cells (Timbrell, 
2001) and found in most organisms (Bräunig et al., 2015). These enzymes are involved in 




activation or inactivation of numerous endogenous and exogenous chemicals (Bräunig et al., 
2015). Cytochrome P450 enzymes are found in the largest concentration in the liver, but are 
found throughout the organism. The cytochrome P450 mono-oxygenase system requires 
another enzyme, NADPH (nicotinamide adenine dinucleotide phosphate-oxidase) 
cytochrome P450 reductase. This enzymes donates electrons to the cytochrome P450 
(Timbrell, 2001). Zebrafish are reported to have 94 genes that encode for cytochrome P450 
enzymes, and they have been classified into 51 gene families (Goldstone et al., 2010). 
These are reportedly divided into two main groups: firstly ones that are principally associated 
with the metabolising endogenous regulatory molecules, these are CYP family 5-51. The 
second group are mainly associated with oxidation of exogenous chemicals and fatty acids, 
these are CYP family 1-3, and to smaller degree, CYP family 4 (Goldstone et al., 2010). It is 
reported that, in zebrafish, five CYP1 genes in four subfamilies have been identified, these 
are cyp1a, cyp1b1, cyp1c1, cyp1c2 and cyp1d1 (Goldstone et al., 2010). The two 
cytochrome P450 genes that were over expressed in the embryos reared in the final effluent, 
microfiltration and AOP1 product waters were from the CYP1 family, cytochrome P450, 
family 1, subfamily A (cyp1a) and cytochrome P450, family 1, subfamily B, polypeptide 1 
(cyp1b1). The protein cyp1a has been induced by exposure to 8-tetrachlorodibenzo-p-dioxin 
(TCDD) in zebrafish embryo at 36 hpf (Andreasen et al., 2002). Another researcher was able 
to detect cyp1 activity in zebrafish embryos from 8 hpf (Otte et al., 2010). However, an 
earlier zebrafish embryo study was not able to detect Cyp1a protein following exposure to 
TCDD until 72 hpf (Mattingly & Toscano, 2001). In the Zfin database it is stated that cyp1b1 
will be active in the embryo from 8-9 hpf into and throughout adulthood, and cyp1a will be 
active from 4-4.33 hpf into and throughout adulthood (University of Oregon, 2015). The 
cyp1a gene was over expressed at 12, 24 and 48 hpf, and the cyp1b1 was over expressed 
just at 12 hpf (Table 6.1). These times are consistent with the findings of Otte et al. (2010) 
and information reported in the Zfin database. 
The aryl hydrocarbon receptor nuclear translocator (ARNTs) belong to the basic helix-loop-
helix PAS family of transcription factors (Prasch et al., 2004). This family includes aryl 
hydrocarbon receptor (AhR), hypoxia inducible factor-1α (HIF1-α), endothelial-specific PAS 
protein-1 (EPAS-1/HIF2-α), single minded, and others. These proteins are reported to be 
associated with detection and adaptation to changes to an organism’s environment (Prasch 
et al., 2003, 2004). It is reported that a number of CYP1s are regulated by the AhR (Bräunig 
et al., 2015). AhR is induced by exposure to potentially toxic xenobiotics, specifically planar 
congeners of polychlorinated dibenzodioxin (PCDDs), polychlorinated dibenzofurans 
(PCDFs), polychlorinated biphenyls (PCBs), a number of polycyclic aromatic hydrocarbons 




2015; Denison & Nagy, 2003; Hinger et al., 2011). In studies referenced by Bräunig et al 
(2015), zebrafish with the ahr2 gene knockdown demonstrated that cyp1a and cyp1b1, as 
well as cyp1ca, were principally regulated by the ahr2 gene, and induced by agonists for the 
receptor.  
Studies have shown that the systems involved in how organisms respond to chemical 
stressors and hypoxia have some molecular targets in common. Also, some substances that 
are observed to affect one system can, on occasion, affect other systems, a process known 
as cross-talk. As already mentioned in Chapter 5, hypoxia inducible transcription factor 1 
(HIF-1) is important for reacting to depleted levels of oxygen. The HIF1-α gene acts as the 
sensor and degrades quickly under normal levels of oxygen. In hypoxic conditions HIF1-α 
dimerizes with HIF1-β (ARNT) before binding to the hypoxia response element on DNA, and 
various enzymes which are involved in blood supply and energy metabolism are transcribed. 
These blood supply enzymes include erythropoietin (EPO) and vascular endothelial growth 
factor (VEGF), and the energy metabolism enzymes include lactate dehydrogenase (LDH). 
Cross-talk between the AhR and HIF systems has been observed, but the results do not 
always come to the same conclusion (McElroy et al., 2012). 
In embryo zebrafish studies reported in the literature, hypoxic conditions are reported to 
decrease some of the responses of AhR agonists. TCDD exposure under normal oxygen 
conditions was observed to increase specific abnormalities in the developing zebrafish 
(oedema in the yolk sac, pericardium, eyes and head, prevention of swim bladder inflation, 
shortening of the lower jaw and nose, and reduction in the peripheral blood flow). In contrast, 
exposure of the embryos to TCDD under hypoxic conditions  reduced the occurrence of the 
abnormalities observed in the TCDD exposed individuals (lack of oedema and the jaw was 
not shortened) (Prasch et al., 2004). Additionally, benzo(a)pyrene (BaP) was observed to 
increase the hypoxic initiation of the production of VEGF, EPO, and LDH (Yu et al., 2008). 
AhR has also been reported to be associated with changes to oestrogen receptor (ER) 
signalling. This is because a number of AhR agonists have been identified as anti-
oestrogens; for example TCDD (McElroy et al., 2012). In a separate study, β-naphthoflavone 
(BNF) was reported to significantly initiate the expression of cyp1a in zebrafish embryos at 
48 hpf. However, the same induction of expression was not observed in HIF1-α in the 
zebrafish embryos. Under hypoxic conditions, cytochrome P450 aromatase (cyp19a2 or 
AromB) was down-regulated in killifish embryos but not in zebrafish embryos. When the 
researchers investigated the effects of hypoxia on cyp1a in zebrafish and killifish embryos, 
the results were variable. However, in zebrafish, hypoxia was observed not to affect the 
expression of cyp1a (McElroy et al., 2012). McElroy et al. (2012) stated that, generally, they 




this was due to down-regulation of metabolic pathways in combination with the down 
regulation of the target gene itself. In this current study, the cyp1a gene was observed to be 
upregulated in the treatment where hypoxic conditions were more likely to occur (i.e. final 
effluent and microfiltration). However, the study by McElroy et al. (2012) found that, if 
anything, hypoxic conditions would reduce the induction of cyp1a, and not act to enhance its 
expression. Also, as the HIF genes were not observed to be differentially expressed in the 
microarray data analysis, it is considered unlikely that low oxygen conditions would have 
directly influenced the cyp1a up-regulation findings.  
6.5.3  Detoxification pathways 
The 2-Factor ANOVA at gene level demonstrated that the developmental stage had the 
greatest influence on the variation in individual genes expressed, relative to individual 
experiments and the different treatments at the IPR plant. Unsurprisingly, this was also the 
case for the pathway analysis. However, the pathways that were observed to be differentially 
expressed, based on the influence of the product waters for both methods of analysis, were 
detoxification pathways. The pathways found to be differentially expressed were: steroid 
hormone biosynthesis, tryptophan metabolism, retinol metabolism, metabolism of 
xenobiotics by cytochrome P450, drug metabolism-cytochrome P450, and drug metabolism-
other enzymes. The cytochrome genes cyp1a and cyp1b1 were found to be over-expressed 
in the embryos reared in product waters from the final effluent; microfiltration and AOP1 
stages of the IPR plant are active in some of the same pathways. The gene cyp1a is active 
in retinol metabolism, steroid hormone biosynthesis, tryptophan metabolism and drug 
metabolism and cyp1b1 is active in steroid hormone biosynthesis and tryptophan 
metabolism. As discussed earlier, somatolactin beta has been associated with 
steroidogenesis and as referenced by Vidal-Dorsch et al. (2013), studies have related 
steroid metabolism pathway disruptions with exposure to nonylphenol. Nonylphenols were 
detected along the IPR treatment plant, and were not removed by microfiltration, reverse 
osmosis, or AOP (Table 6.2) A liver microarray study of mice fed municipal waste water 
effluents for 90 days found alterations to a number of genes related to steroid hormone 
biosynthesis and biosynthesis of unsaturated fatty acids as well as purine metabolism. As 
well as these gene level effects, exposure to the municipal waste water was observed to 
induce liver and kidney injuries and changes of lipid, nucleotide, amino acid and energy 
metabolism and disruptions of signal transduction (Y. Zhang et al., 2013). 
The alterations in retinol metabolism pathway were also of interest. Retinol, including retinal, 
retinoic acid and related compounds, are collectively known as retinoids and Vitamin A is 




excessive levels and the deficiency of retinoids have been linked with embryotoxicity and/or 
teratogenicity (Novák et al., 2008; Rolland, 2000). In a review by Novák et al. (2008) it was 
stated the retinoids are essential for a number of different processes, these include; cell 
differentiation, proliferation, apoptosis, growth and development, epithelial maintenance, 
immune function and reproduction. Organisms do not synthesise their own retinoids, instead 
they must be taken up via the diet. When the levels of vitamin A are sufficient, the retinol is 
converted into retinyl esters (REs) by lecithin:retinol acyltransferase (LRAT) and stored in 
liver cells. When the plasma levels of retinol fall, retinyl ester hydrolase (REH) cleaves the 
REs, releasing the retinol from the liver cells into the plasma. This release system is 
dependent on cellular retinol binding protein I (CRBP I) and retinol binding protein (RBP) 
(Novák et al., 2008). As mentioned above, cytochromes are involved of retinol metabolism, 
once the retinol is converted to retinal and then to the active retinoid, retinoic acid, 
cytochromes catalyse the inactivation of retinoic acids (Novák et al., 2008). It has been 
reported that environmental pollutants are known to affect retinoid metabolism, and the 
alteration of levels of retinoids in organisms has been used as a biomarker. The 
environmental pollutants observed to alter the level of retinoids have included; PCBs, PAHs, 
TCDD, pesticides, polluted sediments and effluents (Novák et al., 2008). There is a 
relationship between polyhalogenated aromatic hydrocarbons and PAHs and alterations in 
vitamin A metabolism. It is understood that the rate of metabolism and breakdown of 
vitamin A is accelerated, causing there to be reduced amounts of it circulating in the plasma 
and stored in the liver (Rolland, 2000). In rats, mice and ring doves, it has been reported that 
some co-planar PCBs have been observed to reduce levels of stored retinoids. Dioxin and 
dioxin-like compounds alter the metabolism of vitamin A, by acting via the AhR, as retinoid 
metabolism involves cytochrome P450 hydroxylation, therefore the induction of cytochrome 
P450 by the dioxins causes excessive amounts of retinoids to be metabolised, lowering the 
levels in the plasma and liver stores (Rolland, 2000).  
A number of studies have investigated retinol levels in fish inhabiting polluted areas. Lake 
sturgeon (Acipenser fulvescens) from a polluted river were observed to have increased 
metabolism of retinoic acid (cited by Novák et al., 2008). In a three year mesocosm study, 
flounder were exposed to polluted harbour sludge. They were observed to have significantly 
reduced levels of retinol in plasma and liver, and reduced levels of REs in the liver. This 
reduced retinol liver level was found to be negatively associated with CYP1A protein levels; 
therefore the association with dioxin-like exposure was made. In the third fish study reviewed 
by Novák et al. (2008), fish in a river that was receiving pulp mill effluent were observed to 
have increased number of malformations in the larvae, including eye deformities, and 




embryos exposed to all-trans-retinoic acid at 10-9 to 10-6 M were observed to have 
malformations which included oedema, deformities of the brain (anophthalmy, microcephaly 
and acephaly), malformed otic placodes and otoliths and shortened and bent tails 
(Herrmann, 1995). In the developmental exposures carried out for the purposes of this 
project, malformations included bent tails and spines, malformed heads and oedema. 
Additionally, it is of note that vitamin A is widely used in cosmetics as an anti-ageing skin 
treatment and reduces pigmentation.  
6.5.4 Time-course analysis 
The information displayed in Table 6.3 indicates the differences in genes expressed between two 
two treatments at the different developmental stages. The smallest FDR values indicate the greatest 
greatest differences. Error! Reference source not found. illustrates some of the most significant 
differences, indicated by the red arrows at the top of the flow chart and FDR values beside the arrow; the 
green arrows underneath the flow chart indicate where the differences in the genes expressed were not 
significant. It can be observed from Error! Reference source not found. that the largest differences in global 
gene expression occurs between the treatments that are further apart in the IPR process, for example 
example final effluent (following a pre-filtration step) and final product (FDR of 0.11). However, 
However, microfiltration and reverse osmosis are “next” to each other in the IPR treatment process but 
process but have a large difference in the genes expressed (FDR 0.15), but as discussed in the General 
the General Introduction chapter, reverse osmosis is known to remove many more contaminants than 
contaminants than microfiltration. Error! Reference source not found. illustrates that in the stages of 
treatment such as final effluent (following a pre-filtration step) and microfiltration, embryos have fewer 
differentially expressed genes (FDR 1.06) than compared to that of microfiltration and final product (FDR 
product (FDR 0.08). This indicates that the product water from the final effluent and microfiltration are 
microfiltration are much more similar to one another than compared to other treatments further along the 
further along the process. It also illustrates that these similarities exist between reverse osmosis and 
osmosis and AOP2 (FDR 1.13) and AOP2 and final product (FDR 1.24). This would suggest that, if the 
that, if the differences are elicited by the contaminants remaining in the product following the different 




water. This was also observed in the 
 
Figure 6.9, with the up-regulation of cytochrome P450, where this up-regulation was 
observed in the first three product waters, but not any in the product waters following reverse 
osmosis treatment. 
Error! Reference source not found. illustrates similar findings as does Error! Reference 
source not found.; however it is examining the differences between the pathways between 
two treatments at the different stages of development. Only three treatment combinations 
were observed to have a significant difference in their expression of the pathways. The first 
two were between final effluent (following a pre-filtration step) and final product (FDR 0.17) 
and microfiltration and final product (FDR 0.12). Similarly to the situation with the individual 
genes (Error! Reference source not found.), these differences fall between the first two 
treatments and the final treatment, suggesting the increased level of treatment is changing 
the influence on the gene expression in the embryos. Interestingly, it also highlights a 
significant difference in pathways expressed between the two AOP treatments (FDR 0.19), 
but the product water from the AOP2 process has also received treatment from reverse 
osmosis, whereas the product water from the AOP1 treatment has only received treatment 
via the pre-filtration and microfiltration. Again this suggests that reverse osmosis greatly 
influences the biological activity of the product water. 
Following on from this, a pseudo-time course was assessed; the quantile normalised data 
using a signed approach had the lowest FDR values and, from these, the top five most 
significantly differentially expressed pathways were highlighted (Table 6.8). Again there were 
metabolic pathways and drug metabolism pathways both up- and down-regulated along the 
treatment process. Another pathway of interest was melanogenesis at 12 hpf being down-
regulated along the treatment process. As discussed in Chapter 5, there was lack of 




interest were tryptophan metabolism and purine metabolism: these were both up- and down-
regulated along the treatment process (Table 6.8). 
In a 120 hour zebrafish embryo development study, benz[a]anthracene (BAA) and 
benz[a]anthracene-7,12-dione (BAQ) were used in the exposure at a concentration of 4 µM 
(Elie et al., 2015). Both BAA and BAQ are PAHs that are structurally similar. Previous 
studies had suggested BAA and BAQ share the same mechanism of toxicity, as they caused 
similar morphological responses and increased the expression of cyp1a by activating the 
AhR2 in zebrafish (Goodale et al., 2013). Following exposure it was determined which 
pathways had been altered; this was done by examining the metabolites and linking them to 
the relevant pathways. The altered pathways included glutathione metabolism, purine 
metabolism and phenylalanine, tyrosine and tryptophan biosynthesis (Elie et al., 2015). 
These results were of interest to this project because there was an observed increase in 
cyp1a gene expression, and both the purine metabolism and tryptophan metabolism 
pathways had been altered along the treatment process. Purine metabolism is considered to 
be important in the homeostatic response of mitochondria to oxidative stress. Exposure of 
the zebrafish to both BAA and BAQ significantly affected the purine metabolism pathway 
(Elie et al., 2015). The levels of tryptophan metabolites were significantly increased following 
exposure to both BAA and BAQ. Tryptophan is a precursor of serotonin, which can be 
subsequently converted to melatonin. Serotonin is a neurotransmitter, and its level was 
reported to increase following exposure to both BAA and BAQ. Serotonin is responsible for 
altering a number of behavioural and neuropsychological processes which include sleep, 
aggression, appetite, memory and rhythmic motor patterns (Elie et al., 2015). It was 
suggested by Elie et al. (2015) that developmental alterations in serotonin and dopamine, 
which was also found to be increased following exposure by both PAHs, and the other 
neuro-transmitter-precursor metabolites (tyrosine, phenylalanine and tryptophan), may be 
indicators of subsequent effects on neuro-behaviour (Elie et al., 2015). 
Of the 29 PAHs that were analysed for along the IPR treatment system between 2008 and 
2011, there were only a few incidences where any occurred above the limit of detection (LoD 
was 0.01 µg/l). In the product water for the microfiltration treatment benzo(ghi)perylene, 
dibenzo(ah)anthracene and fluorene were detected above the limit of detection at an 
average (minimum to maximum (standard deviation)) of 0.59 µg/l (0 to 2.2 µg/l (0.95)), 
0.92 µg/l (0 to 5.5 µg/l (4.13)) and 1.68 µg/l (0.01 to 11.7 µg/l (4.42)), respectively. Over the 
sampling programme conducted at the IPR plant by Thames Water Ltd, each of the PAHs 
detected were sampled for 6 to 7 times, only once or twice being detected above the LoD. 
Benzo[a]anthrancene (BAA) was measured in the treatments from the IPR plant, but was not 




concentrations of 0.010286 µg/l (0.01 to 0.011 µg/l (0.00)) was reported, but this was below 
the LoD. In the product water after microfiltration, AOP1 and AOP2, the same concentrations 
below the LoD were recorded 0.01 µg/l (0.01 to 0.01 µg/l (0.00)). In the aquarium water 
which was sampled in triplicate in August 2013, concentrations of the PAHs were all below 
the LoD (1 ng/l). BAA used in the exposures conducted by Elie et al. (2015) was reported to 
be present at 4 µM, which is equal to 913.16 µg/l; therefore it unlikely that BAA alone was 
responsible for the effects on the purine metabolism and tryptophan metabolism pathways. 
However, the nature of the effluent means the contaminants are present in a complex 
mixture, and therefore it is not possible to assign any effects to one chemical or group of 
chemicals.  
Gene expression levels in fathead minnows exposed to different types of treated municipal 
waste water effluents were recently reported (Vidal-Dorsch, Colli-Dula, et al., 2013). One 
effluent had only undergone primary treatment, so had a higher chemical contaminant load 
than the second effluent, which had undergone secondary treatment. There were distinctly 
different gene expression profiles in the fish exposed to the two effluents, but similar 
physiological responses. It was also found that there was a dose-response in relation to the 
chemical load/degree of treatment. The gene expression in the fish exposed to primary 
treated effluent elicited a higher magnitude of gene response than the effluent that had 
undergone secondary treatment. Of the 332 genes altered in common between the two 
effluents, many were associated with the oxidative stress pathway. The authors also found 
increased transcript levels of ARNT and cyclooxygenase-1 (COX-1), and it was suggested 
that this may indicate the activation of a cellular defence responses against oxidative stress. 
It was also found that cyp2c was up-regulated in both effluents as were transcripts 
associated with cellular stress and apoptosis, immune response and endocrine function. 
However, contrary to my studies using zebrafish embryos, Vidal-Dorsch et al. (2013) did not 
find changes in the expression of cyp1a transcripts in either effluent. It was, however, found 
that retinol binding protein mRNA was induced in the fish exposed to the primary treated 
effluent, but not in the effluent that had undergone secondary treatment (Vidal-Dorsch, Colli-
Dula, et al., 2013). 
The same authors also undertook a gene expression study to investigate a number of 
specific genes in male hornyhead turbot (associated with responses in reproduction, growth, 
development, stress responses, contaminant metabolism and detoxification, response to 
infection and hormone activity) following exposure to two effluents (primary advanced 
treatment and secondary treated effluents) at two concentrations, 0.5% and 5%, and a 
negative and positive (estradiol 8 µg/l) controls. As with the previous study in fathead 




Additionally in this study there was a difference in patterns of expression also at the two 
effluent concentrations. Exposure to estradiol caused production of AhR and cyp1a 
transcripts among others. But this induction was not observed in the two effluent exposures 
at either concentration (Vidal-Dorsch, Bay, et al., 2013). 
Other studies involving exposure to effluents have demonstrated alterations in liver genes 
involving reproduction, immunity, detoxification and metabolism in the fathead minnow 
(Pimephales promelas) (Garcia-Reyero et al., 2011). In another study, Rainbow trout 
(Oncorhynchus mykiss) were exposed to differently treated effluent (conventional treatment, 
GAC, ozonation and UV treatment). The fish exposed to effluent that had undergone 
conventional treatment were observed to have significantly increased liver and heart somatic 
indexes. However, this effect was removed by the other treatments. Gene expression in the 
liver was altered in genes associated with xenobiotic metabolism, including cyp1a, and this 
effect was reduced by GAC or ozone at 15 mg/l. Fish exposed to the ozone treated effluent 
were observed to have increased levels of gene transcripts encoding heat shock protein 
70kDa, which the researchers suggested indicated that ozone-treatment added stress to the 
fish. An estrogen-response gene was induced by treatment with conventionally treated 
effluent, but again this effect was removed by the other treatments. Prostaglandin E 
synthase was induced in the fish exposed to conventional activated sludge and sand filtered 
treated effluent, but this effect was not observed in the other treatments. It was concluded 
that GAC treatment was the most effective at removing the effects observed on gene 
expression (Cuklev et al., 2012). 
Information from the literature has suggested that a number of genes and pathways can be 
induced by sewage effluent; many in common in the ones altered in the current study in 
zebrafish embryos. However, variations exist in patterns of gene expression that are likely 
due to the complex nature of effluents from different sources and undergoing different levels 
of treatments. Also, the species and developmental stage used in the literature vary greatly, 
which adds a further level of complexity in the understanding and interpretation of genomic 
data arising from fish exposure studies.  
6.6 Conclusions 
The first main aim of this section of the project was to determine if any of the product waters 
from any of the treatment stages at the IPR plant caused significant difference in individual 
gene expression levels relevant to specific biological pathways and functions. In the process 
of investigating this research aim zebrafish embryos were exposed to the different IPR 
product waters during the first 48 hours of their development. It was shown that 




the different experiments and the product waters used to rear the embryos. However, the 
gene expression was greatly influenced by the experiment (i.e. exposure 1, 2 and 3). This 
could have been due to use of non-standardised effluents and control waters, indicating how 
sensitive gene expression is in this model organism. 
There were two distinct types of genes expressed in the two halves of the IPR process (pre- 
and post-reverse osmosis). Firstly, somatolactin beta was up-regulated in the post reverse 
osmosis and tap water treatments. The other genes were both cytochrome P450 genes, and 
these were up-regulated in the embryos reared in the treatments pre-reverse osmosis. 
Cytochrome P450 is important for detoxification, and this finding indicates that embryos were 
not being challenged with contaminants capable of inducing cytochrome P450 following 
treatment with reverse osmosis. 
The difference in genetic expression was observed to be greater the further the treatments 
were from one another. Microfiltration and reverse osmosis had different gene expression 
profiles as did the two AOP treatments, again indicating that reverse osmosis was making a 
significant difference to the biological activity of the product water. 
Examination of the functional pathways being affected indicated that detoxification pathways 
were being altered. The detoxification pathways are linked to steroid synthesis, another 
pathway altered. These pathways are also associated with retinol levels and the retinol 
synthesis pathway, which was also altered.  
Only severe hypoxia would have caused a significant alteration in the gene expression, but 
even then other studies found only one HIF gene altered, therefore not observing any 
alterations to the HIF genes is not confirmation that hypoxia did not play a role. However, the 
data available for the dissolved oxygen confirm that severe hypoxia was not a condition 
likely to have occurred. Although, the slight differences in hatching rates and enlarged yolk 
sac could be linked to mild hypoxia. Even though the zebrafish larvae with enlarged yolk 
sacs observed by Long et al. (2015) were exposed to severe hypoxia (dissolved oxygen of 
5%), which is unlikely to have been reached in this current study.  
Using the pseudo time course approach a number of pathways were altered; these included 
melanogensis at 12 hpf being down-regulated along the treatment process, tryptophan 
metabolism, and purine metabolism both up- and down-regulated along the treatment 
process. The second main aim of this section of the project was to identify whether changes 
in gene expression could be associated with the observed changes in phenotype. 
Somatolactin beta was one specific gene to be altered, the significance of the up-regulation 




unclear. However, somatolactin beta has been linked to a number of biological processes, 
including pigmentation. However, studies have found the lack of somatolactin beta does not 
prevent the production of pigmentation in zebrafish. Its altered expression was, however, of 
interest in relation to the lack of pigmentation observed in a number of embryos discussed in 
the previous chapter. The phenotype of reduced/absent pigmentation was again linked to 
the gene expression data as the pseudo time course analysis approach identified an 
alteration in the melanogensis pathway, this was of interest given the developmental 
observations of a lack of pigmentation in some embryos. 
Malformations observed such as bent tails, malformed heads and oedema have been 
associated with alterations to the retinoid pathway, the retinol synthesis pathway was 
observed to be altered. 
The third and final aim of this section of the project was to determine if ‘culprit chemicals’ 
measured in the IPR water could be identified that might explain the observed changes in 
gene expression and phenotype based on current knowledge. This was difficult due to the 
complex nature of the chemicals in known to be present and measured in effluents. 
However, a few were highlighted as possible “culprits”. The induction of cyp1a is associated 
with exposure to PAHs, but the concentrations of these substances along the IPR treatment 
process were typically below the LoD. However, given the complex nature of the 
contaminants in the product waters, it is not possible to target one group of compounds 
based on these data. Both tryptophan metabolism and purine metabolism had been found 
by other researchers to be altered by exposure to PAHs. Nonylphenols were detected along 
the IPR treatment process, not being removed by microfiltration, reverse osmosis, or AOP. It 
is reported in the literature that nonylphenols are related to disruption to the steroid 
metabolism pathway. A number of environmental pollutants have been identified in the 
literature to affect retinoid metabolism, these include PCBs, PAHs, TCDD, pesticides, 
polluted sediments and effluents. Also, vitamin A is widely used in cosmetics, as an anti-
ageing skin treatment and reduces pigmentation. No information was found as to the 
environmental concentration of the chemicals used in cosmetics that could disrupt the 
retinoid pathway. However, the literature seems to indicate that a number of different 
chemicals known to present along the treatment process albeit at low concentrations, can 
impact this pathway, and could be having a combined effect.  
Further work could be done using direct effect analysis to determine the fraction of the 
product waters causing the induction of the cytochrome genes. 
The patterns of gene expression in effluent-exposed fish vary greatly depending on the 











CHAPTER 7: Use of In Vitro and Further In Vivo Assays to 
Investigate the Specific Chemicals 







Following on from the work discussed in Chapters 5 and 6, it had been observed that there 
had been low frequency of a number of different abnormalities, but the lack of pigmentation 
in the embryos correlated with some of the genomic data. The expression of somatolactin 
beta gene had been altered; this is a fish-specific gene with multiple functions, but one of 
them being a role in pigmentation. Analysis of the data from microarrays highlighted a 
number of pathways, along with biotransformation pathways relevant to pigmentation; 
melanogenesis (highlighted as a pathway that had been altered along the IPR treatment 
plant) governs the production of melanin, which determines pigmentation. Based on these 
data, the question arose as to whether any of the chemicals present in the effluent may be 
affecting the pigmentation of the embryos. 
7.2 Aims and Objectives 
7.2.1 Aims:  
1. To determine if the IPR product water contains chemicals or chemical groups that 
could alter melanogenesis. 
2. Determine if the extracts from the passive samplers deployed in the product waters 
along the IPR treatment process are biologically active in a relevant in vitro assay. 
3. Determine if the chemicals identified can reproduce any of the malformations 
observed in IPR product water exposures. 
7.2.2 Objectives:  
1. Conduct a literature search for potential chemicals or groups of chemicals which 
cause embryos to develop without pigmentation. 
2. Examine the analytical chemistry data gathered by Thames Water (gathered over the 
several years of the operation of the pilot IPR plant), to determine if any of the 
chemicals known to reduce pigmentation have also been identified in any of the 
product waters from the IPR pilot plant. 
7.3 Introduction 
Melanogenesis is the process by which melanin is synthesised; the process that gives the 
skin, brain, eyes and hair pigment in humans (Lajis et al., 2012). Melanin is classified into 
three main types depending on the molecular precursor. The types include eumelanin, 




oligomers of 5,6-dihydroxyindole (DHI) and 5,6-dihydroxyindole-2-carboxylic acid (DHICA). 
Pheomelanin is the orange-red melanin and is derived from benzothiazine units. 
Neuromelanin is thought to be a complex of dihydroxyindole and benzothiazine with other 
unknown groups (Hong & Simon, 2007).   
Melanogenesis takes place in melanocytes by melanogenic cytokines and melanogenic 
enzymes including tyrosinase, tyrosinase-related protein 1 (TRP-1) and tyrosinase-related 
protein 2 (TRP-2). Tyrosinase is an essential, rate-limiting enzyme in the melanogenesis 
process (Lajis et al., 2012). It catalyses the hydroxylation of L-tyrosine to 
3,4-dihydroxyphenylalanine (DOPA), the oxidation of DOPA to DOPAquinone, and the 
oxidation of 5,6-dihydroxyindole (DHI) to indole-quinone (Ebanks et al., 2009; Sato et al., 
2008). Without thiols (sulphur analogues of alcohols), the DOPAquinone is converted to 
DOPAchrome and then into DHI or indole 5,6-quinone 2-carboxylic acid (DHICA). The other 
two processes in the melanogenesis pathway are TRP-2 (DOPAchrome tautomerase) which 
catalyses the conversion of DOPAchrome to DHICA, and TRP-1 (DHICAoxidase), which 
catalyses the oxidation of DHICA. An essential messenger in the synthesis of melanin is 
cyclic AMP (cAMP) (Sato et al., 2008). cAMP is produced from a binding reaction between 
α-melanocyte-stimulating hormone (α-MSH) and its specific receptor (MCIR), which results 
in the activation of GTP-binding protein (Gs), which stimulates the production of cAMP. 
cAMP increases the expression of microphthalmia-associated transcription factor (MITF), 
which then stimulates the expression of the gene that encodes for tyrosinase (Ebanks et al., 
2009).  Inhibition of tyrosinase has a significant effect on the melanogenesis process and 
melanin production. Alterations to the production of melanin production cause many 
incidences of hyperpigmentation, post-inflammatory pigmentation, melisma (formation of 
darker patches of pigment on the skin), and the skin aging process (Lajis et al., 2012), as 
well as hypopigmentation. The production of melanin can also be induced by UVB-radiation, 
in order to protect the skin from damage from UV radiation. 
Melanin acts as an antioxidant, it can serve as a metal sink as well as a reservoir for the 
homeostasis of metal ions such as calcium and zinc. It is not clear  what mechanism is  
involved in metal ion release as a consequence of the degeneration of melanosomes within 
a tissue (Hong & Simon, 2007). It is also reported that some intermediates produced during 
melanogenesis are toxic, and if these are not utilised within the process they can become 
cytotoxic and also cause autoimmunological diseases in mammals (Nilsson Sköld et al., 
2013). 




The pigment cells (chromatophores) in zebrafish are derived from the neural crest. They 
consist of three types: melanophores, xanthophores and iridophores. The melanophores 
consist of melanin-containing melanocytes and contribute to the lateral dark stripes of the 
epidermis of the zebrafish. The xanthophores contain pteridine (Nilsson Sköld et al., 2013) 
and are responsible for the yellow pigment and iridophores are reflective platelets, these two 
together are responsible for the yellowish-silver inter-stripes on the dark stripes of the 
melanophores (Choi et al., 2007). There are two other types of chromatophores which are 
not present in zebrafish; erythrophores containing carotenoids, which are responsible for red 
colouration, and cyanophores, which are rarer, but are responsible for blue colouring 
(Nilsson Sköld et al., 2013). The pigmentation of a zebrafish initially begins from the retinal 
pigment epithelium (RPE), which is then followed by the melanocytes on the dorsolateral 
skin. Pigmentation of the skin in zebrafish is reported to be visible from approximately 
24 hpf, tyrosinase is reported to be detectable from approximately 7 hours prior to when 
pigmentation is visible in the RPE. Additionally, the enzymatic activity of tyrosinase has been 
detected 3 hours before pigmentation is visible (Choi et al., 2007). Aggregation of 
melanosomes within melanophores (i.e. concentration of pigment within centre of cells rather 
than dispersed throughout) causes the skin to become pale but also more transparent 
(Nilsson Sköld et al., 2013). 
7.3.2 Chemicals that affect pigmentation 
There are many chemical compounds and pharmaceuticals which have been found to affect 
pigmentation, and there are substances on the open market that are supplied specifically to 
either increase or decrease pigmentation. An example of one of these compounds is 
hydroquinone; it is a skin lightening substance, although it is cytotoxic and has been found to 
be harmful to human health, so its use has been restricted. 
Choi et al. (2007) exposed zebrafish embryos to a number of chemicals and examined the 
pigmentation at 35 hpf and 55 hpf. They found that all three chemicals namely, arbutin, kojic 
acid and 2-mercaptobenxothiazole (MBT) tested in the initial experiment reduced 
pigmentation, but could be acting differently because arbutin and kojic acid significantly 
reduced the pigmentation of the body of the zebrafish embryo, but had little effect on the 
pigmentation of the RPE. In contrast, MBT and 1-phenyl-2-thiourea (PTU) significantly 
reduced the pigmentation in both the RPE and the body. The authors suggested that this 
difference could suggest that either the chemicals have different mechanism of action that 
differentially target the pigmentation of RPE and body, or that the different cell types have 
different sensitivity or permeability to these chemicals. PTU in this study was used as a 




occurring β-D-glucopyranoside of hydroquinone that competitively binds to the L-tyrosine 
binding site of tyrosinase. Kojic acid is also a tyrosinase inhibitor that is used in topical 
depigmentation treatment. MBT contains sulphur and is another tyrosinase inhibitor (Choi et 
al., 2007).  
Nilsson Sköld et al. (2013) reviewed the literature to identify the factors that have been found 
to cause a colour and/or pigment response in fish. The ones that were of relevance to this 
project are as follows: 
 Melatonin - targets Mel1R and causes paleness via aggregation of pigment in 
melanophores, erythrophores and xanthophores. 
 Noradrenaline - targets the α2-adrenoceptors and causes paleness via aggregation 
of pigment in melanophores. 
 Prolactin - targets Prl-R and causes reddish colouration, erythrophore and 
xanthophore dispersion. 
 Prostaglandin (types A2 and B2) - target is unclear, causes melanophore dispersion 
(darker colouration). 
 Somatolactin - target is unclear but causes melanophore aggregation (paler 
colouration). 
7.3.3 Chromatophores as biosensors 
Chromatophores have complex links with the nervous system, and hormones and 
neurotransmitters elicit a response via aggregation or dispersion of the pigment organelles. 
These processes are important for camouflage and self-defence, courtship and mating as 
well as thermoregulation and protection from UV radiation (Dukovcic et al., 2010). When fish 
are stressed, unwell, or experiencing adverse conditions they can appear visibly paler or 
darker in colour (Dukovcic et al., 2010).  
Research has been carried out using fish pigment cell lines, and using these as a biosensor. 
It has been reported that melanophores from the cuckoo wrasse (Labrus ossifagus) are used 
as a biosensor for monitoring levels of catecholamine in human blood (Dukovcic et al., 2010; 
Elwing et al., 1990). Additionally, Siamese fighting fish (Betta splendens) erythrophores have 
been reported to be a useful biosensor for bacterial pathogens (Dukovcic et al., 2010; 
Hutchison et al., 2008) and environmental toxicants (Dierksen et al., 2004; Dukovcic et al., 
2010).  A study investigating whether the use of melanophores from the Chinook salmon 




from B. splendens, found a good correlation between the two assays. When clonidine (a 
α2-adrenergic agonist and imidazoline receptor agonist, used to treat blood pressure, 
anxiety, and ADHD) was used to aggregate pigment cells, the intracellular pigment 
organelles were observed to move towards the centre of the cell, therefore causing the 
melanophores and erythrophores to appear smaller (paler in appearance). MSH was used to 
disperse the melanophores, inducing the intracellular pigment organelles to move towards 
the periphery of the cell, therefore causing the melanophores and erythrophores to appear 
larger (darker in appearance). In the B. splendens erythrophores assays, adenosine and 
MSH both caused erythrophores to disperse, and aggregation was observed in exposure to 
clonidine, dopamine and serotonin. In the O. tsawytscha melanophores, adenosine and 
MSH caused pigment dispersion (i.e. darker in appearance), however; at higher doses 
adenosine (104 µM) caused aggregation of melanophores. Clonidine, dopamine and 
serotonin all caused aggregation in the O. tsawytscha melanophores. Although serotonin 
was observed to initially cause aggregation within 2 minutes of exposure, there was then a 
recovery within 25 minutes (Dukovcic et al., 2010). In the tests for environmental toxicants in 
O. tsawytscha melanophores, residual chlorine (sodium hypochlorite) was introduced as a 
control, to cover the typical levels of chlorine present in drinking water. It was found that this 
level did not cause any effects on melanophores. Mercuric chloride (24.1 mg/l) and sodium 
arsenite (1.9 mg/l) both caused pigment aggregation, which was also found to be the case in 
B. splendens erythrophores. However, the melanophores did not show a response to 
cyanide or paraquat, but aggregation had been observed in earlier studies with B. splendens 
erythrophores (Dukovcic et al., 2010). 
Nilsson Sköld et al., (2013) referenced studies that inoculated frogs with bactericidal 
lipopolysaccharides (LPS) and measured an increase of melanin pigmentation in the testes. 
This was stated to confirm that there is a relationship between internal melanin, melanocytes 
and innate immunity (Nilsson Sköld et al., 2013).  
7.3.4 Tyrosinase inhibitors 
Chemicals used to treat hyperpigmentation are used as skin lighteners both as prescription 
and “over the counter drugs”; they are present in a large variety of cosmetics. From the 
literature, inhibition of tyrosinase appears to be the most common/favourable mode of action 
for these chemicals. Following literature searches, a total of fifty individual chemicals/groups 
of chemicals were identified as being used, or having properties that could reduce the 
appearance of hyperpigmentation or lighten the skin. Due to the widespread use of 
cosmetics, and the nature of their use (skin application), it is highly plausible that active 




and this has been found with other chemicals which are applied directly to the skin 
(UV-filters from sun lotion, N,N-diethyl-meta-toluamide (DEET) from insect repellents etc. 
(Brausch & Rand, 2011; Dhanirama et al., 2011)). From the list of fifty, eight have been 
considered further. These eight were chosen due to their potency and potential high usage. 
They are as follows: 
1. Hydroquinone 
2. Kojic acid 
3. Retinoids 
4. Tretinoin 
5. Vitamin B3/Niacinamide 
6. Hydroxyanisole 
7. 4-n-Butylresorcinol 
8. Salicylic acid 
Apart from salicylic acid, no data were found in relation to these chemicals being detected in 
the environment or at the IPR treatment process. However, this is not to say they are absent 
from the environment and waste water treatment processes, only that there were no data 
from published sampling campaigns found during the time the literature search was 
completed. Data on the occurrence of salicylic acid are detailed in Table 7.1 and Table 7.2. 
7.3.5 Cyclooxygenase enzyme 
Prostaglandins are a class of eicosanoids; there are two types of eicosanoids: 
prostaglandins + thromboxanes and leukotrienes (Moran et al., 2014). Eicosanoids are 
oxygenated products of polyunsaturated fatty acids and they act as messengers in the 
regulation of a number of physiological functions (Moran et al., 2014). Prostaglandins are 
formed from arachidonic acid, in a reaction catalysed by the enzymes prostaglandin 
endoperoxide G/H synthases, which are also referred to as cyclooxygenase (COX) enzymes 
(Grosser et al., 2002; Moran et al., 2014). Firstly, COX acts on the arachidonic acid, the 
product being prostaglandin G2 (hydroperoxide). The enzyme has a second active site for 
hydroperoxidase activity; this transforms any unstable hydroperoxide (prostaglandin G2) to 
prostaglandin H2 (Moran et al., 2014). Prostaglandin H2 is then converted to a number of 
regulatory molecules known as prostanoids; these are a sub-class of eicosanoids consisting 
of prostaglandins, thromboxane A2 and prostacyclins (Figure 7.1) (Ishikawa et al., 2007; 
Moran et al., 2014). There are four main prostaglandins; prostaglandin E2 (PGE2), 
prostacyclin (PGI2), prostaglandin D2 (PGD2), and prostaglandin F2α (PGF2α) (Ricciotti & 
FitzGerald, 2011). Prostanoids are required for numerous physiological processes, including 




glomerular filtration, mediation of pain sensitivity, inflammation, swelling, and haemostasis 
(Ishikawa et al., 2007; Moran et al., 2014). In uninflamed tissues, prostaglandin synthesis is 
relatively low, however there is an immediate increase in production following acute 
inflammation, then leukocytes and immune cells are introduced (Ricciotti & FitzGerald, 
2011). Prostaglandins have been shown to play an important role in the development of 
males (Kugathas et al., 2015). Epidemiological studies as reported in Kugathas et al. (2015) 
have highlighted the potential risk to human health during male sexual differentiation posed 
by inhibiting prostaglandins. Pregnant women who took analgesics such as paracetamol 
(inhibits the COX enzyme) towards the end of the first trimester, and early in the second 
trimester, which is considered to be the time-period of human sexual differentiation, were 
observed to have corresponding increased risk of testicular maldescent (cryptorchidism) in 
their male offspring (Kugathas et al., 2015). 
 
Figure 7.1 The action of cyclooxygenase (COX) on arachidonic acid in the formation of prostaglandins 
(modified from Moran et al., 2014).  
Many pharmaceuticals used to manage pain (for example aspirin, paracetamol and 
ibuprofen) act by blocking the production of some eicosanoids (Moran et al., 2014).  This 




Acetylsalicylic acid (active ingredient of aspirin) irreversibly inhibits COX activity, 
consequently aspirin stops the formation of a number of eicosanoids (Moran et al., 2014).  
There are two forms of COX; COX-1 is a constitutive enzyme that is responsible for 
production of eicosanoids that regulate the secretion of mucin in the stomach. COX-2 is an 
inducible enzyme that is responsible for the production of eicosanoids that act on 
inflammation, pain, and fever, Figure 7.2 (Moran et al., 2014). Aspirin inhibits both COX-1 
and COX-2, which leads to subsequent side effects such as stomach irritation (Moran et al., 
2014). 
 
Figure 7.2 The pathways of COX-1 and -2 in the synthesis of prostaglandins. PG: Prostaglandin (Figure 
modified from (modified Balasubramaniam, 2001). 
7.3.6 Alteration to COX and pigmentation 
As already discussed, the expression of COX-2 is inducible in cells by factors that stimulate 
inflammation, such as cytokines, growth factors, hypoxia and UV light. COX-2 expression is 
up-regulated in the skin following exposure to UV radiation, and this causes the increased 
production of prostaglandin E2 (PGE2) (Kim et al., 2012). It is reported that melanocytes 
have the capacity to produce PGE2 and express COX-2 mRNA (Gledhill et al., 2010; Kim et 
al., 2012). It is also reported that PGE2 produced from melanocytes following exposure to 
UV radiation can stimulate the release of cAMP and tyrosinase activity (Kim et al., 2012; 
Starner et al., 2010). The NSAID acetylsalicyclic acid (aspirin), which is well known for its 
abilities to inhibit both COX-1 and COX-2, has been reported to also inhibit the expression of 




found to inhibit the synthesis of melanin to a greater extent than arbutin and kojic acid, which 
are known tyrosinase inhibitors (Sato et al., 2008). A study was undertaken to assess the 
role of COX-2 in melanogenesis, thus a cell line was used with COX-2 knock-down to test 
the mechanism. The cell lines used in the study were melan-a, (which is a mouse 
melanocyte cell line) and hermes-1, which is an immortalised melanocyte cell line. To test 
the effects of COX-2 knock-down on the melanogenesis pathway, the expression levels of 
MITF, tyrosinase, TRP-1, TRP-2 and gp100 protein were measured. It was found that in the 
cells the decreased level of COX-2 was associated with a marked decrease in the 
expression of MITF, tyrosinase, TRP-1, TRP-2, and gp-100. These results occurred in both 
the mouse and human cell lines. The activity of tyrosinase was also reduced in melan-a cells 
transfected with COX-2 siRNA. The authors of that study considered that the results of their 
study indicated that COX-2 inhibitors could be developed as skin lightening treatments to 
reduce the amount of melanin pigment (J. Y. Kim et al., 2012).  
The anti-fungal agent clotrimazole has also been reported to alter melanogenesis. It was 
found to reduce melanin content in human and mouse melanocytes, and B16F10 mouse 
melanoma cells. It was reported that tyrosinase protein levels were reduced, but without 
changing the expression of tyrosinase mRNA expression. Clotrimazole is an azole 
antimycotic agent; this group of chemicals are known to have anti-inflammatory and 
anti-cancer effects. These effects are reported to be mediated via action on the COX-2-
PGE2 pathway (Chen et al., 2011). 
It has been reported that in mice, PGE2 applied to their skin caused an increase in the 
density of melanocytes (Nordlund et al., 1986). Kim et al. (2012), reported on studies which 
had been carried out to investigate the use of prostaglandin treatment for hypopigmentation 
disorders, and it has been observed to show positive results (Kim et al., 2012). 
7.3.7 COX Inhibitors 
The NSAID aspirin was observed to share structural similarities to certain phthalates, and, 
when tested, these phenolic compounds (phthalates, benzophenones, parabens and 
alklyphenols) along with paracetamol, aspirin, ibuprofen and indomethacin, all inhibited the 
synthesis of PGD2 and PGE2 in a mouse Sertoli cell line model (SC5 cells), human mast 
cells, and in ex vivo isolated rat testes. In addition it was determined that the COX enzyme 
inhibition was the likely mode of action (Kristensen et al., 2011).  
Kugathas et al. (2015) investigated twenty-four pesticides to determine whether they could 
inhibit prostaglandin synthesis. Fifteen of the pesticides (boscalid, chlorpropharm, 




methiocarp, o-phenylphenol (OPP), pirimiphos-methyl, pyrimethanil and tebuconazole) were 
observed to inhibit PGD2 synthesis in the SC5 assay, in a dose-dependent manner. OPP 
was observed to be the most potent pesticide tested, with an IC50 of 175 nM, compared to 
that of ibuprofen of 128 nM. OPP, cypermethrin, cyprodini, linuron, tebuconazole and 
imazalil had IC50s ranging from 175 to 2300 nM, and this range was comparable to the 
known COX inhibitors of ibuprofen with a IC50 of 128 nM and aspirin with a IC50 of 5380 nM 
(Kugathas et al., 2015). 
 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) 
Over recent years there has been growing interest into the presence of pharmaceuticals in 
the environment, and the potential risks they pose to wildlife: NSAIDs have been included in 
this research. One reason the presence of NSAIDs in the environment has been studied is 
that they are widely used to relieve pain and inflammation. They are available via 
prescription, and some are widely available as over the counter medications.  
According to the British National Formulary (BNF) website in 2014 in the UK there were 10 
NSAIDs registered for prescription use (salicylic acid listed below as number eleven is a 
breakdown product of aspirin). These are as follows: 
1. Diclofenac potassium 









11. Salicylic acid 
The concentrations of some of these NSAIDs in influent, effluent, drinking water, and in 





Table 7.1 Environmentally relevant concentrations of NSAIDs in the literature 
NSIADs Concentration(s) 
reported to be 
present in STW 
influent (ng/l) 
Concentration(s) 
reported to be 
present in STW 
effluent (ng/l) 
Concentration(s) 





reported to be 




















































































































































































































































































































b. Bonnybrook WWTP effluent in Calgary, Canada in 2003, not detected there in 2002 (Mei et al., 2006). 
c. Fish Creek WWTP effluent in Calgary, Canada in 2003 (Mei et al., 2006). 
d. Bonnybrook WWTP effluent in Calgary, Canada in 2002 & 2003 (Mei et al., 2006). 
e. Surface water concentrations, downstream Bow River in 2003 (Mei et al., 2006). 
f.  Surface water concentrations, upstream Bow River in 2003 (Mei et al., 2006). 
g. Surface water concentrations, upstream Elbow River in 2004, not detected in 2003 (Mei et al., 2006). 
h. Taken from different sampling points of the rivers of Madrid downstream from the man STPs (Valcárcel 
et al., 2011). 
i. Concentrations in finished drinking water in Germany (Jones et al., 2005, referenced in Watts et al., 
2007). 
j. Median measured concentration (maximum in brackets) of pharmaceuticals in the UK aquatic 
environment (Ashton et al., 2004 and Roberts & Thomas, 2006 referenced by Watts et al., 2007). 
k. Concentrations measured in a sampling exercise at wastewater plants in Cyprus (Fatta-Kassinos et al., 
2011). 
l. Maximum measured Rhine River water concentrations in the Netherlands 2009 (van den Brandhof & 
Montforts, 2010). 
m. Maximum measured sewage treatment plant concentrations in 1999 in the Netherlands (van den 
Brandhof & Montforts, 2010). 
n. Maximum measured surface water concentrations in 1999 in the Netherlands (van den Brandhof & 
Montforts, 2010). 
o. Maximum measured surface water concentrations between 2005-2006 in the Netherlands (van den 
Brandhof & Montforts, 2010). 
p. Maximum measured drinking water concentration between 2005-2006 in the Netherlands (van den 
Brandhof & Montforts, 2010). 
q. Median measured concentration (maximum in brackets) of pharmaceuticals in the UK aquatic 
environment (Bound & Voulvoulis, 2006 referenced by Watts et al., 2007). 
 
As well as concentrations of NSAIDs present in the environment where the data were 
gathered from the wider literature, some NSAIDs were measured in the sampling campaign 
run by Thames Water Ltd in the water of the IPR plant. This sampling started in 2008 and 






Table 7.2 Concentrations (ng/l) of NSAIDs detected at IPR plant at stages where the POCIS samplers were 













Min-Max 0-1492 0-1580 0-12 nd 
Average 316.22 295.17 1.39 nd 
Standard 
Deviation 
432.76 530.23 3.28 
nd 
Ibuprofen 
Min-Max 0-1532.10 0-338 0-58 10.4* 
Average 910.69 65.36 7.16 10.4* 
Standard 
Deviation 
3494.69 110.76 17.64 
N/A 
Mefenamic acid 
Min-Max 0-456 0-553 0-11 nd 
Average 103.73 98.71 2.23 nd 
Standard 
Deviation 
138-78 178.62 3.96 
nd 
Aspirin 
Min-Max 0.1-10 0-48 10-348 ns 
Average 7.53 9.14 60.2 ns 
Standard 
Deviation 
4.48 18.14 106.82 
ns 
Salicylic acid 
Min-Max 0-252 13-104.67 10-20 ns 
Average 71.53 61.68 11.25 ns 
Standard 
Deviation 
88.27 37.72 3.54 
ns 
Paracetamol 
Min-Max 0-2375.50 0-2.26 0-11 nd 
Average 135.75 0.17 2 nd 
Standard 
Deviation 
559.03 0.63 4.06 
nd 
nd: Not detected; ns: not sampled; *The aquarium water was sampled in August 2013, but the pharmaceutical 
screen was only undertaken once, therefore there is not minimum and maximum or standard deviation and the 
average in not a true average. 
Given the possible ability of NSAIDs to affect melanogenesis (via possible interference of 
arachidonic acid metabolism, tyrosinase and the synthesis of prostaglandins), it was decided 
to test the hypothesis that NSAIDs present in the IPR water were responsible for the 
changes in pigmentation observed in the developmental exposures and microarrays. 
Therefore, the ability of water extracts to inhibit COX activity was assessed in vitro, and a 
number of NSAIDs were tested for their ability to disrupt pigmentation in developmental 






The cell line used in this assay was SC5 mouse juvenile Sertoli cells (Hofmann et al., 1992). 
These cells produce a high amount of prostaglandins without prior stimulation (Kristensen et 
al., 2011). Prostaglandin synthesis is dependent on the COX enzyme (Ricciotti & FitzGerald, 
2011), therefore measuring the levels of prostaglandin production can indicate whether the 
COX enzyme is being inhibited.  
Once the SC5 cells had been exposed to the NSAIDs or POCIS extract, PGD2 synthesis 
was determined, using a Prostaglandin D2-MOX enzyme immunoassay (EIA) (Cayman 
Chemicals). In some experiments using the same assay, Kristensen et al. (2011) also 
measured PGE2 synthesis and stimulated the exposed cells with arachidonic acid. This 
allowed them to more confidently determine whether any observed inhibition of 
prostaglandin synthesis occurred upstream of both PGD2 and PGE2 synthases, and was 
likely due to the inhibition of COX-1 and COX-2 enzymes. Following exposures to certain 
chemicals, Kristensen et al. (2011) recorded inhibition of prostaglandin in the EIAs, but 
further studies to investigate the expression of COX genes found that their expression was 
unaffected, indicating that COX gene expression was not associated with the prostaglandin 
inhibition. The authors concluded that their result indicated that the compounds they tested 
directly affected the activity of the COX enzymes, which is the same mode of action as 
ibuprofen, aspirin and paracetamol (Kristensen et al., 2011).  
The detailed methodology is described in the General Material and Methods chapter. 
However, here the dilutions of the NSAIDs and extracts will be explained. On each EIA, a 
standard positive control had to be tested, to ensure that the assay was functioning correctly. 
For this, ibuprofen was used for the first few EIAs, but other NSAIDs known to present in the 
environment and effluents were also tested alongside the extracts: these included aspirin, 
salicylic acid, naproxen, paracetamol, diclofenac and mefenamic acid. From these EIAs with 
these NSAIDs, IC50s (the concentration of the compound needed to cause 50% inhibition of 
the production of prostaglandin in the assay) were derived. For the NSAIDs tested, they 
were initially tested at 8 dilutions and as each assay with the compound was repeated three 






Running the extracts in the assay began with aliquots of 1 ml POCIS extracts derived from 
each of the three replicate discs, and from the eight separate deployments. A pooled sample 
was made of the extracts by combining the extracts from deployments 1 to 8 for each of the 
treatments and POCIS blanks. This resulted in a pooled sample for all POCIS extracts, from 
the POCIS blank, post-reverse osmosis, post-microfiltration and post-final effluent (post 
pre-filtration). Of these pooled samples, eight dilutions were made, 1:200 to 1:125600. The 
SC5 cells were exposed to these extracts and the EIA completed to determine the amount of 
prostaglandin synthesised from the SC5 cells. From these results (see Figure 7.3), four 
dilutions were chosen for more extensive exposures; these were 1:800 to 1:6400, although 
extracts from post-reverse osmosis and POCIS blanks were only carried at one dilution 
(1:200). A further pooled extract was made using the three replicate discs from each 
separate treatment at each separate deployment, in order to investigate the potential for any 
seasonal variation in the biological activity. 
Following the in vitro bioassays of IPR treatment water extracts, developing zebrafish 
embryos were exposed to three NSAIDs (diclofenac, naproxen and mefenamic acid) and 
three tyrosinase inhibitors (4-butylresorinol, nicinamide and kojic acid). These exposures 
took place over a 72 hours period, starting shortly after fertilisation. Environmentally relevant 
concentrations were chosen for the NSAIDs and concentrations below which were 
considered toxic were chosen for the tyrosinase inhibitors (Table 7.3 and Table 7.4). The 
detailed methodology is explained in the General Materials and Methods Chapter. 
Table 7.3 Concentrations of NSAIDs used in the zebrafish developmental exposures  
NSAIDs (ng/l) 
Diclofenac sodium Mefenamic acid Naproxen 
30 000 3000 12500 
3000 300 5000 
300 30 500 
30 3 50 






Table 7.4 The concentrations of tyrosinase inhibitors used in the zebrafish developmental exposures 
Final concentration of tyrosinase inhibitors 
4-n-Butylresorinol 
(µg/l) 
Kojic acid (µg/l) 
Niacinamide 
(mg/l) 
10 5 10 
100 50 100 
1000 500 1000 
 
7.5 Results 
Figure 7.3 shows the amount of prostaglandin synthesised by the SC5 cells expressed as a 
percentage of that of the ethanol control (the ethanol control was 20% ethanol v/v), following 
exposure to the pooled extracts from the POCIS discs deployed at the IPR treatment plant 
post-reverse osmosis, post-microfiltration, and post-final effluent (post pre-filtration). In 
Figure 7.3 it can be observed that the extracts of water following reverse osmosis had little 
effect on the prostaglandin synthesis in the SC5 cells at any dilution tested (levels of 
prostaglandin was >80% in all dilutions). However, the extracts of water following 
microfiltration and in the final effluent (i.e. prior to microfiltration) exhibited a clear 
dose-response, with the most concentrated samples (1:200) causing the levels of 
prostaglandin to be only approximately 10% of that of the solvent control. Additionally, the 
activity in these two product waters appeared very similar. The dilutions of 1:800, 1:1600, 
1:3200 and 1:3200 were chosen to run in further assays, and these results are displayed in 





Figure 7.3 The inhibition of synthesis of prostaglandin in the SC5 cell line (%) using the extracts pooled 
according to replicate and deployment, separated by treatment. POCIS blanks did not inhibit 
prostaglandin synthesis. RO: post-reverse osmosis; MF: post-microfiltration, and FE: post-final effluent 
(post-preflitration). 
Figure 7.4 shows the amount of prostaglandin synthesised by the SC5 cells (expressed as a 
percentage of the ethanol control), following exposure to extracts from the POCIS discs 
deployed in treated product water following microfiltration from the eight separate 
deployments. There was a clear dose-response, but the different deployments made little 
difference to the overall potency except on one occasion (MF7). This was also true for the 
extracts from the POCIS discs deployed in the final effluent product water (Figure 7.5), 
where COX-inhibitory activity was observed in all cases, with the exception of 
FE1.Comparing data in Figure 7.3, Figure 7.4 and Figure 7.5, there was a slight difference in 
the relationship in the extracts from microfiltration and final effluent, for example FE7 had a 
high activity, whereas MF7 did not. 









































Figure 7.4 The inhibition of synthesis of prostaglandin in the SC5 cell line (%) using the extracts which 
were pooled from the three replicate POCIS discs from post-microfiltration (MF) taken from the eight 
different deployments. MF1=Aug-Sept 2011; MF2= Sept-Oct 2011; MF3= Oct-Nov 2011; MF4= Nov-Dec 
2011; MF5= Dec 2011-Jan2012; MF6= Jan-Feb 2012; MF7= Feb 2012; and MF8= Feb-Mar 2012. 
 
Figure 7.5 The inhibition of synthesis of prostaglandin in the SC5 cell line (%) using the extracts which 
were pooled from the three replicate POCIS discs from post-final effluent and post pre-filtration (FE) 
taken from the eight different deployments. FE1=Aug-Sept 2011; FE2= Sept-Oct 2011; FE3= Oct-Nov 
2011; FE4= Nov-Dec 2011; FE5= Dec 2011-Jan2012; FE6= Jan-Feb 2012; FE7= Feb 2012; and FE8= Feb-
Mar 2012. 















































































In addition to the POCIS extracts, a number of NSAIDs were put through the assay to 
assess their relative potency and ability to inhibit COX activity (Figure 7.6). From this figure 
the variation in potencies can be observed. This is further evident in the IC50 derived and 
displayed in Table 7.5. 
 
Figure 7.6 The inhibition of synthesis of prostaglandin in the SC5 cell line (%) using the different 
dilutions of the NSAIDs. 
The IC50s in  Table 7.5 demonstrate that diclofenac is the most potent NSAID, with an IC50 
of 3.451 x10-8 M (10.19 µg/l) and the least potent is salicylic acid with an IC50 of 1.863 x10-5 
M (2573.18 µg/). 
Table 7.5 IC50s of the NSAIDs based on the data presented in Figure 7.6 
NSAID IC50 (M) IC50 (µg/l) 
Diclofenac sodium 3.451e-008 10.19 
Mefenamic acid 8.472e-008 20.44 
Ibuprofen 3.571e-007 73.66 
Naproxen 6.606e-007 152.11 
Aspirin 3.055e-006 550.39 
Paracetamol 6.241e-006 943.42 
Salicylic acid 1.863e-005 2573.18 
 
  





































Table 7.6 IC50 values of a selection of chemicals tested for prostaglandin inhibition using the SC5 cell 
line. The chemical data supplied by Thames Water Ltd. for the product waters at the IPR treatment plant 
have been compared to IC50 data generated from this study and by other research to determine if any of 
the chemicals detected at the IPR plant are likely to be present at biologically active concentrations. 
Test compound Category IC50 (nM) 
Concentration 
in FE (ng/l) 
Concentration 































Mefenamic acid NSAID 84.72
c 
103.73 98.71 
Salicylic acid NSAID 18630
c 
71.53 61.68 
Diethyl phthalate Phthalate 19000
a 
<LoD nd 
Di-n-propyl phthalate Phthalate 2100
a 
ns ns 
Di-n-butyl phthalate Phthalate 2110
a 
<LoD nd 
Diisobutyl phthalate Phthalate 1010
a 
2000 nd 
Butylbenzyl phthalate Phthalate 24500
a 
<LoD nd 
Di-n-pentyl phthalate Phthalate 149000
a 
ns ns 
























Benzophenone 3 Benzophenones 197
a 
ns ns 
Benzophenone 7 Benzophenones 1200
a
 ns ns 
Benzophenone 4 Benzophenones 45600
a 
ns ns 
Benzophenone 12 Benzophenones 69400
a 
ns ns 




Diethylstilbestrol Estrogenic compound 27200
a 
ns ns 
Zearalenol Estrogenic compound 3180
a 
ns ns 
Genistein Estrogenic compound 428000
a 
ns ns 
Bisphenol A Estrogenic compound 2720
a 
12.8 (10-21) nd 






















































a: Kristensen et al., 2011; b: Kugathas et al., 2015; c: results from this current study; ns: not sampled; nd: not 
detected; <LoD: below limit of detection. In the aquarium water, all the pesticides sampled were below limit of 
detection apart from AMPA and metaldehyde, which are not listed in the table. Estradiol (E2) was below the limit 
of detection (0.03 ng/l), none of the other compounds were sampled. 
Table 7.7 IC50s of compounds measured in the final effluent and/or microfiltration product waters relative 
to actual measured concentrations. 
Test compound IC50 (µg/l) Concentration in FE 
(µg/l) 




0.32 (0-1.49) 0.3 (0-1.58) 
Mefenamic acid 20.44
c 
0.1 (0-0.46) 0.099 (0-0.55) 
Ibuprofen 73.66
c 
0.91 (0-15.33) 0.065 (0-0.34) 
Aspirin 550.39
c 
0.0075 (0.0001-0.01) 0.0091 (0-0.048) 
Paracetamol 943.42
c 
0.136 (0-2.38) 0.00017 (0-0.0023) 
Salicylic acid 2573.18
c 












0.013 (0.01-0.021) nd 
Chlorpropham 286.30
b 
0.0096 (0.005-0.025) 0.011 (0.005-0.028) 
Linuron 371.15
b 
0.034 (0.004-0.085) <LoD 
a: Kristensen et al., 2011; b: Kugathas et al., 2015; c: results from this current study; nd: not detected; <LoD: 
below limit of detection 
  
7.5.1 Analytical chemistry of the POCIS extracts 
As described in the General Materials and Methods chapter, pooled POCIS extracts were 
sent to CEFAS laboratories for analysis on the presence of certain pharmaceuticals. Table 





Table 7.8 The concentrations of pharmaceuticals detected in the concentrated 1 ml pooled POCIS disc 
extracts (ng/l) 
Pharmaceutical  
Concentration of pharmaceutical in the extracts from the POCIS 
discs (ng/ml of extract) 
Post FE Post MF Post RO POCIS blank  
Ibuprofen nd nd nd nd 
Diclofenac 4540 3550 nd nd 
Paracetamol nd nd nd nd 
Erythromycin 289 54 nd nd 
Sulfamethoxazole nd 164 nd nd 
Acetyl-sulfamethoxazole nd 33 nd nd 
Trimethoprim 1750 1270 12 nd 
Propanonol 817 687 nd nd 
Clofibric acid nd nd nd nd 
Mefenamic acid 879 682 nd nd 
Dextroproxpoxyphene 119 80 nd nd 
Tamoxifen nd nd nd nd 
Clotrimazole 36 20 <LOQ nd 
nd: not detected; LOQ: Limit of Quantitation 
The data in Table 7.6 can only be used as qualitative values, and it can only be determined 
that ibuprofen and paracetamol were not detected in any of the extracts tested, and that 
diclofenac and mefenamic acid were both detected in the extracts from the POCIS devices 
deployed in the product waters of the final effluent and microfiltration treatments. The 
NSAIDs were not detected in the extracts from the POCIS devices deployed in the product 
water from the reverse osmosis and the POCIS blank extract. To be able to estimate the 
water concentration from the POCIS concentrations, the specific uptake rate has to be 
known, and this has to be experimentally derived. An uptake rate for diclofenac was 
identified, 0.226 l/d (±0.009) (Morin et al., 2013). The equation needed is as follows: 
𝑊𝑎𝑡𝑒𝑟 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 =
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑎𝑛𝑎𝑙𝑦𝑡𝑒 𝑖𝑛 𝑃𝑂𝐶𝐼𝑆 𝑥 𝑀𝑎𝑠𝑠 𝑜𝑓 𝑃𝑂𝐶𝐼𝑆 𝑠𝑜𝑟𝑏𝑒𝑛𝑡
𝑆𝑎𝑚𝑝𝑙𝑖𝑛𝑔 𝑟𝑎𝑡𝑒 𝑥 𝑆𝑎𝑚𝑝𝑙𝑖𝑛𝑔 𝑑𝑢𝑟𝑎𝑡𝑖𝑜𝑛
            
 
The calculated water concentrations for diclofenac were 165 and 129 ng/l based on the 
measured concentration of the analytes in the extracts from the POCIS devices deployed in 
the final effluent and microfiltration product waters, respectively. 
A less accurate estimation can be made by considering the general water uptake of the 
POCIS devices, which were stated to be between 1400 and 8400 ml in a 28 week standard 




extract would be approximately 5000 times more concentrated than ambient water 
concentrations. However, this is an approximation, and does not take into consideration the 
individual chemical’s uptake rate, but it can provide a guide and tool in which to compare the 
chemistry data. This calculation was used and the results plotted on Figure 7.7. The results 
derived from the water sampling and POCIS extracts are very different. For example, the 
water sampling data determined ibuprofen to be the most prevalent NSAID in the product 
water from final effluent, but it is not measured in the POCIS extract. Paracetamol was 
absent in the POCIS extract, but was detectable in all product waters along the process in 
the water sampling, although at a low concentration. The pattern of removal of mefenamic 
acid is similar in both. Both methods indicate that the NSAIDs are being removed along the 







Figure 7.7 The graph to the left shows the concentration of various NSAIDs measured in the product waters following the relevant treatments (final effluent, 
microfiltration and reverse osmosis) taken from data provided by Thames Water Ltd, which had been collected between the years 2008 and 2012. The graph on the 
right was created from the chemical analysis data supplied by CEFAS when they examined the POCIS extracts in regarding the presence of a number of 
pharmaceuticals. For the purposes of this comparison only the relevant pharmaceuticals were used i.e. the NSAIDs. The results supplied by CEFAS are in ng/ml of 
extract, however to carry out a meaningful comparison, the results were divided by 5000, which was the predicted average concentration that resulted from the 
use of the POCIS and converted to ng/l. 




7.5.2 Additional zebrafish embryo exposures 
 NSAIDs 
Tables 7.7, 7.8 and 7.9 detail the number and type of abnormalities observed at 72 hours in 
the zebrafish embryos following exposure to the different NSAIDs. There was only one 
abnormality in the naproxen (Table 7.9) exposure at the highest dose (12500 ng/l). The 
exposure to diclofenac (Table 7.7) resulted in only three occurrences of abnormal zebrafish 
embryos, at the two highest doses (300 and 3000 ng/l) and the lowest (3 ng/l). These varied 
from a slight reduction in pigmentation, stunted growth and a bend in the tail. Mefenamic 
acid (Table 7.8) had a total of eight abnormal embryos in the exposed embryos and two in 
the controls. The abnormalities were varied in type. There were no abnormalities observed in 
any of the solvent controls. 
Table 7.9 Number and type of abnormalities observed in the zebrafish embryos exposed to diclofenac for 
72 hours (nominal concentrations are shown in ng/l) 
Diclofenac 
sodium (ng/l) 
Number of abnormalities at 72 hours 
Exposure 1 Exposure 2 Total 
30 000 0 0 0 
3000 0 1 (less pigment) 1 
300 1 (stunted growth) 0 1 
30 0 0 0 
3 1 (bend in the tail) 0 1 
Solvent control 0 0 0 
0 (control) 0 0 0 
 
Table 7.10 Number and type of abnormalities observed in the zebrafish embryos exposed to mefenamic 
acid for 72 hours (nominal concentrations are shown in ng/l) 
Mefenamic acid 
(ng/l) 
Number of abnormalities at 72 hours 
Exposure 1 Exposure 2 Total 
3000 
1 (stunted growth and curvature, 
redness of the heart, slight oedema) 
1 (cloudy) 
0 2 
300 1 (curvature) 1 (malformed no definition) 2 
30 1 (slow circulation) 0 1 
3 1 (malformed no definition) 0 1 
Solvent control 0 0 0 





Table 7.11 Number and type of abnormalities observed in the zebrafish embryos exposed to naproxen for 
72 hours (nominal concentrations are shown in ng/l) 
Naproxen (ng/l) 
Number of abnormalities at 72 hours 
Exposure 1 Exposure 2 Total 
12500 
0 1 (paler, thinner, oedema of the yolk 
sac and heart) 
1 
5000 0 0 0 
500 0 0 0 
50 0 0 0 
5 0 0 0 
Solvent control 0 0 0 
0 (control) 0 0 0 
 
 Tyrosinase inhibitors 
Table 7.10 details the number and types of abnormalities observed in the zebrafish embryos 
exposed to the different tyrosinase inhibitors. In the second exposure, all the control 
embryos died in the second replicate, and there seemed to be what appeared to be bacterial 
growth in all the exposures. Ideally this exposure would have been repeated, but major 
building/renovation work was due to start in our animal facility. There was one individual 
embryo in the controls that was observed to have a curvature to the spine. This abnormality 
was common throughout the chemical exposures. There were also a number of abnormal 
zebrafish embryos in the group exposed to 4-n-butylresorinol in all doses, these were mostly 
curvature of the spine. This was also true for the group exposed to kojic acid. However, 
there were no abnormal embryos in either the low dose (10 mg/l) or high dose (1000 mg/l) 





Table 7.12 Number and type of abnormalities observed in the zebrafish embryos exposed to tyrosinase 
inhibitors for 72 hours (nominal concentration of chemicals in g/l or mg/l) 
Treatment 
Dosage 
Number of abnormalities at 72 hours 
Exposure 1 Exposure 2 Total 




10 1 (curvature) 2 (curvature) 3 
100 
1 (curvature) 
1 (curvature, redness of the 
heart and stunted growth) 
1 (curvature) 3 






5 1 (curvature) 0 1 
50 
2 (curvature) 
1 (tail curved upwards) 
5 (curvature) 
1 (redness of the heart) 
9 
500 
1 (slight curve) 
2 (curvature) 
2 (curvature) 





10 0 0 0 
100 
3 (curvature) 
1 (stunted, twisted tail) 
3 (curvature) 
1 (redness of the heart) 
8 
1000 0 0 0 
 
7.6 Discussion 
The initial assays, using the pooled extracts from the POCIS discs deployed in the product 
waters from the final effluent, microfiltration, and reverse osmosis treatments, indicated that 
the product water from reverse osmosis treatment had little effect on the synthesis of 
prostaglandin in the SC5 cells, regardless of the dilution of the extract. However, the product 
waters from both the final effluent and microfiltration treatments indicated a significant 
inhibition of the synthesis of prostaglandin in the SC5 cells in a dose-dependent manner 
(Figure 7.3). This indicates that reverse osmosis was effective at removing the compounds 
that were responsible for inhibiting prostaglandin synthesis in the earlier two treatments. 
Further analysis was undertaken to determine if there were any differences in the activity of 
the extracts in this assay associated with the different deployments, i.e. the time of year. 
This was possible, as the POCIS samplers were deployed at the IPR plant in eight separate 
deployments from August 2011 until March 2012, with each deployment lasting 
approximately four weeks. There were three replicate discs from each POCIS at every 




dilutions for the final effluent and microfiltration treatments, but only one dilution (1:200) for 
reverse osmosis as little effects were observed in the initial assays. The results of these 
studies are shown in Figure 7.4 and Figure 7.5. In a similar manner to the initial assay, there 
was a clear dose dependence, and the synthesis of prostaglandin was inhibited in the more 
concentrated samples for product waters from both final effluent and microfiltration. There 
was also no clear pattern to suggest that the individual deployments (deployments 1 to 8, 
August 2011 to March 2012) affected the activity. The 1:200 dilutions of the extract from 
reverse osmosis (data not shown) were similar to the initial assay, and did not inhibit the 
synthesis of prostaglandin in the SC5 cells. This confirmed what was indicated in the initial 
assays, that the reverse osmosis treatment was removing the chemicals responsible for the 
COX-inhibitory activity. 
To further analyse the removal of activity observed following the treatment with reverse 
osmosis, the concentrations of known COX inhibitors were examined in both the product 
waters from the IPR plant and the concentrated POCIS extracts. 
Table 7.2 illustrates the range of concentrations of different NSAIDs detected in the three 
product waters of interest between 2008 and 2012. These values are displayed in Figure 7.7 
where a reduction in the average concentration of each chemicals can be clearly observed 
along the treatment. Based on analysis of processed water samples, microfiltration appears 
to remove a considerable amount of certain compounds of interest, but not others.  To 
illustrate, the average concentration of diclofenac in final effluent is recorded as 316.22 ng/l 
which only decreases to 295.17 ng/l in the microfiltration, providing a removal rate of 6.66%. 
This is similar for mefenamic acid, aspirin and salicylic acid, with calculated removal rates 
(based on the average concentration) from final effluent to microfiltration at 4.84%, -21.38% 
and 13.77%, respectively. However, for ibuprofen and paracetamol, the microfiltration was 
much more efficient, with calculated removal rates (based on the average concentration) of 
92.82 and 99.87%, respectively. It is noteworthy that the reported standard deviations and 
minimum and maximums concentrations for all the compounds examined show a large 
variation (Table 7.2). It is of note that results from Table 7.2 indicate that the concentration of 
aspirin has increased from post final effluent to post RO, this is considered unlikely as more 
aspirin would not be produced during the treatment process. The standard deviation of the 
reported concentration for aspirin at Post RO stage is large, 106.82 and the range of the 
measured concentration is large, 10 to 348 ng/l. Whereas in the post final effluent and post 
MF the standard deviations were 4.48 and 18.14, respectively and the reported 
concentrations ranged from 0.1 to 10 ng/l and 0 to 48 ng/l, respectively. These results 




The small differences in average concentrations of some of the NSAIDs detected 
(diclofenac, mefenamic acid, aspirin and salicylic acid) go some way to explain the similar 
biological activity observed in the prostaglandin synthesis assay, when the SC5 cells were 
exposed to POCIS extracts from the final effluent and microfiltration product waters. 
However, it should be noted that the efficient removal of ibuprofen and paracetamol by the 
microfiltration treatment should have reduced the biological activity of the POCIS extracts 
taken from the microfiltration product water. Moreover, the data from Thames Water Ltd 
indicated that reverse osmosis had a greater efficiency at removing these compounds than 
microfiltration (Table 7.2). The reverse osmosis treatment had removal efficiencies (based 
on average concentrations of chemicals found in the product water from microfiltration 
treatment) of 99.53, 89.05, 97.74 and 81.76% for diclofenac, ibuprofen, mefenamic acid and 
salicylic acid, respectively. This level of removal corresponds to the lack of inhibition 
observed by the extracts taken from the product water following the reverse osmosis 
treatment.  
The chemical data recorded in the extracts themselves were also examined (Table 7.6 and 
Figure 7.7). The data produced by CEFAS of chemicals in the extracts indicated that the 
NSAIDs undergo increased removal as the effluent progresses along the treatment process. 
Using the data from Table 7.6, it can be observed that no ibuprofen was detected in any of 
the three extracts, which was surprising, because it was the most prevalent in the water 
sample data supplied by Thames Water Ltd (Table 7.2). It is reported that environmental 
factors, including water flow, temperature, and the formation of biofilm on the surface of the 
membrane of the POCIS sampling device, can alter the uptake of the compounds (Alvarez, 
2010). Different chemicals have different uptake rates in the membrane, and also 
degradation could have occurred during storage and extraction. Paracetamol was also 
undetected in all three POCIS extracts of the product waters. Similarly, this was surprising 
as paracetamol was detected all three product waters in the water chemistry samples taken 
by Thames Water Ltd.  It is therefore likely that whatever affected the measurement of 
ibuprofen in the POCIS extracts affected the quantification of paracetamol in the same way.  
The ability to estimate the water concentration of chemicals by extrapolation from the 
concentration determined from the POCIS extracts is limited, because there is the 
requirement for an experimentally derived sampling rate (Rs) for each chemical of interest 
(Petty et al., 2004). It is reported that for chemicals without an Rs value, the result should 
only be reported as mass of chemical sampled per POCIS (ng/POCIS) (Alvarez, 2010). The 
results reported in Table 7.6 are reported as ng per 1 ml of extract. These results only 
provide a qualitative value, and can only be used to indicate presence or absence of the 




concentrations in the product waters from final effluent and microfiltration for this compound 
were calculated as 165 and 129 ng/l, respectively. These estimated values are within the 
range detected by Thames Water Ltd. (Table 7.2) of 0 to 1492 ng/l and 0 to 1580 ng/l 
detected in final effluent and microfiltration, respectively. Based on these estimated 
concentrations from the POCIS extracts, diclofenac underwent 21.82% removal following 
microfiltration. This removal rate is greater than what was reported from the water sample 
data; however microfiltration still indicates a limited ability to effectively remove the level of 
this compound. There were no NSAID compounds detected in the extract from the post 
reverse osmosis, or that of the POCIS blank. The lack of NSAIDs detected in the extracts 
corresponds to the limited biological activity observed to take place in the prostaglandin 
synthesis assay, when the SC5 cells were exposed to extracts taken from the POCIS discs 
deployed in the post reverse osmosis product water.  
As already discussed by other researchers, using the same prostaglandin synthesis assay in 
SC5 cells, have found that there are a number of other compounds, rather than just NSAIDs, 
that are observed to inhibit the synthesis of prostaglandin in the cell line. The IC50s of these 
have been compared to chemicals occurrence data collected by Thames Water Ltd. (Table 
7.6 and Table 7.7). Unfortunately, not all the chemicals that had IC50s derived for them were 
sampled at the IPR plant. However, Table 7.7 compares the chemicals that possess IC50s 





The comparisons made in Table 7.7 indicate that the IC50s for diclofenac, mefenamic acid 
and ibuprofen are approximately between 10 and 70 fold greater than the levels detected in 
the effluent, whereas the other chemicals listed the IC50s are hundreds of fold greater than 
the detected concentrations. Another chemical of interest was clotrimazole, a commonly 
used antifungal treatment. It belongs to a group of chemicals that have been reported to 
have anti-inflammatory properties mediated via the COX-2-PGE2 pathway. Additionally, 
when tested in melanocytes, it was found to reduce the production of melanin, via what was 
considered to be indirect action of the tyrosinase, as the gene expression was unaltered 
(Chung et al., 2015). Clotrimazole was found to be present in the POCIS extracts, and the 
water samples, with average concentrations (minimum to maximum (standard deviation)) of 
17.79 ng/l (0-120 ng/l (27.06)) and 5.23 ng/l (0-32 ng/l (9.56)) in the final effluent and 
microfiltration, respectively. Clotrimazole was also detected at 1.4 ng/l in the aquarium water, 
unfortunately there was only one sampling event. 
The biological assay indicated that the POCIS extracts from the devices deployed in both the 
product waters from the final effluent and microfiltration treatments inhibited the production 
of prostaglandin. Both the chemistry analysis carried out on the water samples, and the 
POCIS extracts, have shown that there are a number of chemicals present in these two 
product waters that are known to inhibit prostaglandins, and more specifically PGD2. 
However, the occurrence data available for the chemicals known to have these effects seem 
to show these to be present at concentrations lower than was observed in the activity in the 
assay, even though these were from concentrated extracts. There are many chemicals that 
were not sampled and potentially other chemicals present that have not been tested in this 
bioassay, but could elicit a response. It would be interesting to find out if the combination of 
these chemicals at low concentrations could cause the effects observed in the bioassay in 
the final effluent and microfiltration.  Considering that melanogenesis and prostaglandin 
synthesis can impact on one another, it would also be interesting to test a number of known 
tyrosinase inhibitors in the prostaglandin inhibition assay, to see if they also inhibit 
prostaglandin synthesis. 
The zebrafish embryo assay conducted with the NSAIDs did not demonstrate a consistent 
number of abnormalities. There was just one abnormality in the embryos exposed to 
naproxen (Table 7.9) and exposure to diclofenac had just 3 embryos exhibiting abnormalities 
(Table 7.7). The exposure to mefenamic acid (Table 7.8) produced an increased number of 
embryos with abnormalities, but there were two individuals with abnormalities in the controls. 
Therefore, the increased number of abnormalities could be associated with the conditions of 
the aquarium water for that exposure and/or the quality of the embryos. It would be 




different from that of the controls. Overall, in these exposures there was a smaller variety of 
abnormalities than the exposures to the IPR water, which could be due to the single 
chemical exposure. The number of abnormalities were too small to apply any meaningful 
statistics. 
The abnormalities observed in the zebrafish exposed to the tyrosinase inhibitors (Table 7.10) 
were more consistent in type. However, in the second replicate there was high mortality in 
the treatments and control, which was due to what looked like the appearance of bacterial 
growth, indicative of a problem with the water quality. However, in the controls there was 
only one individual with a curvature in the spine. This abnormality was common amongst the 
fish exposed to chemicals. Skeletal malformations are observed in instances of disruption to 
the retinol metabolism (Herrmann, 1995; Rolland, 2000). 
Main conclusions 
Both the extracts taken from microfiltration and final effluent inhibited the synthesis of 
prostaglandin in the SC5 cell line. However, this inhibition was removed by the reverse 
osmosis treatment.  
NSAIDs were detected in both the water samples and the POCIS extracts. However, it is 
considered that their concentrations would have needed to be greater than what is reported 
to be responsible for the activity detected in the assay. However, in the literature there have 
been other chemicals/environmental contaminants that exhibit the same inhibition of the 
prostaglandin synthesis in the same assay as the NSAIDs. Some of these were also 
detected in the water samples; therefore the activity could be attributable to a mixture of 
chemicals. 
The zebrafish embryos exposures using three NSAIDs did not indicate that the NSAIDs were 
responsible for the lack of pigmentation; however, it would be interesting to test a mixture of 
prostaglandin inhibitors in the same assay. 
Tyrosinase inhibitors also did not induce lack of pigmentation in the zebrafish embryos, but 
there did seem to be an increase in curvatures in the spine. Due to high mortality in one 














The main aim of the project was to assess whether biological activity was reduced in the 
product water from recycled water pilot plant at Deephams waste water treatment works. 
Chemical data from the plant was examined, zebrafish embryos were exposed to these 
waters, their development and gene expression were examined and in vitro tests were 
carried out on extracts taken from points along the process.  
Initially, the chemical data were examined, and it was clear from the data collected over the 
several years of the running of the IPR plant that chemicals included in the analysis were 
being reduced, if not completely removed as the treated water progressed along the 
treatment process. This was not surprising as treatment efficiency of the technologies in 
place have been studied. However, there was still some residual chemical contamination in 
the most thoroughly treated product water, and not every conceivable chemical was and 
could be tested for. This was the reasoning for using a biological assay. 
Zebrafish embryos are widely used in research and in toxicology. They have a number of 
benefits over the use of adult fish; namely it is deemed more ethically sound to use an 
embryos, and they are not considered a protected animal under the UK Home Office 
guidelines, until day 5 following fertilisation, and using a developing organism pin points 
them during this sensitive window.  
A number of developmental exposures were undertaken, in which zebrafish embryos were 
exposed to different product waters from the IPR plant. The exposure design was based on 
the OECD 236 guidelines (OECD, 2006), and therefore lasted for 48 hours (exposure 
starting shortly after fertilisation until 48 hours post fertilisation). In 2013 the OECD updated 
and finalised these guidelines, and recommended an exposure time of 96 hours (OECD, 
2013). However, the exposures had already been completed by this time.  
In the exposures involving measurement of gene expression, significant differences in 
survival were observed between the 48 hpf groups reared in final effluent, and those in the 
rest of the product waters from the treatment process. The survival in the final effluent was 
reduced, but not significantly from the control. However, there were no differences in survival 
between the different repeats of the experiments. One explanation for this was that the three 
repeats of exposures for the gene expression study were all carried out within one month, 
therefore the adult breeding fish would not be affected in any way by increasing age, and 
there would be limited seasonal impact on the product waters from the treatment works. The 
other two types of exposure were repeated over a much longer time period, which could 
have introduced a level of variation. The survival could also have been adversely impacted 
in the gene expression exposure because any dead embryos were not removed from the 




observed in the other exposures occurred within the first 12 hours, it is likely that, in the 48 
hpf group, the live embryos would be inhabiting the same water as the dead and 
decomposing embryos for approximately 36 hours. 
Hatching rates were a straightforward endpoint to measure, and they are reported to be 
correlate with twenty different endpoints, including abnormalities such as curvature in the 
spine, yolk sac size, and yolk sac oedema (Ducharme et al., 2013), and is, therefore, 
considered to be a useful indicator of toxicity. However, as was highlighted in this study, 
differences from exposure 1 in the 48 hour developmental exposure, and 3 and 4 (Figure 5.5 
and Figure 5.6), show that the hatching figures must be recorded at exactly the same time 
for all exposures and repeats, to ensure the data are comparable. The results suggested 
that embryos exposed to the control water had a lower hatching rate than the embryos 
exposed to the water from the IPR treatment and tap waters; there were fewer types of 
abnormalities observed in the embryos in the control group. Additionally, the product waters 
from the treatment plant were treated with chloramine, to prevent biofilm building up in the 
pipework, and the tap water was chlorinated. These obvious similarities between the tap 
water and product waters could have increased the hatching rate compared to the control. 
The heart rate data recorded did not indicate any differences in the heart rates associated 
with the treatments in which the zebrafish embryos were reared. However, heart rate was a 
difficult endpoint to record, and was very variable when the first measurements were 
recorded, although this improved with later exposures (Figure 5.7). Other authors had also 
reported the recording of the heart rates being labour intensive, and that the results were 
variable (Brannen et al., 2010). It is considered that recording heart rates would be only 
worthwhile if there is evidence to suggest that cardiovascular effects are a potential endpoint 
of the exposure media. 
A low frequency of abnormal embryos was recorded in both control waters and treatments. 
However, the nature of the abnormalities observed in the embryos reared in the IPR product 
waters were more variable than those observed in the embryos reared in control waters. 
Additionally, there were more abnormalities observed in the treatments that were classified 
as teratogenic abnormalities. Hypoxic conditions have been reported to cause increased 
abnormal development in zebrafish embryos (Shang & Wu, 2004). However, the data 
available for the oxygen content of the product waters (Table 3.4), did not indicate that the 
embryos in this current work would have been exposed to hypoxic conditions.  Therefore, it 
was considered more likely that the abnormalities were being caused by chemical 
contaminants and biological chance. Abnormalities included oedema of the yolk sac and 




embryo is reported following a number of chemical exposures to anilines and phenols 
(Schulte, 1997; cited in Nagel, 2002); p-tert-butylphenol (Maiwald, 1997 cited in Nagel, 
2002); all-trans-retinoic acid, hydroxyurea and urea (Brannen et al., 2010). 
Two other abnormalities, oedema of the yolk sac and/or heart, and heart malformations were 
observed. Other studies have found the cardiovascular and gross morphology endpoints in 
zebrafish embryo exposures correlated well with perocardial oedema (Ducharme et al., 
2013). Oedema is reported to have a knock-on effect to other adverse symptoms of the 
circulatory system and kidney funtion (Ducharme et al., 2013), but oedema has also been 
associated with disruption to metabolism of retinol  (Herrmann, 1995). Disruption to the 
retinol metabolism is also associated with bent tails and skeletal deformitiies (Herrmann, 
1995), which were observed in the following treatments, with the number of incidences of the 
abnormality recorded in brackets; control (1), Tap (3), final product (1), AOP2 (4), reverse 
osmosis (3) and microfiltration (3). However, it was difficult to associate the variety of 
abnormalities to any one specific chemical. This is because, very often, the exposure studies 
are conducted exposing one single chemical at a time, whereas in the project, the 
developing zebrafish embryos were being challenged with a large number of different 
chemicals, eventhough at low concentrations.  
Zebrafish embryos exposed to the product waters from the different treatments along the 
IPR process were used for microarrays. The total exposure was 48 hours, with pooled 
embryo samples being sampled at 8, 12, 16, 24, 36 and 48 hours post fertilisation. The 
microarrays consisted of the entire genome. The analysis to determine the gene 
differentiation indicated that the developmental stage had the strongest influence over the 
gene expression, but also that there were differences in expression between the different 
exposures, suggesting that there are large differences in the genes expressed due to the 
differing nature of the effluents; the breeding adults and laboratory conditions could also 
have a bearing.  
There were differences observed in the individual genes expressed, namely cytochrome 
P450 (cyp1a and cypb1) and somatolactin beta. The cytochrome P450 is part of 
detoxification process as well as being involved in other pathways, and this was no longer 
observed to be up-regulated in the treatment processes past and including reverse osmosis, 
indicating that reverse osmosis could be removing the contaminants responsible for the 
induction of these biotransformation genes. The picture with somatolactin beta was less 
clear; this gene was up-regulated in the embryos exposed to product waters from reverse 
osmosis, AOP2, final product, and tap water. Somatolactin beta is a fish-specific gene 




pigment melanin is synthesised. This was of particular interest due to the lack of 
pigmentation observed in some of the zebrafish embryos. 
Until relatively recently, the analysis of microarray data has only comprised of significance 
analysis of microarrays (SAMs) (Werner, 2008). This method simply compares lists of genes 
which were up- and down-regulated: from this data alone it is difficult to get any meaningful 
insight into the biological processes potentially being affected, and the potential outcome on 
the organism as a whole. This is because many genes (if not all) possess multiple functions, 
which are dependent on the context ( Falciani et al., 2008; Werner, 2008). It is also important 
to keep in mind, when assessing these gene lists, that not all alterations in mRNA levels are 
directly attributable to the experiment itself (Werner, 2008), since there are normal 
processes still taking place, and, for the purposes of this study, embryo development. Gene 
ontology can be used; this results in lists of genes being created, but within a meaningful 
context. The genes are then categorised based on the functional categories. Following on 
from gene ontology, data from the literature is accumulated and the specific pathways can 
be determined. Pathways focus on physical and functional interactions between the different 
individual genes, instead of focusing solely on the genes themselves (Werner, 2008). When 
looking at the pathways altered in the tissue of organism, or organism as a whole, the 
pathways can be related to toxic, stress, and adaptive responses (Falciani et al., 2008). 
However, it is not possible to examine all pathways with microarray data, as metabolic 
pathways are largely controlled by protein-based events, which are not detectable on the 
microarray. Additionally, kinase-based signalling cascades do not always involve alterations 
in the mRNA levels (Werner, 2008).  This could have been the case in both the 
prostaglandin synthesis, and melanogenesis processes. A step further on from investigating 
pathways is that of networks; commonly, biological processes involve more than one 
pathway. The pathways interconnect, and, as with the individual genes, act in a context-
specific way. This interconnection results in a network; for microarray data, this is mainly a 
regulatory network. However, unlike the pathways, where a computer programme can be 
used to link the genes to a specific pathway based on the data present in the literature, 
networks cannot be easily determined from the literature or pre-compiled pathways. This is 
because the structures within the networks are not fixed, and alter depending on the context. 
It is reported that regulatory networks also target and change (normally only a few genes for 
every pathway are involved), but do so across several pathways within the regulatory 
network (Werner, 2008). Werner (2008) stated that this explains why only a few genes 
normally get highlighted as being altered in a given pathway, and complete pathways will 
never be observed to be co-ordinately up-regulated or down-regulated at the same level as 




The differences in gene expression in the embryos exposed to product waters were greater 
the further the treatments were from one another. For example, there were larger differences 
between the genes expressed in microfiltration and final product water, than final product 
and AOP2 product waters (Error! Reference source not found. and Error! Reference 
source not found.). Treatment with reverse osmosis seemed to reduce the differences in 
gene expression, with microfiltration and reverse osmosis product waters having very 
different gene expression profiles, as did the two AOP treatments: AOP1 not having been 
processed by reverse osmosis, whereas the product water from AOP2 had been treated with 
reverse osmosis. 
The pathways altered along the treatment were steroid hormone biosynthesis, tryptophan 
metabolism, retinol metabolism, metabolism of xenobiotics by cytochrome P450, drug 
metabolisms-cytochrome P450 and drug metabolism-other enzymes. The cytochrome P40 
genes upregulated in the earlier stages of the treatment process (final effluent, microfiltration 
and AOP1) are active in some of these pathways, cyp1a is active in retinol metabolism, 
steroid hormone biosynthesis and drug metabolism, cyp1b1 is active in the steroid hormone 
biosynthesis and tryptophan metabolism. This demonstrates how, as earlier discussed, 
individual genes are active in multiple pathways. From the literature there seemed to be 
strong indications that the pathways were interconnected as well. Dioxin and dioxin-like 
compounds are reported to alter the metabolism of retinoids, by acting via the AhR, this is 
because retinol metabolism involves cytochrome P450. Induction of cytochrome P450 from 
chemical exposure can cause excessive metabolism of the retinol thus decreasing its levels 
in the plasma and liver stores (Rolland, 2000). Some of the retinoids are reported to be used 
for treatment of hyperpigmentation, and interestingly the tyrosinase inhibitors tested in the 
zebrafish embryo assay caused spinal curvatures (not in a dose-dependent manner and at a 
low frequency), which is an abnormality associated with retinol metabolism disruption during 
development. Lack of pigmentation was reported in zebrafish embryos  exposed to the 
retinoid, all-trans-retinoic acid (Brannen et al., 2010). 
As briefly mentioned above, there were some associations between the apical endpoints observed and 
observed and the genes and pathways observed to be altered. Comparisons were made between these 
between these and the chemicals detected in the product waters.  A group of chemicals known to be 
known to be present in the product waters were NSAIDs. Because it is known that COX-1 is synthesised 
synthesised in the skin cells and linked to melanogenesis, it was considered possible that the NSAIDs 
the NSAIDs present could be responsible for the lack of pigmentation in the embryos. It would have been 
would have been interesting to test the retinoid pathway, but there was no readily available in vitro assay 
in vitro assay to test these, and so the decision was taken to test the extracts from the treatment water in 




extracts taken from the final effluent and microfiltration treatments, but this inhibition was removed by 
reverse osmosis. It is surprising that there was not a larger difference between the activities of the 
extracts from the final effluent and microfiltration, as the chemistry data indicated that treatment with 
microfiltration had removed a production of the NSAIDs concentration. The question was then raised 
regarding other chemicals present in the extracts that could be responsible for the inhibition. Other 
authors had found a number of compounds that caused inhibition in the same assay (Kristensen et al., 
2011; Kugathas et al., 2015). Some of the chemicals were also present in the product waters, but all at 
significantly lower concentrations than the IC50 derived for the compounds. There is the possibility that 
possibility that these, and other unknown chemicals, could be present and have a mixture effect, working 
effect, working in combination. The RO removed the biological activity, in a similar way demonstrated by 
demonstrated by the genomic results. However, there were still a variety of abnormalities being observed 
being observed in the RO water (
 
Figure 5.9), therefore, indicating that chemical contaminants are still getting through the 
reverse osmosis treatment, which is evident from the chemical analysis data completed on 
the POCIS extracts Table 7.6 with the presence of trimethoprim still in the extract from the 
reverse osmosis. 
Real-time PCR was performed (results not shown) on a number of genes associated with 
melanogenesis and prostaglandin synthesis, but it is unlikely that the expression levels of 
these were altered, suggesting that the contaminants could have been acting directly on the 




Microarrays produce a simultaneous measure of the expression of thousands of genes 
expressed in tissues of organisms, or, in the case of this project, the organism as a whole. 
When these organisms have been taken from the environment, the gene expression profile 
is not just influenced by the toxicant of interest, but also by genetic make-up, age, diet, 
salinity, temperature, reproductive stage, etc. In addition to these factors that influence the 
gene expression profile, there is also inter-individual variability; these, combined, can cause 
vast variability in gene expression data, and drilling down into the alterations caused by the 
toxicant in question is difficult (Falciani et al., 2008). In the exposures carried out in this 
project, we used organisms at very similar ages, as they were collected soon after 
fertilisation. However, they were from different breeding groups, so there could be slight 
variations in the age, but the batches of eggs collected from the different breeding groups 
were mixed together before sorting and exposing to the different treatments. As a result, 
very slightly younger or older (by minutes) embryos would not be favoured in one specific 
exposure. The embryos were all from the same strain of zebrafish, TU, reducing, slightly, the 
variations in genetic make-up. The temperature during the exposures was kept constant. 
However, the product water from the treatment plant was from treated non-standardised 
effluent, therefore, introducing variability between experiments. This however, made the 
experimental design more environmentally relevant because the embryos were exposed to 
the effluent collected on different days, as if they were exposed in the environment. 
It has been reported that microarray technology, and the use of its data, is advancing, and, if 
a specific alteration to biological pathways in a tissue of an organism can be established, 
and those pathways can be associated with toxic, stress or adaptive responses, then 
expression profiles can be used as a diagnostic tool to determine exposure to certain 
classes of chemicals, and can allow class-prediction, when the samples have been classified 
to a pre-existing database (Falciani et al., 2008).  
When using the gene expression profiles as a potential diagnostic tool, it is also important to 
take into account that gene expression profiles will vary in relation to the dose of toxicant, 
length of exposure, and the time taken between exposure and sampling (Falciani et al., 
2008). This was evident from the data reported by this project; the gene expression was 
influenced by the experiment, suggesting that there could have been alterations in the 
composition of the effluent and water quality. Even if these differences were subtle, the gene 
expression profiles did differ. 
When assessing an exposure that consists of multiple chemical classes, measuring the 
expression of just one single biomarker or individual gene, cannot provide an integrated 




data gathered in this project, a multi-disciplinary approach allows a greater understanding of 
the potential effects of environmental pollutants, and specifically mixtures of environmental 
pollutants containing potentially un-identified compounds, as with the case of effluent. 
Falciani et al. (2008) stated that the use of molecular biomarkers in conjunction with current 
biomonitoring approaches (for example, histopathology) can complement the risk 
assessment, The molecular biomarkers provide valuable information on the mechanisms of 
toxicity and can also detect subtle changes that are associated with adaptive or 
compensatory responses to exposure of the toxicant, and then have the potential to be used 
as a future predictive tool of potential toxicity (Falciani et al., 2008). The alteration in the 
biotransformation pathways observed in the genomic analysis of the exposed embryos could 
be an indication of a compensatory response. 
 When this project was started, data had been collected on a number of chemicals, and 
there was an understanding on how efficiently they were being the concentration of 
removed, specifically by the IPR process, but little was understood regarding the biological 
activity. It was unclear what to expect, which is why the project was begun as 
non-hypothesis driven. The combination of chemistry data, developmental exposures and 
genomic analysis from the use of global gene expression was used to inform potential 
hypotheses. These were the melanogenesis pathway being disrupted by inhibition of the 
COX enzyme and also disruptions to the retinol metabolism pathway resulting in some of the 
skeletal and other developmental abnormalities observed. COX inhibition was taken forward 
as it was feasible to test for this mechanism of action.  
This project has highlighted the importance of combining chemical data with biological 
endpoints, including global gene expression, since chemical screens cannot sample for 
every conceivable chemical. The use of microarrays can direct attention to an endpoint that 
would have been missed by any other approach. 
8.2 Limitations 
The main limitations of this body of work were limited time to complete the initial testing 
before the closing of the IPR pilot plant, the survival rate of the embryos and variations in the 
physico-chemical properties between the IPR product waters and the control. 
Unfortunately, the survival of the embryos in the treatments and controls were below that 
which is considered valid by the OECD, which is >90% (OECD, 2013). The majority of the 
mortalities occurred within the first 12 hours (Figure 5.1): a number of techniques were tried 
to improve this but it was not possible in the time allowed. The IPR plant had been in 




2011, allowing less than a year to plan and complete the main exposure work. If this work 
were to be repeated, more techniques to improve the survival would be tried, for example 
using a variety of embryo mediums, and altering the temperature in the incubator, which was 
held at 28.5⁰C, whereas the OECD guidelines now state 26⁰C. It would also be useful to be 
able to measure the dissolved oxygen within the wells of the 24 well plates; the available 
oxygen probe was too large to measure within the wells themselves. However, the survival 
rate did not show any significant differences between treatments and control in the first two 
study types carried out (developmental exposures and extended exposures), indicating that 
the water from the treatment processes at the IPR plant did not adversely affect the survival 
compared to the controls. If survival was decreased in one experiment it was decreased 
within all treatment groups, indicating that there could have been varying quality of the 
gametes produced by the zebrafish (breeding groups were chosen at random and were not 
kept to same individuals in each breeding group).  
8.3 Recommendations for further work 
It is considered that background differences between the product waters and control were 
greater enough to have potentially masked some of the genetic alterations caused by the 
chemical exposure. Therefore, before embarking on similar work in the future it would be of 
great use to isolate a more appropriate control water. The appropriate control water would 
have the same physico-chemical properties as the product water being tested, i.e. pH, water 
hardness etc. Alterations could either be done to the product water, for example pH 
corrections and adding minerals or a cleaned up version of the product water could be used 
as the specific control. This would greatly increase the number exposures needed and 
therefore workload, i.e. having an individual control for every product water tested, but it 
could greatly increase the informative nature of the gene expression data and would remove 
background noise. 
Two groups of chemicals were highlighted as potentially causing some of the phenotypic 
differences in the zebrafish exposed to the product water from the IPR plant. These were 
NSAIDs and chemicals used in cosmetics marketed to reduce skin pigmentation. A number 
of these chemicals were tested to determine if development of pigmentation in the embryos 
could be altered. However, no changes in pigmentation following exposure to these 
chemicals were observed. Further testing at increased concentrations and even mixtures 
could be informative. Also, effect directed analysis (EDA) could be employed to determine 
what fraction of the effluent, and therefore the identity of the chemicals responsible for the 




Some of the abnormalities such as spinal curvatures, cardiac abnormalities and decreased 
pigmentation have been associated with disputations to retinoid pathway. Additional, the 
retinol metabolism pathway was shown to be disrupted in the embryos exposed to the IPR 
product waters. ,. Therefore, further investigation into the effects on the retinoid pathway, 
and specific retinoid disrupting chemicals would be of interest.  
While investigating the potential causes of lack of pigmentation in the zebrafish embryos, a 
great deal of information was gathered on certain chemicals used in the cosmetics industry 
used specifically to treat hyper-pigmentation or to reduce levels of pigmentation in the skin. 
Many of these chemicals act as tyrosinase inhibitors. Literature searches untaken at the time 
were unable to locate any data of the presence of these chemicals in the environment. As it 
seems apparent these chemicals are widely used, and have the potential to enter the 
environment following application to skin and showering and bathing, it would be of interest 
to determine if they pose a risk and if they are present in the environment. Zebrafish 
embryos could be used to repeat the exposure studies to determine if the abnormalities 
observed in the exposures are repeatable.  
Inhibition of prostaglandin synthesis was established to occur when SC5 cells were exposed 
to concentrated extracts taken from both post final effluent and post microfiltration. This 
inhibition was not observed in the extracts taken from post reverse osmosis. Therefore, it 
was concluded that chemicals causing inhibition of the production prostaglandins were 
present prior to treatment with reverse osmosis. QPCR was carried out on the embryos 
exposed at these treatment points and genes specific to prostaglandin were measured, 
however, an observable difference in the gene expression of this specific gene was not 
observed. Therefore, it was presumed that the inhibition was occurring directly at the protein 
level rather at the gene level, determining this would be of interest.  Additionally, it would be 
of interest to investigate the specific chemicals causing the inhibition of prostaglandin 
synthesis. This was highlighted as potential point of interest due to the NSAIDs being 
measured to be present, but at too lower concentrations to elicit the degree of inhibition 
observed. Suggesting, that other chemicals may have been present in the product waters 
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Pharmaceuticals and oestrogens detected in the aquarium water and tap water 
Component Name Units 
Aquarium Tap 













































































N/A 0 0 
N/A 








N/A 0 0 N/A 



































1.2 1.2 1.2 N/A 
Estrone (E1) ng/l 0.03 0.08 <0.03 0.047 0.03 0.08 0.029 0.18 <0.03 <0.03 0.08 0.03 0.18 0.087 
Estradiol (E2) ng/l <0.03 <0.03 <0.03 0.03 0.03 0.03 0 <0.03 <0.03 <0.03 0.03 0.03 0.03 0 
Ethynyl estradiol 
(EE2) 
ng/l 0.04 <.03 <0.03 0.033 0.03 0.04 0.0057 0.05 <0.03 <0.03 0.037 0.03 0.05 0.012 











1 2 3 mean min max Std dev 1 2 3 mean min max Std dev 
2 3 6-TBA µg/l <0.006 <0.006 <0.006 0.006 0.006 0.006 1.06 x10
-18
 <0.006 <0.006 <0.006 0.006 0.006 0.006 1.06 x10
-18
 
2 4 5-T µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
2 4-D µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 0.003 <0.002 0.0023 0.002 0.003 0.00058 
2 4-DB µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
Ametryne µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Atrazine µg/l <0.005 <0.005 <0.005 0.005 0.005 0.005 0 <0.005 <0.005 <0.005 0.005 0.005 0.005 0 
Bentazone µg/l <0.005 <0.005 <0.005 0.005 0.005 0.005 0 <0.005 <0.005 <0.005 0.005 0.005 0.005 0 
Bromoxynil µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Carbendazim µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Carbethmide µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 0.003 0.003 0.003 0.003 0.003 0.003 5.31 x10
-19
 
Chlortoluron µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
Clopyralid µg/l <0.009 <0.009 <0.009 0.009 0.009 0.009 0 <0.009 <0.009 <0.009 0.009 0.009 0.009 0 
Dicamba µg/l <0.007 <0.007 <0.007 0.007 0.007 0.007 0 <0.007 <0.007 <0.007 0.007 0.007 0.007 0 
Dichloprop µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Diuron µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
Fenoprop µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Flufenacet µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
Fluroxypyr µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
Ioxynil µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Isoproturon µg/l <0.004 <0.004 <0.004 0.004 0.004 0.004 0 <0.004 <0.004 <0.004 0.004 0.004 0.004 0 
Linuron µg/l <0.004 <0.004 <0.004 0.004 0.004 0.004 0 <0.004 <0.004 <0.004 0.004 0.004 0.004 0 
MCPA µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 




Mecoprop µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Metaldehyde µg/l 0.016 0.017 0.013 0.015 0.013 0.017 0.00201 0.025 0.015 0.012 0.017 0.012 0.025 0.0068 
Metazachlor µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Monuron µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19





µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Picloram µg/l <0.004 <0.004 <0.004 0.004 0.004 0.004 0 <0.004 <0.004 <0.004 0.004 0.004 0.004 0 
Prometryn µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Propazine µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Propyzamide µg/l <0.004 <0.004 <0.004 0.004 0.004 0.004 0 <0.004 <0.004 <0.004 0.004 0.004 0.004 0 
Quinmerac µg/l <0.004 <0.004 <0.004 0.004 0.004 0.004 0 <0.004 <0.004 <0.004 0.004 0.004 0.004 0 
Simazine µg/l <0.005 <0.005 <0.005 0.005 0.005 0.005 0 <0.005 <0.005 <0.005 0.005 0.005 0.005 0 
Tebuthiuron µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Terbutryn µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 








µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Aldrin µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Chlorothalonil µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Chlorpropham µg/l <0.005 <0.005 <0.005 0.005 0.005 0.005 0 <0.005 <0.005 <0.005 0.005 0.005 0.005 0 
DDE -op µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
DDE -pp µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
DDT -op µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 









Dieldrin µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Endosulfan A µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
Endosulfan B µg/l <0.004 <0.004 <0.004 0.004 0.004 0.004 0 <0.004 <0.004 <0.004 0.004 0.004 0.004 0 
Endrin µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
HCH -alpha µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
HCH -beta µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
HCH -delta µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
HCH -epsilon µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19





µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
Heptachlor µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Hexachlorobe
nzene 
µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Hexachlorobut
adiene 
µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 <.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19
 
Isodrin µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Methoxychlor µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Pendimethalin µg/l <0.01 <0.01 <0.01 0.01 0.01 0.01 0 <0.01 <0.01 <0.01 0.01 0.01 0.01 0 
Pentachlorobe
nzene 
µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Propachlor µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
TDE - op µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
TDE - pp µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Tecnazene µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Tri-allate µg/l <0.006 <0.006 <0.006 0.006 0.006 0.006 1.062x10
-18
 <.006 <0.006 <0.006 0.006 0.006 0.006 1.062x10
-18
 
Trifluralin µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
Vinclozolin µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 
cis-Chlordane µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
cis-Heptachlor 
epoxide 
µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19












µg/l <0.003 <0.003 <0.003 0.003 0.003 0.003 5.31 x10
-19










µg/l 0.23 <0.1 <0.1 0.14 0.1 0.23 0.076 0.22 <0.1 1.35 0.79 0.221 1.35 0.8 
Glyphosate µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17











1 2 3 mean min max Std dev 1 2 3 mean min max Std dev 
Benzo (A) 
Pyrene 
ng/l <1 <1 <1 1 1 1 0 <1 <1 <1 1 1 1 0 
Benzo(A)pyr
ene 
µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 0.001 <0.001 0.001 0.001 0.001 0 
Benzo(B)flu
oranthene 
µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 0.002 0.001 0.002 0.0017 0.001 0.002 0.00058 
Benzo(K)flu
oranthene 
µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Benzoghiper
ylene 
µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Fluoranthen
e 
µg/l <0.005 <0.005 <0.005 0.005 0.005 0.005 0 0.23 0.23 0.29 0.25 0.23 0.29 0.034 
Indeno1 2 3 
-cdpyrene 
µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 





0.0015 0.0010 0.0008 0.0015 0.000404 
PAH - Total 
of 4 in new 
Reg 200 
µg/l 0 0 0 0 0 0 0 0.002 0.001 0.002 0.0017 0.001 0.002 0.00058 












µg/l <0.01 <0.01 <0.01 0.01 0.01 0.01 0 <0.01 <0.01 <0.01 0.01 0.01 0.01 0 
PCB  008 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 020 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 028 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB  031 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 




PCB  052 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 077 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 101 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 105 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 118 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 126 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB128 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 138 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 149 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 153 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 156 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 169 µg/l <0.001 <0.001 <0.001 0.001 0.001 0.001 0 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
PCB 170 µg/l <0.002 <0.002 <0.002 0.002 0.002 0.002 0 <0.002 <0.002 <0.002 0.002 0.002 0.002 0 























































µg/l <0.02 <0.02 <0.02 0.02 0.02 0.02 0 <0.02 0.02 <0.02 0.02 0.02 0.02 0 
2-
Ethylphenol 






















































µg/l <0.02 <0.02 <0.02 0.02 0.02 0.02 0 <0.02 0.02 <0.02 0.02 0.02 0.02 0 






µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1.7 x10
-17






µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1.7 x10
-17






µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1.7 x10-
17






µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1.7 x10
-17






µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1.7 x10
-17








µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1.7 x10
-17





µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1.7 x10
-17










































































µg/l <0.5 <0.5 <0.5 0.5 0.5 0.5 0 <0.5 0.5 <0.5 0.5 0.5 0.5 0 
1,3,5- µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17
















µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17






µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7x10
-17






µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17









µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17









µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17









µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7x10
-17









µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7x10
-17
 <0.1 0.1 <0.1 0.1 0.1 0.1 1.7 x10
-17
 
Benzene µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17





µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 17 x10
-17








µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17










µg/l 0.16 0.124 <0.1 0.142 0.124 0.16 0.025 4.41 3.94 4.68 4.34 3.94 4.68 0.38 
Carbon 
Disulphide 
µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17








µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17





µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17















µg/l <0.5 <0.5 <0.5 0.5 0.5 0.5 0 <0.5 <0.5 <0.5 0.5 0.5 0.5 0 
Dibromomet
hane 
µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17







µg/l <0.5 <0.5 <0.5 0.5 0.5 0.5 0 <0.5 <0.5 <0.5 0.5 0.5 0.5 0 
Dimethylben
zene : Sum 
of isomers 
(1,3- 1,4-) : 
{m+p 
xylene} 
µg/l <0.2 <0.2 <0.2 0.2 0.2 0.2 3.4x10
-17




butyl ether :- 
{ETBE} 
µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1.7 x10
-17








µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1.7 x10-
17





µg/l <0.5 <0.5 <0.5 0.5 0.5 0.5 0 <0.5 <0.5 <0.5 0.5 0.5 0.5 0 
Hexachloroe
thane 
µg/l <0.5 <0.5 <0.5 0.5 0.5 0.5 0 <0.5 <0.5 <0.5 0.5 0.5 0.5 0 
Isopropylbe
nzene 
µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17






µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17
 <0.1 <0.1 <0.1 0.1 0.1 0.1 1.7 x10
-17
 









µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17






µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17







µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7x10
-17





µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17







µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17









µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7x10
-17







µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1.7 x10
-17













µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17








µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7x10
-17








µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17






µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17








µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 1. 7 x10
-17









µg/l <0.1 <0.1 <0.1 0.1 0.1 0.1 17x10
-17




















1 2 3 mean min max Std dev 1 2 3 mean min max Std dev 
Aluminium µg/l 20.1 15.7 20.7 18.83 15.7 20.7 2.73 47 35.3 36.2 39.5 35.3 47 6.51 
Antimony µg/l <0.5 <0.5 <0.5 0.5 0.5 0.5 0 <0.5 <0.5 <0.5 0.5 0.5 0.5 0 
Arsenic µg/l 0.9 1.1 0.9 0.97 0.9 1.1 0.12 0.8 0.7 0.8 0.77 0.7 0.8 0.058 
Barium µg/l 19 19 17.4 18.47 17.4 19 0.92 19.1 22.8 19.6 20.5 19.1 22.8 2.0075 
Boron µg/l 83 87 80 83.33 80 87 3.51 56 59 55 56.67 55 59 2.08 
Boron mg/l 0.083 0.087 0.08 0.083 0.08 0.087 0.0035 0.056 0.059 0.055 0.057 0.055 0.059 0.0021 
Bromate mg/l 0.001 0.001 0.001 0.001 0.001 0.001 0 0.002 0.002 0.002 0.002 0.002 0.002 0 
Bromate µg/l 1.2 1.3 1.2 1.23 1.2 1.3 0.058 1.5 1.6 1.8 1.6 1.5 1.8 0.15 
Bromide mg/l 0.11 0.11 0.11 0.11 0.11 0.11 0.0032 0.017 0.01 0.014 0.013 0.01 0.017 0.00404 
Cadmium µg/l <0.2 <0.2 <0.2 0.2 0.2 0.2 3.4 x10
-17





µg/l <0.2 <0.2 <0.2 0.2 0.2 0.2 3.4x10
-17
 <0.2 <0.2 <0.2 0.2 0.2 0.2 3.4 x10
-17
 
Calcium mg/l 115.1 112.2 101.9 109.73 101.9 115.1 6.94 113.4 115.9 116.5 115.27 113.4 116.5 1.64 
Chromium µg/l <1.2 2 <1.2 1.47 1.2 2 0.46 <1.2 <1.2 <1.2 1.2 1.2 1.2 0 
Chromium 
Dissolved 
µg/l <1.2 <1.2 1.2 1.2 1.2 1.2 0 <1.2 <1.2 <1.2 1.2 1.2 1.2 0 
Cobalt µg/l <0.7 <0.7 <0.7 0.7 0.7 0.7 1.36 x10
-16
 <0.7 <0.7 <0.7 0.7 0.7 0.7 1.36 x10
-16
 
Copper µg/l <10 <10 <10 10 10 10 0 13 17 18 16 13 18 2.65 
Fluoride µg/l 141 100 116 119 100 141 20.66 157 101 121 126.33 101 157 28.38 
Iron µg/l <1 <1 <1 1 1 1 0 7.7 8.1 11 8.93 7.7 11 1.8 
Iron Dissolved µg/l <1 <1 <1 1 1 1 0 <1 1.2 2.9 1.7 1 2.9 1.044 
Lead µg/l <0.3 <0.3 <0.3 0.3 0.3 0.3 0 <0.3 <0.3 <0.3 0.3 0.3 0.3 0 
Lithium mg/l 0.009 0.009 0.008 0.0087 0.008 0.009 0.00058 0.006 0.01 0.007 0.0077 0.006 0.01 0.0021 
Lithium µg/l 8.8 8.6 7.9 8.43 7.9 8.8 0.47 6.2 9.8 6.9 7.63 6.2 9.8 1.91 
Magnesium mg/l 4.2 4.1 3.7 4 3.7 4.2 0.27 4.1 4.1 3.9 4.033 3.9 4.1 0.12 
Magnesium 
Dissolved 




Manganese µg/l 0.7 0.9 <0.7 0.77 0.7 0.9 0.12 <0.7 5.8 1.2 2.57 0.7 5.8 2.81 
Manganese 
Dissolved 
µg/l <0.7 <0.7 <0.7 0.7 0.7 0.7 1.36 x10
-16
 <0.7 4.2 1.4 2.1 0.7 4.2 1.85 
Mercury µg/l 
 
<0.12 <0.12 0.12 0.12 0.12 0 
 
<0.12 <0.12 0.12 0.12 0.12 0 
Molybdenum µg/l <1.6 2.3 <1.6 1.83 1.6 2.3 0.404 <1.6 <1.6 <1.6 1.6 1.6 1.6 2.72 x10
-16
 
Nickel µg/l <1.6 8 <1.6 3.73 1.6 8 3.70 <1.6 5.4 2.6 3.2 1.6 5.4 1.97 
Potassium mg/l 6.6 6.3 5.7 6.2 5.7 6.6 0.46 6.3 6.5 6.3 6.37 6.3 6.5 0.12 
Selenium µg/l 0.8 1.1 0.9 0.93 0.8 1.1 0.15 1 1.3 1.2 1.17 1 1.3 0.15 
Sodium mg/l 41.5 40.3 36.5 39.43 36.5 41.5 2.61 39.9 40.7 39.2 39.93 39.2 40.7 0.75 
Strontium mg/l 0.36 0.35 0.31 0.34 0.31 0.36 0.025 0.34 0.36 0.35 0.35 0.34 0.36 0.0104 
Sulphide mg/l <0.01 <0.01 <0.01 0.01 0.01 0.01 0 <0.01 <0.02 <0.01 0.013 0.01 0.02 0.0058 
Sulphide µg/l <10 <10 <10 10 10 10 0 <10 <20 <10 13.33 10 20 5.77 
Total CN Low 
Level 
µg/l 1.4 <1 <1 1.13 1 1.4 0.23 1.4 <1 <1 1.13 1 1.4 0.23 
Vanadium µg/l <1.6 <1.6 <1.6 1.6 1.6 1.6 2.72 x10
-16
 <1.6 <1.6 <1.6 1.6 1.6 1.6 2.72 x10
-16
 










1 2 3 mean min max Std dev 1 2 3 mean min max Std dev 
Alkalinity as 
CaCO3 




mg/l 254 251 257 254 251 257 3 253 249 260 254 249 260 5.57 
Ammoniacal 
Nitrogen 
mg/l <0.02 <0.02 <0.02 0.02 0.02 0.02 0 <0.02 <0.02 <0.02 0.02 0.02 0.02 0 
Ammonium as 
NH4 
mg/l <0.03 <0.03 <0.03 0.03 0.03 0.03 0 <0.03 <0.03 <0.03 0.03 0.03 0.03 0 
BOD (5 Day 
using ATU) 
mg/l <1.9 <1.9 <1.9 1.9 1.9 1.9 2.72 x10
-16






mg/l 1.6 1.5 1.5 1.53 1.5 1.6 0.058 1.8 1.6 1.7 1.7 1.6 1.8 0.1 
Carbon Total 
Organic 
mg/l 1.5 1.4 1.6 1.5 1.4 1.6 0.1 1.8 1.6 1.7 1.7 1.6 1.8 0.1 
Chloride as Cl mg/l 59.01 58.35 59.23 58.86 58.35 59.23 0.46 58.22 57.63 59.73 58.53 57.63 59.73 1.08 
COD mg/l <10 11.1 11.3 10.8 10 11.3 0.7 <10 <10 12.3 10.77 10 12.3 1.33 









672 663 661 665.3 661 672 5.86 669 677 675 673.67 669 677 4.16 
Hardness 
Total as Ca 




mg/l 278 274 282 278 274 282 4 274 277 279 276.67 274 279 2.52 
Nitrate as N mg/l 5.1 5.1 5.3 5.17 5.1 5.3 0.12 5.6 6 6.1 5.9 5.6 6.1 0.27 
Nitrate as 
NO3 








Nitrite as N mg/l <0.001 0.004 <0.001 0.002 0.001 0.004 0.0017 <0.001 <0.001 <0.001 0.001 0.001 0.001 0 
Nitrite as NO2 mg/l <0.01 0.01 <0.01 0.01 0.01 0.01 0 <0.01 <0.01 <0.01 0.01 0.01 0.01 0 
Nitrogen Total 
Oxidised as N 
mg/l 5.1 5.1 5.3 5.167 5.1 5.3 0.12 5.6 6 6.1 5.9 5.6 6.1 0.27 
P  SOL 
Reactive 








mg/l 0.99 0.99 0.98 0.99 0.98 0.99 0.0079 1.001 1.029 0.99 1.005 0.99 1.029 0.022 
Phosphorus 
Total by ICP 








mg/l <1.9 <1.9 <1.9 1.9 1.9 1.9 2.72 x10
-16





mg/l 61.9 60.9 61.5 61.43 60.9 61.9 0.503 58.9 59.4 57.6 58.63 57.6 59.4 0.93 
Total Nitrogen 
as N 
mg/l 6.3 6.8 7.1 6.73 6.3 7.1 0.404 6.8 7.1 7 6.97 6.8 7.1 0.15 
Turbidity 
(FTU) 






Microbiological tests on the aquarium and tap water 





1 2 3 mean min max Std dev 1 2 3 mean min max Std dev 
22⁰C PC   neat no/ml >300 >300 46 215.33 46 300 146.65 1 0 0 0.33 0 1 0.58 
37⁰C PC   neat no/ml 26 12 0 12.67 0 26 13.01 0 0 0 0 0 0 0 
Cl.perf-Veg&Spores pres. 
neat 
no/100 ml 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Coliform neat MPN/100 ml 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
E.coli        neat MPN/100 ml 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Enteroccoci presumptive 
neat 
no/100 ml 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
PC: Plate Count 
MPN: Most Probable Number 
Radioactivity tests on the aquarium and tap water 
Component Name Units 
Aquarium Tap 
1 2 3 mean min max Std dev 1 2 3 mean min max Std dev 
Alpha Activity - 
Total 
Bq/l 0.04 <0.04 <0.04 0.04 0.04 0.04 0 <0.04 <0.04 <0.04 0.04 0.04 0.04 0 
Beta Activity - 
Total 
Bq/l 0.18 0.15 0.17 0.17 0.15 0.18 0.015 0.18 0.18 0.18 0.18 0.18 0.18 3.4 x10
-17
 
 
 
